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Abstract  
In this PhD research, different palladium-catalyzed syntheses of polycyclic nitrogen 
heterocycles starting from ortho-dihaloarenes were developed. First, convenient 
syntheses of pyrrole-fused derivatives via palladium-catalyzed domino C-C/C-N 
coupling of ortho-dihaloarenes with imines were accomplished. In another context of 
the study, the employment of ortho-dihaloarenes for palladium-catalyzed sequential 
regioselective Suzuki reaction with ortho-bromophenyl boronic acid/double C-N 
coupling with primary amines afforded corresponding indole-fused structures. Finally, 
protocols for the synthesis of previously unexplored phenanthridine-fused aromatic 
compounds were described, which feature a palladium-catalyzed regioselective 
Sonogashira reaction of ortho-dihaloarenes followed by domino or one-pot 
C-N coupling/hydroamination/C-H arylation. 
 
In dieser Promotionsarbeit wurden verschiedene palladium-katalysierte Synthesen von 
kondensierten Pyrrolen, Indolen und Phenanthridinen aus ortho-Dihaloarenen 
untersucht. Zuerst wurde eine praktische Synthese von kondensierten Pyrrolen durch 
palladium-katalysierte C-C/C-N Dominokupplungen erstellt. Außerdem wurden 
ortho-Dihaloarenen durch sequentielle regioselektive Suzuki Reaktion/zweifache C-N 
Kupplung zur Synthese von kondensierten Indolen eingesetzt. Des Weiteren wurden 
ortho-Dihaloarenen eingesetzt um kondensierte Phenanthridine durch regioselektive 
Sonogashira Reaktion und anschließende Domino-C-N Kupplung/Hydroaminierung/ 
C-H Arylierung zu synthetisieren. 
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1. General introduction 
Nitrogen heterocycles are undoubtedly involved in a plethora of important processes in 
living creatures on earth. For instance, the genetic codes DNAs are comprised of two 
base pairs cytosine/guanine and thymine/adenine, which incorporate heterocycles purine 
and pyrimidine (Figure 1).
[1]
 Moreover, heme, which is a porphyrin complex, has 
diverse biological functions in living organisms including electron transfer, 
transportation of diatomic gases and chemical analysis (Figure 1).
[2]
 Another porphyrin 
complex named chlorophyll is an extremely important biomolecule for the 
photocatalytic process in plants (Figure 1).
[3]
 
 
 
  
cytosine/guanine thymine/adenine purine pyrimidine 
 
  
porphyrin heme chlorophyll 
Figure 1: Examples of biologically important nitrogen heterocycles 
Owing to their immense importance, nitrogen heterocycles are center of research in 
many fields, in which a great number of nitrogen heterocycles were explored with 
important applications. In pharmaceutical research, biochemists have discovered and 
developed important drugs, for example emtricitabin being employed for the treatment 
of HIV (Figure 2).
[4]
 Furthermore, chemists have developed powerful catalysts for 
innovative reactions, for example NHC1 has been applied in C-C and C-N couplings 
with esters and amines (Figure 2).
[5]
 In material science, physicists have explored 
materials with enhanced physical properties, for instance CPB has been used in 
OLED-layers (Figure 2).
[6]
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emtricitabin NHC1 CBP 
Figure 2: Several relevant nitrogen compounds with applications 
In order to provide scientists in the field of pharmaceutical and material science with 
product libraries for their research, synthetic chemists were devoted since more than a 
century to develop convenient syntheses of nitrogen heterocycles. Examples for these 
are Hantzsch pyridine synthesis,
[7]
 Biginelli synthesis of 3,4-dihydropyrimidin-
2(1H)-ones,
[8]
 Paal-Knorr furan and pyrrole synthesis,
[9]
 Fischer indole synthesis
[10]
 and 
Friedländer quinoline synthesis,
[11]
 to name but a few. Nevertheless, given the sheer 
number and the enormous diversity of nitrogen heterocycles in nature and in research, 
even more powerful, modular and convenient syntheses still remain highly desired.  
 
Scheme 1: Transition metal catalyzed cross-coupling reaction 
Fortunately, the last four decades have witnessed a boom in the development of 
cross-coupling reactions catalyzed by transition metals. These catalysts possess great 
potential for furnishing new C-C, C-N and C-O bonds. As a result, a number of new 
reaction concepts have been realized. For example, in a Kumada reaction, a Grignard 
reagent couples with a haloarene in the presence of transition metal catalysts, forming 
corresponding C-C cross-coupling product (Scheme 1).
[12]
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Scheme 2: Several important transition metal-catalyzed cross-coupling reactions 
 
Consequently, their potential for creating new bonds has been extensively studied, 
ultimately leading to the establishment of a number of distinct chemical 
transformations. These reactions differ in coupling partners, and were named after their 
discoverers including Kumada, Negishi, Suzuki, Stille, Buchwald-Hartwig and 
Sonogashira (Scheme 2). For example, in a Suzuki cross-coupling reaction an 
organoborane is accomodated with an aryl halide as coupling partner, while a Stille 
cross-coupling reaction takes advantages of an organohalide and an organostanne.
[13]
  
Among the transition metal catalysts, the chemistry of palladium-catalyzed 
cross-coupling has witnessed a striking development, becoming broadly useful in 
organic synthesis.
[14]
 Using palladium-catalysts, a large number of structurally 
complicated compounds with biological and physical relevance have been synthesized 
(Scheme 3).
[15]
 Overall, palladium-catalyzed cross-coupling reactions have brought 
enormous enhancements and revolutionized the reaction concepts in organic synthesis. 
Hence, the pioneers in this field Richard F. Heck, Ei-ichi Negishi and Akira Suzuki 
were awarded the Nobel Prize in chemistry in 2010.
[16]
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Scheme 3: Example of palladium-catalyzed reaction in organic synthesis[17], [18], [19], [20] 
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1.1. General mechanism of palladium-catalyzed cross-coupling 
reactions 
In general, the mechanism of palladium-catalyzed cross-coupling reactions features a 
catalytic cycle, in which the three essential steps are the oxidative addition, the 
transmetallation and the reductive elimination (Scheme 4). The catalytic cycle is 
initiated by a catalytically active Pd
0
-species. This can be introduced as a pre-catalyst, 
for example Pd(PPh3)4 and Pd(PtBu3)2, or can be generated in situ from a palladium 
source including Pd2dba3 and Pd(OAc)2 with corresponding phosphine ligands. The 
catalytically active Pd
0
-species reacts with an organohalide RX in an oxidative addition, 
forming organopalladium species RPd
II
[L2]X. This process is commonly considered to 
be the rate determining step of the catalytic cycle. In the following transmetallation, the 
organic group of the coupling partner is transferred to the Pd
II
-species. Finally, the 
Pd
II
-species forms the corresponding cross-coupling product in a reductive elimination 
step, while catalytically active Pd
0
-species is regenerated (Scheme 4). 
 
Scheme 4: General catalytic cycle of palladium-catalyzed cross-coupling reactions 
The electronic and steric natures of the phosphine ligands can influence certain steps of 
the catalytic cycle including the oxidative addition and the 
reductive elimination. Strong -donating ligands facilitate the 
oxidative addition by increasing electron density around the 
palladium. On the other hand, the reductive elimination is 
accelerated by bulky ligands, especially those exhibiting large Tolman cone angles.
[21]
 
The chemical structures of several important phosphine ligands are shown in Table 1.  
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Table 1: Chemical structures of several phosphine ligands 
 
 
CataCXium A 
 
SPhos 
 
XPhos 
 
JohnPhos 
 
BINAP 
 
Xantphos 
 
dppe 
 
DTBPF 
 
dppf 
 
 
1.2. Palladium-catalyzed Suzuki cross-coupling reaction 
 
In seek of suitable coupling partners for palladium-catalyzed cross-coupling reactions, 
initial observation of the potential of organoboranes as coupling partners with 
aryl/alkenyl halides was documented by Heck et al. in 1975. In this report, it was 
determined that the cross-coupling process occurred in the presence of stoichiometric 
palladium. In 1979, Suzuki et al. successfully elevated the level of this chemistry by 
reporting a catalytic approach for the cross-coupling of organoboranes and aryl/alkenyl 
halides (Scheme 5).
[22]
 The key to this success is the use of bases in order to activate the 
organoboranes to organoboronates that are finally capable of engaging in a 
transmetallation during the catalytic cycle.  
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Scheme 5: First example of palladium-catalyzed Suzuki cross-coupling reaction[22] 
 
In general, aryl boronic acids are accessible from aryl halides with boron sources via 
two common pathways (Scheme 6).
[23]
 In the first route, aryl halides are converted to 
Grignard or lithium reagents which react with boron sources to form corresponding aryl 
boron compounds. Alternatively, aryl halides and boron sources are treated on 
cross-coupling reaction to generate aryl boron products (Scheme 6). Frequently 
employed boron sources for these transformations are pinacol borane (HBpin), 
bis(pinacolato)diboron (B2pin2), and trimethyl borates (B(OMe)3). Recently, an 
iridium-catalyzed aromatic borylation via C-H activation approach has been developed 
by Hartwig et al., representing a promising borylation method for the future 
(Scheme 6).
[24]
  
 
Scheme 6: Synthesis of aryl boronic acids 
In comparison, alkyl and alkenyl boron compounds can be synthesized via chemo- and 
regioselective addition of boron sources to alkenes and alkynes, respectively 
(Scheme 7). In this reaction, alkynyl is more active than alkenyl group and the 
formation of trans- is preferred over the formation of cis-configured isomers.  
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Scheme 7: Stereo- and regioselective synthesis of organoboranes 
 
In total, the Suzuki cross-coupling reaction exhibits significant advantages including 
air-/moisture-stable and less-toxic organoboron substrates, high functional group 
tolerance with wide diversity of starting materials and reaction media. Nowadays, this 
reaction is known as a powerful and prevalently employed tool for making new 
Csp2-Csp2 and Csp2-Csp3 bonds from organoboranes and aryl/alkenyl halides.
[25]
 A large 
number of biologically important structures have been synthesized using Suzuki 
cross-coupling reactions (Figure 3).
[26]
 
 
 
 
 
Michellamine B
[27]
 Helenaquinone
[28]
 Dermocanarin 2
[29]
 
Figure 3: Examples of biologically important structures synthesized by Suzuki 
cross-coupling reaction 
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1.3. Palladium-catalyzed Sonogashira cross-coupling reaction 
 
The history of cross-coupling reactions with alkynes was initiated in 1869 when Glaser 
et al. discovered that copper acetylides dimerized under air forming diphenyl 
diacetylenes (Scheme 8).
[30]
 In 1957, it was further explored that alkynes are capable of 
participating in copper-catalyzed cross-coupling reactions with haloalkynes 
(Scheme 8).
[31]
  
 
 
Scheme 8: Copper-catalyzed cross-coupling reaction of alkynes and alkynyl salts 
 
In 1963, Stephens and Castro disclosed that alkynyl copper salts underwent a reaction 
with haloarenes in organic bases as media to form corresponding cross-coupling 
products (Scheme 8).
[32]
 However, these methods are limited by several remarkable 
shortcomings including the stoichiometric use of copper, the need of high reaction 
temperature, the poor solubility of the alkynyl copper salts and the problem of the 
formation of homo-coupling products. 
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Scheme 9: Palladium-catalyzed cross-coupling of aryl halides with alkynes 
 
In 1975, palladium-catalyzed cross-coupling reactions of aryl halides with alkynes were 
concurrently documented by Heck et al.,
[33]
 Cassar et al.
[34]
 and Sonogashira et al.
[35]
 
(Scheme 9). In the reports of Heck et al. and Cassar et al., the reactions employ 
palladium as a sole catalyst, requiring elevated reaction temperatures. In comparison, 
Sonogashira et al. used copper as a co-catalyst that allows the conduction of the reaction 
at room temperature. Overall, this reaction displays high tolerance against functional 
groups and proves especially effective for making new Csp-Csp and Csp2-Csp bonds in 
conjugated enynes and enediynes of structurally complex molecules.  
It is worth mentioning that the products of the Sonogashira reaction can often be 
accommodated as precursors in further chemical transformations.
[36]
 For example, they 
can be reduced to alkanes or alkenes (Scheme 10). Alternatively, they can participate in 
different types of cyclization reactions to construct complex structures, for example 
indole, benzofuran, isoquinolinone, oxyindole and isochromenone (Scheme 10). These 
above distinct advantages have rendered Sonogashira reaction an important platform for 
the synthesis of a great number of natural products nowadays (Figure 4).
[37]
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Scheme 10: Possible following transformations of the products of Sonogashira 
cross-coupling reaction 
 
 
 
 
 
 
calicheamicin γ1[38] maduropeptin[39] calothrixin B[40] 
Figure 4: Natural products obtained by Sonogashira cross-coupling reaction 
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1.4. Palladium-catalyzed Buchwald-Hartwig C-N cross-coupling 
reaction 
 
As CAr-N bonds are abundant in natural products, synthetic chemists have devoted great 
efforts to developing new methodologies to construct them. In classic chemistry, these 
bonds were created by several pathways including nitration/reduction of aromatic 
compound, SN-Ar reaction and Ullmann-Goldberg reaction (Scheme 11).
[41]
 
Unfortunately, these methods were suffered from low regioselectivity and limited 
substrate scope. For example, the SN-Ar reaction and Ullmann-Goldberg reaction failed 
with electronically neutral and electronically rich aromatic systems.  
 
 
Scheme 11: Formations of CAr-N bonds in classic chemistry 
 
These shortcomings in substrate scope have been gradually solved by the development 
of transition metal catalysts. In 1983, Migita et al. reported the first palladium-catalyzed 
C-N cross-coupling reaction (Scheme 12).
[42]
 The reaction worked compatibly with 
electronically neutral and sterically hindered amines, but necessarily employed toxic 
tin-reagents. 
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Scheme 12: Examples of palladium-catalyzed C-N cross-coupling reaction 
In 1994, Hartwig et al. elucidated the formation of the active catalyst Pd[P(o-Tol)3]2 
during this C-N cross-coupling reaction.
[43]
 Later in this year, Buchwald et al. published 
an improved procedure for this reaction by using an argon purge in the reaction 
setup.
[44]
 Through this system, diethylamine was removed during the in situ generation 
of aminostannanes, thus allowing a broader amine scope with higher resulting yields. 
In 1995, Buchwald and Hartwig independently found that the employment of the bulky 
bases NaOtBu and LiHMDS enables a C-N cross-coupling without the use of toxic 
tin-reagents (Scheme 12).
[45]
 However, the scope of the reaction was still limited to 
secondary amines due to the uncontrollable overreaction of primary amines and the 
hydrodehalogenation of haloarenes. 
 
Scheme 13: Buchwald-Hartwig C-N cross-coupling using bidentate phosphine ligands 
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To address these limitations, further ligands for the Buchwald-Hartwig 
C-N cross-coupling reaction were developed. In 1996, Buchwald et al. and Hartwig et 
al. independently reported that the bidentate ligands BINAP and dppf gave resulting 
C-N cross-coupling products in good yields with diverse types of primary amines using 
lower catalyst loading (Scheme 13).
[46]
 Moreover, these conditions allowed the utility of 
aryl iodides and aryl triflates. It is assumed that the bidentate nature of these ligands 
fixes the active catalysts during the catalytic cycle. As a result, the liberation of the 
coordination sites of the active catalysts during the catalytic cycle is suppressed, thus 
the undesired -hydride elimination is prevented. 
In search of more powerful ligands for the Buchwald-Hartwig C-N cross-coupling 
reaction, it was discovered that the steric property of ligands was crucial during the 
reaction in some instances.
[47]
 Voluminous phosphine ligands allow C-N cross-coupling 
reactions with a broader range of amines including electronically poor and heterocyclic 
derivatives, and with different types of aryl halides including chloride and triflate 
(Scheme 14). 
 
Scheme 14: Buchwald-Hartwig C-N cross-coupling reactions using bulky phosphine 
ligands 
Later development of the Buchwald-Hartwig C-N cross-coupling reaction also unlocked 
a remaining limitation in the reaction between amines and aryl halides, namely the use 
of ammonia to construct primary aryl amines. The problem for this lays in the formation 
of tight bonds between ammonia with the active catalyst that finally inhibits the 
catalytic activity. To circumvent this, benzophenone imine or silyl amide were 
accommodated as ammonia equivalence (Scheme 15).
[48]
 These reagents undergo C-N 
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cross-coupling reactions with aryl halides before being subjected to hydrolysis to 
assemble the corresponding primary amines. 
 
Scheme 15: Strategy of Buchwald-Hartwig C-N cross-coupling reaction for the generation 
of primary amines 
At present, the scope of substrates for the Buchwald-Hartwig C-N cross-coupling 
reaction has been successfully extended beyond amines. Further competent nitrogen-
containing reagents can be engaged in the reaction including amides,
[49]
 
carbamates,
[49c, 49d]
 sulfonamides,
[49c]
 sulfoximes,
[50]
 hydrazones
[51]
 and pyrrole-
derivatives
[49d, 52]
 (Scheme 16). The Buchwald-Hartwig C-N cross-coupling reaction has 
become a convenient tool for making new C-N bonds, thereby being broadly applied in 
organic synthesis to prepare a large number of important compounds (Figure 5).
[53]
  
 
Scheme 16: Examples of Buchwald-Hartwig C-N coupling with further 
nitrogen-containing reagents 
  
 
DUP-721
[54]
 FN-325
[55]
 (+)-epi-indolactam V
[56]
 
Figure 5: Biologically important structures synthesized by Buchwald-Hartwig 
C-N cross-coupling reaction 
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1.5. Palladium-catalyzed C-H arylation 
In nature, C-H functionalization is observed in several enzymatic biosynthesis. For 
example, biotin is synthesized by double C-H functionalization catalyzed by biotin 
synthase, forming two new C-S bonds in an extremely atom-economic manner 
(Scheme 17).
[57]
  
 
Scheme 17: Example of C-H functionalization reaction in nature 
Table 2: Bond dissociation energy of several C-H and C-Hal bonds (kcal∙mol-1)[58]  
 
105 
 
101 
 
99 
 
94 
 
111 
 
89 
 
79 
 
94 
 
113 
 
90 
 
70 
 
70 
 
84 
 
72 
 
74 
 
72 
 
91 
 
80 
 
59 
 
51 
 
97 
 
84 
 
67 
 
63 
Intrigued by these natural enzymatic processes, endeavor was devoted to bringing this 
reaction concept into practical organic chemistry. In order to achieve this target, many 
challenges have to be overcome. For instance, the bond dissociation energies of the C-H 
bonds are generally higher than those of C-Hal bonds (Table 2), and C-H bonds possess 
no electron lone pairs for coordinating with active catalysts. Thus, they cannot engage 
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in an oxidative addition during the catalytic cycle like C-Hal bonds. Moreover, unlike 
several C-M bonds, they are not capable of undergoing a transmetallation. Finally, ideal 
catalysts for the C-H functionalization have to meet further criteria including being 
selective to discriminate different C-H bonds, slow in catalyzing over-functionalization, 
and stable against possible oxidants and functional groups. 
 
Scheme 18: Example of palladium-catalyzed C-H activation[59]  
 
Scheme 19: General proposed mechanisms of the C-H activation step 
For these reasons, these C-H bonds require particular “activation” during the catalytic 
cycle. For example, the incorporation of appropriate neighboring groups and organic 
acids was documented to streamline the C-H activation process. In the exemplified C-H 
activation reaction shown in Scheme 18,
[59]
 the catalysts are directed to the 
neighborhood of the C-H bonds at the ortho-position by the carbonyl group. 
Subsequently, palladium catalysts and p-toluenesulfonic acid synergistically activate 
this C-H bond, forming corresponding final product. In the absence of any of them, the 
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reaction turns intact. However, the detailed mechanism of these activation processes 
still remains elusive. General C-H activation steps have been proposed to follow several 
mechanistic modalities including concerted metalation deprotonation, -bond 
metathesis and oxidative addition (Scheme 19).
[60]
 
 
 
Scheme 20: Examples of palladium-catalyzed C-H functionalization[61] 
 
Among different C-H functionalization methods, of practical importance in organic 
synthesis are the three forms of C-H arylation between C-H/C-X, C-H/C-H and 
C-H/C-M bonds (Scheme 20).
[62]
 These arylation reactions differ in the active catalyst 
during the catalytic cycle, namely Pd
0
 for the reaction between C-H/C-X bonds and Pd
II
 
for the reaction between C-H/C-H and between C-H/C-M bonds. Alike other C-H 
activation reactions, the exact mechanisms of these reactions have not yet been fully 
explained. They have been conjectured to depend on the substrates, catalysts and 
reaction conditions (Scheme 21). Despite this fact, tremendous developments were 
achieved in relation to the practical application of C-H arylation in organic synthesis. 
More recently, C-H arylation has become an increasingly powerful platform for making 
structurally complex compounds (Figure 6).  
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Scheme 21: Examples of general mechanism of palladium-catalyzed C-H arylation 
 
 
(+)-gilvocarcin M
[63]
 decaphenylcorannulene
[64]
 
Figure 6: Example of structurally complex compounds synthesized by C-H arylation 
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1.6. Selectivity in palladium-catalyzed cross-coupling reactions 
Selectivity is an important issue in organic chemistry. It is understood as the preference 
of one functional group over others during the reaction. There are several types of 
selectivity. For example, the term chemo-selectivity describes the reaction selection 
between two chemically different groups, and the site-selectivity is for identical 
chemical groups at different positions. On the other hand, the term regioselectivity is 
used for the predominant formation of one isomer over others, while stereoselectivity is 
related to the selective formation of one stereoisomer over others during the reaction.
[65]
 
In practice, the term regioselective can be used for both site- and chemo-selective 
issues. Representative examples for different types of selectivity in organic synthesis 
are demonstrated in Scheme 22. 
 
 
Scheme 22: Examples of selectivity in organic synthesis[66] 
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With this regard, palladium-catalyzed cross-coupling reactions can proceed in 
chemo-selective and site-selective fashion. In chemo-selective palladium-catalyzed 
cross-coupling reactions, the general reactivity order of the halogen atoms is 
F < Cl < OTf ≈ Br < I. Taken example a in Scheme 22, position 3 of the pyridine ring is 
more reactive in a Suzuki cross-coupling reaction, as Br is more reactive than Cl. On the 
other hand, the attack of general palladium-catalyzed cross-coupling reactions prefers 
electron-deficient over electron-rich carbon atoms. Therefore, the Suzuki cross-coupling 
reaction in example b in Scheme 22 proceeds site-selectively at position 2 since it is 
more electron-deficient than position 3.
[66a]
  
 
Scheme 23: Example of catalyst-controlled selectivity in palladium-catalyzed 
cross-coupling reaction[67] 
Other factors which can have remarkable influence on the selectivity of 
palladium-catalyzed cross-coupling reactions are the palladium-source and the 
ligand.
[68]
 For instance, the Suzuki cross-coupling reaction of 2,4-dibromobenzoic acid 
with 4-tolylboronic acid (Scheme 23) takes part preferentially at the position 2 of 
2,4-dibromobenzoic acid under the presence of phosphine ligand-free catalyst Pd2dba3, 
while the selectivity is reversed by using catalyst system Pd(OAc)2/DPEPhos.
[67]
 The 
reason for the ortho-selectivity by the use of catalyst Pd2dba3 is possibly attributed to a 
coordination of the carboxyl group with the active catalyst during the catalytic cycle. 
This interaction enhances the proximity of the bromine atom at ortho-position with the 
active catalyst during the catalytic cycle. In contrast, the use of the sterically 
encumbering bidentate ligand DPEPhos is believed to block the coordination between 
the carboxyl group and the catalyst Pd(OAc)2. As a result, the bromine atom at 
para-position becomes sterically favored during the reaction.  
22 
 
2. Motivation, objectives and methodologies of this PhD 
research 
2.1. Motivation  
Ortho-dihaloarenes are aromatic compounds with two halogen atoms next to each other. 
With two electrophilic reaction centers, these compounds have considerable potential to 
undergo a reaction with a bi-nucleophilic partner, in which a five- or six-membered ring 
is formed. For example, ortho-dibromobenzene reacts with diphenylamine in a 
palladium-catalyzed domino C-N/C-C cross-coupling (Scheme 24).[69]  
 
Scheme 24: Example of synthesis of heterocycle from ortho-dihaloarenes[69] 
Table 3: Further examples of heterocycles synthesized from ortho-dihaloarenes 
   
isoindoline-1,3-dione 
[70]
 
3-alkylidene- 
isoindolin-1-one
[71]
 
1,2,3-trialkyl-1H-indole
[72]
 
 
  
indoline
[73]
 1H-benzo[d]imidazole
[74]
 benzo[d]oxazole
[75]
 
   
benzo[4,5]imidazo 
[1,2-a]pyridine
[76]
 
benzo[d]imidazo[2,1-
b]thiazole
[77]
 
benzo[4,5]-thiazolo[3,2-b] 
[1,2,4]triazole
[77]
 
  
 
benzofurane
[78]
 benzo[kl]-xanthene
[78b]
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First, in the presence of the catalyst system Pd(OAc)2/PCy3, a C-N coupling between 
ortho-dibromobenzene and diphenylamine takes place wherein IM1 is formed. Next, an 
intramolecular C-H arylation of IM1 is triggered by the same catalyst system to afford 
the corresponding carbazole (Scheme 24). With this reference, ortho-dihaloarenes were 
applied in a number of other syntheses with amines, carbon monoxides, amides, ketones 
and phenols delivering different fused nitrogen heterocycles (Table 3). 
2.2. Objectives 
The main target of this study is the development of new convenient, atom-economic and 
effective methodologies to prepare nitrogen-containing polycyclic aromatic compounds. 
Starting materials for these syntheses are ortho-dihaloarenes of pyridine, quinoline, 
naphthalene, thiophene, benzothiophene and pyrimidine, since various derivatives of 
these heterocycles were frequently documented with biological and physical 
properties.
[79]
  
2.3. Methodologies 
In the first part of the PhD research, the domino C-C/C-N coupling reaction of 
ortho-dihaloarenes SM1-2 with imines is investigated. From these chemical 
transformations, azaindole-fused compounds PR1-2 are obtained 
(Scheme 25 - method a, Chapter 3.1). 
The following part focuses on the reaction model sequential regioselective Suzuki 
reaction/double C-N coupling. Ortho-dihaloarenes SM2-4 are applied as starting 
materials for these reactions, ultimately furnishing corresponding carbazole-fused 
derivatives PR3-5 (Scheme 25 - method b, Chapter 3.2). 
Finally, regioselective Sonogashira reaction followed by domino/one-pot C-N coupling/ 
hydroamination/C-H arylation is studied across ortho-dihaloarenes SM2, SM5 and 
SM6, affording hitherto unexplored phenanthridine-fused compounds PR6-8 
(Scheme 25 - method c, Chapter 3.3). 
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Scheme 25: Synthesis of different nitrogen-containing aromatic compounds in this study 
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3. Results and discussion 
3.1. Synthesis of pyrrole-fused heterocycles by domino C-C/C-N 
coupling of imines with ortho-dihaloarenes 
Imines are considered as ambident bi-nucleophilic anions and alternatives to 
enolates.
[80]
 Their applications in organic synthesis were introduced in the early 
1960s.
[80]
 In these publications, imines were utilized in alkylation and aldol 
condensation reactions. The employment of imines displayed less by-products 
compared to the uses of ketones and enolates.
[80-81]
 Henceforth, they were frequently 
applied as synthons for C=O
[82]
 and C-N
[83]
 bonds in organic synthesis (Scheme 26). 
Nevertheless, the application of imines in classic synthesis was limited by being unable 
to form new C-C or C-N bonds directly from imines and haloarenes (Scheme 27). 
 
Scheme 26: Applications of imines in the classic synthesis 
 
Scheme 27: Limitations in the application of imines in classic synthesis 
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Fortunately, the development of palladium chemistry has gradually enabled both C-C 
and C-N cross-coupling reactions between imines and haloarenes. The first C-N 
coupling of imines with haloarenes was published in 1997 (Scheme 28).
[48c, 84]
 However, 
the use of imine in these C-N couplings with haloarenes was limited by the sole 
application as ammonia equivalence (Chapter 1.4). In 2007, the first C-C cross-coupling 
of haloarenes with imines was disclosed by Barluenga et al. (Scheme 28).
[72b]
 More 
importantly, the study took advantage of the ambident property of the imine, triggering 
both C-C and C-N bond formation reactions by the same catalysts to construct indole 
structure (Scheme 28).  
 
Scheme 28: Palladium-catalyzed cross-coupling with imines[48c] [72b, 72c] 
 
In this regard, it was envisaged that this reaction concept can be adapted to the 
accommodation of nitrogen-containing ortho-dihaloarenes for the syntheses of 
azaindoles (PR1, Chapter 3.1.1) and pyrroloquinolines (PR2, Chapter 3.1.2).  
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3.1.1. Synthesis of azaindoles from ortho-dihalopyridines 
 
In nature, azaindoles are considered as bioisosteres of the ubiquitous indole moiety.
[85]
 
A large number of azaindole derivatives represent potential candidates for application in 
medicine. For instance, 7-azatryptophan has been applied as fluorescent marker for 
visualizing protein-protein interactions in bioligcal systems (Figure 7).
[86]
 In addition, 
BMS-378806 is an inhibitor against HIV-attachments,
[87]
 while Aza3 can be utilized as 
an anti-tubercular agent (Figure 7).
[88]
 Taking this biological importance into account, 
an increasing number of drugs derived from azaindoles have been developed and 
released in the pharmaceutical industry.
[89]
 
 
 
 
7-azatryptophan BMS-378806 Aza3 
Figure 7: Biologically important azaindole derivatives 
Generally, the synthesis of azaindoles begins with a pyridine ring, followed by an 
annulation to form the corresponding azaindole skeleton.
[90]
 In classic chemistry, the 
annulation proceeded via different syntheses including Fischer,
[91]
 Madelung,
[92]
 
Reissert,
[93]
 Bartoli,
[94]
 and Chichibabin.
[95]
 Nonetheless, many of them are suffered 
from reliance on harsh conditions, low yields or low tolerance against functional 
groups. Fortunately, these limitations have been gradually solved owed to the striking 
development of palladium-catalyzed cross-coupling reactions. To date, the annulation 
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can be accomplished via (a, b) C-N/Heck couplings,
[96]
 (c) Suzuki/C-N couplings,
[97]
 
(d) C-N/C-N couplings,
[72a]
 (e) hydroamination
[98]
 and (f) Larock synthesis 
(Scheme 29).
[99]
 Herein, a facile and effective synthetic elaboration of 4- and 
7-azaindoles (product series PR1) via palladium-catalyzed domino C-C/C-N coupling 
of ortho-dihalopyridines and imines is demonstrated (Scheme 30). 
 
Scheme 29: Previous palladium-catalyzed synthesis of azaindoles 
 
Scheme 30: Synthesis of azaindoles in this study 
At first, 2,3-dibromopyridine (1a) and 1-bis(4-methoxyphenyl)ethan-1-imine (2a) were 
chosen as model substrates for the optimization experiments (Table 4). Starting from 
these substrates, the conditions for the indole synthesis documented by Barluenga et al. 
were adopted.
[72c]
 Unfortunately, these conditions resulted in the formation of product 
mixture of 4- and 7-azaindoles in 12% yield (entry 1, Table 4). Next, bidentate ligands 
including BINAP, Xantphos and DavePhos were tested, but proved unsuccessful. 
Conversely, the monodentate ligands PPh3, CataCXium A and PCy3 gave rise to the 
formation of the corresponding 4- and 7-azaindoles 3a and 4a. Based on these results, 
the robustness of these catalyst systems was checked by surveying the influences of 
palladium sources, bases and temperatures. Suitable conditions for selective generation 
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of 4- and 7-azaindoles were found, but the yields were moderate (entries 4 and 9, 
Table 4). In comparison, remarkable improvement was observed in the presence of the 
catalytic system Pd(OAc)2/PCy3 with the base NaOtBu in dioxane (entry 8, Table 4). 
Under these conditions, the resulting azaindoles 3a and 4a were furnished in 91% yield, 
despite an insufficient regioselectivity (3a:4a were formed in 2:3 ratio). 
Table 4: Optimization study for the synthesis of 4- and 7-azaindoles 3a and 4a 
 
Entry [Pd]-Source Ligand Base Solvent Yield (3a:4a) 
1 Pd2dba3 XPhos NaOtBu Dioxane 12%
a
 (1:1)
a 
2 Pd2dba3 DavePhos NaOtBu Dioxane 7%
b
 (0:1)
b 
3 Pd2dba3 PtBu3 NaOtBu Dioxane - 
4 Pd2dba3 PPh3 NaOtBu Dioxane 39%
b
 (1:0)
b 
5 Pd2dba3 P(o-Tol)3 NaOtBu Dioxane - 
6 Pd2dba3 CataCXium A NaOtBu Dioxane 53%
b
 (1:2)
b 
7 Pd2dba3 PCy3 NaOtBu Dioxane 73%
b
 (2:1)
b 
8 Pd(OAc)2 PCy3 NaOtBu Dioxane 91%
a
 (2:3)
a 
9 Pd(OAc)2 PCy3 K2CO3 Dioxane 39%
b
 (0:1)
b 
Reaction conditions: 1a (0.10 mmol), 2a (0.11 mmol), [Pd]-source (0.06 mmol), ligand (0.012 mmol), base (0.28 mmol), 
dioxane (2 ml), 105 °C, 48 h 
a isolated yield; b determined by NMR-spectroscopy 
 
Subsequently, efforts were conducted in order to enhance the regioselectivity from the 
conditions 8 in Table 5. To this end, 2-bromo-3-chloropyridine (1b) was utilized as 
starting material for the reaction. With respect to electronic effect, the chemical 
transformation prefers position 2 over position 3, since it is more electron-deficient. 
More importantly, the presence of an additional chemo-selective effect occurring in the 
same direction (position 2 > position 3, Br > Cl) synergistically raises the discrimination 
in the reactivity between position 2 and position 3. Accordingly, it was expected to 
obtain higher regioselectivity by using 2-bromo-3-chloropyridine (1b) compared to the 
utility of 2,3-dibromopyridine (1a). 
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Table 5: Synthesis of 4-azaindoles 3a-o 
 
 
3a (80%) 
 
3b (95%) 
 
3c (72%) 
 
3d (51%) 
 
3e (48%) 
 
3f (59%) 
 
3g (63%) 
 
3h (67%) 
 
3i (58%) 
 
3j (52%) 
 
3k (79%) 
 
3l (53%) 
 
3m (59%) 
 
3n (89%) 
 
3o (84%) 
Reaction conditions: 1a (0.30 mmol), 2a-o (0.33 mmol), Pd(OAc)2 (0.018 mmol), PCy3 (0.036 mmol), NaOtBu (0.84 mmol), 
dioxane (6 ml), 105 °C, 16 - 48 h. The yields were referred to as isolated yields. 
31 
 
Gratifyingly, by applying 2-bromo-3-chloropyridine (1b) in the reaction with imine 2a 
using the conditions 8 in Table 4, the resulting 4-azaindole 3a was assembled as single 
regioisomer in very good yield with an excellent level of regioselectivity (Table 5). 
Motivated by this result, the preparative scope of the reaction was explored. Different 
electron-rich and electron-poor imines were engaged, giving 4-azaindoles 3b-o 
(Table 5). The yields varied from moderate to excellent. In general, the yields were 
good for electron-rich systems, for example 4-azaindoles 3n and 3o in Table 6. The best 
yield was found with electron-rich 4-azaindole 3b in 95%, while the lowest occurred 
with 4-azaindole 3e in 48%. However, no further detailed information with reference to 
the correlation between the synthetic efficiency and the chemical structure was revealed 
from the data. 
 
Figure 8: Molecular structure of 3c in the crystal 
The molecular structure of 4-azaindole 3c was independently confirmed by X-ray 
crystal structure analysis (Figure 8). As can be seen, the atoms in the azaindole ring are 
bounded in a planar configuration. The phenyl rings at position 1 and position 2 twist 
out of the azaindole plane by 35.2 and 69.3 °, respectively. With this conformation, the 
steric repulsion between the phenyl rings at position 1 and 2 was diminished.  
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Table 6: Synthesis of 7-azaindoles 4a-o 
 
 
4a (81%) 
 
4b (75%) 
 
4c (70%) 
 
4d (68%) 
 
4e (47%) 
 
4f (47%) 
 
4g (72%) 
 
4h (63%) 
 
4i (59%) 
 
4j (57%) 
 
4k (61%) 
 
4l (56%) 
 
 
4m (76%) 
 
4n (67%) 
 
4o (86%) 
Reaction conditions: 1c (0.30 mmol), 2a-o (0.33 mmol), Pd(OAc)2 (0.018 mmol), PCy3 (0.036 mmol), NaOtBu (0.84 mmol), 
dioxane (6 ml), 105 °C, 16 - 48 h. The yields were referred to as isolated yields. 
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Following the successful synthesis of 4-azaindoles, further investigation of the reaction 
of 2-chloro-3-bromopyridine (1c) with different imines was undertaken (Table 6). In the 
structure of 2-chloro-3-bromopyridine (1c), the chemo-selectivity is reversed, because 
the positions of Br and Cl are switched. Therefore, position 3 of the pyridine ring turns 
to be more reactive than position 2, since the chemo-selective effect (Br > Cl) generally 
overwhelms the electronic effect (position 3 > position 2) in palladium-catalyzed 
cross-coupling reactions. As expected, by employing 3-bromo-2-chloropyridine (1c) in 
the reactions with different imines, the resulting 7-azaindoles 4a-o were afforded in 
moderate to very good yields (Table 6). The highest yield was observed for the largely 
aromatic 7-azaindole 4o in 86%. In contrast, both 7-azaindoles 4n and 4o were 
furnished in lowest yields (47%), presumably as a result of steric effect. 
Additional X-ray structure determination confirmed the molecular structures of 
7-azaindoles 4g and 4n (Figure 9-10). In similarity with the structure of 4-azaindole 3c, 
the azaindole rings of 7-azaindoles 4g and 4n are regarded as planar. Additionally, the 
phenyl rings at position 1 of the azaindole rings of both 7-azaindoles 4g and 4n twist 
out of the aromatic plane by 45.25(5) and 60.20(4) °, respectively, due to steric 
repulsion. In comparison, the deviations from the azaindole plane observed at position 2 
of these compounds are 57.94(4) °(4g) and 42.00(3) °(4n). 
In summary, 4- and 7-azaindoles were successfully prepared using palladium-catalyzed 
domino C-C/C-N coupling of ortho-dihalopyridines with imines. The regiochemistry of 
these chemical transformations was dictated by the chemo-selectivity present in the 
ortho-dihalopyridine starting materials (Br versus Cl). 
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Figure 9: Molecular structure of 4g in the crystal 
 
 
 
Figure 10: Molecular structure of 4n in the crystal 
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3.1.2. Synthesis of pyrroloquinolines from ortho-dihaloquinolines 
 
With a wide scope of the synthesis of 4- and 7-azaindoles demonstrated in 
Chapter 3.1.1, further investigation of the reaction of ortho-dihaloquinoline with imines 
to assemble pyrroloquinolines (product series PR2) was undertaken. Pyrroloquinolines 
were reported with antineoplastic,
[100]
 antitubercular
[101]
 and cytotoxic activities.
[102]
 For 
example, SB-742457 is a potential 5-HT6 receptor antagonist drug for the treatment of 
cognitive disorder diseases (Figure 11).
[103]
  
 
 
 
SB-742457 1H-pyrrolo[3,2-c]quinoline 1H-pyrrolo[2,3-b]quinoline 
Figure 11: Examples of pyrroloquinolines with biological relevance 
Among different pyrroloquinoline architectures, 1H-pyrrolo[2,3-b]quinolines and 
1H-pyrrolo[3,2-c]quinolines are of interest in this study (Figure 11). Until recently, 
several approaches for the synthesis of these pyrroloquinolines have been known, 
namely K
+
/Cs
+
-mediated 5-endo-dig cyclization,
[104]
 carbonyl azide 
formation/cyclization/ decarboxylation,
[105]
 bromination/intramolecular SN2 
reaction,
[106]
 hydrazine formation/ thermal cyclization,
[107]
 intramolecular 
heteroannulation of internal imines,
[108]
 SN-Ar reaction/cyclization
[109]
 and tandem 
reaction of isocyanide
[110]
 (Scheme 31). Unfortunately, to a certain extent these 
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syntheses are considered tedious and not modular. Therefore, the palladium-catalyzed 
domino C-C/C-N coupling of ortho-dihaloquinolines with imines would offer a new 
convenient and modular access to these structures (Scheme 32). 
 
Scheme 31: Previously documented synthesis of 1H-pyrrolo[2,3-b]quinolines and 
1H-pyrrolo[3,2-c]quinolines 
 
Scheme 32: Synthesis of 1H-pyrrolo[2,3-b]quinolines and 1H-pyrrolo[3,2-c]quinolines in 
this study 
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The synthetic efforts began with the optimization of the model reaction of 3-bromo-
2-chloroquinoline (5a) and 1-bis(4-methoxyphenyl)ethan-1-imine (2a) affording 
pyrroloquinoline 6a (Table 7). The choice of the phosphine ligands for this screening 
was based on the previous optimization results of the azaindole synthesis described in 
Table 4. 
 
Table 7: Optimization study of the synthesis of 1H-pyrrolo[2,3-b]quinoline 6a 
 
Entry Pd-source Ligand Yield
 
1 Pd(OAc)2 CataCXium A 61% 
2 Pd(OAc)2 PCy3 85% 
3 Pd(OAc)2 PPh3 45% 
4 Pd(OAc)2 XPhos 21% 
Reaction conditions: 5a (0.10 mmol), imines (0.11 mmol), Pd(OAc)2 (0.008 mmol), PCy3 (0.016 mmol), NaOtBu (0.28 mmol), 
dioxane (2 ml), 105 °C, 24 h. The yields were referred to as isolated yields. 
From the screening data, the catalyst system Pd(OAc)2/PCy3 was found to be the best 
conditions, assembling pyrroloquinoline 6a in good yield (85%). It is noteworthy that 
these conditions are identical to those used the synthesis of azaindoles described in 
Chapter 3.1.1.  
Pyrroloquinolines 6b-i were prepared on treatment with 3-bromo-2-chloroquinoline 
(5a) under these conditions in up to 85% yields (Table 8). It seems likely that the 
incorporation of electron-withdrawing groups (-F and -CF3) hampers the formation of 
the products, since the yields obtained with pyrroloquinoline 6d and 6i were lower. 
Pyrroloquinoline 6i gave the lowest yield in 56%. Conversely, good yields were 
obtained with electron-rich 1H-pyrrolo[2,3-b]quinolines 6a, 6b, 6g and 6h, all being 
greater than 75%, with the highest observed for 6g in 90% yield. 
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Table 8: Synthesis of 1H-pyrrolo[2,3-b]quinolines 6a-i 
   
 
6a (85%) 
 
6b (75%) 
 
6c (78%) 
 
6d (60%) 
 
6e (80%) 
 
6f (88%) 
 
6g (90%) 
 
6h (87%) 
 
6i (56%)  
Reaction conditions: 5a (0.30 mmol), imines (0.33 mmol), Pd(OAc)2 (0.024 mmol), PCy3 (0.048 mmol), NaOtBu (0.84 mmol), 
dioxane (6 ml), 105 °C, 24 h. The yields were referred to as isolated yields. 
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Encouraged by these results, further investigations were accomplished for the reaction 
of imines with 3-bromo-4-chloroquinoline (5b) (Table 9). Applying the same 
conditions, pyrroloquinolines 7a-f were assembled in between 46% and 82% yield 
(Table 9). Compared to the prior series, the yields obtained with these derivatives are 
slightly lower in general. It is possibly interpreted as a result of the electronic 
compulsion between the substituents at position 1 with the benzene ring of the quinoline 
structure that potentially lowers the stability of the entire system. From Table 11, it is 
observed in agreement with prior series that products bearing electron-withdrawing 
groups -F and -CF3 7e-f gave lower yields (46% and 58%, respectively). In comparison, 
the highest yield was achieved with electronically rich pyrroloquinoline 7a in 82% 
yield. 
Table 9: Synthesis of pyrrolo[3,2-c]quinolines 7a-f 
 
 
7a (82%) 
 
7b (61%) 
 
7c (72%) 
 
7d (67%) 
 
7e (46%) 
 
7f (58%) 
Reaction conditions: 5b (0.30 mmol), imines (0.33 mmol), Pd(OAc)2 (0.024 mmol), PCy3 (0.048 mmol), NaOtBu (0.84 mmol), 
dioxane (6 ml), 105 °C, 24 h. The yields were referred to as isolated yields. 
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The molecular structure of 1H-pyrrolo[3,2-c]quinoline 7f was additionally confirmed by 
X-ray structure determination (Figure 12). The structure exhibits a planar 
pyrroloquinoline ring. The phenyl rings at position 1 and 2 twist out of the plane by 
83.4(3) and 31.7(5) °, respectively, owing to steric repulsion.  
 
 
Figure 12: Molecular structure of 1H-pyrrolo[3,2-c]quinoline 7f in the crystal 
 
Taken together, two isomeric pyrroloquinolines were prepared by palladium-catalyzed 
domino C-C/C-N coupling of imines with ortho-dihaloquinolines in moderate to good 
yields. The synthetic utility and versatility of the method are manifested and can be 
adapted to other ortho-dihaloarenes to enable access to more pyrrole-fused aromatic 
systems. 
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3.2. Synthesis of indole-fused heterocycles from ortho-dihaloarenes by 
regioselective Suzuki reaction followed by double C-N coupling 
Indole is a biologically important heterocycle which is prevalently distributed in nature. 
In bacterial culture, it is an intercellular molecule which regulates biological functions 
including plasmid stability and spore formation.
[111]
 Furthermore, indole is incorporated 
in the chemical structure of the amino acid tryptophan, which participates in the 
synthesis of proteins and serves as a precursor to the neurotransmitters melatonin and 
serotonin in human (Figure 13).
[112]
  
 
  
tryptophan carbazole -carboline 
Figure 13: Several biologically and physically important indole-derived structures 
The development of different indole derivatives has attracted attention from the 
scientific community. Among these, fused indole heterocycles have gained increasing 
importance, particularly in the field of medicinal and material science. Taken carbazole 
as an example of an indole-fused scaffold, a handful of carbazole derivatives were 
found with antitumor activities,
[113]
 or possess low bandgap suitable for the applications 
in high-performance solar cell techniques.
[79c, 114]
 Another example of indole-fused 
heterocycles, namely -carboline, is incorporated in alkaloids with benzodiazepine 
inverse agonisting properties (Figure 13).
[115]
 
The preparation of fused-indole heterocycles can be achieved by classic syntheses, such 
as Fischer-indole synthesis, Diels-Alder addition and Cadogan cyclization.
[116]
 Besides, 
the synthesis can also utilize transition metal catalysts, proceeding through different 
types of transformations including C-N cross-coupling, hydroamination and domino 
C-C/C-N coupling.
[116]
 Among them, a development relevant to this PhD research is the 
practical preparation of carbazoles reported by Nozaki et al. in 2003 (Scheme 33).
[117]
 
The synthesis capitalizes the potential of the Buchwald-Hartwig amination and the 
entropic privilege of the intramolecular reaction. 2,2'-Dibromo-1,1'-biphenyl and amines 
are accommodated in a double C-N cross-coupling reaction Noteworthy, the couplings 
occur uneventfully even with sterically congested amines. 
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Scheme 33: Synthesis of carbazoles by double C-N cross-coupling reaction[117] 
 
To date, several modifications of this method have been developed by Langer et al.
[118]
 
In these studies, one phenyl ring in the structure of the substrates 1,1’-dihalobiaryls was 
exchanged by a heterocycle. The corresponding substrates were synthesized by applying 
regioselective Suzuki reactions of ortho-dihaloarenes with (2-bromophenyl)boronic 
acid (8) (Scheme 34). These strategies are compatible with a broader range of starting 
materials, which couple with primary amines to give different indole-fused structures 
(Scheme 34). Along with this development, further modifications of the Nozaki 
carbazole synthesis have been developed for the preparation of indoloquinolines 
(PR3, Chapter 3.2.1), benzo[a]carbazoles (PR4, Chapter 3.2.2) and thienoindoles 
(PR5, Chapter 3.2.3) in this contribution.  
 
 
Scheme 34: Examples of previously reported syntheses of indole-fused heterocycles by 
sequential regioselective Suzuki reaction/double C-N coupling 
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3.2.1. Synthesis of indoloquinolines from ortho-dihaloquinolines  
 
Indoloquinolines are biologically active scaffolds which were documented with 
antimalarial 
[119]
 and antitumor properties.
[120]
 Moreover, they can interact with DNA
[121]
 
or can be employed as inhibitor for DYRK1A
[122]
 and NQ01,
[123]
 to name but a few. For 
example, IDQ3D was discovered as G-quadruplex stabilizer in human cells,
[124]
 while 
MDIQ2 represents a cytotoxic DNA topoisomerase II inhibitor
[125]
 (Figure 14).  
  
IDQ3D MDIQ2 
Figure 14: Examples of indoloquinoline related compounds with biological importance  
The chemistry of two indoloquinoline derivatives namely 11H-indolo[3,2-c]quinoline 
and 6H-indolo[2,3-b]quinoline is focused in this study. Their preparations can be 
carried out using classic syntheses including  Fischer indolization,
[126]
 Pictet-Sprengler 
cyclization
[127]
 and Curtius rearragement.
[128]
 Moreover, the synthesis can be 
accomplished by exploiting the potential of transition metal catalysts
[129]
, for example 
Suzuki,
[130]
 Sonogashira,
[131]
 C-N coupling/C-H activation,
[132]
 isocyanide insertion,
[133]
 
and carbonylative cyclization
[134]
 (Scheme 35).  
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In this relation, the application of sequential regioselective Suzuki reaction of 
ortho-dihaloquinolines with (2-bromophenyl)boronic acid (8) followed by double 
C-N coupling offers a new convenient pathway to 11-substituted 
11H-indolo[3,2-c]quinolines and 6-substituted 6H-indolo[2,3-b]quinolines 
(Scheme 36). 
 
Scheme 35: Examples of palladium-catalyzed synthesis of indoloquinolines [130a, 132a-f, 133c, 
134]  
 
Scheme 36: Synthesis of 11-substitued 11H-indolo[3,2-c]quinolines and 6-substitued 
6H-indolo[2,3-b]quinolines in this study 
Noticeably, the preparation of 11H-indolo[3,2-c]quinolines bearing substituents at 
position 11 using current synthetic platforms still remains a synthetic challenge. Thus 
far, it has been enabled to synthesize 11H-indolo-[3,2-c]quinolines with no substituents 
at position 11, followed by a regioselective successive alkylation (Scheme 37).
[135]
 The 
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regioselectivity of the reaction relies on the low pKa value of the N-H group at position 
11 and the higher basicity of the nitrogen atom at position 5. In basic medium, the N-H 
group at position 11 is preferentially deprotonated. The following nucleophilic attack 
with an alkyl halide proceeds at this position, as the aromaticity of the system is 
retained until the formation of final product (Scheme 38). On the other hand, in a 
neutral medium, the higher basicity of the nitrogen atom at position 5 takes over, 
resulting in a higher nucleophilic character at this position in the N-alkylation reaction. 
However, this regioselective successive alkylation was thus far solely documented for 
the methylation,
[135]
 possibly due to its incompatibility with other substituents.  
 
Scheme 37: Regioselective methylation of 11H-indolo[3,2-c]quinoline 
 
Scheme 38: Mechanism of the regioselective methylation of 11H-indolo[3,2-c]quinolines 
at position 11 
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The initial studies focused on the reaction of 2,3-dihalo-2-methylquinolines 5c-d with 
(2-bromophenyl)boronic acid (8). Among these 2,3-dihalo-2-methylquinolines, 
3-bromo-4-chloro-2-methylquinoline (5c) failed to give the desired product 
3-(2-bromophenyl)-4-chloro-2-methylquinoline (9a) with satisfying yield 
(23%, Scheme 39). It is presumably ascribed to the lack of reactivity of the bromine 
atom. For this reason, 4-chloro-3-iodo-2-methylquinoline (5d) was utilized instead. In 
palladium-catalyzed reactions, iodine is considered to be more reactive than bromine. 
Hence 4-chloro-3-iodo-2-methylquinoline (5d) was expected to deliver better result. 
Pleasingly, the yield increased to 42% (Scheme 40), which was followed by the study of 
the double C-N coupling of 3-(2-bromophenyl)-4-chloro-2-methylquinoline (9a) with 
different primary amines.  
 
 
Scheme 39: Regioselective Suzuki reaction of 3-bromo-4-chloro-2-methylquinoline (5c) 
with boronic acid 8  
 
 
Scheme 40: Regioselective Suzuki reaction of 4-chloro-3-iodo-2-methylquinoline (5d) 
with boronic acid 8 
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Next, an optimization study was carried out for the reaction of 3-(2-bromophenyl)-
4-chloro-2-methylquinoline (9a) with p-toluidine (10a), in which indoloquinoline 11a 
was formed (Table 10). From the screening results, PtBu3∙HBF4 proved superior to 
other phosphorous ligands, furnishing indoloquinoline 11a in virtually quantitative yield 
(95%, entry 2, Table 10).  
Table 10: Optimization study for the synthesis of indoloquinoline 11a  
 
Entry Ligand  Yield
 
1 SPhos 56% 
2 PtBu3∙HBF4  95% 
3 dppf  63% 
4 (S)-BINAP 78% 
Reaction conditions: 9a (0.10 mmol), 10a (0.15 mmol), Pd2dba3 (0.005 mmol), ligands (0.005 mmol for 
monodentate or 0.010 mmol for bidentate ligands), NaOtBu (0.24 mmol), toluene (2 ml), 100 °C, 14 h; 
The yields were referred to as isolated yields  
 
Subsequently, the preparative scope of the reaction was assessed. The reaction of 
3-(2-bromophenyl)-4-chloro-2-methylquinoline (9a) with different electron-rich 
aromatic primary amines 10a-n assembled corresponding indoloquinolines 11a-n in 
good to excellent yields (Table 11). 
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Table 11: Synthesis of 11H-indolo[3,2-c]quinolines 11a-n from electronically rich and 
electronically neutral aromatic amines 
 
11a (93%) 11b (89%) 11c (93%) 11d (92%) 
 
11e (93%) 11f (90%) 11g (95%) 
 
11h (91%) 
 
11i (89%) 11j (97%) 11k (85%) 11l (89%) 
 
11m (83%) 
 
11n (91%)   
Reaction conditions: 9a (0.150 mmol), 10a-n (0.225 mmol), Pd2dba3 (0.0075 mmol), PtBu3∙HBF4 (0.015 mmol), NaOtBu 
(0.36 mmol), toluene (3 ml), 100 °C, 24 h. The yields were referred to as isolated yields. 
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Table 12: Optimization study for the synthesis of indolo[3,2-c]quinoline 11o  
 
Entry Ligand  Yield
 
1 SPhos  73% 
2 PtBu3∙HBF4  67% 
3 dppf  59% 
4 (S)-BINAP  95% 
Reaction conditions: 9a (0.10 mmol), 10o (0.15 mmol), Pd2dba3 (0.005 mmol), ligand (0.005 mmol for 
monodentate or 0.010 mmol for bidentate ligands, NaOtBu (0.24 mmol), toluene (2 ml), 100 °C, 14 h. 
The yields were referred to as isolated yields. 
For the employment of electronically poor aryl amines, PtBu3∙HBF4 did not perform 
effectively. Thus, another ligand screening was accomplished for the reaction of 
3-(2-bromophenyl)-4-chloro-2-methylquinoline (9a) and 4-fluoroaniline (10o) 
(Table 12). (S)-BINAP was identified as the preferred ligand for this reaction. When 
using the catalyst system Pd2dba3/(S)-BINAP and the base NaOtBu in toluene, the 
resulting indoloquinoline 11o was afforded in 95% (entry 4, Table 12).  
Applying these optimum conditions, the scope of the double C-N coupling with 
electron-poor aromatic amines 11o-q was probed (Table 13). The yields were obtained 
in the range between 77% and 95% (Table 13). The conditions were also found to be 
applicable for the treatment of 3-(2-bromophenyl)-4-chloro-2-methylquinoline (9a) with 
benzylic and aliphatic amines, in which the resulting indoloquinolines 11r-t were 
afforded in good to excellent yield (Table 13).  
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Table 13: Synthesis of indolo[3,2-c]quinolines 11o-t from electron-poor aromatic, 
benzylic and aliphatic amines  
  
 
11o (95%) 
 
11p (77%) 
 
11q (93%) 
 
11r (96%) 
 
11s (83%) 
 
11t (78%) 
Reaction conditions: 9a (0.150 mmol), 10o-t (0.225 mmol), Pd2dba3 (0.0075 mmol), (S)-BINAP (0.0075 mmol), 
NaOtBu (0.36 mmol), toluene (3 ml), 100 °C, 24 h. The yields were referred to as isolated yields. 
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The molecular structure of indoloquinoline 11g was independently confirmed by X-ray 
crystal analysis. The asymmetric unit of indoloquinoline 11g comprises three molecular 
units, of which a representative is illustrated in Figure 15. The core indoloquinoline ring 
adopts a planar configuration. The methoxylphenyl groups in these molecules deviate 
from the aromatic plane with angles of 63.53(3) °, 87.13(4) ° and 78.84(3) °. Further 
observation of these structures reveals π-π-stacking interactions in the molecular 
network (Figure 16). The shortest distance between two adjacent indoloquinoline planes 
is 3.639 Å.  
 
 
Figure 15: Molecular structure of 11H-indolo[3,2-c]quinoline 11g in the crystal 
 
Figure 16: --Stacking interactions in the crystal of 11H-indolo[3,2-c]quinoline 11g 
52 
 
With a series of 11H-indolo[3,2-c]quinolines 11a-t successfully prepared, the synthesis 
of 6H-indolo[2,3-b]quinolines from 2,3-dihaloquinolines was ascertained. First, the 
reaction of 3-bromo-2-chloroquinoline (5a) with (2-bromophenyl)boronic acid (8) 
occurred predominantly at position 3 of the quinoline ring, since the chemo-selective 
effect dominates in this instance. The resulting 3-(2-bromophenyl)-2-chloroquinoline 
(9b) was generated in good yield (Scheme 41).  
 
Scheme 41: Regioselective Suzuki reaction of 3-bromo-2-chloroquinoline (5a) 
Next, the reaction of 3-(2-bromophenyl)-2-chloroquinoline (9b) with p-toluidine (10a) 
was optimized (Table 15). During the optimization, different ligands were applied using 
the palladium source Pd2dba3 and the base NaOtBu in toluene (Table 15). Among these 
ligands, PtBu3∙HBF4 worked most effectively, yielding indoloquinoline 12a in 95% 
(entry 2, Table 14). It is worth noting that these conditions are identical to those applied 
for the assembly of indoloquinolines 11a-n. 
Table 14: Optimization study of the synthesis of 6H-indolo[2,3-b]quinoline 12a 
 
Entry Ligand  Yield
 
1 Xantphos  59%  
2 PtBu3∙HBF4   95% 
3 SPhos  68% 
4 dppf  55%  
5 (S)-BINAP   68% 
Reaction conditions: 9b (0.10 mmol), 10a (0.15 mmol), Pd2dba3 (0.005 mmol), ligand (0.005 mmol for monodentate 
or 0.010 mmol for bidentate ligands), NaOtBu (0.24 mmol), toluene (2 ml), 100 °C, 14 h.  
The yields were referred to as isolated yields. 
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The reaction under the optimized conditions proved effective across different primary 
amines (Table 15). Corresponding indoloquinolines 12a-h were afforded in up to 95% 
yield (Table 15). In general, the yields obtained with electronically neutral and 
electronically rich aromatic amines were similarly high (12a-d, Table 15). The highest 
yield gave indoloquinoline 12a in 95%. In comparison, lower yields were afforded with 
aliphatic and electronically poor aromatic amines, with the lowest observed for 
indoloquinoline 12g (Table 15).  
Table 15: Synthesis of 6H-indolo[2,3-b]quinolines 12a-h 
 
 
12a (95%) 
 
12b (91%) 
 
12c (89%) 
 
12d (92%) 
 
12e (83%) 
 
12f (75%) 
 
12g (68%) 
 
12h (80%) 
 Reaction conditions: 9b (0.150 mmol), amines (0.225 mmol), Pd2dba3 (0.0075 mmol), PtBu3∙HBF4 (0.015 mmol), 
NaOtBu (0.36 mmol), toluene (3 ml), 100 °C, 24 h. The yields were referred to as isolated yields. 
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To summarize, the preparation of 6H-indolo[3,2-c]quinolines and 
6H-indolo[2,3-b]quinolines by regioselective Suzuki reaction followed by double C-N 
coupling was established, demonstrating a wide scope with electron-rich, electron-poor 
aromatic and aliphatic amines being compatible. Noticeably, the syntheses of these two 
derivatives employed the same reaction conditions for the incorporation of 
electronically rich and electronically neutral aromatic amines. 
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3.2.2. Synthesis of benzo[a]carbazoles from ortho-dihalonaphthalene 
 
Benzo[a]carbazole is a fused form of carbazole with larger structure and greater 
aromaticity.
[136]
 With these largely fused aromatic systems, they are considered as 
potential candidates for medicinal and material application. In the medicinal field, a 
handful of derivatives of benzo[a]carbazole are capable of interacting with DNA,
[137]
 
binding on estrogen receptor
[138]
 or selectively inhibiting on cyclin dependent 
Kinase 4.
[139]
 Additionally, other benzo[a]carbazole derivatives have been applied in the 
field of OLED and solar cell.
[79c, 114]
 Representative examples of benzo[a]carbazoles 
with potential applications as antitumor agent (R16-8)
[113]
 and BTB-sensitizers for high 
efficient solar cell (JY22)
[79c]
 are illustrated in Figure 17. Given this remarkable 
potential for applications in both biological and physical field, a large number of patents 
have emerged with reference to benzo[a]carbazole structures lately. 
  
R16-8 JY22 
Figure 17: Examples of benzo[a]carbazole derivatives with biological and physical 
importance 
In classic chemistry, the installation of benzo[a]carbazole scaffolds can be 
accomplished via different approaches including Diels-Alder reaction,
[140]
 Fischer 
synthesis/selective oxidation,
[113, 141]
 Fischer-Borsche indole synthesis,
[142]
 Cadogan 
cyclization,
[143]
 Scholl-type oxidative cyclization,
[144]
 or by exploiting the dual character 
of benzoquinone.
[145]
 The development of palladium-catalyzed chemistry have 
ultimately offered additional possibilities for their synthesis, for example 
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by C-C coupling/C-H activation,
[146]
 C-N coupling/C-H activation,
[147]
 Sonogashira/ 
hydroamination/cyclization
[148]
 and isocyanide insertion/C-H activation
[149]
 
(Scheme 42). Despite these significant progresses, convenient and atom-efficient 
methods using facilely attainable starting materials for the preparation of these 
biologically and physically important scaffolds are still needed.  
 
Scheme 42: Examples of palladium-catalyzed synthesis of benzo[a]carbazole[146-149] 
Following the synthesis of indoloquinolines in Chapter 3.2.1, another study for the 
assembly of benzo[a]carbazoles (PR4) from 1,2-dihalonaphthalene was undertaken in 
this contribution (Scheme 43).  
 
Scheme 43: Synthesis of benzo[a]carbazoles in this study 
At the beginning of the study, 1-bromo-2-(2-bromophenyl)naphthalene (14) was 
obtained from the regioselective Suzuki reaction of 1-bromonaphthalen-2-yl 
trifluoromethanesulfonate (13) with (2-bromophenyl)boronic acid (8) under the 
previously reported conditions (Scheme 44).
[150]
 Remarkably, the regioselectivity of this 
reaction was reversed compared to that given in the original report. This is possibly 
ascribed to the presence of the electron-withdrawing and voluminous bromine atom at 
the ortho-position of the boronic acid 8.  
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Scheme 44: Regioselective Suzuki reaction of ortho-dihalonaphthalene 13 
 
The resulting 1-bromo-2-(2-bromophenyl)naphthalene (14) and 4-methoxyaniline were 
selected as model substrates for the optimization study of the double C-N coupling. 
Different ligands were applied in the presence of the catalyst Pd2dba3 and the base 
NaOtBu in toluene (Table 16). From the optimization results, the monodentate ligand 
PtBu3∙HBF4 afforded benzo[a]carbaole 15a in good yield (89%), but Xantphos 
outperformed giving benzo[a]carbazole 15a in nearly quantitative yield (95%). 
 
Table 16: Optimization for the synthesis of benzo[a]carbazole 15a 
 
Entry Ligand Yield
 
1 PtBu3∙HBF4   89% 
2 (S)-BINAP   90% 
3 SPhos   92% 
4 dppf  65% 
5 Xantphos   95% 
Reaction conditions: 14 (0.10 mmol), amine (0.15 mmol), Pd2dba3 (0.005 mmol), ligands (0.01 mmol for monodentate or 
0.005 mmol for bidentate ligands), NaOtBu (0.24 mmol), toluene (2 ml), 100 °C, 14 h.  
The yields were referred to as isolated yields. 
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Table 17: Synthesis of benzo[a]carbazoles 15a-n 
 
15a (95%) 15b (82%) 15c (87%) 15d (91%) 
 
15e (78%) 15f (81%) 15g (87%) 
 
15h (83%) 
 
15i (88%) 
 
15j (83%) 
 
15k (78%)
* 
 
15l (67%)
* 
 
15m (93%)
* 
 
15n (90%)
* 
 
15o (91%)
* 
 
Reaction conditions: 14 (0.150 mmol), amine (0.225 mmol), Pd2dba3 (0.0075 mmol), XantPhos (0.0075 mmol), 
NaOtBu (0.36 mmol), toluene (3 ml), 100 °C, 24 h. The yields were referred to as isolated yields.  
* 14 (0.150 mmol), amine (0.225 mmol), Pd2dba3 (0.0075 mmol), (S)-BINAP (0.0075 mmol), NaOtBu (0.36 mmol), toluene (3 ml), 
100 °C, 14 h. The yields were referred to as isolated yields. 
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With the optimized conditions in hand, the preparative scope of the reaction was 
evaluated. Different primary aryl amines were applied (Table 17). For electron-poor and 
nonaryl amines, Xantphos delivered products in low yields, thus (S)-BINAP was used 
instead. Noticeably, (S)-BINAP proved to be the most suited ligand for the double C-N 
coupling with electron-deficient aromatic amines in Chapter 2.2.1. Among the 
synthesized benzo[a]carbazoles, the highest yield was obtained with 15a (95%), while 
the lowest was observed for the electronically poor system 15l (67%). In comparison, 
the yields afforded with benzylic and aliphatic amines were very good, all being higher 
than 90% (15m-o, Table 17). However, no clear correlation between chemical structures 
and obtained yields was observed. 
In conclusion, benzo[a]carbazoles were efficiently synthesized by iterative reaction 
sequence involving a regioselective Suzuki reaction and a double C-N coupling. The 
reactions proceeded in good to excellent yields. 
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3.2.3. Synthesis of thienoindoles from ortho-dihalothiophenes 
 
Thiophene naturally exists as minority in petroleum. Notwithstanding this minority, 
thiophene-fused heterocycles have great potential for applications in medicine and 
material science. For example, Olanzapine has been employed for the treatment of 
schizophrenia,
[151]
 and DTTO can be used as fluorescent markers for visualizing 
biological cells
[152]
 (Figure 18). 
 
 
 
Olanzapine DTTO TI-DTBT3 
Figure 18: Relevant thiophene-derived compounds 
This study focuses on the chemistry of thienoindoles. These compounds were reported 
with antiviral properties.
[153]
 Furthermore, thienoindoles can be incorporated in the 
structures of polymers for solar cell applications. For example, TI-DTBT3 is a 
donor-acceptor conjugated polymer with high charge carrier mobility (Figure 18).
[154]
 
The first syntheses of these thienoindoles were accomplished in 1982 by the reaction of 
(a) substituted indole with thioamide
[155]
 and (b) 3-hydroxythiophene with hydrazine
[153]
 
(Scheme 45). Although these syntheses were considered tedious and not modular, no 
improvement was documented until 2000. Fortunately, modern palladium-catalyzed 
cross-coupling reactions have allowed the synthesis of thienoindoles through more 
convenient routes. These syntheses start with a Suzuki reaction to furnish a new C-C 
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bond from the thiophene or benzene backbone, followed by a ring-closure. The 
ring-closing process can be accomplished in different manners including (c) nitrene 
insertion,
[156]
 (d) oxidative C-N coupling
[157]
 or (e) Cadogan cyclization
[158]
 
(Scheme 45).  
Scheme 45: Previously reported synthesis of thieno[3,2-b]indoles and thieno[3,4-
b]indoles 
Here, a convenient and efficient approach for the synthesis of thieno[3,2-b]indoles and 
thieno[3,4-b]indoles (product series PR5) is presented. The protocol features a 
site-selective Suzuki reaction of ortho-dihalothiophenes with (2-bromophenyl)boronic 
acid (8), followed by a double C-N coupling with primary amines (Scheme 46). 
 
Scheme 46: Synthesis of thieno[3,2-b]indoles and thieno[3,4-b]indoles in this study 
 
At first, 2,3-dibromothiophene (16a) was converted into the desired 3-bromo-
2-(2-bromophenyl)thiophene (17a) after the treatment with (2-bromophenyl)boronic 
62 
 
acid (8) under palladium-catalyzed conditions (Scheme 47). The reaction proceeded 
smoothly, with site-selectivity favoring position 2 over position 3 of the thiophene ring. 
The resulting 3-bromo-2-(2-bromophenyl) thiophene (17a) was accessed in 82% yield 
(Scheme 47). 
 
Scheme 47: Site-selective Suzuki reaction of 2,3-dibromothiophene 
Thereafter, 3-bromo-2-(2-bromophenyl) thiophene (17a) and 4-toluidine were chosen as 
model substrates for the optimization of the double C-N coupling. In the presence of the 
palladium source Pd2dba3 and the base NaOtBu in toluene, the ligand screening was 
conducted (Table 18). From the optimization experiments, dppf proved to be the best 
ligand while giving thieno[3,2-b]indole 18a in 97% yield (entry 2, Table 18).  
Table 18: Optimization study for synthesis of thieno[3,2-b]indole 18a 
 
Entry Ligand  Yield
 
1 PtBu3∙HBF4 86% 
2 dppf 97% 
3 SPhos 65% 
4 (S)-BINAP 67% 
Reaction conditions: 17a (0.10 mmol), amine (0.15 mmol), Pd2dba3 (0.005 mmol), ligands (0.005 mmol for 
monodentate or 0.010 mmol for bidentate ligands), NaOtBu (0.24 mmol), toluene (2 ml), 100 °C, 14 h. 
The yields were referred to as isolated yields. 
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Table 19: Synthesis of thieno[3,2-b]indoles 18a-t 
 
 
18a (97%) 
 
18b (77%) 
 
18c (83%) 
 
18d (90%) 
 
18e (90%) 
 
18f (98%) 
 
18g (91%) 
 
18h (92%) 
 
18i (87%) 
 
18j (92%) 
 
18k (89%) 
 
18l (92%) 
 
18m (92%) 
 
18n (78%) 
 
18o (72%) 
 
18p (91%)
b
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18q (86%)
b
 
 
18r (81%)
b
 
 
18s (95%)
b
 
 
18t (75%)
b
 
Reaction conditions: 17a (0.150 mmol), amine (0.225 mmol), Pd2dba3 (0.0075 mmol), dppf (0.0075 mmol), NaOtBu (0.36 mmol), 
toluene (3 ml), 100 °C, 24 h. The yields were referred to as isolated yields. 
b 17a (0.150 mmol), amine (0.225 mmol), Pd2dba3 (0.0075 mmol), (S)-BINAP (0.0075 mmol), NaOtBu (0.36 mmol), toluene (3 ml), 
100 °C, 14 h.  
The yields were referred to as isolated yields.  
The reaction of 3-bromo-2-(2-bromophenyl) thiophene (17a) with different primary 
amines under these optimized conditions proceeded with good to excellent yields of 
corresponding thieno[3,2-b]indoles 18a-t (Table 19). For electron-poor and aliphatic 
amines, the ligand dppf gave low yields, and (S)-BINAP was used instead. The highest 
yield was obtained with the electron-rich thieno[3,2-b]indole 18f (98%) in contrasting 
to the lowest yield observed for the large -system 18o (72%). Moreover, the synthesis 
also allowed the incorporation of sterically hindered amines in the case of 18b (77%) 
and 18k (89%). 
 
 
Scheme 48: Site-selective Suzuki reaction of 3,4-dibromothiophene 
In another context, the preparation of thieno[3,4-b]indoles following the same strategy 
was studied. 3-Bromo-4-(2-bromophenyl)thiophene (17b) was attained from the 
site-selective Suzuki reaction of 3,4-dibromothiophene (16b) with 
(2-bromophenyl)boronic acid (8) (Scheme 48).  
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Table 20: Optimization for the synthesis of thieno[3,4-b]indole 19a 
 
Entry Ligand  Yield
 
1 PtBu3∙HBF4  95% 
2 dppf  43% 
3 SPhos  65% 
4 (S)-BINAP  36% 
Reaction conditions: 17b (0.10 mmol), amine (0.15 mmol), Pd2dba3 (0.005 mmol), ligands (0.005 mmol for 
monodentate or 0.010 mmol for bidentate ligands), NaOtBu (0.24 mmol), toluene (2 ml), 100 °C, 14 h.  
The yields were referred to as isolated yields. 
 
Table 21: Synthesis of thieno[3,4-b]indoles 19a-f 
 
 
19a (95%) 
 
19b (65%) 
 
19c (83%) 
 
19d (85%) 
 
19e (81%) 
 
19f (78%) 
Reaction conditions: 17b (0.150 mmol), amine (0.225 mmol), Pd2dba3 (0.0075 mmol), PtBu3∙HBF4 (0.015 mmol), 
NaOtBu (0.36 mmol), toluene (3 ml), 100 °C, 24 h. The yields were referred to as isolated yields. 
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The influence of the ligands on the reaction of 3-bromo-4-(2-bromophenyl)thiophene 
(17b) and 4-toluidine was surveyed (Table 20). The screening data revealed that 
PtBu3∙HBF4 was the preferred ligand for this reaction, furnishing corresponding 
thienoindole 19a in almost quantitative yield (entry 1, Table 20).  
These conditions were applied for the reaction of 3-bromo-4-(2-bromophenyl)thiophene 
(17b) with different primary aryl amines, delivering corresponding thienoindoles 19a-f 
in good to excellent yields (65% - 95%, Table 21). In general, the involvement of 
electron donating groups on the amines resulted in high yield of desired 
thieno[3,4-b]indoles. The highest yield of 95% was observed for the product 19a which 
was selected as model substrate for the above optimization. In comparison, 
thieno[3,4-b]indole 19b was created in moderate yield (65%), possibly as a result of 
steric hindrance.  
To conclude, the preparation of thieno[3,2-b]indoles and thieno[3,4-b]indoles from 
ortho-dibromothiophenes following sequential site-selective Suzuki reaction/double 
C-N coupling was successfully conducted. The double C-N coupling reaction proceeded 
with good to excellent yields. The key for the success of the reaction was the ligand 
choice.  
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3.3. Synthesis of phenanthridine-fused heterocycles from 
ortho-dihaloarenes by regioselective Sonogashira reaction followed 
by domino C-N coupling/hydroamination/C-H arylation 
The concept hydroamination describes the direct formation of new C-N bond through 
the addition of an N-H group to a multiple C-C bond. The atom-economic property of 
this concept makes it appealing to synthetic chemists. However, classic chemistry only 
allowed such a C-N formation via conjugate addition of electron-rich amines to 
electron-poor alkynyl groups (Scheme 49).   
 
Scheme 49: Conjugate addition on alkynyl group in classic chemistry[159] 
For other systems, an activation of the amine or the alkynyl group is required. In 1935, 
an early effort was made to activate the amines using alkali metal, albeit in harsh 
conditions (Scheme 50). Later studies discovered milder conditions by using bases, 
metal catalysts of rare earth group, group IV, and late transition metals.
[160]
 
 
Scheme 50: Early example of hydroamination 
 
 
Scheme 51: Example of palladium-catalyzed domino reaction involving intramolecular 
hydroamination[161] 
Of practical importance among different types of hydroamination are the 
palladium-catalyzed intramolecular hydroamination reactions via 5-endo-dig cyclization 
which form pyrrole structures.
[162]
 These reactions were frequently applied in a domino 
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fashion with other transformations including alkylation,
[163]
 Michael,
[164]
 Heck,
[165]
 
Sonogashira,
[166]
 reductive elimination
[167]
 and carbonylation
[134]
 to form different fused 
heterocycles. These reaction concepts were considered as atom-economic and gained 
therefore increasing attention in organic chemistry recently (Scheme 51). 
One of the interests in this study is the development of new convenient and 
atom-economic syntheses of nitrogen-containing polycyclic aromatic compounds, 
which involve Sonogashira-, C-N coupling, hydroamination and C-H arylation in 
one-pot or domino manner. Regarding this, an indole synthesis from ortho-haloanilines 
and aryl acetylenes via domino Sonogashira reaction/hydroamination was disclosed by 
Larock et al. in 1991 (Scheme 52).
[168]
 In 2005, Ackermann et al. reported a 
construction of indole by domino C-N coupling/hydroamination using 
ortho-halo(arylethynyl)-benzenes and aryl amines as starting materials (Scheme 52).
[169]
 
Later, this reaction model was optimized for the ortho-halo(arylethynyl) heterocyclic 
systems of benzothiophene,
[170]
 coumarin
[171]
 and quinolone.
[172]
 
 
Scheme 52: Synthesis of indole by intramolecular hydroamination 
 
 
Scheme 53: Synthesis of phenanthridine-fused heterocycles by C-H arylation 
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Further atom-economic syntheses of nitrogen heterocycles incorporating Sonogashira 
reaction, C-N coupling and hydroamination emerged in 2006. They were reports with 
reference to the construction of phenanthridines (Scheme 53).
[173]
 In these syntheses, a 
six-membered ring arises from a C-X/C-H typed C-H arylation. 
 
Scheme 54: Synthesis of indolo[1,2-f]phenanthridines by one-pot hydroamination/C-H 
arylation[174] 
 
Scheme 55: Synthesis of phenanthridine-fused heterocycles by regioselective Sonogashira 
reaction followed by a domino C-N coupling/hydroamination/C-H arylation[175] 
In 2014, this C-H arylation was exploited in a one-pot process involving a domino 
Chan-Lam C-N coupling followed by a hydroamination (Scheme 54).
[174]
 In 2015, the 
preparations of phenanthridine-fused compounds which involved domino C-N 
coupling/hydroamination/C-H arylation have been finally devised by Langer et al. 
(Scheme 55).
[175]
 The syntheses started with an ortho-dihaloarene which underwent a 
regioselective Sonogashira reaction to form an ortho-halo-(arylalkynyl)arene. Next, the 
reactions of the ortho-halo-(arylalkynyl)arenes with different ortho-haloaryl amines 
proceeded via domino C-N coupling/intramolecular hydroamination/C-H arylation to 
assemble corresponding phenanthridine-fused heterocycles (Scheme 55). 
In this contribution, the reaction model domino C-N coupling/hydroamination/C-H 
arylation was further exploited representing a gateway to phenanthridine-fused 
compounds (PR6-8, Chapter 3.3.1-3) with no synthetic precedent.  
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3.3.1. Synthesis of benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridines 
from 2,3-dibromobenzothiophenes  
 
Phenanthridine is a tricyclic heterocycle, of which fused derivatives have found 
applications in medicine and material science. For example, sanguinarine is a potential 
candidate for the treatment of cancer, 
[176]
 while BT2 exhibits interesting photochemical 
properties
[177]
 (Figure 19). Henceforth, great efforts were devoted to synthesize fused 
derivatives of phenanthridine with coumarin, pyrrole, purine, indole, imidazole, 
benzimidazole and quinazoline.
[177-178]
  
 
  
sanguinarine BT2 
benzo[4',5']thieno[2',3':4,5]-
pyrrolo[1,2-f]phenanthridine 
Figure 19: Relevant phenanthridine-fused compounds 
Herein, a synthetic procedure towards a series of phenanthridine-fused benzothiophenes 
(PR6) was developed. The protocol begins with a site-selective Sonogashira reaction of 
2,3-dibromobenzothiophene with aryl acetylenes, followed by a domino C-N 
coupling/hydroamination/C-H arylation with ortho-bromoaryl amines to afford 
corresponding benzo[4',5']thieno[2',3':4,5]-pyrrolo[1,2-f]phenanthridines (Scheme 56). 
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Scheme 56: Synthesis of phenanthridine-fused heterocycles in this study 
Initial efforts were conducted to carry out the site-selective Sonogashira reaction of 
2,3-dibromothiophene (20) with different aryl acetylenes (Table 22). The reactions 
proceed exclusively at position 2 of 2,3-dibromothiophene, furnishing 3-bromo-
2-(arylethynyl)benzo[b]thiophenes 22a-c in good yields (Table 22). 
Table 22: Synthesis of 3-bromo-2-(arylethynyl)benzo[b]thiophenes 22a-c 
 
 
22a (80%) 
 
22b (85%) 
 
22c (87%) 
Reaction conditions: 2,3-Dibromothiophene (20) (3.0 mmol), aryl acetylene (4.5 mmol), Pd(PPh3)2Cl2 (0.15 mmol), 
CuI (0.3 mmol), NEt3 (2.0 ml), 80 °C, 14 h. The yields were referred to as isolated yields. 
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Table 23: Optimization study for the synthesis of benzo[4',5']thieno[2',3':4,5]pyrrolo-
[1,2-f]phenanthridine (24a) 
 
Entry Pd-source Ligand Base Yield  
1 Pd(OAc)2 Xantphos Cs2CO3 30% 
2 Pd(PPh3)4 Xantphos Cs2CO3 - 
3 Pd(OAc)2 dppf Cs2CO3 35% 
4 Pd(OAc)2 dppe Cs2CO3 42% 
5 Pd(OAc)2 XPhos Cs2CO3 38% 
6 Pd(OAc)2 DavePhos Cs2CO3 40% 
7 Pd(OAc)2 (S)-BINAP Cs2CO3 34% 
8 Pd(OAc)2 SPhos Cs2CO3 30% 
9 Pd(OAc)2 PPh3 Cs2CO3 30% 
10 Pd(OAc)2 PtBu3∙HBF4 Cs2CO3 65% 
11 Pd(PPh3)4 PtBu3∙HBF4 Cs2CO3 - 
12 Pd2dba3 PtBu3∙HBF4 Cs2CO3 55% 
13 Pd(OAc)2 PtBu3∙HBF4 K2CO3 - 
14 Pd(OAc)2 PtBu3∙HBF4 KOtBu - 
15
a 
Pd(OAc)2 PtBu3∙HBF4 Cs2CO3 60% 
16
b 
Pd(OAc)2 PtBu3∙HBF4 Cs2CO3 - 
Reaction conditions: 1a (0.1 mmol), 2a (0.12 mmol), [Pd]-source (0.01 mmol), ligand (0.02 mmol for monodentate and 0.01 mmol 
for bidentate ligands), base (0.3 mmol), DMF (3 ml), 140 °C, 24 h. The yields were referred to as isolated yields. 
a reaction was carried out at 160 °C; b reaction was carried out at 120 °C 
 
Next, the domino C-N coupling/hydroamination/C-H arylation of 3-bromo-
2-(arylethynyl)benzo[b]thiophenes 22a-c with different ortho-bromoaryl amines was 
studied, in which corresponding benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]-
phenanthridines were obtained (Table 23). For the optimization experiments, 3-bromo-
2-(arylethynyl)benzo[b]thiophene 22a and 2-bromoaniline (23a) were chosen as model 
substrates. The optimization study was initiated by adopting previously documented 
conditions for analogous procedures, in which indolo[1,2-f]phenanthridines and 
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azaindolo[1,2-f]phenanthridines were assembled by taking advantage of domino C-N 
coupling/hydroamination/C-H arylation reaction (entries 1-2, Table 23). Unfortunately, 
these conditions were unsuccessful. 
After evaluating other ligands in the presence of Pd(OAc)2 with the base Cs2CO3 in 
DMF (entries 3 - 10, Table 23), the highest yield was observed by using PtBu3∙HBF4 
(65%, entry 10, Table 23). Subsequently, different options of ligand sources, bases, 
solvents and reaction temperatures were exhausted (entries 11 - 16, Table 23), but 
proved to be futile in improving the yields. Therefore, the conditions 10 in Table 24 
were chosen for further preparative studies. Interestingly, the parameters of these 
conditions including catalysts, base and solvent were identical to those applied for the 
previously documented synthesis of 1H-benzo[4,5]thieno-[3,2-b]pyrroles by domino 
C-N coupling/hydroamination (Scheme 57).
[170]
 
 
Scheme 57: Previously documented synthesis of 1H-benzo[4,5]thieno[3,2-b]pyrrole by 
domino C-N coupling/hydroamination[170] 
 
Applying the above optimized conditions, the reaction of 3-bromo-
2-(arylethynyl)benzo[b]thiophene 22a-c with 2-bromoaryl amines 23a-c delivered 
corresponding benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridines 24a-o in 55% - 80% 
yield (Table 24). The highest yield gave the electron-rich system 24l.  
Table 24: Synthesis of benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridines 24a-o 
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24a (65%) 
 
24b (68%) 
 
24c (58%) 
 
24d (70%) 
 
24e (60%) 
 
24f (55%) 
 
24g (62%) 
 
24h (57%) 
 
24i (58%) 
  
24j (75%) 
 
24k (58%) 
 
24l (77%) 
 
24m (80%) 
 
24n (66%) 
 
24o (60%) 
Reaction conditions: 22a-c (0.32 mmol), amine (0.38 mmol), Pd(OAc)2 (0.032 mmol), PtBu3∙HBF4 (0.064 mmol), base 
(0.96 mmol), DMF (4 ml), 140 °C, 24 h. The yields were referred to as isolated yields. 
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Scheme 58: Alternative route to benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridines 
In the next place, an alternative route to benzothieno[2’,3’:4,5]pyrrolo-
[1,2-f]phenanthridine was ascertained (Scheme 58). In this route, both bromine atoms 
are incorporated in the starting material 3-bromo-2-((2-bromophenyl)ethynyl)benzo[b]-
thiophene (25). Therefore, the second reaction partner is simply aryl amine instead of 
ortho-bromoaryl amine (Scheme 59). It is assumed that Pd catalyst would likely attack 
the C-Br bond at the benzothiophene first (Scheme 58). After the hydroamination, the 
C-H arylation would occur with the second C-Br bond to form the corresponding 
product (Scheme 58). 
 
Scheme 59: Synthesis of 3-bromo-2-((2-bromophenyl)ethynyl)benzo[b]thiophene (25) 
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Table 25: Synthesis of benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridines 26a-h 
 
 
26a (60%) vs. 24a (65%) 
 
26b (65%) vs. 24b (58%) 
 
26c (50%) vs. 24c (58%) 
 
26d (65%) 
 
26e (60%) 
 
26f (52%) 
 
26g (55%) 
 
26h (48%)  
Reaction conditions: 22a-c (0.32 mmol), amine (0.38 mmol), Pd(OAc)2 (0.032 mmol), PtBu3∙HBF4 (0.064 mmol), 
Cs2CO3(0.96 mmol), DMF (4 ml), 140 °C, 24 h. The yields were referred to as isolated yields.
 
Pleasingly, under the best conditions described in Table 24, the reaction of 3-bromo-
2-((2-bromophenyl)ethynyl)benzo[b]thiophene (25) with different aryl amines proved to 
be similarly effective compared to the prior procedure (26a-c, Table 25). The yield 
observed for benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridine 26b was even slightly 
higher by applying this procedure. Further application of these conditions for the 
reactions with other amines afforded benzothieno[2’,3’:4,5]pyrrolo-
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[1,2-f]phenanthridines 26d-h in moderate to good yields (48% - 65%, Table 25). 
Electronically rich, electronically poor and even sterically encumbering amines proved 
to be compatible reaction partners for this chemical transformation. 
 
 
Figure 20: Molecular structure of benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridine 24h 
The molecular structure of benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridine 24h was 
independently confirmed by X-ray structure determination (Figure 20). The aromatic 
backbone exhibits a noticeable distortion from planarity due to the electronic repulsion 
between the rings (C17 - C22) and (C10 - C15).  
To summarize, by applying regioselective Sonogashira reaction of 
2,3-dibromothiophene and aryl acetylene followed by domino C-N coupling/ 
hydroamination/C-H arylation, the previously unknown fused systems of 
phenanthridine with benzothiophene were attained in moderate to good yields. For the 
domino C-N coupling/hydroamination/C-H arylation reaction, two alternative sets of 
starting materials were applied with the first set involving two bromine atoms at two 
individual reaction partners and the second set consisting of two bromine atoms at the 
sole substrate.  
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3.3.2. Synthesis of quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines from 
ortho-dihaloquinoline  
 
On the basis of the synthesis of benzothieno[2’,3’:4,5]pyrrolo-[1,2-f]phenanthridines, 
further effort was devoted to prepare quinolino[3',4':4,5]pyrrolo-[1,2-f]phenanthridines 
28a-p (product series PR7) by an analogous route (Scheme 60).  
 
Scheme 60: Synthesis of quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines in this study 
Initially, the regioselective Sonogashira reaction of 4-chloro-3-iodo-2-methylquinoline 
(5d) with electronically rich, -neutral and -poor aryl acetylenes (21a-e) was carried out. 
Although position 4 of the quinoline ring is more electron-deficient than position 3, the 
reaction prefers the latter over the former. The reason for this was the higher reactivity 
of the iodine compared to chlorine atom. Furthermore the chemo-selectivity factor 
would take over electronic effect in general palladium-catalyzed reaction. For this 
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reason, the reactions afforded regioselectively 4-chloro-2-methyl-
3-(arylethynyl)quinolines 27a-e (Table 26).  
Table 26: Synthesis of 4-chloro-2-methyl-3-(arylethynyl)quinolines 27a-e by 
regioselective Sonogashira reaction 
 
27a (70%) 27b (75%) 27c (80%) 
27d (83%) 27e (78%)  
Reaction conditions: 4-Chloro-3-iodo-2-methylquinoline (5d) (3.0 mmol), aryl acetylene (4.5 mmol), Pd(PPh3)2Cl2 (0.15 mmol), 
CuI (0.3 mmol), NEt3 (2.0 ml), 80 °C, 14 h. The yields were referred to as isolated yields. 
 
Next, 4-chloro-2-methyl-3-(arylethynyl)quinoline (27a) and 2-bromo-4-methylaniline 
(23a) were selected as model substrates for the optimization study of the domino C-N 
coupling/hydroamination/C-H arylation. In the presence of Pd(OAc)2 and the base 
Cs2CO3 in DMF, different ligands were probed. It was found that both monodentate and 
bidentate ligands yielded the desired product 28a, but SPhos emerged as preferred 
ligand giving 6-methylquinolino[3’,4’:4,5]-pyrrolo[1,2-f]phenanthridine 28a in 65% 
yield (entry 9, Table 28). Next, the robustness of these reaction conditions was checked. 
By changing the base, the reaction failed to deliver the expected results. Besides, the 
palladium source Pd2dba3 proved inferior, while Pd(PPh3)4 yielded virtually no 
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corresponding product (entry 10-11, Table 27). Therefore, the best conditions 9 in 
Table 27 were applied for the study of the preparative reaction scope of the reaction. 
Table 27: Optimization study for the synthesis of 6-methylquinolino-
[3’,4’:4,5]pyrrolo[1,2-f]phenanthridine (28a) 
 
 Entry [Pd]-Source Ligand  Base Yield 
1 Pd(OAc)2 Xantphos  Cs2CO3 25% 
2 Pd(OAc)2 dppe  Cs2CO3 42% 
3 Pd(OAc)2 dppf  Cs2CO3 30% 
4 Pd(OAc)2 DavePhos  Cs2CO3 45% 
5 Pd(OAc)2 (S)-BINAP  Cs2CO3 38% 
6 Pd(OAc)2 Xphos  Cs2CO3 40% 
7 Pd(OAc)2 PtBu3∙HBF4  Cs2CO3 50% 
8 Pd(OAc)2 PPh3  Cs2CO3 30% 
9 Pd(OAc)2 Sphos  Cs2CO3 65% 
10 Pd(PPh3)4 Sphos  Cs2CO3 - 
11 Pd2dba3 Sphos  Cs2CO3 55% 
12 Pd(OAc)2 Sphos  K2CO3 - 
13 Pd(OAc)2 Sphos KOtBu - 
Reaction conditions: 27a (0.1 mmol), amine (0.12 mmol), [Pd]-source (0.01 mmol), ligand (0.02 mmol for monodentate or 
0.01 mmol for bidentate ligands), base (0.3 mmol), DMF (3 ml), 140 °C, 24 h. The yields were referred to as isolated yields. 
Under these conditions, the reaction of 4-chloro-2-methyl-3-(arylethynyl)quinolines 
27a-e with different 2-bromo-aryl amines produced corresponding 
quinolino[3’,4’:4,5]pyrrolo[1,2-f]phenanthridines 28a-p in moderate to good yields 
(42% - 81%, Table 28). Aryl amines with different electronic structures were tolerated, 
but there is no correlation between the structure and the reaction yield revealed from the 
data.  
81 
 
Table 28: Synthesis of quinolino[3’,4’:4,5]pyrrolo[1,2-f] phenanthridines 28a-p 
 
 
28a (65%) 
 
28b (60%) 
 
28c (58%) 
 
28d (67%) 
 
28e (70%) 
 
28f (63%) 
 
28g (62%) 
 
28h (67%) 
 
28i (58%) 
 
28j (81%) 
 
28k (65%) 
 
28l (42%) 
82 
 
 
28m (47%) 
 
28n (64%) 
 
28o (67%) 
 
28p (53%)   
Reaction conditions: 27a-e (0.32 mmol), amine (0.38 mmol), Pd(OAc)2 (0.032 mmol), SPhos (0.064 mmol), base (0.96 mmol), 
DMF (4 ml), 140 °C, 24 h. The yields were referred to as isolated yields. 
 
Figure 21: Molecular structure of 28l in crystal 
The molecular structure of quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine 28l was 
independently confirmed by means of X-ray crystallographic analysis (Figure 21). The 
structure proof reveals a helical distortion structure of the core aromatic ring. The 
distortion from the planarity is interpreted as the result of the electronic repulsion 
between the hydrogen atoms of the rings (C1-C6) and (C19-C24). 
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In summary, a series of quinolino[3’,4’:4,5]pyrrolo[1,2-f]phenanthridines was 
synthesized by regioselective Sonogashira reaction followed by domino C-N 
coupling/hydroamination/C-H arylation in moderate to good yields. Compared to the 
synthesis of benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridines in Chapter 3.3.1, 
the monodentate ligand SPhos demonstrated higher effectiveness for the preparation of 
quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines in this study.  
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3.3.3. Synthesis of 11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]-
phenanthridines from 5,6-dihalopyrimidine 
 
Pyrimidine-fused heterocycles were first known in 1776 during the isolation of uric acid 
by Scheele et al.
[179]
 However, their chemistry progressed only since the second half of 
the 1800s, while several syntheses were established.
[180]
 Later, pyrimidines were 
identified to be the core structures of the nucleobases cytosine/guanine and 
thymine/adenine that constitute the DNAs.
[181]
 This finding has motivated scientists to 
carry out further research into fused-pyrimidines, from which a sheer number of 
potential candidates for the application as drugs have been disclosed. For example, 
NQPPs displays enhanced anti-proliferative activity (Figure 22).  
 
 
 
pyrimidine cytosine/guanine NQPPs 
   
uric acid thymine/adenine 
pyrimido[5',4':4,5]pyrrolo[1,2-
f]phenanthridine 
Figure 22: Examples of several pyrimidine-related compounds 
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The successes in the syntheses of benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]-
phenanthridines (Chapter 3.3.1) and quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines 
(Chapter 3.3.2) underpins a further investigation into the synthesis of 
11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines (PR8) in this 
contribution (Scheme 61). Similarly, the synthesis starts with a regioselective 
Sonogashira reaction of 4-chloro-5-iodo-2,6-dimethylpyrimidine (29) with different aryl 
acetylene (step 1, Scheme 61). Subsequently, the corresponding products 4-chloro-
2,6-dimethyl-5-(arylethynyl)-pyrimidines 30a-f are coupled with different 2-haloaryl 
amine via a domino C-N coupling/hydroamination to afford corresponding products 
31a-f (step 2a, Scheme 61), which undergo further C-H arylation, furnishing final 
11,13-dimethylpyrimido-[5',4':4,5]pyrrolo[1,2-f]phenanthridines 32a-f (step 2b, 
Scheme 61). For this synthesis, a subjection of additional catalysts and a change of 
reaction solvents between step 2a and step 2b following a one-pot procedure are 
required (Scheme 61). 
 
Scheme 61: Synthesis of 11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines 
in this study 
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At the outset of the study, the Sonogashira reaction of 4-chloro-5-iodo-
2,6-dimethylpyrimidine (29) with aryl acetylenes delivered predominantly 
corresponding 4-chloro-2,6-dimethyl-5-(phenylethynyl)pyrimidines 30a-f in moderate 
to good yields (Table 29). The selectivity in this reaction was imparted by the 
preference in the reactivity of iodine against chlorine. 
Table 29: Synthesis of 4-chloro-2,6-dimethyl-5-(phenylethynyl)pyrimidines 30a-f by 
regioselective Sonogashira reaction 
 
 
30a (75%) 30b (78%) 30c (80%) 
30d (84%) 30e (62%) 30f (89%) 
Reaction conditions: 4-Chloro-5-iodo-2,6-dimethylpyrimidine (29) (3.0 mmol), aryl acetylene (4.5 mmol), 
Pd(PPh3)2Cl2 (0.15 mmol), CuI (0.3 mmol), NEt3 (2.0 ml), 80 °C, 14 h. The yields were referred to as isolated yields. 
To study the following domino C-N coupling/hydroamination, 4-chloro-2,6-dimethyl-
5-(phenylethynyl)pyrimidine 30a and 2-bromoaniline were chosen as model substrates 
for the optimization. In the presence of the palladium source Pd(OAc)2, the base 
Cs2CO3 and the solvent DMF, the influence of different ligands was monitored. Among 
these ligands, Xantphos was identified as the best ligand, giving corresponding product 
31a in 60% yield (entry 1, Table 30). Next, the palladium sources and bases were tuned. 
This revealed that the palladium source Pd(PPh3)4 resulted in an increase of yield 
compared to Pd(OAc)2. Conducting the reaction in the presence of the catalyst system 
Pd(PPh3)4/Xantphos with the base Cs2CO3 in DMF led to the formation of product 31a 
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in 72% yield (entry 10, Table 30). In contrast, by changing the palladium source to 
Pd2dba3, the yield dropped to 50% (entry 11, Table 30). Besides, the presence of the 
base Cs2CO3 proved crucial for this chemical transformation. The reaction failed to 
furnish the desired products when other bases were applied. 
Table 30: Optimization study for the synthesis of 7-(2-bromophenyl)-2,4-dimethyl-
6-phenyl-7H-pyrrolo[2,3-d]pyrimidine (31a) 
 
Entry [Pd]-source Ligand Base Yield
 
1 Pd(OAc)2 Xantphos Cs2CO3 60% 
2 Pd(OAc)2 XPhos Cs2CO3 45% 
3 Pd(OAc)2 SPhos Cs2CO3 40% 
4 Pd(OAc)2 PtBu3∙HBF4 Cs2CO3 55% 
5 Pd(OAc)2 dppe Cs2CO3 42 
6 Pd(OAc)2 PPh3 Cs2CO3 37 
7 Pd(OAc)2 dppf Cs2CO3 30 
8 Pd(OAc)2 Davephos Cs2CO3 34 
9 Pd(OAc)2 (S)-BINAP Cs2CO3 25 
10 Pd(Ph3P)4 Xantphos Cs2CO3 72% 
11 Pd2dba3 Xantphos Cs2CO3 50 
12 Pd(Ph3P)4 Xantphos K2CO3 - 
13 Pd(Ph3P)4 Xantphos KOtBu - 
Reaction conditions: 30a (0.1 mmol), amine (0.12 mmol), [Pd]-source (0.01 mmol), ligand (0.02 mmol for monodentate or 
0.01 mmol for bidentate ligands), base (0.3 mmol), DMF (3 ml), 100 °C, 14 h. The yields were referred to as isolated yields. 
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Scheme 62: Synthesis of 11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine 
by C-H arylation 
 
Subsequently, the C-H arylation of 7-(2-bromophenyl)-2,4-dimethyl-6-phenyl-
7H-pyrrolo[2,3-d]pyrimidine (31a) was examined. On treatment with catalyst system 
Pd(OAc)2/PPh3 in toluene at 100 °C, 11,13-dimethylpyrimido[5',4':4,5]pyrrolo-
[1,2-f]phenanthridine 32a was furnished in 87% yield (Scheme 62).  
Following this result, a further investigation into the feasibility of conducting the 
domino C-N coupling/hydroamination and the C-H arylation in an one-pot procedure 
was carried out. After the domino C-N coupling/hydroamination was finished, the 
solvent was removed in vacuo followed by the addition of new catalysts and solvent. 
The mixture was heated at 100 °C for additional 6 hours. Gratifyingly, the 
corresponding 11,13-dimethylpyrimido-[5',4':4,5]pyrrolo[1,2-f]-phenanthridine 32a was 
afforded via this one-pot process in 65% yield. This result indicates that the yield was 
not remarkably suffered following a one-pot procedure. Therefore, this model was 
chosen for the following study of the preparative scope of the method. 
Applying this procedure for the reaction of 4-chloro-2,6-dimethyl-
5-(phenylethynyl)pyrimidines 30a-f and different 2-bromoaryl amines, corresponding 
pyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines 32a-p were isolated in moderate to 
good yields (Table 31). There was no clear trend between chemical structure and 
reaction yield. The highest yield gave the system 32g (75%), whereas the lowest 
reaction efficiency was observed for 32n (42%). 
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Table 31: Synthesis of pyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines 32a-i 
 
 
32a (65%) 
 
32b (60%) 
 
32c (70%) 
 
32d (63%) 32e (72%) 32f (70%) 
32g (75%) 32h (55%) 32i (65%) 
32j (51%) 32k (57%) 32l (65%) 
90 
 
32m (72%) 32n (42%) 32o (45%) 
32p (67%)   
Reaction conditions: 30a-f (0.32 mmol), amine (0.38 mmol), Pd(PPh3)4 (0.032 mmol), XantPhos (0.032 mmol), base (0.96 mmol), 
DMF (4 ml), 100 °C, 14 - 24 h; then Pd(OAc)2 (0.032 mmol), PPh3 (0.064 mmol), toluene (2 ml), 100 °C, 6 h.  
The yields were referred to as isolated yields. 
 
To sum up, a synthesis of pyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines was 
developed by regioselective Sonogashira reaction, followed by one-pot domino 
C-N coupling/hydroamination and C-H arylation. In difference to the synthesis of 
benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridines (Chapter 3.3.1) and 
quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines (Chapter 3.3.2), an one-pot procedure 
was applied, in which an addition of further catalysts and a change of solvent between 
the domino C-N coupling/hydroamination and the C-H arylation were key to the 
success of the method.  
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4. Conclusion 
In this PhD research, eight different series PR1-8 of 169 nitrogen-containing 
heterocycles were isolated from ortho-dihaloarenes by three different strategies.  
First, the palladium-catalyzed domino C-C/C-N coupling of imines with 
ortho-dihalopyridines and ortho-dihaloquinolines employed identical reaction 
conditions, furnishing corresponding azaindoles (PR1) and pyrroloquinolines (PR2) in 
moderate to good yields. 
Next, indoloquinolines (PR3), benzo[a]carbazoles (PR4) and thienoindoles (PR5) were 
obtained by regioselective Suzuki reaction/double C-N coupling. The resulting yields 
were from good to excellent. It came obvious that the choice of ligand was essential for 
the performance of the double C-N coupling. 
Finally, product series PR6-8 were synthesized by regioselective Sonogashira reaction 
followed by domino/one-pot C-N coupling/hydroamination/C-H arylation in moderate 
to good yields. Noticeably, the synthesis of the product series PR9 required a switch of 
solvent and an addition of further catalysts between the C-N coupling/hydroamination 
and the C-H arylation.  
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5. Experimental section 
Solvents used for the work-up and column chromatography were distilled using 
standard procedures. Molecular sieves were dried at 300 °C for more than 10 hours. If 
not otherwise noted, other chemicals and solvents were obtained from commercial 
sources without further purification. Column chromatography was performed using 
normal silica gel with particle sizes 0.006 - 0.043 nm. 
NMR measurements were performed with Bruker AVANCE 250 II (built 2006), Bruker 
AVANCE 300 III (built 2007) and Bruker AVANCE 500 (built 2001). NMR peaks 
were calibrated using standard signals of chloroform (7.260 ppm for 
1
H-NMR, 
77.160 ppm for 
13
C-NMR), acetone (2.050 ppm for 
1
H-NMR, 29.840 ppm for 
13
C-NMR) and DMSO (2.500 ppm for 
1
H-NMR, 39.520 ppm for 
13
C-NMR). For peak 
description, abbreviations s (singlet), d (duplet), t (triplett), q (quartet), sept (septet) and 
pt (pseudo triplet) were used. 
IR measurements were recorded on a Nicolet 380 FT-IR spectrometer using ATR 
sampling technique. For peak description, abbreviations w (weak), m (medium) and s 
(strong) were used. 
GC/MS measurements were carried out with Finnigan MAT 95-XP device using HP-5 
capillary column with helium carrier gas and electron ionization (EI) scan technique at 
70 eV. HRMS was measured with a Finnigan MAT 95 XP device.  
The calculations of the yields via NMR-spectroscopy were performed using 
dimethylsulfone as internal standard.  
Crystallographic data were collected on a Bruker Kappa APEX II Duo diffractometer. 
The structure was solved by direct methods
[182]
 and refined by full-matrix least-squares 
procedures.
[183]
 XP (Bruker AXS) and Mercury
[184]
 were used for molecular graphics. 
5.1. General synthetic procedures 
3-Bromo-2-chloroquinoline
[132c]
 (5a), 3-bromo-4-chloroquinoline
[132c]
 (5b), 3-bromo-
4-chloro-2-methylquinoline
[185]
 (5c), 4-chloro-3-iodo-2-methylquinoline
[186]
 (5d), 
1-bromonaphthalen-2-yl trifluoromethanesulfonate
[150]
 (13) and 4-chloro-5-iodo-
2,6-dimethylpyrimidine
[187]
 (29) were synthesized according previously documented 
procedures. 
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5.1.1. Synthesis of imines 2a-o 
To a dried flask, ketone (10.0 mmol), amine (10.0 mmol), NaHCO3 (4.20 g) and 
molecular sieve 4Å (8.00 g) in 10.0 ml toluene were added. Subsequently, the reaction 
mixture was heated to 80 °C or refluxed overnight. After the reaction was finished 
(monitored by TLC), the mixture was taken up in dichloromethane and filtered. The 
solvents were removed under reduced pressure. The products were purified by 
recrystallization in heptane/ethyl acetate or by Kugelrohr distillation under reduced 
pressure. 
5.1.2. Synthesis of 4-azaindoles 3a-o and 7-azaindoles 4a-o 
2-Bromo-3-chloropyridine (1b) or 3-bromo-2-chloropyridine (1c) (0.3 mmol), imine 
2a-o (0.33 mmol), Pd(OAc)2 (0.018 mmol), PCy3 (0.036 mmol) and NaOtBu 
(0.84 mmol) were put into a dried glass pressure tube. The tube was then evacuated and 
backfilled three times with argon. Dried 1,4-dioxane (6.0 ml) was added to the tube 
under argon atmosphere. The reaction mixture was sealed by a Teflon cap, stirred for 10 
minutes at room temperature, and subsequently heated to 105 °C for 16 - 48 hours. The 
reaction was controlled by TLC until completion. Thereafter, it was cooled down to 
room temperature, taken up in dichloromethane and filtered. The solvent was removed 
by evaporation in vacuo. The residue was purified by column chromatography 
(heptane/ethyl acetate). 
5.1.3. Synthesis of pyrroloquinolines 6a-i and pyrroloquinolines 7a-f 
3-Bromo-2-chloroquinoline (5a) or 3-bromo-4-chloroquinoline (5b) (0.3 mmol), imine 
(0.33 mmol), Pd(OAc)2 (0.018 mmol), PCy3 (0.036 mmol) and NaOtBu (0.84 mmol) 
were put into a dried glass pressure tube. The tube was then evacuated and backfilled 
three times with argon. Dried 1,4-dioxane (6.0 ml) was added to the tube under argon 
atmosphere. The reaction mixture was sealed by a Teflon cap, stirred for 10 minutes at 
room temperature, and subsequently heated to 105 °C for 24 hours. The reaction was 
controlled by TLC until completion. Thereafter, it was cooled down to room 
temperature, taken up in dichloromethane and filtered. The solvent was removed by 
evaporation in vacuo. The residue purified by column chromatography (heptane/ethyl 
acetate). 
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5.1.4. Synthesis of 3-(2-bromophenyl)-4-chloro-2-methylquinoline (9a)  
3,4-Dihalo-2-methylquinoline 5c-d (3.0 mmol), (2-bromophenyl)boronic acid (8) 
(4.2 mmol), Pd(PPh3)4 (0.15 mmol) and Na2CO3 (6.0 mmol) were added to a dried glass 
pressure tube. The tube was evacuated and backfilled three times with argon. The solids 
were solved in 10.0 ml of DMF and 1.0 ml of distilled water. The tube was sealed with 
a Teflon cap and heated to 100 °C for 24 hours. After the reaction completed 
(monitored by TLC), it was allowed to cool to room temperature. To the reaction 
mixture, Na2SO4 was added, diluted with ethyl acetate and filtered. The solvent was 
removed under reduced pressure. The crude oil was purified by column chromatography 
(heptane/ethyl acetate). 
5.1.5. Synthesis of 3-(2-bromophenyl)-2-chloroquinoline (9b)  
3-Bromo-2-chloroquinoline (5a) (3.0 mmol), (2-bromophenyl)boronic acid (8) 
(3.6 mmol), Pd(dppf)Cl2 (0.3 mmol) and Cs2CO3 (6.0 mmol) were added to a dried 
glass pressure tube. The tube was evacuated and backfilled three times with argon. The 
solids were solved in 5.0 ml of dried THF. The tube was sealed with a Teflon cap and 
heated to 60 °C for 10 hours. After the reaction completed (monitored by TLC), it was 
allowed to cool to room temperature. The solvent was removed under reduced pressure. 
The crude oil was purified by column chromatography (heptane). 
5.1.6. Synthesis of 1-bromo-2-(2-bromophenyl)naphthalene (14)  
1-Bromonaphthalen-2-yl trifluoromethanesulfonate (13) (3.0 mmol), 
(2-bromophenyl)boronic acid (8) (3.3 mmol), Pd(PPh3)4 (0.15 mmol) and K3PO4 
(6.0 mmol) were added to a dried glass pressure tube. The tube was evacuated and 
backfilled three times with argon, then 5.0 ml of dried 1,4-dioxane was added. The tube 
was sealed with a Teflon cap and heated to 90 °C for 5 hours. After the reaction 
completed (monitored by TLC), it was allowed to cool to room temperature. The 
reaction mixture was filtered, and the solvent was removed under reduced pressure. The 
crude oil was purified by column chromatography (heptane). 
5.1.7. Synthesis of 3-bromo-2-(2-bromophenyl)-thiophene (17a) and 3-bromo-
4-(2-bromophenyl)thiophene (17b) 
To a dried glass pressure tube were added 2,3- or 3,4-dibromothiophene 16a-b 
(3.0 mmol), (2-bromophenyl)boronic acid (8) (3.3 mmol), Pd(PPh3)4 (0.15 mmol), 
Na2CO3 (6.0 mmol). The tube was evacuated and backfilled three times with argon. 
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Subsequently, the solids were solved in 8.0 ml of 1,4-dioxane and 2.0 ml of distilled 
water. The tube was sealed by a Teflon cap and heated to 100 °C for 14 hours. After the 
reaction was finished (monitored by TLC), it was allowed to cool to room temperature 
and Na2SO4 was added to the mixture, diluted with ethyl acetate and filtered. The 
solvent was removed under reduced pressure. The crude oil was purified by column 
chromatography (heptane). 
5.1.8. Synthesis of indoloquinolines 11a-t and indoloquinolines 12a-h  
3-(2-Bromophenyl)-4-chloro-2-methylquinoline (9a) or 3-(2-bromophenyl)-
2-chloroquinoline (9b) (0.15 mmol), amine (0.225 mmol), Pd2dba3 (0.0075 mmol), 
PtBu3∙HBF4 (0.015 mmol) or (S)-BINAP (0.0075 mmol) and NaOtBu (0.36 mmol) were 
added to a dried glass pressure tube. The tube was evacuated and backfilled three times 
with argon. To this tube, 3.0 ml of dried toluene was added. The mixture was heated to 
100 °C for 14 hours. After the reaction completed (monitored by TLC), it was allowed 
to cool to room temperature. The solvent was removed under reduced pressure. The 
crude oil was purified by column chromatography (heptane/ethyl acetate). 
5.1.9. Synthesis of benzo[a]carbazoles 15a-o  
1-Bromo-2-(2-bromophenyl)naphthalene (14) (0.15 mmol), amine (0.225 mmol), 
Pd2dba3 (0.0075 mmol), Xantphos (0.0075 mmol) or (S)-BINAP (0.0075 mmol) and 
NaOtBu (0.36 mmol) were added to a dried glass pressure tube. The tube was evacuated 
and backfilled three times with argon, then 3.0 ml of dried toluene was added. The 
mixture was heated to 100 °C for 14 hours until completion (monitored by TLC). After 
cooling to room temperature, the solvent was removed under reduced pressure. The 
crude oil was purified by column chromatography (heptane/ethyl acetate). 
5.1.10. Synthesis of thienoindoles 18a-t and thienoindoles 19a-f  
3-Bromo-2-(2-bromophenyl)thiophene (17a) (0.15 mmol), amine (0.225 mmol), 
Pd2dba3 (0.0075 mmol), dppf or (S)-BINAP (0.0075 mmol) or PtBu∙HBF4 
(0.015 mmol) and NaOtBu (0.36 mmol) were added to a dried glass pressure tube. The 
tube was evacuated and backfilled three times with argon, then 3.0 ml of dried toluene 
was added. The mixture was heated to 100 °C for 14 hours until completion (monitored 
by TLC). After cooling to room temperature, the solvent was removed under reduced 
pressure. The crude oil was purified by column chromatography (heptane/ethyl acetate). 
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5.1.11. Synthesis of 3-bromo-2-(arylethynyl)-benzo[b]thiophenes 22a-c  
2,3-Dibromobenzothiophene (20) (3.0 mmol), aryl acetylene (3.6 mmol), Pd(PPh3)2Cl2 
(0.15 mmol) and CuI (0.3 mmol) were added to a dried glass pressure tube. The tube 
was evacuated and backfilled three times with argon, then 2.0 ml of triethylamine was 
added. The tube was sealed with a Teflon cap and stirred at room temperature for 
14 hours until completion (monitored by TLC). After cooling to room temperature, the 
solvent was removed under reduced pressure. The crude oil was purified by column 
chromatography (heptane/ethyl acetate). 
5.1.12. Synthesis of 4-chloro-2-methyl-3-(arylethynyl)quinolines 27a-e  
4-Chloro-3-iodo-2-methylquinoline (5d) (3.0 mmol), aryl acetylene (4.5 mmol), 
Pd(PPh3)2Cl2 (0.15 mmol) and CuI (0.3 mmol) were added to a dried glass pressure 
tube. The tube was evacuated and backfilled three times with argon, then 4.0 ml of 
triethylamine was added. The tube was sealed with a Teflon cap and heated to 80 °C for 
14 hours until completion (monitored by TLC). After cooling to room temperature, the 
solvent was removed under reduced pressure. The crude oil was purified by column 
chromatography (heptane/ethyl acetate). 
5.1.13. Synthesis of 4-chloro-2,6-dimethyl-5-(phenylethynyl)pyrimidines 30a-f  
4-Chloro-5-iodo-2,6-dimethylpyrimidine (29) (3.0 mmol), aryl acetylene (4.5 mmol), 
Pd(PPh3)2Cl2 (0.15 mmol) and CuI (0.3 mmol) were added to a dried glass pressure 
tube. The tube was evacuated and backfilled three times with argon, then 2.0 ml of 
triethylamine was added. The tube was sealed with a Teflon cap and heated to 80 °C for 
14 hours until completion (monitored by TLC). After cooling to room temperature, the 
solvent was removed under reduced pressure. The crude oil was purified by column 
chromatography (heptane/ethyl acetate). 
5.1.14. Synthesis of benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridines 
24a-o and benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridines 
26a-h  
3-Bromo-2-(phenylethynyl)benzo[b]thiophenes (22a-c) or 3-bromo-
2-((2-bromophenyl)ethynyl)benzo[b]-thiophene (25) (0.32 mmol), aryl amine 
(0.38 mmol), Pd(OAc)2 (0.032 mmol), PtBu3∙HBF4 (0.064 mmol) and Cs2CO3 
(0.96 mmol) were added to a dried glass pressure tube. The tube was evacuated and 
backfilled three times with argon, then 4.0 ml of dried DMF was added. The tube was 
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sealed with a Teflon cap and heated to 140 °C for 24 hours. After cooling to room 
temperature, H2O was poured to the reaction mixture and extracted with CH2Cl2. The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The 
residue was purified by column chromatography (heptane/ethyl acetate). 
5.1.15. Synthesis of quinolino[3',4':4,5]pyrrolo-[1,2-f]phenanthridines 28a-p  
4-Chloro-3-(arylethynyl)quinoline (27a-e) (0.3 mmol), ortho-bromoaryl amine 
(0.36 mmol), Pd(OAc)2 (0.03 mmol), SPhos (0.06 mmol) and Cs2CO3 (0.9 mmol) were 
added to a dried glass pressure tube. The tube was evacuated and backfilled three times 
with argon, then 4.0 ml of dried DMF was added. The tube was sealed with a Teflon 
cap and heated to 140 °C for 24 hours. After cooling to room temperature, H2O was 
poured to the reaction mixture and extracted with CH2Cl2. The combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The residue was purified by column 
chromatography (heptane/ethyl acetate). 
5.1.18. Synthesis of 11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]-
phenanthridines 32a-i  
To a dried flask, 4-chloro-2,6-dimethyl-5-(phenylethynyl)pyrimidine (30a-b) 
(0.3 mmol), ortho-bromoaryl amine (0.36 mmol), Pd(PPh3)3 (0.03 mmol), Xantphos 
(0.03 mmol), Cs2CO3 (0.9 mmol) and dried DMF (4.0 ml) were added. The flask was 
heated to 100 °C for 14 - 24 hours under argon atmosphere. The reaction profile was 
checked by TLC until completion of the first step. After cooling to room temperature, 
the solvent was removed under reduced pressure. To the reaction mixture, Pd(OAc)2 
(0.03 mmol), PPh3 (0.06 mmol) and 4.0 ml of dried toluene were added. The reaction 
mixture was heated for further 6 hours under argon atmosphere. After the reaction was 
completed, the solvent was removed under reduced pressure. The residue was purified 
by column chromatography (heptane/ethyl acetate). 
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5.2. Spectral data 
5.2.1. Synthesis of azaindoles from imines by domino C-C/C-N coupling 
5.2.1.1.Imines 
N,1-bis(4-Methoxyphenyl)ethan-1-imine (2a): 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.03 - 7.85 (m, 2H, CHAr), 7.00 - 6.84 (m, 4H, CHAr), 
6.80 - 6.71 (m, 2H, CHAr), 3.87 (s, 3H, OCH3), 3.82 (s, 
3H, OCH3), 2.23 (s, 3H, CH3-imine). 
13
C NMR (63 MHz, 
CDCl3) δ = 165.1 (CAr), 161.7 (CAr), 156.1 (CAr), 145.5 
(CAr), 132.7 (CAr), 129.0 (2CHAr), 121.2 (2CHAr), 114.4
 
(2CHAr), 113.8 (2CHAr), 55.6 (OCH3), 55.5 (OCH3), 17.3 (CH3-imine). MS (EI, 70 eV): 
m/z (%) = 256 (10), 255 [M]
+
 (54), 241 (17), 240 (100), 197 (11). 92 (15), 77 (12), 64 
(13), 63 (14). HRMS (EI): Calculated for C16H17O2N [M]
+
 255.12538 found 255.12542. 
1
H- and 
13
C-NMR spectral data are in accordance with the literature.
[188] 
N-(3-Methoxyphenyl)-1-(4-methoxyphenyl)ethan-1-imine (2b): 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.88 (d, 3J = 8.9 Hz, 2H, CHAr), 
7.34 - 7.17 (m, 1H, CHAr), 6.88 (d, 
3
J = 8.9 Hz, 2H, 
CHAr), 6.56 (ddd, 
3
J = 8.3 Hz, 
4
J = 2.3 Hz, 
4
J = 1.1 Hz, 
1H, CHAr), 6.48 - 6.33 (m, 2H, CHAr), 3.87 (s, 3H, 
OCH3), 3.80 (s, 3H, OCH3), 2.22 (s, 3H, CH3-imine). 
13
C NMR (63 MHz, CDCl3) δ = 165.1 (CAr), 161.8 (CAr), 160.4 (CAr), 153.1 (CAr), 130.7 
(CAr), 129.9 (CHAr), 129.1 (2CHAr), 113.8 (2CHAr), 112.2 (CHAr), 109.0 (CHAr), 105.5 
(CHAr), 55.6 (OCH3), 55.4 (OCH3), 17.4 (CH3-imine). MS (EI, 70 eV): m/z (%) = 255 
[M]
+
 (47), 241 (19), 240 (100), 92 (25), 77 (27). HRMS (EI): Calculated for C16H17O2N 
[M]
+
 255.12538 found 255.12520. 
1
H-NMR spectral data is in accordance with the 
literature.
[189] 
1-(4-Methoxyphenyl)-N-phenylethan-1-imine (2c): 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.95 (d, 3J = 8.9 Hz, 2H, CHAr), 7.42 - 7.29 
(m, 2H, CHAr), 7.12 - 7.02 (m, 1H, CHAr), 6.96 (d, 
3
J = 8.9 Hz, 
2H, CHAr), 6.80 (dd, 
3
J = 8.4 Hz, 
4
J = 1.2 Hz, 2H, CHAr), 3.87 
(s, 3H, OCH3), 2.21 (s, 3H, CH3-imine). 
13
C NMR (63 MHz, 
CDCl3) δ = 164.7 (CAr), 161.7 (CAr), 152.0 (CAr), 132.3 (CAr), 129.0 (2CHAr), 129.0 
(2CHAr), 123.2 (CHAr), 119.7 (2CHAr), 113.7 (2CHAr), 55.5 (OCH3), 17.3 (CH3-imine). 
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MS (EI, 70 eV): m/z (%) = 225 [M]
+
 (36), 211 (14), 210 (100), 167 (11), 118 (12), 92 
(10), 78 (12), 77 (86), 63 (13), 51 (21). HRMS (EI): Calculated for C15H15NO [M]
+
 
225.11482 found 225.11471. 
1
H- and 
13
C-NMR spectral data are in accordance with the 
literature.
[190] 
1-(4-Methoxyphenyl)-N-(naphthalen-2-yl)ethan-1-imine (2d): Pale yellow crystal, 
mp. 107 - 108 °C, purified by recrystallization, 61% yield. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.10 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.86 (d, 
3
J = 8.9 Hz, 1H, CHAr), 
7.79 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.60 (d, 
3
J = 8.2 Hz, 1H, 
CHAr), 7.53 - 7.35 (m, 3H, CHAr), 7.02 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.80 (dd, 
3
J = 7.2 , 
4
J = 1.2 Hz, 1H, CHAr), 3.90 (s, 3H, OCH3), 2.18 (s, 3H, CH3-imine). 
13
C NMR (63 MHz, 
CDCl3) δ = 166.0 (CAr), 162.1 (CAr), 148.3 (CAr), 134.5 (CAr), 132.2 (CAr), 129.4 
(2CHAr), 128.3 (CHAr), 126.5 (CAr), 126.4 (CHAr), 126.2 (CHAr), 125.7 (CHAr), 124.0 
(CHAr), 123.4 (CHAr), 114.1 (CHAr), 114.0 (2CHAr), 55.8 (OCH3), 17.8 (CH3-imine). 
IR (ATR, cm
-1
): ṽ = 3060 (w), 3012 (w), 2975 (w), 2954 (w), 2840 (w), 2050 (w=, 1962 
(w), 1913 (w), 1849 (w), 1821 (w), 1788 (w), 1632 (m), 1596 (m), 1504 (m), 1437 (m), 
1360 (m), 1307 (m), 1251 (s), 1173 (m), 1024 (m), 960 (m), 838 (s), 777 (s), 572 (m). 
MS (EI, 70 eV): m/z (%) = 276 (16), 275 [M]
+
 (80), 261 (20), 260 (100), 217 (20), 127 
(64), 77 (15). HRMS (EI): Calculated for C19H17NO [M]
+
 275.13047 found 275.13030. 
N-(2,3-Dihydro-1H-inden-5-yl)-1-(4-methoxyphenyl)ethan-1-imine (2e): Yellow 
solid, mp. 61 - 62 °C, purified by Kugelrohr distillation, 
54% yield. 
1
H NMR  (250 MHz, Chloroform-d) δ = 7.94 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 7.17 (d, 
3
J = 7.9 Hz, 1H, 
CHAr), 6.95 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.67 (d, 
4
J = 1.2 Hz, 1H, CHAr), 6.56 (dd, 
3
J = 7.8 Hz, 
4
J = 2.0 Hz, 1H, CHAr), 3.87 (s, 3H, 
OCH3), 2.90 (t, 
3
J = 7.4 Hz, 4H, CH2-aliphatic), 2.22 (s, 3H, CH3-imine), 2.17 - 2.02 (m, 2H, 
CH2-aliphatic). 
13
C NMR (63 MHz, CDCl3) δ = 161.6 (CAr), 145.2 (CAr), 138.9 (CAr), 
132.5 (CAr), 130.7 (CAr), 129.0 (2CHAr), 124.6 (CHAr), 117.7 (CHAr), 115.9 (CHAr), 
113.9 (CAr), 113.7 (2CHAr), 55.5 (OCH3), 33.2 (CH2-aliphatic), 32.5 (CH2-aliphatic), 25.77 
(CH2-aliphatic), 17.3 (CH3-imine). IR (ATR, cm
-1
): ṽ = 3093 (w), 3015 (w), 2967 (w), 2931 
(m), 2841 (m), 2062 (w), 2051 (w), 1983 (w), 1923 (w), 1671 (w), 1628 (m), 1598 (s), 
1507 (m), 1483 (m), 1444 (m), 1364 (m), 1304 (m), 1255 (s), 1234 (m), 1173 (s), 1118 
(m), 1027 (s), 839 (s), 832 (s), 573 (s). MS (EI, 70 eV): m/z (%) = 266 (9), 265 [M]
+
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(47), 250 (100), 115 (30), 91 (13). HRMS (EI): Calculated for C18H19ON [M]
+
 
265.14612 found 265.14612. 
N-(3,5-Dimethylphenyl)-1-(4-methoxyphenyl)ethan-1-imine (2f): Yellow solid, 
mp. 74 - 75 °C, purified by Kugelrohr distillation, 
54% yield. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.92 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 6.94 (d, 
3
J = 8.9 Hz, 2H, CHAr), 
6.72 (s, 1H, CHAr), 6.42 (s, 2H, CHAr), 3.87 (s, 3H, OCH3), 
2.31 (s, 6H, CH3), 2.26 - 2.17 (m, 3H, CH3-imine). 
13
C NMR 
(63 MHz, CDCl3) δ = 164.4 (CAr), 161.6 (CAr), 151.9 (CAr), 138.6 (2CAr), 132.4 (CAr), 
130.7 (CAr), 128.9 (2CHAr), 124.8 (CHAr), 117.4 (2CHAr), 113.7 (2CHAr), 55.5 (OCH3), 
21.5 (CH3), 17.3 (CH3-imine). IR (ATR, cm
-1
): ṽ = 3005 (w), 2959 (w), 2913 (m), 2838 
(w), 2732 (w), 2052 (w), 1910 (w), 1626 (m), 1590 (s), 1509 (m), 1454 (m), 1366 (m), 
1308 (m), 1251 (s), 1171 (m), 1028 (s), 829 (s), 689 (m), 571 (s). MS (EI, 70 eV): 
m/z (%) = 254 (10), 253 [M]
+
 (51), 239 (21), 238 (100), 105 (13), 77 (17). HRMS (EI): 
Calculated for C17H19ON [M]
+
 253.14612 found 253.14642. 
N-(4-Methoxyphenyl)-1-phenylethan-1-imine (2g): 
1
H NMR (250 MHz, 
Chloroform-d) δ = 8.02 - 7.91 (m, 2H, CHAr), 7.49 - 7.37 (m, 
3H, CHAr), 6.97 - 6.85 (m, 2H, CHAr), 6.81 - 6.71 (m, 2H, 
CHAr), 3.82 (s, 3H, OCH3), 2.26 (s, 3H, CH3-imine). 
13
C NMR 
(63 MHz, CDCl3) δ = 166.0 (CAr), 156.1 (CAr), 144.9 (CAr), 
139.9 (CAr), 130.5 (CHAr), 128.5 (2CHAr), 127.3 (2CHAr), 120.9 (2CHAr), 114.4 
(2CHAr), 55.9 (OCH3), 17.5 (CH3-imine). MS (EI, 70 eV): m/z (%) = 226 (13), 225 [M]
+
 
(58), 211 (20), 210 (100), 195 (15), 167 (18), 64 (17), 63 (15), 51 (16). HRMS (EI): 
Calculated for C15H15NO [M]
+
 225.11482 found 225.11486. 
1
H- and 
13
C-NMR spectral 
data are in accordance with the literature.
[191] 
N-(4-Methoxyphenyl)-1-(4-(trifluoromethyl)phenyl)ethan-1-imine (2h): 
1
H NMR 
(300 MHz, Chloroform-d) δ = 8.07 (d, 3J = 8.1 Hz, 2H, 
CHAr), 7.69 (d, 
3
J = 8.2 Hz, 2H, CHAr), 6.93 (dd, 
3
J = 9.3 Hz, 
4
J = 2.7 Hz, 2H, CHAr), 6.83 - 6.66 (m, 2H, 
CHAr), 3.83 (s, 3H, OCH3), 2.28 (s, 3H, CH3-imine). 
19
F NMR (282 MHz, CDCl3) δ = -62.7 (F3C). 
13
C NMR 
(63 MHz, CDCl3): δ = 164.4 (CAr), 156.3 (CAr), 144.1 (CAr), 142.9 (CAr), 131.9 (q, 
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2
JCF = 32.4 Hz, CAr), 127.5 (2CHAr), 125.4 (q, 
3
JCF = 3.8 Hz, 2CHAr), 124.1 (q, 
1
JCF = 269.9 Hz, CF3), 120.7 (2CHAr), 114.3 (2CHAr), 55.5 (OCH3), 17.4 (CH3-imine). 
MS (EI, 70 eV): m/z (%) = 294 (10), 293 [M]
+
 (56), 279 (16), 278 (100), 148 (12), 92 
(15), 77 (21), 64 (12). HRMS (EI): Calculated for C16H14ONF3 [M]
+
 293.10220 found 
293.10235. 
1
H- and 
13
C-NMR spectral data are in accordance with the literature.
[192] 
1-(4-Fluorophenyl)-N-(4-methoxyphenyl)ethan-1-imine (2i): 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.01 - 7.92 (m, 2H, CHAr), 7.17 - 7.05 
(m, 2H, CHAr), 6.96 - 6.86 (m, 2H, CHAr), 6.79 - 6.69 (m, 
2H, CHAr), 3.82 (s, 3H, OCH3), 2.24 (s, 3H, CH3-imine). 
19
F NMR (282 MHz, CDCl3) δ = -110.7 (FCAr). 
13
C NMR 
(126 MHz, CDCl3) δ = 164.5 (CAr), 164.4 (d, 
1
JCF = 250.4 Hz, CAr), 156.2 (CAr), 144.8 (CAr), 136.1 (d, 
4
JCF = 3.1 Hz, CAr), 129.3 (d, 
3
JCF = 8.6 Hz, 2CHAr), 120.9 (2CHAr), 115.4 (d, 
2
JCF = 21.6 Hz, 2CHAr), 114.4 (2CHAr), 
55.7 (OCH3), 17.4 (CH3-imine). MS (EI, 70 eV): m/z (%) = 243 [M]
+
 (55), 229 (16), 228 
(100), 185 (11), 92 (12), 77 (16). HRMS (EI): Calculated for C15H14ONF [M]
+
 
243.10539 found 243.10547. 
1
H- and 
19
F-NMR spectral data are in accordance with the 
literature.
[193]
 
1-(4-Fluorophenyl)-N-phenylethan-1-imine (2j): 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.04 - 7.94 (m, 2H, CHAr), 7.35 (t, 
3
J = 7.8 Hz, 2H, CHAr), 
7.21 - 7.05 (m, 3H, CHAr), 6.84 - 6.76 (m, 2H, CHAr), 2.22 (s, 3H, 
CH3-imine). 
19
F NMR (282 MHz, CDCl3) δ = -105.3 (FCAr). 
13
C NMR (75 MHz, CDCl3) δ = 164.6 (d, 
1
JCF = 252 Hz, CFAr), 
164.5 (CAr), 152.8 (CAr), 136.1 (CAr), 130.2 (d, 
3
JCF = 8.6 Hz, 2CHAr), 130.2 (2CHAr), 
124.6 (CHAr), 120.2 (2CHAr), 116.7 (d, 
2
JCF = 21.5 Hz, 2CHAr), 17.5 (CH3-imine). 
MS (EI, 70 eV): m/z (%) = 213 [M]
+
 (51), 199 (14), 198 (100), 121 (5), 78 (5), 77 (64), 
51 (20). HRMS (EI): Calculated for C14H12NF [M]
+
 213.09483 found 213.09477. 
1
H- and 
13
C-NMR spectral data are in accordance with the literature.
[194]
 
N-(4-Fluorophenyl)-1-phenylethan-1-imine (2k): 
1
H NMR (300 MHz, Chloroform-d) 
δ = 7.99 - 7.96 (m, 2H, CHAr), 7.49 - 7.43 (m, 3H, CHAr), 7.08 - 7.04 (m, 2H, CHAr), 
6.78 - 6.74 (m, 2H, CHAr), 2.24 (s, 3H, CH3-imine). 
13
C NMR (75 MHz, CDCl3) δ = 166.5 
(CAr), 159.5 (d, 
1
JCF = 241.1 Hz, CFAr), 147.8 (d, 
4
JCF = 2.4 Hz, CAr), 139.5 (CAr), 130.7 
(CHAr), 128.4 (2CHAr), 127.3 (2CHAr), 120.8 (d, 
3
JCF = 8.2 Hz, 2CHAr), 115.7 (d, 
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2
JCF = 22.0 Hz, 2CHAr), 17.4 (CH3-imine). MS (EI, 70 eV): 
m/z (%) = 213 [M]
+
 (48), 199 (14), 198 (100), 136 (14), 95 (35), 
77 (15), 75 (18). HRMS (EI): Calculated for C14H12NF [M]
+
 
213.09483 found 213.09496.
1
H- and 
13
C-NMR spectral data is in 
accordance with the literature.
[195] 
N,1-Diphenylethan-1-imine (2l): 
1
H NMR (300 MHz, Chloroform-d) δ = 8.02 - 7.94 
(m, 2H, CHAr), 7.50 - 7.42 (m, 3H, CHAr), 7.39 - 7.31 (m, 2H, CHAr), 
7.12 - 7.05 (m, 1H, CHAr), 6.83 - 6.77 (m, 2H, CHAr), 2.24 (s, 3H, 
CH3-imine). 
13
C NMR (63 MHz, Acetone-d
6
) δ = 165.5 (CAr), 152.9 
(CAr), 140.3 (CAr), 131.1 (CHAr), 129.7 (2CHAr), 129.0 (2CHAr), 
128.0 (2CHAr), 123.8 (CHAr), 120.0 (2CHAr), 17.2 (CH3-imine). MS (EI, 70 eV): 
m/z (%) = 195 [M]
+
 (41), 181 (13), 180 (100), 118 (16), 103 (11), 77 (87), 76 (12), 51 
(39), 50 (12). HRMS (EI): Calculated for C14H13N [M]
+
 195.10425 found 195.10362. 
1
H- and 
13
C-NMR spectral data are in accordance with the literature.
[196] 
1-([1,1'-Biphenyl]-4-yl)-N-phenylethan-1-imine (2m): 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.05 (d, 3J = 8.4 Hz, 2H, CHAr), 7.68 (d, 
3
J = 8.4 Hz, 2H, CHAr), 7.65 (d, 
3
J = 8.0 Hz, 2H, CHAr), 
7.51 - 7.42 (m, 2H, CHAr), 7.40 - 7.33 (m, 3H, CHAr), 7.09  (t, 
3
J = 7.2 Hz, 1H, CHAr), 6.81  (d, 
3
J = 7.6 Hz, 2H, CHAr), 2.26 
(s, 3H, CH3-imine). 
13
C NMR (63 MHz, CDCl3) δ = 165.2 
(CAr), 151.9 (CAr), 143.3 (CAr), 140.6 (CAr), 138.5 (CAr), 129.1 (2CHAr), 129.0 (2CHAr), 
127.9 (CHAr), 127.8 (2CHAr), 127.3 (2CHAr), 127.2 (2CHAr), 123.4 (CHAr), 119.6 
(2CHAr), 17.5 (CH3-imine). MS (EI, 70 eV): m/z (%) = 272 (11), 271 [M]
+
 (45), 257 (21), 
256 (100), 179 (15), 152 (22), 151 (14), 77 (60), 51 (22). HRMS (EI): Calculated for 
C20H17N [M]
+
 271.13555 found 271.13552. 
1
H- and 
13
C-NMR spectral data are in 
accordance with the literature.
[197] 
1-(Naphthalen-2-yl)-N-phenylethan-1-imine (2n): 
1
H NMR (300 MHz, 
Chloroform-d): δ = 8.35 (s, 1H, CHAr), 8.23 (d, 
3
J = 8.8 Hz, 2H, 
CHAr), 7.96 - 7.85 (m, 3H, CHAr), 7.59 - 7.48 (m, 2H, CHAr), 
7.38 (dd, 
3
J = 7.6 Hz, 
3
J = 7.6 Hz, 2H, CHAr), 7.12 (t, 
3
J = 7.6 Hz, 1H, CHAr), 6.84 (d, 
3
J = 7.6 Hz, 2H, CHAr), 2.36 (s, 
3H, CH3-imine). 
13
C NMR (63 MHz, CDCl3) δ = 165.5 (CAr), 151.8 (CAr), 137.0 (CAr), 
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134.6 (CAr), 133.1 (CAr), 129.1 (2CHAr), 129.1 (CHAr), 128.2 (CHAr), 127.8 (2CHAr), 
127.3 (CHAr), 126.5 (CHAr), 124.4 (CHAr), 123.5 (CHAr), 119.6 (2CHAr), 17.5 
(CH3-imine). MS (EI, 70 eV): m/z (%) = 245 [M]
+
 (45), 231 (19), 230 (100), 153 (16), 127 
(21), 126 (12), 77 (55), 51 (22). HRMS (EI): Calculated for C18H15N [M]
+
 245.11990 
found 245.12002. 
1
H- and 
13
C-NMR spectral data are in accordance with the 
literature.
[196]
  
N,1-Di(naphthalen-2-yl)ethan-1-imine (2o): Brown crystal, mp. 136 - 137 °C, purified 
by recrystallization, 47% yield. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.47 (s, 1H, CHAr), 8.41 (dd, 
3
J = 8.7 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 8.02 - 7.80 (m, 5H, 
CHAr), 7.63 (m, 1H, CHAr), 7.60 - 7.54 (m, 2H, CHAr), 
7.52 - 7.39 (m, 3H, CHAr), 6.86 (d, 
3
J = 7.2 Hz, 1H, CHAr), 2.35 (s, 3H, CH3-imine).  
13
C NMR (75 MHz, CDCl3) δ = 136.7 (CAr), 134.8 (CAr), 134.4 (CAr), 133.1 (CAr), 129.7 
(CAr), 129.2 (CHAr), 128.6 (CAr), 128.3 (CHAr), 128.2 (CHAr), 128.1 (CHAr), 127.9 
(CHAr), 127.5 (CHAr), 126.6 (CHAr), 126.3 (CAr), 126.2 (CHAr), 126.1 (CHAr), 125.6 
(CHAr), 124.5 (CHAr), 123.8 (CHAr), 123.6 (CHAr), 113.8 (CHAr), 17.9 (CH3-imine). 
IR (ATR, cm
-1
): ṽ = 3468 (w), 3397 (w), 3239 (w), 3084 (w), 3050 (m), 3006 (w), 2963 
(w), 2852 (w), 2704 (w), 2561 (w), 1938 (w), 1915 (w), 1848 (w), 1690 (w), 1625 (s), 
1570 (m), 1504 (m), 1433 (w), 1387 (m), 1366 (m), 1292 (m), 1293 (m), 1223 (m), 
1129 (m), 1080 (m), 1014 (m), 858 (m), 802 (m), 777 (s), 747 (m), 868 (m). 
MS (EI, 70 eV): m/z (%) = 296 (17), 295 [M]
+
 (74), 281 (23), 280 (100), 153 (15), 127 
(67), 126 (29). HRMS (EI): Calculated for C22H17N [M]
+
 295.13555 found 295.13563. 
5.2.1.2.4-Azaindoles 
1,2-bis(4-methoxyphenyl)-1H-pyrrolo[3,2-b]pyridine (3a): Yellow solid, 
mp. 188 - 189 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.40 (s, 1H, CHAr), 7.39 (d, 
3
J = 8.5 Hz, 1H, CHAr), 
7.16 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.07 (d, 
3
J = 8.9 Hz, 2H, 
CHAr), 6.98 (dd, 
3
J = 8.3 Hz, 
3
J = 4.5 Hz, 1H, CHAr), 6.87 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 6.83 (s, 1H, CHAr), 6.73 (d, 
3
J = 8.9 Hz, 2H, CHAr), 3.75 (s, 3H, OCH3), 3.71 (s, 3H, OCH3). 
13
C NMR (63 MHz, 
CDCl3) δ = 159.4 (CAr), 158.8 (CAr), 146.5 (CAr), 144.2 (CAr), 143.8 (CAr), 132.4 
(CHAr), 130.3 (2CHAr), 128.9 (2CHAr), 124.2 (CAr), 117.5 (CHAr), 116.6 (CHAr), 114.6 
(2CHAr), 113.8 (CAr), 113.8 (2CHAr), 102.9 (CHAr), 55.5 (OCH3), 55.2 (OCH3). 
  Appendix 
S13 
 
IR (ATR, cm
-1
): ṽ = 3122 (w), 3076 (w), 2918 (m), 2848 (w), 2045 (w), 1923 (w), 1716 
(w), 1608 (m), 1510 (s), 1498 (s), 1458 (m), 1414 (s), 1247 (s), 1186 (m), 1104 (m), 
1025 (s), 923 (m), 834 (s), 800 (s), 789 (s), 729 (m), 644 (w), 580 (s). MS (EI, 70 eV): 
m/z (%) = 331 (24), 330 [M]
+
 (100), 315 (28), 243 (17). HRMS (ESI): Calculated for 
C21H18N2O2 [M+H]
+
 331.14410 found 331.14419. 
1-(3-Methoxyphenyl)-2-(4-methoxyphenyl)-1H-pyrrolo[3,2-b]pyridine (3b): Yellow 
oil. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.39 (dd, 
3
J = 4.7 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.46 (d, 
3
J = 8.2 Hz, 
1H, CHAr), 7.23 (t, 
3
J = 8.1 Hz, 1H, CHAr), 7.16 (d, 
3
J = 8.8 Hz, 2H, CHAr), 6.97 (dd, 
3
J = 8.3 Hz, 
3
J = 4.7 Hz, 
1H, CHAr), 6.83 (s, 1H, CHAr), 6.86 - 6.80 (m, 1H, CHAr), 6.76 - 6.69 (m, 3H, CHAr), 
6.67 (m, 1H, CHAr), 3.69 (s, 3H, OCH3), 3.64 (s, 3H, OCH3). 
13
C NMR (63 MHz, 
CDCl3) δ = 160.4 (CAr), 159.6 (CAr), 146.9 (CAr), 144.3 (CHAr), 144.0 (CAr), 138.8 
(CAr), 132.1 (CAr), 130.4 (2CHAr), 130.2 (CHAr), 124.3 (CAr), 120.1 (CHAr), 117.6 
(CHAr), 116.9 (CHAr), 113.9 (2CHAr), 113.6 (CHAr), 113.4 (CHAr), 103.7 (CHAr), 55.5 
(OCH3), 55.3 (OCH3). IR (ATR, cm
-1
): ṽ = 3036 (w), 2002 (w), 2933 (w), 2834 (w), 
2926 (w), 2034 (w), 1891 (w), 1676 (w), 1588 (s), 1491 (s), 1454 (m), 1411 (s), 1281 
(m), 1246 (s), 1172 (s), 1027 (s), 833 (m), 778 (s), 725 (m), 694 (m), 552 (m). 
MS (EI, 70 eV): m/z (%) = 331 (25), 330 [M]
+
 (100), 315 (24), 243 (17). HRMS (EI): 
Calculated for C21H18O2N2 [M]
+
 330.13628 found 330.13602. 
2-(4-Methoxyphenyl)-1-phenyl-1H-pyrrolo[3,2-b]pyridine (3c): Yellow solid, 
mp. 137 - 138 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.40 (m, 1H, CHAr), 7.43 (d, 
3
J = 8.1 Hz, 1H, CHAr), 
7.38 - 7.26 (m, 3H, CHAr), 7.17 - 7.09 (m, 4H, CHAr), 6.97 
(dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr), 6.85 (s, 1H, CHAr), 
6.71 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.69 (s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) 
δ = 159.6 (CAr), 146.8 (CAr), 144.1 (CHAr) 144.1 (CAr), 137.8 (CAr), 132.2 (CAr), 130.5 
(2CHAr), 129.6 (2CHAr), 127.9 (2CHAr), 127.7 (CHAr), 124.2 (CAr), 117.6 (CHAr), 116.9 
(CHAr), 113.9 (2CHAr), 103.6 (CHAr), 55.3 (OCH3). IR (ATR, cm
-1
): ṽ = 3117 (w), 3060 
(w), 2960 (w), 2834 (w), 1595 (m), 1500 (s), 1414 (s), 1242 (m), 1179 (m), 1023 (m), 
834 (m), 782 (s), 700 (s), 598 (m). MS (EI, 70 eV): m/z (%) = 301 (23), 300 [M]
+
 (100), 
285 (39), 255 (27), 128 (10), 77 (10), 51(8). HRMS (EI): Calculated for C20H16ON2 
[M]
+
 300.12571 found 300.12513 
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2-(4-Methoxyphenyl)-1-(naphthalen-2-yl)-1H-pyrrolo[3,2-b]pyridine (3d): Yellow 
solid, mp. 140 - 141 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 8.50 (dd, 3J = 4.6 Hz, 4J = 1.5 Hz, 1H, 
CHAr), 7.94 (dd, 
3
J = 8.3 Hz, 
4
J = 1.1 Hz, 2H, CHAr), 
7.56 - 7.52 (m, 1H, CHAr), 7.48 (d, 
3
J = 8.3 Hz, 1H, CHAr), 
7.47 - 7.33 (m, 2H, CHAr), 7.33 (dd, 
3
J = 7.3 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.18 (d, 
3
J = 8.8 Hz, 2H, CHAr), 7.07 (d, 
3
J = 7.2 Hz, 2H, CHAr), 
6.97 (dd, 
3
J = 8.3 Hz, 
3
J = 4.5 Hz, 1H, CHAr), 6.66 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.69 (s, 
3H, OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 159.6 (CAr), 146.8 (CAr), 145.5 (CAr), 144.1 
(CHAr), 134.5 (CAr), 134.5 (CAr), 133.4 (CAr), 131.2 (CAr), 129.8 (2CHAr), 129.1 (CHAr), 
128.6 (CHAr), 127.5 (CHAr), 127.3 (CHAr), 126.9 (CHAr), 125.7 (CHAr), 124.3 (CAr), 
123.2 (CHAr), 118.2 (CHAr), 116.9 (CHAr), 113.9 (2CHAr), 103.1 (CHAr), 55.3 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3048 (w), 2921 (w), 2850 (w), 1607 (m), 1496 (m), 1417 (m), 1251 
(s), 1178 (m), 1024 (m), 842 (m), 806 (s), 797 (s), 773 (s), 590 (m), 539 (m). 
MS (EI, 70 eV): m/z (%) = 351 (22), 350 [M]
+
 (100), 335 (17), 305 (20), 153 (11). 
HRMS (ESI): Calculated for C24H18N2O [M+H]
+
 351.14919 found 351.14934 
1-(2,3-Dihydro-1H-inden-5-yl)-2-(4-methoxyphenyl)-1H-pyrrolo[3,2-b]pyridine 
(3e): Yellow solid, mp. 51 - 52 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.39 (dd, 3J = 4.7 Hz, 4J = 1.4 Hz, 1H, 
CHAr), 7.41 (ddd, 
3
J = 8.3 Hz, 
4
J = 1.4 Hz, 
5
J = 0.8 Hz, 1H, 
CHAr), 7.19 (d, 
4
J = 1.7 Hz, 1H, CHAr), 7.18 - 7.14 (m, 2H, 
CHAr), 7.02 - 6.99 (m, 1H, CHAr), 6.96 (dd, 
3
J = 8.3 Hz, 
4
J = 4.7 Hz, 1H, CHAr), 6.86 (dd, 
3
J = 7.9 Hz, 
4
J = 2.0 Hz, 1H, CHAr), 6.82 (d, 
5
J = 0.7 Hz, 1H, CHAr), 6.73 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.71 (s, 3H, OCH3), 2.87 - 2.83 
(m, 4H, CH2-aliphatic), 2.13 - 1.99 (m, 2H, CH2-aliphatic). 
13
C NMR (63 MHz, CDCl3) 
δ = 159.5 (CAr), 146.8 (CAr), 145.8 (CAr), 144.2 (CAr), 144.1 (CHAr), 144.0 (CAr), 135.8 
(CAr), 132.5 (CAr), 130.4 (2CHAr), 125.9 (CHAr), 125.1 (CHAr), 124.5 (CAr), 123.8 
(CHAr), 117.7 (CHAr), 116.7 (CHAr), 113.9 (2CHAr), 103.2 (CHAr), 55.4 (OCH3), 33.0 
(CH2-aliphatic), 32.7 (CH2-aliphatic), 25.7 (CH2-aliphatic). IR (ATR, cm
-1
): ṽ = 3038 (w), 3005 
(w), 2924 (m), 2844 (m), 2197 (w), 2058 (w), 2035 (w), 1889 (w), 1722 (w), 1674 (w), 
1068 (m), 1596 (w), 1496 (s), 1412 (s), 1281 (m), 1246 (s), 1174 (s), 1028 (m), 832 (m), 
780 (s), 726 (m). MS (EI, 70 eV): m/z (%) = 341 (25), 340 [M]
+
 (100), 325 (18), 156 
(12), 115 (6). HRMS (EI): Calculated for C23H20ON2 [M]
+
 340.15701 found 340.15685. 
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1-(3,5-Dimethylphenyl)-2-(4-methoxyphenyl)-1H-pyrrolo[3,2-b]pyridine (3f): 
Yellow solid, mp. 143 - 144 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.38 (dd, 3J = 4.7 Hz, 4J = 1.4 Hz, 1H, 
CHAr), 7.41 (dd, 
3
J = 8.2 Hz, 
4
J = 2.1 Hz, 1H, CHAr), 7.17 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 6.96 (dd, 
3
J = 8.3 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.92 (s, 1H, CHAr), 6.82 (d, 
5
J = 0.7 Hz, 1H, CHAr), 6.78 - 6.69 (m, 4H, CHAr), 3.70 (s, 3H, OCH3), 2.22 (s, 6H, 
CH3). 
13
C NMR (63 MHz, CDCl3) δ = 159.5 (CAr), 146.9 (CAr), 144.1 (CAr), 144.0 
(CHAr), 139.3 (2CAr), 137.62 (CAr), 132.3 (CAr), 130.4 (2CHAr), 129.5 (CHAr), 125.6 
(2CHAr), 124.5 (CAr), 117.7 (CHAr), 116.7 (CHAr), 113.9 (2CHAr), 103.3 (CHAr), 55.4 
(OCH3), 21.4 (2CH3). IR (ATR, cm
-1
): ṽ = 3038 (w), 3008 (w), 2920 (w), 2837 (w), 
1610 (m), 1594 (m), 1497 (s), 1413 (s), 1377 (m), 1250 (s), 1177 (m), 1037 (m), 837 
(m), 783 (m). MS (EI, 70 eV): m/z (%) = 329 (25), 328 [M]
+
 (100), 313 (21), 269 (13), 
157 (12). HRMS (EI): Calculated for C22H20ON2 [M]
+
 328.15701 found 328.15685. 
1-(4-Methoxyphenyl)-2-phenyl-1H-pyrrolo[3,2-b]pyridine (3g): Yellow solid, 
mp. 146 - 147 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.50 (d, 
3
J = 4.1 Hz, 1H, CHAr), 7.50 (d, 
3
J = 8.2 Hz, 1H, CHAr), 
7.35 - 7.25 (m, 5H, CHAr), 7.14 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.08 
(dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr), 6.99 (s, 1H, CHAr), 6.94 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 3.84 (s, 3H, OCH3). 
13
C NMR 
(63 MHz, CDCl3) δ = 158.9 (CAr), 146.3 (CAr), 144.2 (CAr), 143.9 (CHAr), 132.6 (CAr), 
131.7 (CAr), 130.2 (CAr), 129.1 (2CHAr), 128.9 (2CHAr), 128.3 (2CHAr), 127.9 (CHAr), 
117.8 (CHAr), 116.9 (CHAr), 114.7 (2CHAr), 103.8 (CHAr), 55.5 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3128 (w), 3012 (w), 2921 (w), 2850 (w), 2044 (w), 1891 (w), 1852 
(w), 1597 (m), 1510 (s), 1414 (s), 1245 (s), 1176 (m), 1022 (m), 843 (m), 769 (s), 696 
(s), 583 (m). MS (EI, 70 eV): m/z (%) = 301 (22), 300 [M]
+
 (100), 209 (19), 285 (18), 
255 (22), 128 (11). HRMS (EI): Calculated for C20H16ON2 [M]
+
 300.12571 found 
300.12562. 
1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrolo[3,2-b]pyridine 
(3h): Yellow solid, mp. 143 - 144 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.52 (dd, 
3
J = 4.6 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.56 - 7.47 (m, 3H, CHAr), 7.41 (d, 
3
J = 8.1 Hz, 2H, 
CHAr), 7.14 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.10 (dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr), 
7.04 (d, 
5
J = 0.7 Hz, 1H, CHAr), 6.96 (d, 
3
J = 8.9 Hz, 2H, CHAr), 3.85 (s, 3H, OCH3). 
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19
F NMR (282 MHz, CDCl3) δ = -62.7 (F3C). 
13
C NMR 
(63 MHz, CDCl3) δ = 159.3 (CAr), 146.4 (CAr), 144.7 
(CHAr), 142.2 (CAr), 135.4 (CAr), 133.0 (CAr), 130.0 (CAr), 
129.8 (q, 
2
JCF = 32.6 Hz, CAr), 129.2 (2CHAr), 129.0 
(2CHAr), 125.4 (q, 
3
JCF = 3.7 Hz, 2CHAr), 124.1 (q, 
1
JCF = 272.1 Hz, CF3), 118.0 (CHAr), 117.7 (CHAr), 115.0 (2CHAr), 105.2 (CHAr), 55.6 
(OCH3). IR (ATR, cm
-1
): ṽ = 3044 (w), 3014 (w), 2959 (w), 2932 (w), 2840 (w), 1726 
(w), 1616 (w), 1514 (s), 1416 (m), 1322 (s), 1317 (s), 1245 (m), 1167 (s), 1109 (s), 
1061 (m), 856 (m), 804 (s), 758 (m), 623 (m). MS (EI, 70 eV): m/z (%) = 369 (23), 368 
(100), 367 (19), 255 (11), 182 (11), 128 (11). HRMS (EI): Calculated for C21H15ON2F3 
[M]
+
 368.11310 found 368.11256. 
2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1H-pyrrolo[3,2-b]pyridine (3i): Yellow 
solid, mp. 143 - 144 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.42 (dd, 3J = 4.6 Hz, 4J = 1.5 Hz, 1H, CHAr), 7.40 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.4 Hz, 
4
J = 0.7 Hz, 1H, CHAr), 7.20 (dd, 
3
J = 8.9 Hz, 
3
J = 5.3 Hz, 2H, CHAr), 7.05 (d, 
3
J = 8.9 Hz, 2H, 
CHAr), 6.99 (dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr), 6.92 (m, 
1H, CHAr), 6.90 - 6.83 (m, 4H, CHAr), 3.76 (s, 3H, OCH3). 
19
F NMR (282 MHz, CDCl3) 
δ = -113.3 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 162.6 (d, 
1
JCF = 248.6 Hz, CAr), 
159.1 (CAr), 146.5 (CAr), 144.4 (CHAr), 143.1 (CAr), 132.6 (CAr), 131.0 (d, 
3
JCF = 8.2 Hz, 
2CHAr), 130.1 (CAr), 129.0 (2CHAr), 128.1 (d, 
4
JCF = 3.4 Hz, CAr), 117.8 (CHAr), 117.2 
(CHAr), 115.6 (d, 
2
JCF = 21.7 Hz, 2CHAr), 114.8 (2CHAr), 103.9 (CHAr), 55.6 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3117 (w), 3050 (w=, 3014 (w), 2916 (w), 2835 (w), 1600 (m), 1558 
(w), 1515 (s), 1496 (s), 1419 (m), 1359 (m), 1248 (s), 1221 (m), 1158 (m), 1108 (m), 
1024 (s), 840 (s), 681 (s), 577 (s). MS (EI, 70 eV): m/z (%) = 319 (23), 318 [M]
+
 (100), 
317 (17), 275 (18), 137 (9). HRMS (EI): Calculated for C20H15ON2F [M]
+
 318.11629 
found 318.11615. 
2-(4-Fluorophenyl)-1-phenyl-1H-pyrrolo[3,2-b]pyridine (3j): Yellow solid, 
mp. 128 - 129 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.44 (s, 1H, CHAr), 7.48 (d, 
3
J = 8.3 Hz, 1H, CHAr), 
7.42 - 7.28 (m, 3H, CHAr), 7.26 - 7.08 (m, 4H, CHAr), 7.04 (dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr), 6.95 - 6.82 (m, 3H, CHAr). 
19
F NMR (282 MHz, CDCl3) δ = -112.9 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 162.7 
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(d, 
1
JCF = 249.0 Hz, CFAr), 146.1 (CAr), 143.8 (CHAr), 143.4 (CAr), 137.3 (CHAr), 132.3 
(CAr), 131.0 (d, 
3
JCF = 8.2 Hz, 2CHAr), 129.8 (2CHAr), 128.1 (CAr), 127.9 (2CHAr), 127.8 
(d, 
4
JCF = 3.4 Hz, CAr), 118.3 (CHAr), 117.3 (CHAr), 115.6 (d, 
2
JCF = 21.7 Hz, 2CHAr), 
104.1 (CHAr). IR (ATR, cm
-1
): ṽ = 3046 (w), 2920 (w), 2851 (w), 1893 (w), 1596 (m), 
1495 (s), 1412 (s), 1359 (m), 1219 (m), 1156 (m), 1013 (m), 835 (s), 798 (s), 782 (s), 
696 (s), 594 (s). MS (EI, 70 eV): m/z (%) = 289 (20), 288 [M]
+
 (100), 287 (47), 286 
(15), 120 (7), 77 (12), 51 (12). HRMS (EI): Calculated for C19H13FN2 [M]
+
 288.10573 
found 288.10600. 
1-(4-Fluorophenyl)-2-phenyl-1H-pyrrolo[3,2-b]pyridine (3k): Yellow solid, 
mp. 120 - 121 °C. 
1
H NMR (500 MHz, Chloroform-d) δ = 8.51 
(dd, 
3
J = 4.6 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.49 (ddd, 
3
J = 8.3 Hz, 
4
J = 1.4 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.28 -7.23 (m, 5H, CHAr), 
7.22 - 7.17 (m, 2H, CHAr), 7.15 - 7.07 (m, 3H, CHAr), 6.99 (s, 1H, 
CHAr). 
19
F NMR (282 MHz, CDCl3) δ = -113.2 (FCAr). 
13
C NMR 
(63 MHz, CDCl3) δ = 161.8 (d, 
1
JCF = 248.2 Hz, CFAr), 146.8 (CAr), 144.6 (CHAr), 144.1 
(CAr), 133.7 (d, 
4
JCF = 3.0 Hz, CAr), 133.6 (CAr), 131.6 (CAr), 129.5 (d, 
3
JCF = 8.5 Hz, 
2CHAr), 129.2 (2CHAr), 128.5 (2CHAr), 128.3 (CHAr), 117.6 (CHAr), 117.3 (CHAr), 
116.6 (d, 
2
JCF = 22.8 Hz, 2CHAr), 104.7 (CHAr). IR (ATR, cm
-1
): ṽ = 3054 (w), 2924 
(w), 2853 (w), 1888 (w), 1599 (w), 1560 (w), 1507 (s), 1415 (s), 1221 (s), 1153 (m), 
965 (m), 850 (m), 763 (s), 693 (s), 581 (s). MS (EI, 70 eV): m/z (%) = 289 (21), 288 
[M]
+
 (100), 287 (45), 286 (14), 143 (8), 75 (7). HRMS (EI): Calculated for C19H13NF 
[M]
+
 288.10573 found 288.10531. 
1,2-Diphenyl-1H-pyrrolo[3,2-b]pyridine (3l): Yellow solid, mp. 117 - 118 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.49 (d, 3J = 4.3 Hz, 1H, 
CHAr), 7.54 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.46 - 7.34 (m, 3H, CHAr), 
7.28 - 7.25 (m, 4H, CHAr), 7.24 - 7.20 (m, 2H, CHAr), 7.20 - 7.17 
(m, 1H, CHAr), 7.07 (dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr), 6.99 
(d, 
5
J = 0.5 Hz, 1H, CHAr). 
13
C NMR (63 MHz, CDCl3) δ = 146.7 (CAr), 144.3 (CAr), 
144.1 (CHAr), 137.8 (CAr), 132.4 (CAr), 131.8 (CAr), 129.6 (2CHAr), 129.2 (2CHAr), 
128.4 (2CHAr), 128.2 (CHAr), 127.9 (2CHAr), 127.8 (CHAr), 117.9 (CHAr), 117.2 (CHAr), 
104.5 (CHAr). IR (ATR, cm
-1
): ṽ = 3046 (w), 2920 (w), 2850 (w), 1595 (m), 1558 (w), 
1598 (m), 1454 (w), 1412 (s), 1382 (m), 1327 (m), 1290 (m), 1178 (m), 1113 (m), 963 
(m), 769 (s), 690 (s), 604 (s). MS (EI, 70 eV): m/z (%) = 271 (21), 270 [M]
+
 (100), 269 
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(52), 268 (18), 77 (12), 51 (14). HRMS (ESI): Calculated for C19H14N2 [M+H]
+
 
271.12297 found 271.12302. 
1
H- and 
13
C-NMR spectral data are in accordance with the 
literature.
[169j]
 
2-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrrolo[3,2-b]pyridine (3m): Yellow solid, 
mp. 169 - 170 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.45 (d, 3J = 4.5 Hz, 1H, CHAr), 7.55 - 7.25 (m, 13H, 
CHAr), 7.24 - 7.15 (m, 2H, CHAr), 7.07 - 6.97 (m, 2H, 
CHAr). 
13
C NMR (63 MHz, CDCl3) δ = 146.7 (CAr), 
144.4 (CAr), 143.7 (CHAr), 140.8 (CAr), 140.3 (CAr), 137.7 (CAr), 132.5 (CAr), 130.7 
(CAr), 129.7 (2CHAr), 129.5 (2CHAr), 128.9 (2CHAr), 127.9 (2CHAr), 127.9 (CHAr), 
127.7 (CHAr), 127.1 (2CHAr), 127.1 (2CHAr), 117.8 (CHAr), 117.2 (CHAr), 104.6 (CHAr). 
IR (ATR, cm
-1
): ṽ = 3113 (w), 3061 (w), 2921 (w), 2851 (w), 1920 (w), 1681 (w), 1596 
(m), 1494 (m), 1411 (s), 1353 (m), 844 (m), 805 (m), 785 (m), 769 (s), 698 (s), 605 (m). 
MS (EI, 70 eV): m/z (%) = 346 [M]
+
 (100), 347 (27), 345 (32), 269 (8), 77 (11), 51 (7). 
HRMS (EI): Calculated for C25H18N2 [M]
+
 346.14645 found 346.14578. 
2-(Naphthalen-2-yl)-1-phenyl-1H-pyrrolo[3,2-b]pyridine (3n): Brownish solid, 
mp. 130 - 131 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.46 (s, 1H, CHAr), 7.80 - 7.57 (m, 4H, CHAr), 7.51 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.44 - 7.13 (m, 8H, CHAr), 7.11 - 6.97 
(m, 2H, CHAr). 
13
C NMR (63 MHz, CDCl3) δ = 146.6 (CAr), 
144.2 (CHAr), 144.1 (CAr), 137.7 (CAr), 133.2 (CAr), 132.8 
(CAr), 129.7 (2CHAr), 129.7 (CAr), 129.2 (CAr), 128.6 (CHAr), 128.4 (CHAr), 128.0 
(CHAr), 127.9 (2CHAr), 127.8 (CHAr), 127.6 (CHAr), 126.7 (CHAr), 126.6 (CHAr), 126.6 
(CHAr), 118.0 (CHAr), 117.3 (CHAr), 104.8 (CHAr). IR (ATR, cm
-1
): ṽ = 3053 (w), 2923 
(w), 2851 (w), 1592 (m), 1497 (s), 1414 (s), 1288 (m), 865 (m), 827 (m), 781 (s), 759 
(m), 693 (s). MS (EI, 70 eV): m/z (%) = 321 (26), 320 [M]
+
 (100), 319 (49), 318 (16), 
159 (7). HRMS (ESI): Calculated for C23H16N2 [M+H]
+
 320.13080 found 320.13045. 
1,2-Di(naphthalen-2-yl)-1H-pyrrolo[3,2-b]pyridine (3o): yellow solid, 
mp. 157 - 158 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.46 (dd, 3J = 4.6 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.85 (dd, 
3
J = 8.3 Hz, 
3
J = 3.4 Hz, 1H, CHAr), 7.69 (d, 
4
J = 1.3 Hz, 1H, CHAr), 7.63 - 7.55 (m, 1H, CHAr), 7.52 - 7.26 (m, 10H, CHAr), 7.23 (dd, 
3
J = 8.6 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 7.18 - 7.15 (m, 1H, CHAr), 7.04 (ddd, 
3
J = 8.3 Hz, 
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4
J = 1.4 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 6.92 (dd, 
3
J = 8.3 Hz, 
3
J = 4.6 Hz, 1H, CHAr). 
13
C NMR (75 MHz, CDCl3) 
δ = 146.7 (CAr), 145.3 (CAr), 144.4 (CAr), 134.4 (CHAr), 134.3 
(CAr), 133.6 (CAr), 133.0 (CAr), 132.7 (CAr), 131.1 (CAr), 
129.2 (CAr), 129.1 (CHAr), 128.5 (CHAr), 128.2 (CHAr), 127.9 
(CHAr), 127.8 (CHAr), 127.5 (CHAr), 127.5 (CHAr), 127.2 (CHAr), 126.8 (CHAr), 126.4 
(CHAr), 126.3 (CHAr), 125.9 (CHAr), 125.5 (CHAr), 123.1 (CHAr), 118.2 (CHAr), 117.2 
(CHAr), 104.4 (CHAr). IR (ATR, cm
-1
): ṽ = 3050 (w), 2923 (w), 2850 (w), 1595 (m), 
1505 (m), 1465 (m), 1415 (m), 1399 (m), 1284 (m), 1016 (m), 863 (m), 798 (m), 770 
(s), 755 (m), 663 (m), 589 (m). MS (EI, 70 eV): m/z (%) = 371 (31), 370 [M]
+
 (100), 
369 (36), 368 (13), 367 (15), 184 (13). HRMS (EI): Calculated for C27H18N2 [M]
+
 
370.14645 found 370.14572. 
5.2.1.3.7-Azaindoles 
1,2-Bis(4-Methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine (4a): White solid, 
mp. 145 - 146 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.22 (dd, 3J = 4.7 Hz, 4J = 1.5 Hz, 1H, CHAr), 7.85 (dd, 
3
J = 7.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.22 - 7.09 (m, 4H, 
CHAr), 7.02 (dd, 
3
J = 7.8 Hz, 
3
J = 4.8 Hz, 1H, CHAr), 
6.92 - 6.82 (m, 2H, CHAr), 6.78 - 6.69 (m, 2H, CHAr), 6.56 
(s, 1H, CHAr), 3.75 (s, 3H, OCH3), 3.71 (s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) 
δ = 159.3 (CAr), 158.6 (CAr), 150.0 (CAr), 143.2 (CHAr), 141.2 (CAr), 130.2 (2CHAr), 
129.9 (CAr), 129.5 (2CHAr), 128.0 (CHAr), 124.6 (CAr), 120.9 (CAr), 116.8 (CHAr), 114.4 
(2CHAr), 113.8 (2CHAr), 99.9 (CHpyrrole), 55.4 (OCH3), 55.2 (OCH3). IR (ATR, cm
-1
): 
ṽ = 3114 (w), 3049 (w), 3018 (w), 2929 (w), 2835 (w), 2037 (w), 1905 (w), 1833 (w), 
1610 (m), 1567 (w), 1515 (s), 1500 (s), 1454 (m), 1371 (m), 1301 (m), 1242 (s), 1184 
(m), 1024 (m), 833 (s), 798 (s), 766 (s), 584 (m). MS (EI, 70 eV): m/z (%) = 331 (18), 
330 [M]
+
 (83), 329 (100), 286 (11), 243 (17), 121 (7). HRMS (ESI): Calculated for 
C21H18N2O2 [M+H]
+
 331.14410 found 331.14454. 
1-(3-Methoxyphenyl)-2-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine (4b): Yellow 
oil. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.30 - 8.04 (m, 1H, CHAr), 7.83 (t, 
3
J = 8.0 Hz, 1H, CHAr), 7.32 - 7.06 (m, 3H, CHAr), 7.06 - 6.93 (m, 1H, CHAr), 
6.92 - 6.62 (m, 5H, CHAr), 6.55 (d, 
3
J = 9.6 Hz, 1H, CHAr), 3.69 (s, OCH3), 3.63 (s, 3H, 
OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 160.1 (CAr), 159.5 (CAr), 150.0 (CAr), 143.4 
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(CHAr), 141.2 (CAr), 138.3 (CAr), 130.2 (2CHAr), 129.8 
(CHAr), 128.1 (CHAr), 124.8 (CAr), 121.1 (CHAr), 121.0 
(CAr), 117.1 (CHAr), 114.3 (CHAr), 113.9 (2CHAr), 113.5 
(CHAr), 100.6 (CHAr), 55.5 (OCH3), 55.4 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3041 (w), 3001 (w), 2933 (w), 2834 (w), 2222 (w), 2032 (w), 1920 
(w), 1731 (w), 1604 (m), 1588 (m), 1498 (s), 1455 (m), 1406 (s), 1368 (m), 1283 (m), 
1247 (s), 1173 (m), 1028 (m), 833 (m), 802 (m), 767 (m), 692 (m), 612 (m). 
MS (EI, 70 eV): m/z (%) = 331 (20), 330 [M]
+
 (98), 329 (100), 243 (16), 121 (13). 
HRMS (EI): Calculated for C21H18O2N2 [M]
+
 330.13628 found 330.13539. 
2-(4-Methoxyphenyl)-1-phenyl-1H-pyrrolo[2,3-b]pyridine (4c): Yellow solid, 
mp. 138 - 139 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.21 (dd, 3J = 4.8 Hz, 4J = 1.6 Hz, 1H, CHAr), 7.83 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.37 - 7.28 (m, 2H, 
CHAr), 7.28 - 7.19 (m, 3H, CHAr), 7.11 (d, 
3
J = 8.8 Hz, 2H, 
CHAr), 7.02 (dd, 
3
J = 7.8 Hz, 
3
J = 4.8 Hz, 1H, CHAr), 6.70 (d, 
3
J = 8.8 Hz, 2H, CHAr), 
6.56 (s, 1H, CHpyrrole), 3.68 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.3 (CAr), 
149.9 (CAr), 143.3 (CHAr), 141.1 (CHAr), 137.2 (CAr), 130.2 (2CHAr), 129.1 (2CHAr), 
128.5 (2CHAr), 128.1 (CHAr), 127.3 (CHAr), 124.6 (CAr), 121.0 (CAr), 117.0 (CHAr), 
113.8 (2CHAr), 100.5 (CHpyrrole), 55.2 (OCH3). IR (ATR, cm
-1
): ṽ = 3044 (w), 3008 (w), 
2953 (m), 2833 (m), 1674 (w), 1608 (m), 1500 (s), 1408 (s), 1368 (m), 1242 (s), 1182 
(m), 1024 (s), 836 (m), 799 (s), 766 (s), 696 (s), 597 (s). MS (EI, 70 eV): m/z (%) = 301 
(18), 300 [M]
+
 (91), 299 (100), 285 (8), 255 (31), 128 (18), 51 (9). HRMS (EI): 
Calculated for C20H16ON2 [M]
+
 300.12571 found 300.12482. 
2-(4-Methoxyphenyl)-1-(naphthalen-2-yl)-1H-pyrrolo[2,3-b]pyridine (4d): Yellow 
solid, mp. 123 - 124 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 8.13 (dd, 3J = 4.8 Hz, 4J = 1.6 Hz, 1H, 
CHAr), 7.91 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 
7.87 - 7.77 (m, 2H, CHAr), 7.48 - 7.30 (m, 3H, CHAr), 
7.29 - 7.18 (m, 2H, CHAr), 7.05 (d, 
3
J = 8.8 Hz, 1H, CHAr), 
7.04 - 6.97 (m, 1H, CHAr), 6.69 (s, 1H, CHpyrrole), 6.55 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.58 
(s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 159.3 (CAr), 150.9 (CAr), 143.4 (CAr), 
142.5 (CAr), 134.4 (CHAr), 134.2 (CAr), 131.7 (CAr), 129.5 (2CHAr), 129.0 (CHAr), 128.3 
(CHAr), 128.1 (CHAr), 127.6 (CHAr), 127.0 (CHAr), 126.4 (CHAr), 125.5 (CHAr), 124.6 
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(CAr), 123.5 (CHAr), 120.9 (CAr), 116.9 (CHAr), 113.7 (2CHAr), 100.0 (CHpyrrole), 55.1 
(OCH3). IR (ATR, cm
-1
): ṽ = 3604 (w), 3388 (w), 3044 (w), 2961 (w), 2835 (w), 1609 
(m), 1497 (s), 1469 (m), 1425 (m), 1298 (m), 1245 (s), 1176 (m), 1024 (m), 833 (m), 
798 (s), 761 (s). MS (EI, 70 eV): m/z (%) = 351 (23), 350 [M]
+
 (100), 349 (87), 305 
(29), 243 (25), 153 (13). HRMS (EI): Calculated for C24H18N2O [M+H]
+
 351.14919 
found 351.14934. 
1-(2,3-Dihydro-1H-inden-5-yl)-2-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine 
(4e): Yellow oil. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.21 (dd, 3J = 4.7 Hz, 4J = 1.7 Hz, 1H, CHAr), 7.83 (dd, 
3
J = 7.8 Hz, 
4
J = 1.7 Hz, 1H, CHAr), 7.19 - 7.12 (m, 3H, 
CHAr), 7.11 (s, 1H, CHAr), 7.00 (dd, 
3
J = 7.8 Hz, 
3
J = 4.8 Hz, 1H, CHAr), 6.94 (dd, 
3
J = 7.9 Hz, 
4
J = 1.9 Hz, 
1H, CHAr), 6.73 (d, 
3
J = 8.8 Hz, 2H, CHAr), 6.55 (s, 1H, CHpyrrole), 3.70 (s, 1H, OCH3), 
2.84 (t, 
3
J = 7.0 Hz, 4H, CH2-aliphatic), 2.09 - 1.93 (m, 2H, CH2-aliphatic). 
13
C NMR 
(63 MHz, CDCl3) δ = 159.3 (CAr), 150.3 (CAr), 145.3 (CAr), 143.8 (CAr), 143.3 (CHAr), 
141.4 (CAr), 135.3 (CAr), 130.3 (2CHAr), 128.0 (CHAr), 126.5 (CHAr), 125.0 (CAr), 124.8 
(CHAr), 124.6 (CHAr), 121.0 (CAr), 116.8 (CHAr), 113.9 (2CHAr), 100.0 (CHpyrrole), 55.4 
(OCH3), 33.1 (CH2-aliphatic), 32.8 (CH2-aliphatic), 25.7 (CH2-aliphatic). IR (ATR, cm
-1
): 
ṽ = 3042 (w), 2944 (m), 2839 (w), 1675 (w), 1609 (m), 1499 (s), 1407 (m), 1248 (s), 
1176 (m), 1030 (m), 834 (m), 803 (m), 769 (m). MS (EI, 70 eV): m/z (%) = 341 (17), 
340 (79), 339 [M]
+
 (100), 296 (10), 115 (12). HRMS (EI): Calculated for C23H19ON2 
[M]
+
 339.14919 found 339.14923. 
1-(3,5-Dimethylphenyl)-2-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine (4f): 
Yellow solid, mp. 95 - 96 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.21 (dd, 3J = 4.8 Hz, 4J = 1.5 Hz, 1H, 
CHAr), 7.83 (dd, 
3
J = 7.8 Hz, 
3
J = 1.5 Hz, 1H, CHAr), 7.15 
(d, 
3
J = 8.7 Hz, 2H, CHAr), 7.01 (dd, 
3
J = 7.8 Hz, 
3
J = 4.8 Hz, 1H, CHAr), 6.90 (s, 1H, CHAr), 6.85 (s, 2H, 
CHAr), 6.72 (d, 
3
J = 8.8 Hz, 2H, CHAr), 6.55 (s, 1H, CHpyrrole), 3.71 (s, 3H, OCH3), 2.22 
(s, 6H, CH3). 
13
C NMR (63 MHz, CDCl3) δ = 159.3 (CAr), 150.2 (CAr), 143.3 (CHAr), 
141.3 (CAr), 138.7 (2CAr), 137.1 (CAr), 130.2 (2CHAr), 129.6 (CHAr), 128.0 (CHAr), 
126.5 (2CHAr), 124.9 (CAr), 121.0 (CAr), 116.8 (CHAr), 113.8 (2CHAr), 100.1 (CHpyrrole), 
55.3 (OCH3), 21.5 (2CH3). IR (ATR, cm
-1
): ṽ = 3040 (w), 3006 (w), 2917 (w), 2836 
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(w), 1609 (m), 1546 (w), 1498 (s), 1473 (m), 1405 (s), 1369 (m), 1247 (s), 1175 (m), 
1026 (m), 836 (m), 801 (m), 767 (m), 696 (m). MS (EI, 70 eV): m/z (%) = 329 (21), 328 
[M]
+
 (99), 327 (100), 313 (12), 312 (14), 269 (17), 157 (12), 135 (10). HRMS (ESI): 
Calculated for C22H19ON2 [M-H]
+
 327.14919 found 327.14906. 
1-(4-Methoxyphenyl)-2-phenyl-1H-pyrrolo[2,3-b]pyridine (4g): Yellow solid, 
mp. 188 - 189 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.24 
(dd, 
3
J = 4.7 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.87 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.28 - 7.11 (m, 7H, CHAr), 7.03 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.85 (d, 
3
J = 8.9 Hz, 2H, 
CHAr), 6.63 (s, 1H, CHpyrrole), 3.74 (s, 3H, OCH3). 
13
C NMR 
(63 MHz, CDCl3) δ = 158.7 (CAr), 150.1 (CAr), 143.5 (CHAr), 141.2 (CAr), 132.2 (CAr), 
129.8 (CAr), 129.4 (2CHAr), 128.9 (2CHAr), 128.3 (CHAr), 128.3 (2CHAr), 127.7 (CHAr), 
120.8 (CAr), 116.9 (CHAr), 114.4 (2CHAr), 100.9 (CHpyrrole), 55.4 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3067 (w), 3043 (w), 3010 (w), 2840 (w), 1901 (w), 1856 (w), 1604 
(w), 1510 (m), 1419 (m), 1236 (s), 1025 (s), 842 (m), 806 (m), 752 (s), 693 (s), 556 (s). 
MS (EI, 70 eV): m/z (%) = 301 (13), 300 [M]
+
 (68), 299 (100), 256 (27), 255 (20), 128 
(9). HRMS (ESI): Calculated for C20H15ON2 [M-H]
+
 299.11789 found 299.11775. 
1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrolo[2,3-b]pyridine 
(4h): Yellow solid, mp. 158 - 159 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.27 (dd, 3J = 4.7 Hz, 4J = 1.6 Hz, 1H, 
CHAr), 7.89 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.45 
(d, 
3
J = 8.3 Hz, 2H, CHAr), 7.33 (d, 
3
J = 8.1 Hz, 2H, CHAr), 
7.15 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.05 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.88 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.70 (s, 1H, CHpyrrole), 3.75 (s, 
3H, OCH3). 
19
F NMR (235 MHz, CDCl3) δ = -62.6 (F3C).
13
C NMR (63 MHz, CDCl3) 
δ = 159.0 (CAr), 150.5 (CAr), 144.5 (CHAr), 139.5 (CAr), 135.8 (CAr), 129.7 (q, 
2
JCF = 32.6 Hz, CAr), 129.6 (CAr), 129.5 (2CHAr), 129.0 (2CHAr), 128.9 (CHAr), 125.4 (q, 
3
JCF = 3.8 Hz, 2CHAr), 124.2 (q, 
1
JCF = 272.1 Hz, CF3), 120.6 (CAr), 117.3 (CHAr), 114.7 
(2CHAr), 102.3 (CHpyrrole), 55.6 (OCH3). IR (ATR, cm
-1
): ṽ = 3020 (w), 2971 (w), 2843 
(w), 2549 (w), 2315 (w), 2051 (w), 1934 (w), 1869 (w), 1613 (m), 1567 (w), 1515 (s), 
1468 (m), 1442 (m), 1323 (s), 1300 (m), 1250 (s), 1162 (s), 1115 (s), 1028 (m), 918 
(m), 844 (s), 800 (s), 764 (s), 591 (m), 561 (m). MS (EI, 70 eV): m/z (%) = 369 (13), 
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368 [M]
+
 (69), 367 (100), 324 (22), 323 (10), 255 (7). HRMS (ESI): Calculated for 
C21H14ON2F3 [M-H]
+
 367.10527 found 367.10514. 
2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine (4i): Yellow 
solid, mp. 173 - 174 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.24 (dd, 3J = 4.7 Hz, 4J = 1.6 Hz, 1H, CHAr), 7.86 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.23 - 7.10 (m, 4H, CHAr), 
7.04 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.94 - 6.83 (m, 
4H, CHAr), 6.59 (s, 1H, CHpyrrole), 3.75 (s, 3H, OCH3). 
19
F NMR (282 MHz, CDCl3) δ = -113.6 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 162.5 
(d, 
1
JCF = 248.2 Hz, CAr), 158.9 (CAr), 150.2 (CAr), 143.9 (CHAr), 140.3 (CAr), 130.8 (d, 
3
JCF = 8.1 Hz, 2CHAr), 129.8 (CAr), 129.6 (2CHAr), 128.5 (CAr), 128.4 (CHAr), 120.8 
(CAr), 117.1 (CHAr), 115.5 (d, 
2
JCF = 21.7 Hz, 2CHAr), 114.6 (2CHAr), 100.9 (CHpyrrole), 
55.6 (OCH3). IR (ATR, cm
-1
): ṽ = 3103 (w), 3014 (w), 2969 (w), 2841 (w), 2050 (w), 
1893 (w), 1602 (w), 1511 (s), 1496 (s), 1297 (m), 1245 (s), 1152 (m), 1106 (m), 1029 
(m), 834 (s), 813 (s), 773 (s), 581 (s). MS (EI, 70 eV): m/z (%) = 319 (12), 318 [M]
+
 
(67), 317 (100), 274 (29), 273 (21), 137 (7), 63 (8). HRMS (ESI): Calculated for 
C20H14ON2F [M-H]
+
 317.10847 found 317.10836. 
2-(4-Fluorophenyl)-1-phenyl-1H-pyrrolo[2,3-b]pyridine (4j): White solid, 
mp. 141 - 142 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.34 
(d, 
3
J = 4.7 Hz, 1H, CHAr), 7.90 (d, 
3
J = 7.8 Hz, 1H, CHAr), 
7.35 (d, 
3
J = 7.7 Hz, 2H, CHAr), 7.29 (d, 
3
J = 7.1 Hz, 1H, 
CHAr), 7.23 (d, 
3
J = 7.1 Hz, 2H, CHAr), 7.17 (dd, 
3
J = 7.1 Hz, 
3
J = 5.3 Hz, 2H, CHAr), 7.15 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.89 (t, 
3
J = 8.7 Hz, 2H, CHAr), 6.70 (s, 1H, CHpyrrole). 
19
F NMR (282 MHz, CDCl3) δ = -113.4 
(FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 162.6 (d, 
1
JCF = 248.4 Hz, CFAr), 149.8 (CAr), 
143.8 (CHAr), 140.3 (CAr), 136.9 (CAr), 130.8 (d, 
3
JCF = 8.2 Hz, 2CHAr), 129.3 (2CHAr), 
128.6 (CHAr), 128.5 (2CHAr), 128.4 (d, 
4
JCF = 3.4 Hz, CAr), 127.7 (CHAr), 121.0 (CAr), 
117.3 (CHAr), 115.5 (d, 
2
JCF = 21.7 Hz, 2CHAr), 101.5 (CHpyrrole). IR (ATR, cm
-1
): 
ṽ = 3064 (w), 3043 (w), 2921 (w), 1589 (m), 1543 (m), 1496 (s), 1424 (m), 1402 (m), 
1220 (s), 1157 (m), 840 (s), 802 (s), 768 (s), 691 (s), 592 (s), 539 (m). MS (EI, 70 eV): 
m/z (%) = 289 (10), 288 [M]
+
 (62), 287 (100), 286 (21), 143 (6), 51 (7). HRMS (ESI): 
Calculated for C19H13FN2 [M+H]
+
 289.11355 found 289.11359. 
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1-(4-Fluorophenyl)-2-phenyl-1H-pyrrolo[2,3-b]pyridine (4k): Yellow solid, 
mp. 164 - 165 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.31 
(dd, 
3
J = 4.7 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.95 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.35 - 7.20 (m, 7H, CHAr), 7.16 - 7.04 (m, 
3H, CHAr), 6.64 (s, 1H, CHpyrrole). 
19
F NMR (282 MHz, CDCl3) 
δ = -114.4 (FCAr). 
13
C NMR (75 MHz, CDCl3) δ = 161.7 (d, 
1
JCF = 247.1 Hz, CFAr), 150.1 (CAr), 143.8 (CHAr), 141.2 (CAr), 133.1 (d, 
4
JCF = 3.2 Hz, 
CAr), 132.0 (CAr), 130.1 (d, 
3
JCF = 8.6 Hz, 2CHAr), 129.1 (2CHAr), 128.6 (CHAr), 128.5 
(2CHAr), 128.1 (CHAr), 121.0 (CAr), 117.3 (CHAr), 116.1 (d, 
2
JCF = 22.8 Hz, 2CHAr), 
101.6 (CHpyrrole). IR (ATR, cm
-1
): ṽ = 3110 (w), 3059 (w), 3008 (w), 2924 (w), 1907 
(w), 1858 (w), 1675 (w), 1568 (w), 1508 (m), 1420 (m), 1208 (m), 1096 (w), 852 (m), 
804 (s), 747 (s). 698 (s), 552 (m). MS (EI, 70 eV): m/z (%) = 289 (10), 288 [M]
+
 (60), 
287 (100), 286 (21), 75 (11). HRMS (ESI): Calculated for C19H12FN2 [M-H]
+
 
287.09790 found 287.09747. 
1,2-Diphenyl-1H-pyrrolo[2,3-b]pyridine (4l): White solid, mp. 130 - 132 °C. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.33 (dd, 3J = 4.7 Hz, 4J = 1.6 Hz, 
1H, CHAr), 7.97 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 
7.48 - 7.26 (m, 10H, CHAr), 7.14 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, 
CHAr), 6.74 (s, 1H, CHpyrrole). 
13
C NMR (63 MHz, CDCl3) 
δ = 150.1 (CAr), 143.8 (CHAr), 141.3 (CAr), 137.2 (CAr), 132.3 (CAr), 129.2 (2CHAr), 
129.1 (2CHAr), 128.5 (2CHAr), 128.5 (CHAr), 128.4 (2CHAr), 127.9 (CHAr), 127.5 
(CHAr), 121.0 (CAr), 117.2 (CHAr), 101.6 (CHpyrrole). IR (ATR, cm
-1
): ṽ = 3116 (w), 
3064 (w), 2925 (w), 1852 (w), 1594 (m), 1540 (m), 1496 (s), 1474 (m), 1425 (m), 1401 
(m), 1370 (m), 1224 (s), 1158 (m), 841 (m), 799 (s), 767 (s), 692 (s), 593 (s). 
MS (EI, 70 eV): m/z (%) = 271 (11),270 [M]
+
 (59), 269 (100), 268 (21), 135 (8). 
HRMS (ESI): Calculated for C19H14N2 [M+H]
+
 271.12297 found 271.12322. 
1
H- and 
13
C-NMR spectral data are in accordance with the literature.
[198]
 
2-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrrolo[2,3-b]pyridine (4m): White solid, 
mp. 182 - 183 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.36 (dd, 3J = 4.7 Hz, 4J = 1.5 Hz, 1H, CHAr), 7.99 
(dd, 
3
J = 7.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.48 (d, 
3
J = 7.0 Hz, 2H, CHAr), 7.42 (d, 
3
J = 8.3 Hz, 2H, CHAr), 
7.39 - 7.31 (m, 4H, CHAr), 7.28 (m, 4H, CHAr), 7.26 - 7.21 (m, 2H, CHAr), 7.15 (dd, 
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3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.80 (s, 1H, CHpyrrole). 
13
C NMR (63 MHz, CDCl3) 
δ = 150.2 (CAr), 143.8 (CHAr), 140.9 (CAr), 140.5 (CAr), 140.4 (CAr), 137.2 (CAr), 131.1 
(CAr), 129.3 (2CHAr), 129.3 (2CHAr), 128.9 (2CHAr), 128.6 (2CHAr), 128.5 (CHAr), 
127.6 (CHAr), 127.5 (2CHAr), 127.1 (2CHAr), 127.0 (CHAr), 121.0 (CAr), 117.2 (CHAr), 
101.6 (CHpyrrole). IR (ATR, cm
-1
): ṽ = 3110 (w), 3050 (w), 3034 (w), 3001 (w), 1591 
(w), 1500 (m), 1421 (m), 1293 (w), 1247 (w), 997 (w), 842 (m), 807 (m), 760 (s), 694 
(s), 610 (w). MS (EI, 70 eV): m/z (%) = 347 (19), 346 [M]
+
 (84), 345 (100), 268 (8), 
173 (6), 77 (9). HRMS (ESI): Calculated for C25H18N2 [M+H]
+
 347.15419 found 
347.15428. 
2-(Naphthalen-2-yl)-1-phenyl-1H-pyrrolo[2,3-b]pyridine (4n): Yellow solid, 
mp. 180 - 181 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.37 (dd, 3J = 4.7 Hz, 4J = 1.5 Hz, 1H, CHAr), 8.01 (dd, 
3
J = 7.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.83 (d, 
4
J = 1.1 Hz, 1H, 
CHnaphthalene), 7.81 - 7.77 (m, 1H, CHAr), 7.71 (d, 
3
J = 8.9 Hz, 
2H, CHAr), 7.54 - 7.43 (m, 2H, CHAr), 7.43 - 7.30 (m, 6H, 
CHAr), 7.17 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 6.87 (s, 1H, CHpyrrole). 
13
C NMR 
(63 MHz, CDCl3) δ = 150.1 (CAr), 143.8 (CHAr), 141.2 (CAr), 137.2 (CAr), 133.3 (CAr), 
132.8 (CAr), 129.7 (CAr), 129.3 (2CHAr), 128.6 (CHAr), 128.5 (2CHAr), 128.3 (CHAr), 
128.3 (CHAr), 127.9 (CHAr), 127.8 (CHAr), 127.5 (CHAr), 126.6 (CHAr), 126.6 (CHAr), 
126.5 (CHAr), 121.1 (CAr), 117.3 (CHAr), 102.0 (CHpyrrole). IR (ATR, cm
-1
): ṽ = 3053 
(w), 2923 (w), 2851 (w), 1957 (w), 1930 (w), 1879 (w), 1865 (w), 1674 (w), 1592 (m), 
1499 (m), 1416 (s), 1293 (m), 827 (m), 802 (s), 772 (s), 755 (s), 596 (s), 578 (m). 
MS (EI, 70 eV): m/z (%) = 321 (15),320 [M]
+
 (68), 319 (100), 318 (22), 317 (10), 159 
(13). HRMS (ESI): Calculated for C23H16N2 [M+H]
+
 321.13862 found 321.13885. 
1,2-Di(naphthalen-2-yl)-1H-pyrrolo[2,3-b]pyridine (4o): Yellow solid, 
mp. 168 - 169 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.29 (dd, 3J = 4.7 Hz, 3J = 1.6 Hz, 1H, CHAr), 8.07 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.96 - 7.87 (m, 2H, 
CHAr), 7.75 (d, 
4
J = 1.3 Hz, 1H, CHAr), 7.71 - 7.64 (m, 1H, 
CHAr), 7.60 - 7.51 (m, 2H, CHAr), 7.51 - 7.45 (m, 2H, CHAr), 
7.45 - 7.42 (m, 1H, CHAr), 7.42 - 7.34 (m, 4H, CHAr), 7.31 (dd, 
3
J = 8.6 Hz, 
4
J = 1.8 Hz, 
1H, CHAr), 7.17 (dd, 
3
J = 7.8 Hz, 
3
J = 4.7 Hz, 1H, CHAr), 7.00 (s, 1H, CHAr). 
13
C NMR 
(75 MHz, CDCl3) δ = 151.2 (CAr), 144.0 (CHAr), 142.5 (CAr), 134.4 (CAr), 134.2 (CAr), 
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133.0 (CAr), 132.6 (CAr), 131.7 (CAr), 129.5 (CAr), 129.1 (CHAr), 128.5 (CHAr), 128.4 
(CHAr), 128.2 (CHAr), 127.7 (CHAr), 127.7 (CHAr), 127.5 (CHAr), 127.5 (CHAr), 127.1 
(CHAr), 126.5 (CHAr), 126.3 (CHAr), 126.2 (CHAr), 125.8 (CHAr), 125.5 (CHAr), 123.4 
(CHAr), 120.8 (CAr), 117.1 (CHAr), 101.4 (CHAr). IR (ATR, cm
-1
): ṽ = 3052 (w), 2922 
(w), 2851 (w), 1929 (w), 1595 (m), 1415 (m), 1297 (m), 958 (w), 786 (m), 768 (s), 758 
(s). MS (EI, 70 eV): m/z (%) = 371 (28), 370 [M]
+
 (99), 369 (100), 367 (16), 243 (25), 
184 (10), 127 (11), 77 (6). HRMS (EI): Calculated for C27H18N2 [M]
+
 370.14645 found 
370.14531. 
5.2.2. Synthesis of pyrroloquinolines from imines by domino C-C/C-N coupling 
5.2.2.1.Pyrrolo[2,3-b]quinolines 
1,2-Bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoline (6a): Pale yellow solid, 
mp. 201 - 203 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.36 (s, 1H, CHpyridine), 8.05 (d, 
3
J = 8.9 Hz, 1H, 
CHAr), 7.92 (dd, 
3
J = 8.2 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.57 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.7 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.40 (ddd, 
3
J = 8.1 Hz, 
3
J = 6.7 Hz, 
4
J = 1.2 Hz, 
1H, CHAr), 7.33 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.28 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.98 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.84 (d, 
3
J = 8.8 Hz, 2H, CHAr), 6.75 (s, 1H, CHpyrrole), 3.87 (s, 
3H, OCH3), 3.81 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.8 (CAr), 158.7 
(CAr), 145.3 (CHAr), 145.1 (CAr), 130.4 (2CHAr), 130.1 (CAr), 129.8 (2CHAr), 128.5 
(CHAr), 128.0 (CHAr), 127.5 (CHAr), 126.7 (CAr), 125.6 (CAr), 125.1 (CAr), 124.6 (CAr), 
123.3 (CHAr), 122.5 (CAr), 114.4 (2CHAr), 114.0 (2CHAr), 99.8 (CHAr), 55.6 (OCH3), 
55.4 (OCH3). IR (ATR, cm
-1
) ṽ = 3112 (w), 3049 (w), 3013 (w), 2930 (w), 2831 (w), 
2546 (w), 2050 (w), 1891 (w), 1793 (w), 1605 (m), 1570 (m), 1514 (m), 1496 (m), 1397 
(m), 1293 (m), 1247 (s), 1177 (m), 1027 (m), 894 (m), 829 (s), 768 (m), 745 (m), 628 
(m), 590 (m). MS (EI, 70 eV): m/z = 381 (23), 380 [M]
+
 (98), 379 (100), 336 (15), 294 
(10), 293 (23), 292 (12). HRMS (ESI): Calculated for C25H20N2O [M+H]
+
 381.15975 
found 381.16007. 
1-(3-Methoxyphenyl)-2-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoline (6b): Pale 
yellow solid, mp. 180 - 181 °C.
1
H NMR (300 MHz, Chloroform-d) δ = 8.37 (s, 1H, 
CHpyridine), 8.08 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.93 (dd, 
3
J = 8.2 Hz, 
3
J = 1.6 Hz, 1H, 
CHAr), 7.59 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.7 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.42 (ddd, 
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3
J = 8.1 Hz,
 3
J = 6.7 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.35 
(d, 
3
J = 8.1 Hz, 1H, CHAr), 7.30 (d, 
3
J = 8.7 Hz, 2H, 
CHAr), 7.04 (t, 
4
J = 2.2 Hz, 1H, CHAr), 6.98 (ddd, 
3
J = 7.9 Hz, 
4
J = 1.9 Hz, 
5
J = 0.9 Hz, 1H, CHAr), 6.92 
(ddd, 
3
J = 8.3 Hz, 
4
J = 2.6 Hz, 
5
J = 1.0 Hz, 1H, CHAr), 6.85 (d, 
3
J = 8.8 Hz, 2H, CHAr), 
6.76 (s, 1H, CHpyrrole), 3.81 (s, 3H, OCH3), 3.78 (s, 3H, OCH3). 
13
C NMR (75 MHz, 
CDCl3) δ = 160.0 (CAr), 159.8 (CAr), 151.4 (CAr), 145.2 (CAr), 145.0 (CAr), 138.3 (CAr), 
130.3 (2CHAr), 129.6 (CHAr), 128.6 (CHAr), 128.0 (CHAr), 127.5 (CHAr), 126.6 (CHAr), 
125.7 (CAr), 124.6 (CAr), 123.4 (CHAr), 122.5 (CAr), 121.1 (CHAr), 114.4 (CHAr), 114.0 
(2CHAr), 113.3 (CHAr), 100.4 (CHAr), 55.5 (OCH3), 55.4 (OCH3). IR (ATR, cm
-1
) 
ṽ = 3066 (w), 3053 (w), 2950 (w), 2930 (w), 2907 (w), 2834 (w), 1594 (m), 1493 (m), 
1453 (m), 1393 (m), 1376 (m), 1284 (m), 1246 (m), 1181 (m), 1171 (m), 1123 (m), 
1027 (m), 991 (m), 892 (m), 839 (s), 785 (m), 773 (m), 754 (m), 695 (m), 615 (m). 
MS (EI, 70 eV): m/z = 381 (25), 380 [M]
+
 (100), 379 (91), 321 (10), 293 (14), 146 (10). 
HRMS (ESI): Calculated for C25H20N2O2 [M+H]
+
 381.15975 found 381.15979. 
2-(3,5-Dimethylphenyl)-1-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoline (6c): Pale 
yellow solid, mp. 210 - 212 °C .
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.36 (s, 1H, CHpyridine), 8.08 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.92 (dd, 
3
J = 8.3 Hz, 
4
J = 1.5 Hz, 
1H, CHAr), 7.58 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.40 (ddd, 
3
J = 8.1 Hz, 
3
J = 6.8 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.29 (d, 
3
J = 8.8 Hz, 
2H, CHAr), 7.02 (d, 
3
J = 0.8 Hz, 2H, CHAr), 7.01 (s, 1H, CHAr), 6.84 (d, 
3
J = 8.8 Hz, 2H, 
CHAr), 6.75 (s, 1H, CHpyrrole), 3.81 (s, 3H, OCH3), 2.33 (s, 6H, CH3). 
13
C NMR 
(63 MHz, CDCl3) δ = 159.7 (CAr), 145.2 (CAr), 138.6 (CHAr), 137.0 (2CAr), 136.2 (CAr), 
135.2 (CAr), 130.3 (2CHAr), 129.3 (CHAr), 128.6 (CHAr), 128.0 (CHAr), 127.4 (CHAr), 
126.5 (2CHAr), 125.6 (CAr), 124.7 (CAr), 123.3 (CHAr), 122.6 (CAr), 114.4 (CAr), 113.9 
(2CHAr), 99.9 (CHAr), 55.4 (OCH3), 21.5 (2CH3). IR (ATR, cm
-1
) ṽ = 3114 (w), 3062 
(w), 3041 (w), 3016 (w), 2918 (w), 2839 (w), 2042 (w), 1980 (w), 1946 (w), 1898 (w), 
1604 (m), 1498 (m), 1397 (m), 1331 (m), 1250 (s), 1182 (m), 1118 (m), 1022 (m), 904 
(m), 836 (m), 753 (m), 613 (m). MS (EI, 70 eV): m/z = 379 (24), 378 [M]
+
 (100), 377 
(90), 363 (13), 362 (15), 320 (12), 319 (22), 159 (14). HRMS (ESI): Calculated for 
C26H22N2O [M+H]
+
 379.18049 found 379.18053. 
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2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoline (6d): Pale 
yellow solid, mp. 240 - 242 °C. 
1
H NMR (250 MHz, 
DMSO-d6) δ = 8.55 (s, 1H, CHpyridine), 8.02 (dd, 
3
J = 8.3 Hz, 
3
J = 1.6 Hz, 1H, CHAr), 7.86 (d, 
3
J = 8.9 Hz, 
1H, CHAr), 7.59 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.7 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.49 - 7.35 (m, 3H, CHAr), 7.27 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 7.14 (t, 
3
J = 8.9 Hz, 2H, CHAr), 7.02 (d, 
3
J = 8.9 Hz, 2H, 
CHAr), 6.95 (s, 1H, CHpyrrole), 3.83 (s, 3H, OCH3).
 19
F NMR (235 MHz, DMSO) 
δ = -113.1 (FCAr). 
13
C NMR (63 MHz, DMSO) δ = 161.7 (d, 1JCF = 247.1 Hz, CFAr), 
158.1 (CAr), 151.1 (CAr), 144.4 (CAr), 143.6 (CAr), 130.37 (d, 
3
JCF = 8.3 Hz, 2CHAr), 
129.4 (CAr), 129.3 (2CHAr), 127.71 (d, 
4
JCF = 3.2 Hz, CAr), 127.6 (CHAr), 127.2 (CHAr), 
127.0 (CHAr), 126.2 (CHAr), 124.8 (CAr), 122.6 (CHAr), 121.3 (CAr), 114.8 (d, 
2
JCF = 21.8 Hz, 2CHAr), 114.0 (2CHAr), 100.2 (CHAr), 55.0 (OCH3). 
IR (ATR, cm
-1
) ṽ = 3110 (w), 3072 (w), 3052 (w), 3022 (w), 2937 (w), 2964 (w), 2922 
(w), 2850 (w), 2828 (w), 1570 (m), 1513 (s), 1496 (s), 1401 (m), 1298 (m), 1242 (m), 
1226 (m), 1164 (m), 1026 (m), 886 (m), 844 (s), 823 (m), 775 (m), 732 (s), 629 (m), 
588 (m). MS (EI, 70 eV): m/z = 369 (17), 368 [M]
+
 (77), 367 (100), 324 (25), 323 (17), 
162 (10). HRMS (ESI): Calculated for C24H17FN2O [M+H]
+
 369.13977 found 
369.13985. 
2-([1,1'-Biphenyl]-4-yl)-1-(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoline (6e): Pale 
yellow solid, mp. 230 - 231 °C. 
1
H NMR (250 MHz, 
DMSO-d6) δ = 8.56 (s, 1H, CHpyridine), 8.04 (dd, 
3
J = 8.2 Hz, 
4
J = 1.7 Hz, 1H, CHAr), 7.87 (dd, 
3
J = 8.6 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.69 - 7.67 (m, 
1H, CHAr), 7.70 - 7.59 (m, 3H, CHAr), 7.61 - 7.55 
(m, 1H, CHAr), 7.53 - 7.39 (m, 5H, CHAr), 7.39 - 7.29 (m, 3H, CHAr), 7.09 - 7.01 (m, 
3H, CHAr), 3.84 (s, 3H, OCH3). 
13
C NMR (63 MHz, DMSO) δ = 158.1 (CAr), 151.2 
(CAr), 144.4 (CAr), 144.1 (CAr), 139.5 (CAr), 138.8 (CAr), 130.2 (CAr), 129.6 (CHAr), 
129.2 (2CHAr), 128.6 (2CHAr), 128.3 (2CHAr), 127.5 (CHAr), 127.2 (CHAr), 127.1 
(CHAr), 126.9 (2CHAr), 126.1 (2CHAr), 126.0 (CHAr), 125.9 (CHAr), 124.8 (CAr), 122.5 
(CAr), 121.3 (CAr), 113.9 (2CHAr), 100.2 (CHAr), 55.0 (OCH3). IR (ATR, cm
-1
) ṽ = 3049 
(w), 3026 (w), 3010 (w), 2950 (w), 2933 (w), 2906 (w), 2854 (w), 2833 (w), 1610 (w), 
1567 (w), 1514 (m)k, 1483 (m), 1424 (m), 1330 (m), 1299 (m), 1244 (m), 1173 (m), 
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1035 (m), 891 (m), 842 (m), 820 (m), 756 (s), 732 (s), 697 (m), 593 (m). 
MS (EI, 70 eV): m/z = 427 (28), 426 [M]
+
 (100), 425 (99), 382 (26), 381 (17), 77 (12). 
HRMS (ESI): Calculated for C30H22N2O [M+H]
+
 427.18049 found 427.18019. 
2-([1,1'-Biphenyl]-4-yl)-1-(2,3-dihydro-1H-inden-4-yl)-1H-pyrrolo[2,3-b]quinoline 
(6f): Pale yellow solid, mp. 218 - 220 °C. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 8.33 (s, 1H, 
CHpyridine), 8.03 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.86 (dd, 
3
J = 8.3 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.56 - 7.50 (m, 
3H, CHAr), 7.47 (d, 
3
J = 8.4 Hz, 2H, CHAr), 7.40 - 7.35 (m, 3H, CHAr), 7.34 (d, 
4
J = 3.1 Hz, 2H, CHAr), 7.32 - 7.27 (m, 1H, CHAr), 7.26 - 7.24 (m, 1H, CHAr), 7.20 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.07 (dd, 
3
J = 7.9 Hz, 
4
J = 2.0 Hz, 1H, CHAr), 6.81 (s, 1H, 
CHpyrrole), 2.88 (td, 
3
J = 7.4 Hz, 
3
J = 4.8 Hz, 4H, CH2-aliphatic), 2.06 (p, 
3
J = 7.5 Hz, 2H, 
CH2-aliphatic). 
13
C NMR (63 MHz, CDCl3) δ = 151.8 (CAr), 145.3 (CAr), 145.0 (CHAr), 
143.7 (CAr), 140.8 (CAr), 140.4 (CAr), 135.1 (CAr), 131.1 (CAr), 129.4 (2CHAr), 129.0 
(2CHAr), 128.5 (CHAr), 128.1 (CHAr), 127.7 (CHAr), 127.1 (2CHAr), 127.0 (2CHAr), 
126.8 (CHAr), 126.6 (CHAr), 125.6 (CAr), 124.8 (CHAr), 124.7 (CHAr), 123.4 (CHAr), 
122.5 (CAr), 114.0 (CAr), 112.2 (CAr), 100.9 (CHAr), 33.1 (CH2 aliphatic), 32.8 (CH2 aliphatic), 
25.7 (CH2 aliphatic). IR (ATR, cm
-1
) ṽ = 3062 (w), 3048 (w), 3027 (w), 2936 (w), 2891 
(w), 2840 (w), 2245 (w), 1562 (w), 1492 (m), 1482 (m), 1396 (m), 1330 (m), 1252 (m), 
1122 (w), 905 (m), 842 (m), 754 (m), 729 (s), 694 (m), 601 (m). 
MS (EI, 70 eV): m/z = 437 (27), 436 [M]
+
 (94), 435 (100), 407 (14), 115 (11). HRMS 
(ESI): Calculated for C32H24N2 [M+H]
+
 437.20123 found 437.20101. 
2-(4-Methoxyphenyl)-1-(naphthalen-1-yl)-1H-pyrrolo[2,3-b]quinoline (6g): Pale 
yellow solid, mp. 163 - 164 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.45 (s, 1H, CHAr), 8.01 - 7.88 (m, 
4H, CHAr), 7.56 (dd, 
3
J = 8.1 Hz, 
3
J = 7.3 Hz, 1H, 
CHAr), 7.52 - 7.46 (m, 3H, CHAr), 7.48 - 7.36 (m, 1H, 
CHAr), 7.37 (d, 
3
J = 1.3 Hz, 1H, CHAr), 7.31 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.6 Hz, 
3
J = 1.2 Hz, 1H, CHAr), 7.20 (d, 
3
J = 8.8 Hz, 2H, CHAr), 6.90 
(s, 1H, CHAr), 6.66 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.70 (s, 3H, OCH3). 
13
C NMR (75 MHz, 
CDCl3) δ = 159.7 (CAr), 147.8 (CAr), 146.5 (CAr), 139.8 (CAr), 134.6 (CAr), 134.5 (CAr), 
132.0 (CHAr), 129.7 (2CHAr), 129.0 (CHAr), 128.7 (CAr), 128.5 (CAr), 128.4 (CHAr), 
128.1 (CHAr), 128.0 (CHAr), 127.7 (CHAr), 127.5 (CHAr), 126.9 (CHAr), 126.5 (CHAr), 
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125.7 (CHAr), 124.5 (CAr), 123.9 (CHAr), 123.4 (CHAr), 122.5 (CAr), 113.9 (2CHAr), 99.7 
(CHAr), 55.3 (OCH3).IR (ATR, cm
-1
) ṽ = 3060 (w), 2997 (w), 2921 (m), 2850 (w), 1599 
(m), 1575 (m), 1496 (m), 1465 (m), 1393 (m), 1330 (m), 1250 (m), 1181 (m), 1025 (m), 
866 (m), 834 (m), 792 (m), 767 (s), 750 (s), 731 (s), 623 (m). MS (EI, 70 eV): m/z = 401 
(30), 400 [M]
+
 (100), 399 (48), 356 (15), 355 (27), 354 (10), 293 (42), 292 (12). 
HRMS (ESI): Calculated for C28H20N2O [M+H]
+ 
401.16484 found 401.16472. 
1-(Naphthalen-1-yl)-2-(naphthalen-2-yl)-1H-pyrrolo[2,3-b]quinoline (6h): Pale 
yellow solid, mp. 208 - 210 °C.
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.52 (s, 1H, CHpyridine), 8.03 - 7.88 
(m, 4H, CHAr), 7.80 (s, 1H, CHAr), 7.74 - 7.65 (m, 1H, 
CHAr), 7.61 - 7.50 (m, 5H, CHAr), 7.50 - 7.37 (m, 5H, 
CHAr), 7.37 - 7.29 (m, 2H, CHAr), 7.11 (s, 1H, CHpyrrole). 
13
C NMR (63 MHz, CDCl3) δ = 146.6 (CAr), 134.6 
(CAr), 134.3 (CAr), 133.1 (CAr), 133.0 (CAr), 132.0 (CAr), 131.6 (CAr), 129.4 (CAr), 129.2 
(CHAr), 128.4 (CHAr), 128.4 (2CHAr), 128.2 (2CHAr), 128.1 (CHAr), 127.9 (CAr), 127.9 
(2CHAr), 127.7 (CHAr), 127.0 (CHAr), 126.7 (CHAr), 126.5 (CHAr), 126.4 (CHAr), 125.8 
(CHAr), 125.7 (CHAr), 125.7 (CHAr), 125.7 (CAr), 123.8 (CHAr), 123.6 (CHAr), 122.4 
(CAr), 101.3 (CHAr). IR (ATR, cm
-1
) ṽ = 3050 (w), 2957 (w), 2921 (w), 2851 (w), 1945 
(w), 1921 (w), 1592 (m), 1497 (m), 1467 (m), 1418 (m), 1391 (m), 1324 (m), 1290 (m), 
1259 (m), 1014 (m), 894 (m), 826 (m), 793 (m), 766 (m), 745 (s), 726 (s), 598 (m). 
MS (EI, 70 eV): m/z = 421 (31), 420 [M]
+
 (100), 419 (66), 418 (12), 417 (15), 294 (11), 
293 (50), 292 (19), 209 (11), 127 (15). HRMS (ESI): Calculated for C31H20N2 [M+H]
+ 
421.16993 found 421.16957. 
1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrolo[2,3-b]quinoline 
(6i): Pale yellow solid, mp. 214 - 215 °C. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.37 (s, 1H, CHpyridine), 
8.05 (d, 
3
J = 8.6 Hz, 1H, CHAr), 7.87 (d, 
3
J = 8.2 Hz, 
1H, CHAr), 7.59 - 7.45 (m, 3H, CHAr), 7.41 - 7.30 (m, 
3H, CHAr), 7.23 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.91 (d, 
3
J = 8.9 Hz, 2H, CHAr), 6.82 (s, 1H, CHpyrrole), 3.79 (s, 3H, OCH3). 
19
F NMR (235 MHz, 
CDCl3) δ = -62.7 (F3C). 
13
C NMR (126 MHz, CDCl3) δ = 159.0 (CHAr), 151.3 (CAr), 
145.3 (CAr), 143.5 (CAr), 135.6 (CAr), 130.14 (q, 
2
JCF = 32.7 Hz, CAr), 129.7 (2CHAr), 
129.5 (CAr), 129.2 (2CHAr), 128.3 (CHAr), 128.2 (CHAr), 125.6 (CAr), 125.5 (CAr), 125.3 
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(q, 
3
JCF = 3.7 Hz, 2CHAr), 125.2 (CAr), 124.13 (q, 
1
JCF = 272.2 Hz, CF3), 123.7 (CHAr), 
122.1 (CHAr), 114.7 (2CHAr), 102.1 (CHAr), 55.6 (OCH3). IR (ATR, cm
-1
) ṽ = 2924 (w), 
2836 (w), 1513 (m), 1442 (m), 1321 (m), 1165 (m), 1122 (s), 1012 (m), 719 (s), 592 
(m). MS (EI, 70 eV): m/z = 419 (17), 418 [M]
+
 (75), 417 (100), 374 (21), 373 (12). 
HRMS (ESI): Calculated for C25H17F3N2O [M+H]
+
 419.13657 found 419.13670.  
5.2.2.2.Pyrrolo[2,3-c]quinolines 
1,2-Bis(4-methoxyphenyl)-1H-pyrrolo[3,2-c]quinoline (7a):  Pale yellow solid, 
mp. 198 - 200 °C.
1
H NMR (300 MHz, Chloroform-d) 
δ = 9.11 (s, 1H, CHpyridine), 8.09 (dd, 
3
J = 8.2 Hz, 
4
J = 1.1 Hz, 
1H, CHAr), 7.40 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.0 Hz, 
4
J = 2.3 Hz, 
1H, CHAr), 7.19 (d, 
3
J = 8.8 Hz, 2H, CHAr), 7.13 - 7.04 (m, 
4H, CHAr), 6.90 (d, 
3
J = 8.8 Hz, 2H, CHAr), 6.78 (s, 1H, 
CHpyrrole), 6.68 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.80 (s, 3H, 
OCH3), 3.67 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 160.0 (CAr), 159.3 (CAr), 
146.0 (CHAr), 144.8 (CAr), 141.7 (CAr), 135.9 (CAr), 132.2 (CAr), 130.8 (2CHAr), 130.5 
(2CHAr), 130.4 (CHAr), 126.1 (CHAr), 125.3 (CHAr), 124.5 (CAr), 121.2 (CAr), 120.7 
(CHAr), 118.5 (CAr), 114.9 (2CHAr), 113.7 (2CHAr), 102.8 (CHAr), 55.6 (OCH3), 55.3 
(OCH3). IR (ATR, cm
-1
) ṽ = 3102 (w), 3055 (w), 3009 (w), 2934 (w), 2910 (w), 2834 
(w), 2547 (w), 1608 (m), 1508 (m), 1491 (m), 1441 (m), 1366 (m), 1242 (s), 1175 (m), 
1028 (m), 836 (m), 803 (m), 755 (s), 585 (m), 431 (m). MS (EI, 70 eV): m/z = 381 (27), 
380 [M]
+
 (100), 365 (28), 293 (11). HRMS (ESI): Calculated for C25H20N2O2 [M+H]
+
 
381.15975 found 381.15965. 
2-(3-Methoxyphenyl)-1-(4-methoxyphenyl)-1H-pyrrolo[3,2-c]quinoline (7b): 
Yellow solid, mp. 168 - 170 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 9.21 (s, 1H, CHpyridine), 8.21 (d, 
3
J = 8.4 Hz, 
1H, CHAr), 7.51 (ddd, 
3
J = 8.4 Hz, 
3
J = 5.5 Hz, 
4
J = 2.8 Hz, 1H, 
CHAr), 7.49 - 7.35 (m, 1H, CHAr), 7.23 - 7.17 (m, 4H, CHAr), 
7.08 (ddd, 
3
J = 8.4 Hz, 
4
J = 2.5 Hz, 
5
J = 1.0 Hz, 1H, CHAr), 7.02 
(ddd, 
3
J = 7.7 Hz, 
4
J = 1.9 Hz, 
5
J = 1.0 Hz, 1H, CHAr), 6.90 (s, 
1H, CHpyrrole), 6.89 (d, 
4
J = 1.9 Hz, 1H, CHAr), 6.78 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.77 (s, 
3H, OCH3), 3.76 (s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 160.7 (CAr), 159.4 
(CAr), 145.8 (CHAr), 144.5 (CAr), 141.6 (CAr), 140.6 (CAr), 135.7 (CAr), 130.7 (2CHAr), 
130.5 (CHAr), 130.1 (CHAr), 126.3 (CHAr), 125.5 (CHAr), 124.3 (CAr), 121.9 (CHAr), 
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121.2 (CAr), 120.8 (CHAr), 118.4 (CAr), 115.4 (CHAr), 115.0 (CHAr), 113.8 (2CHAr), 
103.1 (CHAr), 55.7 (CH3), 55.3 (CH3). IR (ATR, cm
-1
) ṽ = 3059 (w), 2996 (w), 2964 
(w), 2936 (m), 2835 (m), 1604 (m), 1489 (s), 1367 (m), 1288 (m), 1248 (m), 1175 (m), 
1023 (m), 843 (m), 762 (s), 690 (m), 558 (m).  MS (EI, 70 eV): m/z (%) = 381 (26), 380 
[M]
+
 (100), 365 (26). HRMS (EI): Calculated for C25H20O2N2 [M]
+
 380.15193 found 
380.15172.  
2-(Naphthalen-2-yl)-1-phenyl-1H-pyrrolo[3,2-c]quinoline (7c): Yellow solid, 
mp. 177 - 178 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 9.27 
(s, 1H, CHpyridine), 8.25 (d, 
3
J = 8.6 Hz, 1H, CHAr), 7.81 - 7.73 
(m, 2H, CHAr), 7.69 (dd, 
3
J = 9.2 Hz, 
4
J = 2.9 Hz, 2H, CHAr), 
7.58 - 7.48 (m, 4H, CHAr), 7.48 - 7.43 (m, 4H, CHAr), 7.33 (dd, 
3
J = 8.5 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 7.25 - 7.19 (m, 1H, CHAr), 
7.19 - 7.14 (m, 1H, CHAr), 7.10 (s, 1H, CHpyrrole). 
13
C NMR 
(63 MHz, CDCl3) δ = 145.9 (CHAr), 144.6 (CAr), 141.7 (CAr), 139.6 (CAr), 136.2 (CAr), 
133.1 (CAr), 132.6 (CAr), 130.2 (CHAr), 130.0 (2CHAr), 129.7 (2CHAr), 129.6 (CHAr), 
129.3 (CAr), 128.9 (CHAr), 128.3 (CHAr), 127.8 (CHAr), 127.7 (CHAr), 127.0 (CHAr), 
126.6 (CHAr), 126.5 (2CHAr), 125.6 (CHAr), 121.3 (CAr), 120.8 (CHAr), 118.4 (CAr), 
104.3 (CHAr). IR (ATR, cm
-1
) ṽ = 3059 (w), 2923 (w), 2169 (w), 1497 (m), 1366 (m), 
1169 (w), 932 (m), 862 (m), 752 (m), 723 (s), 693 (m), 638 (m), 475 (m). 
MS (EI, 70 eV): m/z = 371 (27), 370 [M]
+
 (100), 369 (24), 184 (11). HRMS (EI): 
Calculated for C27H18N2 [M]
+
 370.14645 found 370.14589. 
2-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrrolo[3,2-c]quinoline (7d): Yellow solid, 
mp. 203 - 204 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 9.26 
(s, 1H, CHpyridine), 8.24 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.59 - 7.52 
(m, 6H, CHAr), 7.54 - 7.46 (m, 1H, CHAr), 7.48 - 7.39 (m, 5H, 
CHAr), 7.35 (d, 
3
J = 7.3 Hz, 1H, CHAr), 7.31 (d, 
3
J = 8.6 Hz, 2H, 
CHAr), 7.21 (ddd, 
3
J = 8.1 Hz, 
3
J = 6.2 Hz, 
4
J = 1.3 Hz, 1H, 
CHAr), 7.14 (ddd, 
3
J = 8.5 Hz, 
4
J = 1.6 Hz, 
5
J = 0.6 Hz, 1H, 
CHAr), 7.04 (s, 1H, CHpyrrole). 
13
C NMR (63 MHz, CDCl3) 
δ = 145.9 (CHAr), 144.6 (CAr), 141.4 (CAr), 140.5 (CAr), 140.3 (CAr), 139.6 (CAr), 136.1 
(CAr), 130.8 (CAr), 130.2 (CHAr), 130.0 (2CHAr), 129.8 (2CHAr), 129.6 (2CHAr), 129.6 
(CHAr), 128.9 (2CHAr), 127.7 (CHAr), 127.0 (2CHAr), 126.9 (2CHAr), 126.5 (CHAr), 
125.6 (CHAr), 121.3 (CAr), 120.7 (CHAr), 118.4 (CAr), 103.9 (CHAr). 
  Appendix 
S33 
 
IR (ATR, cm
-1
) ṽ = 3369 (w), 3031 (w), 2957 (w), 2855 (w), 1497 (m), 1481 (m), 1367 
(m), 1332 (m), 1005 (m), 840 (m), 755 (s), 691 (m), 605 (m), 508 (m). 
MS (EI, 70 eV): m/z = 397 (31), 396 [M]
+
 (100), 395 (17). HRMS (EI): Calculated for 
C29H20N2 [M]
+
 396.16210 found 396.16215. 
2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1H-pyrrolo[3,2-c]quinoline (7e): Yellow 
solid,  mp. 174 - 175 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 9.12 (s, 1H), 8.13 (dd, 3J = 7.9 Hz, 5J = 0.8 Hz, 1H, CHAr), 
7.43 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.2 Hz, 
4
J = 2.1 Hz, 1H, CHAr), 
7.24 - 7.08 (m, 6H, CHAr), 6.97 - 6.82 (m, 5H, CHAr), 3.82 (s, 
3H, OCH3).
 19
F NMR (235 MHz, CDCl3) δ = -113.6 (FCAr). 
13
C NMR (126 MHz, CDCl3) δ = 162.5 (d, 
1
JCF = 248.4 Hz, 
CFAr), 160.2 (CAr), 145.9 (CHAr), 144.7 (CAr), 140.9 (CAr), 136.2 (CAr), 131.8 (CAr), 
131.3 (d, 
3
JCF = 8.1 Hz, 2CHAr), 130.5 (2CHAr), 130.2 (CHAr), 128.2 (d, 
4
JCF = 3.4 Hz, 
CAr), 126.4 (CHAr), 125.6 (CHAr), 121.0 (CAr), 120.7 (CHAr), 118.5 (CAr), 115.4 (d, 
2
JCF = 21.6 Hz, 2CHAr), 115.0 (2CHAr), 103.6 (CHAr), 55.7 (OCH3). 
IR (ATR, cm
-1
) ṽ = 3102 (w), 3059 (m), 2995 (m), 2962 (m), 2931 (m), 2833 (m), 1510 
(s), 1489 (m), 1440 (m), 1369 (m), 1335 (m), 1294 (m), 1239 (m), 1217 (m), 1182 (m), 
1028 (m), 838 (m), 811 (m), 760 (s), 699 (m), 578 (m), 422 (m). 
MS (EI, 70 eV): m/z = 369 (26), 368 [M]
+
 (100), 353 (17). HRMS (EI): Calculated for 
C24H17ON2F [M]
+
 368.13194 found 368.13161. 
1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrolo[3,2-c]quinoline 
(7f): Yellow solid, mp. 146 - 147 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 9.22 (s, 1H, CHpyridine), 8.22 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.4 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.57 - 7.54 
(m, 1H, CHAr), 7.54 - 7.48 (m, 2H, CHAr), 7.41 - 7.35 (m, 2H, 
CHAr), 7.31 (d, 
3
J = 8.8 Hz, 2H, CHAr), 7.23 (dd, 
3
J = 6.6 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.19 (ddd, 
3
J = 8.5 Hz, 
4
J = 1.8 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.07 - 7.01 (m, 3H, CHAr), 3.92 (s, 3H, OCH3).
 19F NMR 
(282 MHz, CDCl3) δ = -62.6 (F3C). 
13
C NMR (63 MHz, CDCl3) δ = 160.4 (CAr), 145.9 
(CHAr), 144.7 (CAr), 140.1 (CAr), 136.7 (CAr), 135.6 (CAr), 131.6 (CAr), 130.5 (2CHAr), 
130.2 (CHAr), 129.7 (q, 
2
JCF = 32.6 Hz, CAr), 129.5 (2CHAr), 126.8 (CHAr), 125.8 
(CHAr), 125.2 (q, 
3
JCF = 3.8 Hz, 2CHAr), 124.13 (q, 
1
JCF = 272.1 Hz, CF3), 121.0 (CAr), 
120.8 (CHAr), 118.4 (CAr), 115.2 (2CHAr), 104.8 (CHAr), 55.7 (OCH3). 
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IR (ATR, cm
-1
) ṽ = 3065 (w), 2999 (w), 2963 (w), 2935 (w), 2837 (w), 2185 (w), 1511 
(m), 1322 (m), 1250 (m), 1160 (m), 1111 (m), 1066 (m), 838 (m), 764 (m), 725 (s), 701 
(m), 637 (m), 429 (m). MS (EI, 70 eV): m/z = 419 (26), 418 [M]
+
 (100), 403 (17). 
HRMS (EI): Calculated for C25H17ON2F3 [M]
+
 418.12875 found 418.12870. 
5.2.3. Synthesis of indoloquinolines by sequential regioselective Suzuki 
reaction/double C-N coupling 
5.2.3.1.Starting materials for double C-N coupling 
3-(2-Bromophenyl)-4-chloro-2-methylquinoline (9a): Colorless oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.26 (ddd, 3J = 8.4 Hz, 4J = 1.5 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 8.15 (d, 
3
J = 8.6 Hz, 1H, CHAr), 7.85 - 7.73 
(m, 2H, CHAr), 7.64 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.3 Hz, 
1H, CHAr), 7.48 (td, 
3
J = 7.5 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 
7.43 - 7.28 (m, 1H, CHAr), 7.26 (dd, 
3
J = 7.5 Hz, 
4
J = 1.9 Hz, 1H, CHAr), 2.48 (s, 3H, 
CH3). 
13
C NMR (63 MHz, CDCl3) δ = 158.0 (CAr), 147.4 (CAr), 142.1 (CAr), 138.3 
(CAr), 133.4 (CAr), 133.2 (CHAr), 130.9 (CHAr), 130.8 (CHAr), 130.2 (CHAr), 128.8 
(CHAr), 128.1 (CHAr), 127.3 (CHAr), 125.1 (CAr), 124.8 (CHAr), 123.8 (CAr), 24.7 (CH3). 
IR (ATR, cm
-1
): ṽ = 3660 (w), 3399 (w), 3060 (m), 2998 (w), 2954 (w), 2919 (w), 2848 
(w), 1613 (m), 1581 (m), 1555 (m), 1475 (m), 1433 (m), 1394 (m), 1345 (s), 1253 (w), 
1057 (m), 1026 (m), 924 (m), 840 (m), 751 (s), 638 (m), 592 (m). MS (EI, 70 eV): 
m/z (%) = 335 (29), 334 (18), 333 [M]
+
 (100), 331 (71), 298 (12), 296 (11), 254 (16), 
253 (12), 252 (43), 251 (10), 176 (45), 175 (14), 174 (10), 150 (15), 126 (13), 109 (10), 
88 (14), 87 (14), 75 (15). HRMS (EI): Calculated for C16H11NBrCl [M]
+
 330.97579 
found 330.97625, calculated for C16H11N
81
BrCl [M]
+
 332.97.97374 found 332.97349, 
calculated for C16H11NBr
37
Cl [M]
+
 332.97284 found 332.97349, calculated for 
C16H11N
81
Br
37
Cl [M]
+
 334.97079 found 334.97103. 
3-(2-Bromophenyl)-2-chloroquinoline (9b-71): Yellow solid, mp. 124 - 125 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.10 (d, 3J = 8.5 Hz, 1H, 
CHAr), 8.07 (s, 1H, CHpyridine), 7.85 (dd, 
3
J = 8.2 Hz, 
4
J = 1.6 Hz, 
1H, CHAr), 7.78 (ddd, 
3
J = 8.5 Hz, 
3
J = 7.0 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.72 (dd, 
3
J = 7.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.60 (ddd, 
3
J = 8.1 Hz, 
3
J = 7.0 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.47 - 7.40 (m, 1H, CHAr), 7.38 - 7.29 
(m, 2H, CHAr). 
13
C NMR (75 MHz, CDCl3) δ = 150.0 (CAr), 147.4 (CAr), 139.2 (CHAr), 
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138.7 (CAr), 134.3 (CAr), 132.9 (CHAr), 131.4 (CHAr), 130.9 (CHAr), 130.2 (CHAr), 128.6 
(CHAr), 127.8 (CHAr), 127.5 (CHAr), 127.5 (CHAr), 127.0 (CAr), 124.1 (CAr). 
IR (ATR, cm
-1
): ṽ = 3055 (w), 2921 (w), 1560 (m), 1477 (m), 1362 (m), 1134 (m), 1095 
(m), 1023 (m), 922 (m), 747 (s), 653 (m), 596 (m). MS (EI, 70 eV): m/z (%) = 321 (17), 
320 (10), 319 (63), 318 (12), 317 (49), 240 (34), 239 (19), 238 (100), 204 (16), 203 
(96), 202 (28), 201 (27), 150 (11), 119 (13), 101 (18). HRMS (EI): Calculated for 
C15H9N
81
BrCl [M]
+
 318.95809 found 318.95836, calculated for C15H9N
81
Br
37
Cl 
320.95514 found 320.05587. 
5.2.3.2.Indolo[3,2-c]quinolines 
6-Methyl-11-(p-tolyl)-11H-indolo[3,2-c]quinoline (11a): Yellow oil. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 8.32 - 8.27 (m, 1H, CHAr), 8.21 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.48 (d, 
3
J = 7.7 Hz, 2H, CHAr), 7.44 (dd, 
3
J = 6.1 Hz, 
4
J = 3.2 Hz, 2H, CHAr), 7.40 (d, 
3
J = 8.2 Hz, 2H, 
CHAr), 7.36 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 1H, 
CHAr), 7.25 - 7.18 (m, 2H, CHAr), 3.28 (s, 3H, CH3), 2.58 (s, 3H, CH3). 
13
C NMR 
(75 MHz, CDCl3) δ = 154.9 (CAr), 146.1 (CAr), 142.1 (CAr), 140.2 (CAr), 139.7 (CAr), 
135.9 (CAr), 131.0 (2CHAr), 129.2 (CHAr), 128.7 (2CHAr), 127.9 (CHAr), 125.3 (CHAr), 
124.5 (CHAr), 122.4 (CAr), 121.9 (CHAr), 121.7 (CHAr), 121.6 (CHAr), 116.7 (CAr), 114.3 
(CAr), 110.8 (CHAr), 25.0 (CH3-quinoline), 21.5 (CH3-Ar). IR (ATR, cm
-1
): ṽ = 3057 (w), 
3035 (w), 2951 (w), 2918 (w), 2852 (w), 1560 (w), 1509 (m), 1428 (m), 1365 (m), 1197 
(w), 1118 (w), 740 (s), 507 (m). MS (EI, 70 eV): m/z (%) = 323 (27), 322 [M]
+
 (100), 
321 (24), 306 (8), 153 (10). HRMS (ESI): Calculated for C23H18N2 [M+H]
+
 323.15428 
found 323.15462. 
11-(3,5-Dimethylphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11b): Yellow solid, 
mp. 182 - 183 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.34 - 8.30 (m, 1H, CHAr), 8.23 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
7.63 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.49 - 7.44 (m, 2H, CHAr), 7.40 (dd, 
3
J = 8.4 Hz, 
5
J = 0.8 Hz, 
1H, CHAr), 7.32 (s, 1H, CHAr), 7.29 - 7.22 (m, 2H, CHAr), 7.16 
(s, 2H, CHAr), 3.30 (s, 3H, CH3-quinoline), 2.47 (s, 6H, CH3-Ar). 
13
C NMR (75 MHz, CDCl3) δ = 154.9 (CAr), 146.1 (CAr), 142.0 (2CAr), 140.2 (CAr), 
140.1 (CAr), 138.4 (CAr), 131.2 (CHAr), 129.2 (CHAr), 127.8 (CHAr), 126.4 (2CHAr), 
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125.2 (CHAr), 124.5 (CHAr), 122.3 (CAr), 122.1 (CHAr), 121.7 (CHAr), 121.5 (CHAr), 
116.7 (CAr), 114.2 (CAr), 110.9 (CHAr), 25.0 (CH3-quinoline), 21.4 (2CH3-Ar). 
IR (ATR, cm
-1
): ṽ = 3038 (w), 2995 (w), 2960 (w), 2916 (w), 2855 (w), 1595 (w), 1560 
(m), 1506 (m), 1470 (m), 1363 (m), 1244 (m), 1181 (w), 1023 (w), 858 (m), 744 (s), 
726 (m). MS (EI, 70 eV): m/z (%) = 337 (28), 336 [M]
+
 (100), 160 (8). HRMS (ESI): 
Calculated for C24H20N2 [M+H]
+
 337.16993 found 337.1701.  
11-(2,3-Dihydro-1H-inden-5-yl)-6-methyl-11H-indolo[3,2-c]quinoline (11c): White 
solid, mp. 185 - 186 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.33 - 8.27 (m, 1H, CHAr), 8.22 (dd, 
3
J = 8.6 Hz, 
4
J = 1.4 Hz, 
1H, CHAr), 7.61 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.50 (d, 
3
J = 8.0 Hz, 1H, CHAr), 7.47 - 7.42 (m, 2H, 
CHAr), 7.39 (d, 
3
J = 7.5 Hz, 1H, CHAr), 7.34 (s, 1H, CHAr), 
7.30 - 7.19 (m, 3H, CHAr), 3.29 (s, 3H, CH3-quinoline), 3.19 - 2.99 (m, 4Haliphatic, CH2), 
2.34 - 2.19 (m, 2Haliphatic, CH2). 
13
C NMR (63 MHz, CDCl3) δ = 154.9 (CAr), 146.9 
(CAr), 146.1 (CAr), 146.0 (CAr), 142.2 (CAr), 140.3 (CAr), 136.4 (CAr), 129.0 (CHAr), 
128.0 (CHAr), 126.7 (CHAr), 125.9 (CHAr), 125.2 (CHAr), 124.7 (CHAr), 124.5 (CHAr), 
122.3 (CAr), 122.0 (CHAr), 121.6 (CHAr), 121.6 (CHAr), 116.7 (CAr), 114.2 (CAr), 110.9 
(CHAr), 33.0 (CH2), 32.8 (CH2), 25.6 (CH2), 24.9 (CH3-quinoline). IR (ATR, cm
-1
): 
ṽ = 3039 (w), 3004 (w), 2946 (m), 2841 (m), 1561 (m), 1493 (m), 1428 (m), 1361 (m), 
1238 (m), 1154 (m), 838 (w), 734 (s), 627 (w), 429 (m). MS (EI, 70 eV): m/z (%) = 349 
(30), 348 [M]
+
 (100), 347 (25), 160 (7). HRMS (EI): Calculated for C25H20N2 [M]
+
 
348.16210 found 348.16164. 
11-(4-(tert-Butyl)phenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11d): Yellow solid, 
mp. 137 - 138 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.33 - 8.28 (m, 1H, CHAr), 8.23 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
7.69 (d, 
3
J = 8.7 Hz, 2H, CHAr), 7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.48 - 7.40 (m, 4H, CHAr), 
7.32 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.6 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 
7.25 - 7.17 (m, 2H, CHAr), 3.29 (s, 3H, CH3-quinoline), 1.49 (s, 9H, CH3-tBu). 
13
C NMR 
(63 MHz, CDCl3) δ = 154.8 (CAr), 152.9 (CAr), 145.9 (CAr), 142.1 (CAr), 140.2 (CAr), 
135.7 (CAr), 129.0 (CHAr), 128.3 (2CHAr), 127.9 (CHAr), 127.2 (2CHAr), 125.3 (CHAr), 
124.6 (CHAr), 122.3 (CHAr), 121.9 (CHAr), 121.6 (CHAr), 116.7 (CAr), 114.2 (CAr), 112.9 
(CAr), 110.9 (CHAr), 35.0 (CtBu), 31.5 (3CH3-tBu), 25.0 (CH3-quinoline). IR (ATR, cm
-1
): 
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ṽ = 3393 (w), 3064 (w), 3045 (w), 2956 (m), 2903 (w), 2866 (w), 1561 (m), 1506 (m), 
1458 (m), 1429 (m), 1323 (m), 1239 (m), 1199 (m), 1116 (m), 740 (s), 629 (m). 
MS (EI, 70 eV): m/z (%) = 364 [M]
+
 (100), 349 (52), 307 (8), 160 (11). HRMS (ESI): 
Calculated for C26H24N2 [M+H]
+
 365.20123 found 365.20144. 
6-Methyl-11-phenyl-11H-indolo[3,2-c]quinoline (11e): Yellow solid, 
mp. 195 - 196 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.30 
(ddd, 
3
J = 6.2 Hz, 
4
J = 3.1 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 8.22 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.73 - 7.66 (m, 3H, CHAr), 7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.8 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.56 - 7.51 (m, 
2H, CHAr), 7.45 (dd, 
3
J = 6.2 Hz, 
4
J = 3.1 Hz, 2H, CHAr), 7.29 (dd, 
3
J = 8.4 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 7.23 - 7.17 (m, 2H, CHAr), 3.28 (s, 3H, 
CH3-quinoline). 
13
C NMR (75 MHz, CDCl3) δ = 155.0 (CAr), 146.2 (CAr), 142.1 (CAr), 
140.2 (CAr), 138.7 (CAr), 130.5 (2CHPh), 129.8 (CHAr), 129.4 (CHAr), 129.1 (2CHPh), 
128.0 (CHAr), 125.5 (CHAr), 124.7 (CHAr), 122.5 (CAr), 121.9 (CHAr), 121.9 (CHAr), 
121.8 (CHAr), 116.7 (CAr), 114.5 (CAr), 110.8 (CHAr), 25.1 (CH3-quinoline). 
IR (ATR, cm
-1
): ṽ = 3055 (w), 2992 (w), 2947 (w), 2912 (w), 2848 (w), 1591 (w), 1559 
(m), 1502 (m), 1455 (m), 1435 (m), 1368 (m), 1235 (m), 1197 (m), 1917 (m), 736 (s), 
701 (m), 625 (m). MS (EI, 70 eV): m/z (%) = 309 (22), 308 [M]
+
 (100), 307 (30), 153 
(5). HRMS (ESI): Calculated for C22H16N2 [M+H]
+
 309.13862 found 309.13876. 
 6-Methyl-11-(4-(methylthio)phenyl)-11H-indolo[3,2-c]quinoline (11f): Yellow 
solid, mp. 170 - 171 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.32 - 8.26 (m, 1H, CHAr), 8.21 (d, 
3
J = 8.0 Hz, 1H, CHAr), 
7.61 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.51 
(d, 
3
J = 8.7 Hz, 2H, CHAr), 7.47 - 7.37 (m, 5H, CHAr), 7.28 - 7.23 
(m, 1H, CHAr), 7.23 - 7.17 (m, 1H, CHAr), 3.26 (s, 3H, 
CH3-quinoline), 2.64 (s, 3H, SCH3). 
13
C NMR (63 MHz, CDCl3) δ = 154.8 (CAr), 146.0 
(CAr), 142.0 (CAr), 140.9 (CAr), 140.1 (CAr), 135.1 (CAr), 129.2 (2CHAr), 127.9 (CHAr), 
127.3 (2CHAr), 125.4 (CHAr), 124.7 (CHAr), 122.4 (CAr), 121.8 (2CHAr), 121.7 (2CHAr), 
116.6 (CAr), 114.3 (CAr), 110.7 (CHAr), 25.0 (CH3-quinoline), 15.4 (SCH3). IR (ATR, cm
-1
): 
ṽ = 3054 (w), 2948 (w), 2918 (w), 1560 (w), 1496 (m), 1432 (m), 1363 (m), 1198 (m), 
1087 (m), 737 (s), 626 (m), 511 (m). MS (EI, 70 eV): m/z (%) = 355 (27), 354 [M]
+
 
(100), 306 (10), 153 (6). HRMS (EI): Calculated for C23H18N2S [M]
+
 354.11852 found 
354.11843. 
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11-(4-Methoxyphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11g): Yellow solid, 
mp. 234 - 236 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.54 
(d, 
3
J = 8.4 Hz, 1H, CHAr), 8.32 - 8.28 (m, 1H, CHAr), 7.68 
(ddd, 
3
J = 8.4 Hz, 
3
J = 6.6 Hz, 
4
J = 1.7 Hz, 1H, CHAr), 7.51 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.45 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.38 
(ddd, 
3
J = 8.4 Hz, 
4
J = 1.7 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.32 (dd, 
3
J = 6.7 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.25 - 7.17 (m, 3H, CHAr), 4.00 (s, 3H, OCH3), 
3.42 (s, 3H, CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 160.4 (CArOCH3), 154.5 
(Cquinoline-Me), 144.9 (CAr), 142.4 (CAr), 140.5 (CAr), 130.7 (CAr), 129.9 (2CHAr), 128.3 
(CHAr), 125.6 (CHAr), 124.9 (CHAr), 122.2 (CHAr), 121.9 (CHAr), 121.9 (CAr), 121.7 
(CHAr), 116.5 (CAr), 115.6 (2CHAr), 114.1 (CHAr), 113.9 (CAr), 110.9 (CHAr), 55.7 
(OCH3), 24.2 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3398 (w), 3056 (m), 3004 (w), 2958 
(w), 2933 (m), 2837 (m), 2546 (m), 2198 (m), 2056 (w), 1891 (w), 1635 (m), 1606 (m), 
1508 (s), 1435 (s), 1368 (m), 1296 (m), 1248 (s), 1198 (m), 1026 (m), 908 (m), 842 (m), 
723 (s), 526 (m). MS (EI, 70 eV): m/z (%) = 338 [M]
+
 (100), 323 (10), 294 (21), 147 
(14). HRMS (EI): Calculated for C23H18ON2 [M]
+
 338.14136 found 338.14096. 
11-(3-Methoxyphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11h): Yellow solid, 
mp. 206 – 207 °C. 1H NMR (300 MHz, Chloroform-d) 
δ = 8.32 - 8.28 (m, 1H, CHAr), 8.22 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
7.64 - 7.60 (m, 1H, CHAr), 7.60 - 7.56 (m, 1H, CHAr), 7.50 - 7.41 
(m, 2H, CHAr), 7.38 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 
1H, CHAr), 7.28 - 7.20 (m, 3H, CHAr), 7.13 (ddd, 
3
J = 7.7 Hz, 
4
J = 1.9 Hz, 
5
J = 1.0 Hz, 1H, CHAr), 7.05 (t, 
4
J = 2.2 Hz, 1H, 
CHAr), 3.85 (s, 3H, OCH3), 3.28 (s, 3H, CH3-quinoline). 
13
C NMR (75 MHz, CDCl3) 
δ = 161.1 (CArOCH3), 154.8 (CAr), 146.0 (CAr), 141.9 (CAr), 140.0 (CAr), 139.6 (CAr), 
131.1 (CHAr), 129.2 (CHAr), 128.0 (CHAr), 125.4 (CHAr), 124.7 (CHAr), 122.4 (CHAr), 
122.0 (CAr), 121.7 (2CHAr), 121.1 (CHAr), 116.6 (CAr), 115.7 (CHAr), 114.3 (CAr), 114.2 
(CHAr), 110.8 (CHAr), 55.6 (OCH3), 25.0 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3037 (w), 
3008 (w), 2967 (w), 2837 (w), 1594 (m), 1494 (m), 1427 (m), 1364 (m), 1243 (m), 1029 
(m), 860 (m), 793 (m), 737 (s), 709 (m), 635 (m). MS (EI, 70 eV): m/z (%) = 339 (25), 
338 [M]
+
 (100), 323 (6), 294 (12). HRMS (ESI): Calculated for C23H18N2O [M+H]
+
 
339.14919 found 339.14961. 
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11-(2-Methoxyphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11i): Brown oil. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.36 - 8.25 (m, 2H, CHAr), 
7.73 - 7.59 (m, 2H, CHAr), 7.52 (dd, 
3
J = 7.7 Hz, 
4
J = 1.7 Hz, 1H, 
CHAr), 7.49 - 7.45 (m, 2H, CHAr), 7.39 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 7.31 - 7.15 (m, 4H, CHAr), 
3.60 (s, 3H, OCH3), 3.33 (s, 3H, CH3-quinoline). 
13
C NMR (75 MHz, 
CDCl3) δ = 156.5 (CArOCH3), 154.6 (CAr), 145.2 (CAr), 141.6 (CAr), 140.6 (CAr), 131.3 
(CHAr), 130.4 (CHAr), 128.6 (CHAr), 128.1 (CHAr), 126.8 (CAr), 125.4 (CHAr), 124.8 
(CHAr), 122.5 (CAr), 121.7 (CHAr), 121.7 (CHAr), 121.6 (CHAr), 121.2 (CHAr), 117.0 
(CAr), 114.3 (CAr), 112.8 (CHAr), 110.7 (CHAr), 55.8 (OCH3), 24.5 (CH3-quinoline). 
IR (ATR, cm
-1
): ṽ = 3358 (m), 3056 (m), 3011 (m), 2939 (m), 2839 (m), 2563 (w), 1596 
(m), 1559 (m), 1502 (s), 1455 (m), 1432 (m), 1366 (m), 1244 (m), 1118 (m), 1019 (m), 
741 (s), 626 (m). MS (EI, 70 eV): m/z (%) = 338 [M]
+
 (100), 323 (12), 293 (10). 
HRMS (EI): Calculated for C23H18ON2 [M]
+
 338.14136 found 338.14102.  
11-(3,5-Dimethoxyphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11j): Yellow solid, 
mp. 203 - 204 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.33 - 8.27 (m, 1H, CHAr), 8.22 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
7.63 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.53 - 7.43 (m, 3H, CHAr), 7.34 - 7.24 (m, 2H, CHAr), 6.77 (t, 
4
J = 2.3 Hz, 1H, CHAr), 6.68 (d, 
4
J = 2.3 Hz, 2H, CHAr), 3.83 
(s, 6H, OCH3), 3.28 (s, 3H, CH3-quinoline). 
13
C NMR (63 MHz, 
CDCl3) δ = 162.0 (2CArOCH3), 154.8 (CAr), 146.1 (CAr), 141.7 (CAr), 140.1 (CAr), 139.9 
(CAr), 129.2 (CHAr), 127.9 (CHAr), 125.4 (CHAr), 124.7 (CHAr), 122.4 (CAr), 122.1 
(CHAr), 121.7 (2CHAr), 116.5 (CAr), 114.3 (CAr), 110.8 (CHAr), 106.9 (2CHAr), 101.9 
(CHAr), 55.7 (2OCH3), 25.0 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3004 (m), 2966 (m), 
2939 (m), 2858 (m), 1607 (m), 1582 (m), 1422 (m), 1192 (m), 1151 (s), 1060 (m), 989 
(m), 854 (m), 745 (s), 724 (m), 633 (m). MS (EI, 70 eV): m/z (%) = 369 (27), 368 [M]
+
 
(100), 309 (7). HRMS (EI): Calculated for C24H20O2N2 [M]
+
 368.15193 found 
368.15148. 
11-(2,4-Dimethoxyphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11k): White solid, 
mp. 137 - 138 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.33 - 8.26 (m, 1H, CHAr), 
8.22 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.49 - 7.41 (m, 3H, CHAr), 7.39 (dd, 
3
J = 8.0 Hz, 
5
J = 0.9 Hz, 1H, CHAr), 7.24 
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(ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 
7.19 - 7.13 (m, 1H, CHAr), 6.74 (d, 
3
J = 8.0 Hz, 2H, CHAr), 3.98 
(s, 3H, OCH3), 3.56 (s, 3H, OCH3), 3.28 (s, 3H, CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 161.8 (CArOCH3), 157.4 
(CArOCH3), 154.8 (CAr), 145.7 (CAr), 141.9 (CAr), 140.6 (CAr), 
130.8 (CHAr), 128.9 (CHAr), 127.8 (CHAr), 125.2 (CHAr), 124.6 (CAr), 122.4 (CAr), 121.6 
(CAr), 121.5 (CHAr), 121.2 (CAr), 119.8 (CAr), 117.2 (CHAr), 114.2 (CHAr), 110.6 (CHAr), 
105.1 (CHAr), 100.2 (CHAr), 55.8 (OCH3), 55.7 (OCH3), 24.8 (CH3-quinoline). 
IR (ATR, cm
-1
): ṽ = 3369 (w), 3057 (w), 3011 (w), 2930 (w), 2838 (w), 2573 (w), 1605 
(w), 1587 (m), 1510 (m), 1368 (m), 1285 (m), 1208 (m), 1159 (m), 1021 (m), 835 (m), 
744 (s), 547 (m). MS (EI, 70 eV): m/z (%) = 369 (26), 368 [M]
+
 (100), 293 (5), 281 (9), 
147 (5). HRMS (EI): Calculated for C24H20O2N2 [M]
+
 368.15193 found 368.15197. 
6-Methyl-11-(3,4,5-trimethoxyphenyl)-11H-indolo[3,2-c]quinoline (11l): White 
solid, mp. 201 - 202 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.33 - 8.28 (m, 1H, CHAr), 8.24 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
7.63 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.51 - 7.45 (m, 2H, CHAr), 7.43 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 7.34 - 7.28 (m, 2H, CHAr), 6.76 (s, 
2H, CHAr), 4.06 (s, 3H, OCH3), 3.84 (s, 6H, OCH3), 3.29 (s, 
3H, CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 154.8 (CAr), 154.6 (2CArOCH3), 145.8 
(CAr), 142.0 (CAr), 140.1 (CAr), 138.8 (CAr), 133.8 (CAr), 129.0 (CHAr), 128.1 (CHAr), 
125.5 (CHAr), 124.9 (CHAr), 122.3 (CAr), 121.9 (CHAr), 121.8 (CHAr), 121.7 (CHAr), 
116.5 (CAr), 114.1 (CAr), 110.8 (CHAr), 106.0 (2CHAr), 61.2 (OCH3), 56.4 (2OCH3), 
24.8 (CH3-quinoline). IR  (ATR, cm
-1
): ṽ = 3049 (w), 2993 (w), 2939 (w), 2827 (w), 2454 
(w), 1591 (m), 1503 (m), 1346 (w), 1227 (m), 1118 (s), 1000 (m), 747 (s). 
MS (EI, 70 eV): m/z (%) = 398 [M]
+
 (100), 383 (22), 297 (8). HRMS (EI): Calculated 
for C25H22O3N2 [M]
+
 398.16249 found 398.16215. 
6-Methyl-11-(naphthalen-1-yl)-11H-indolo[3,2-c]quinoline (11m): Red solid, 
mp. 197 - 198 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.38 (ddd, 3J = 8.0 Hz, 
4
J = 1.2 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 8.20 (d, 
3
J = 8.4 Hz, 2H, CHAr), 8.07 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.82 - 7.66 (m, 2H, CHAr), 7.58 - 7.54 (m, 1H, CHAr), 
7.53 - 7.49 (m, 1H, CHAr), 7.49 - 7.43 (m, 1H, CHAr), 7.38 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.2 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.27 (ddd, 
3
J = 8.2 Hz, 
3
J = 6.8 Hz, 
4
J = 1.2 Hz, 
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1H, CHAr), 7.10 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.02 - 6.99 (m, 1H, 
CHAr), 6.99 - 6.94 (m, 2H, CHAr), 3.35 (s, 3H, CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 155.0 (CAr), 146.1 (CAr), 142.2 
(CAr), 140.8 (CAr), 135.0 (CAr), 134.7 (CAr), 131.1 (CAr), 130.2 
(CHAr), 129.1 (CHAr), 128.5 (CHAr), 127.9 (CHAr), 127.8 (CHAr), 
127.2 (CHAr), 127.2 (CHAr), 126.0 (CHAr), 125.5 (CHAr), 124.7 
(CHAr), 122.8 (CHAr), 122.5 (CHAr), 121.8 (CHAr), 121.5 (CHAr), 116.6 (CAr), 114.4 
(CAr), 111.0 (CHAr), 100.0 (CAr), 25.1 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3047 (m), 
2889 (w), 2915 (w), 2849 (w), 1595 (w), 1560 (m), 1508 (m), 1433 (m), 1364 (m), 1240 
(m), 1117 (m), 776 (m), 738 (s), 638 (m). MS (EI, 70 eV): m/z (%) = 359 (30), 358 [M]
+
 
(100), 357 (20), 178 (5). HRMS (ESI): Calculated for C26H18N2 [M+H]
+
 359.15428 
found 359.15493. 
11-(Anthracen-2-yl)-6-methyl-11H-indolo[3,2-c]quinoline (11n): Yellow solid, 
mp. 290 - 291 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.66 (d, 
4
J = 1.3 Hz, 1H, CHAr), 8.54 (d, 
4
J = 1.1 Hz, 1H, CHAr), 8.39 - 8.26 
(m, 4H, CHAr), 8.17 - 8.02 (m, 2H, CHAr), 7.64 - 7.55 (m, 3H, 
CHAr), 7.53 - 7.40 (m, 4H, CHAr), 7.36 - 7.28 (m, 1H, CHAr), 7.11 
(ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 3.35 (s, 3H, 
CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 154.7 (CAr), 142.1 
(CAr), 140.3 (CAr), 135.1 (CAr), 132.6 (CAr), 132.4 (CAr), 131.3 
(CAr), 131.2 (CHAr), 131.0 (CAr), 128.3 (CHAr), 128.2 (2CHAr), 127.9 (2CHAr), 127.2 
(CHAr), 126.9 (2CHAr), 126.4 (2CHAr), 125.7 (CAr), 125.6 (CHAr), 124.9 (CHAr), 122.5 
(CAr), 122.0 (2CHAr), 121.8 (CHAr), 116.6 (CAr), 114.5 (CAr), 110.9 (CHAr), 24.6 
(CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3046 (w), 2911 (w), 1672 (m), 1582 (m), 1558 (m), 
1430 (m), 1364 (m), 1289 (m), 736 (s), 636 (m), 468 (s). MS (EI, 70 eV): m/z (%) = 409 
(32), 408 [M]
+
 (100), 407 (54), 204 (11). HRMS (EI): Calculated for C30H20N2 [M]
+
 
408.16210 found 408.16132. 
11-(4-Fluorophenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11o): Orange solid, 
mp. 226 - 227 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.38 (d, 3J = 8.4 Hz, 1H, 
CHAr), 8.32 - 8.24 (m, 1H, CHAr), 7.64 (dt, 
3
J = 8.4 Hz, 
4
J = 4.3 Hz, 1H, CHAr), 
7.57 - 7.46 (m, 4H, CHAr), 7.45 - 7.36 (m, 2H, CHAr), 7.27 (m, 2H, CHAr), 7.22 - 7.15 
(m, 1H, CHAr), 3.32 (s, 3H, CH3-quinoline). 
19
F NMR (235 MHz, CDCl3) δ = -110.0 
(FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 163.1 (d, 
1
JCF = 250.8 Hz, CArF), 154.3 (CAr), 
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144.2 (CAr), 142.2 (CAr), 140.5 (CAr), 134.1 (d, 
4
JCF = 3.5 Hz, CAr), 
130.7 (d, 
3
JCF = 8.8 Hz, 2CHAr), 128.7 (CHAr), 128.0 (CHAr), 126.0 
(CHAr), 125.3 (CHAr), 122.4 (CHAr), 122.3 (CAr), 121.8 (CHAr), 
121.6 (CHAr), 117.7 (d, 
2
JCF = 22.8 Hz, 2CHAr), 116.2 (CAr), 114.2 
(CAr), 110.8 (CHAr), 23.8 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3060 
(w), 2465 (w), 2426 (w), 1886 (w), 1636 (w), 1585 (w), 1506 (m), 1436 (m), 1370 (m), 
1220 (m), 1198 (m), 845 (m), 756 (m), 738 (m), 521 (m). MS (EI, 70 eV): 
m/z (%) = 327 (23), 326 [M]
+
 (100), 325 (28). HRMS (EI): Calculated for C22H15N2F 
[M]
+
 326.12138 found 326.12098. 
11-(4-Chlorophenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11p): Yellow solid, 
mp. 261 - 262 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.59 (d, 
3
J = 8.4 Hz, 1H, CHAr), 8.34 - 8.24 (m, 1H, CHAr), 7.76 - 7.66 (m, 
3H, CHAr), 7.58 - 7.47 (m, 4H, CHAr), 7.38 - 7.32 (m, 2H, CHAr), 
7.24 - 7.17 (m, 1H, CHAr), 3.43 (s, 3H, CH3-quinoline). 
13
C NMR 
(63 MHz, CDCl3) δ = 153.8 (CAr), 149.7 (CAr), 146.0 (CAr), 142.2 
(CHAr), 140.7 (CAr), 136.3 (CAr), 136.2 (CAr), 131.0 (2CHAr), 130.1 
(2CHAr), 129.5 (CHAr), 126.6 (CHAr), 126.1 (CHAr), 123.0 (CHAr), 122.2 (CAr), 121.9 
(CHAr), 121.7 (CHAr), 115.8 (CAr), 114.2 (CAr), 111.0 (CHAr), 22.8 (CH3-quinoline). 
IR (ATR, cm
-1
): ṽ = 3050 (w), 2453 (m), 1876 (w), 1584 (w), 1493 (m), 1433 (m), 1368 
(m), 1198 (m), 1085 (m), 1013 (m), 843 (m), 740 (s), 626 (m), 508 (m). MS (EI, 70 eV): 
m/z (%) = 342 [M]
+
 (100), 306 (8), 153 (14). HRMS (EI): Calculated for C22H15N2Cl 
[M]
+
 342.09183 found 342.09087, calculated for C22H15N2
37
Cl [M]
+
 344.08888 found 
344.08934. 
4-(6-Methyl-11H-indolo[3,2-c]quinolin-11-yl)benzonitrile (11q): White solid, 
mp. 221 - 222 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.35 - 8.26 (m, 1H, CHAr), 8.22 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
8.01 (d, 
3
J = 8.7 Hz, 2H, CHAr), 7.70 (d, 
3
J = 8.7 Hz, 2H, CHAr), 
7.62 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.6 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 
7.53 - 7.44 (m, 2H, CHAr), 7.30 - 7.13 (m, 3H, CHAr), 3.25 (s, 3H, 
CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 154.9 (CAr), 146.0 (CAr), 142.8 (CAr), 
141.3 (CAr), 139.7 (CAr), 134.3 (2CHAr), 130.0 (2CHAr), 129.5 (CHAr), 128.3 (CHAr), 
125.9 (CHAr), 125.0 (CHAr), 122.8 (CAr), 122.4 (CHAr), 122.1 (CHAr), 121.3 (CHAr), 
117.8 (CAr), 116.1 (CAr), 115.0 (CAr), 113.6 (CAr), 110.2 (CHAr), 24.9 (CH3-quinoline). 
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IR (ATR, cm
-1
): ṽ = 3033 (w), 2992 (w), 2919 (w), 2654 (w), 2475 (w), 2226 (w), 1602 
(w), 1561 (m), 1431 (m), 1363 (m), 1228 (m), 1198 (m), 1117 (w), 733 (s), 626 (m), 
547 (m). MS (EI, 70 eV): m/z (%) = 334 (23), 333 [M]
+
 (100), 331 (23). HRMS (EI): 
Calculated for C23H15N3 [M]
+
 333.12605 found 333.12566. 
11-Benzyl-6-methyl-11H-indolo[3,2-c]quinoline (11r): Yellow oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.32 - 8.23 (m, 2H, CHAr), 8.15 
(ddd, 
3
J = 8.4 Hz, 
4
J = 1.3 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 7.64 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.55 - 7.52 (m, 
1H, CHAr), 7.52 - 7.51 (m, 1H, CHAr), 7.50 - 7.44 (m, 1H, CHAr), 
7.39 (ddd, 
3
J = 8.6 Hz, 
3
J = 7.1 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.33 - 7.28 (m, 3H, CHAr), 7.19 - 7.14 (m, 2H, CHAr), 5.95 (s, 2H, 
CH2-aliphatic), 3.23 (s, 3H, CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 154.7 (CAr), 
145.9 (CAr), 140.8 (CAr), 140.0 (CAr), 136.2 (CHAr), 129.3 (CHAr), 129.2 (2CHAr), 128.0 
(CHAr), 127.8 (CHAr), 125.8 (2CHAr), 125.6 (CHAr), 125.1 (CHAr), 122.5 (CHAr), 122.0 
(CHAr), 121.7 (CHAr), 121.7 (CHAr), 116.6 (CAr), 114.3 (CAr), 109.7 (CHAr), 49.4 (CH2), 
24.8 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3031 (m), 2921 (m), 2852 (m), 1561 (m), 1513 
(m), 1441 (m), 1350 (m), 1239 (m), 1122 (m), 738 (s), 724 (s), 689 (m), 470 (m). 
MS (EI, 70 eV): m/z (%) = 323 (16), 322 [M]
+
 (63), 231 (15), 204 (7), 91 (100), 65 (12). 
HRMS (EI): Calculated for C23H18N2 [M]
+
 322.14645 found 322.14659. 
11-(4-Methoxybenzyl)-6-methyl-11H-indolo[3,2-c]quinoline (11s): Yellow solid, 
mp. 168 - 169 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.29 
(dt, 
3
J = 7.7 Hz, 
4
J = 1.0 Hz, 2H, CHAr), 8.20 (ddd, 
3
J = 8.5 Hz, 
4
J = 1.4 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 7.66 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.57 - 7.52 (m, 2H, CHAr), 
7.50 - 7.38 (m, 2H, CHAr), 7.09 (m, 2H, CHAr), 6.84 (d, 
3
J = 8.7 Hz, 2H, CHAr), 5.93 (s, 2H, CH2-aliphatic), 3.74 (s, 3H, 
OCH3), 3.26 (s, 3H, CH3-quinoline). 
13
C NMR (63 MHz, CDCl3) δ = 159.2 (CArOCH3), 
154.5 (CAr), 145.5 (CAr), 140.8 (CAr), 140.0 (CAr), 129.0 (CHAr), 128.1 (CHAr), 128.0 
(CAr), 127.0 (2CHAr), 125.6 (CHAr), 125.3 (CHAr), 122.4 (CAr), 122.0 (CHAr), 121.8 
(CHAr), 121.7 (CHAr), 116.6 (CAr), 114.6 (2CHAr), 114.2 (CAr), 109.8 (CHAr), 55.3 
(OCH3), 48.9 (CH2), 24.6 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3059 (w), 3002 (w), 2962 
(w), 2936 (w), 2907 (w), 2830 (w), 2641 (w), 1613 (w), 1560 (w), 1511 (m), 1439 (m), 
1242 (m), 1164 (w), 1024 (m), 808 (m), 741 (s), 506 (m). MS (EI, 70 eV): 
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m/z (%) = 352 [M]
+
 (25), 122 (12), 121 (100), 95 (5), 78 (8). HRMS (EI): Calculated for 
C24H20ON2 [M]
+
 352.15701 found 352.15643. 
6-Methyl-11-pentyl-11H-indolo[3,2-c]quinoline (11t): Yellow oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.35 (dd, 3J = 8.4 Hz, 4J = 1.0 Hz, 
1H, CHAr), 8.28 (dd, 
3
J = 8.4 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 8.23 (dt, 
3
J = 8.0 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 7.71 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.63 - 7.51 (m, 3H, CHAr), 
7.42 (ddd, 
3
J = 8.0 Hz, 
3
J = 6.0 Hz, 
4
J = 2.2 Hz, 1H, CHAr), 
4.74 - 4.60 (m, 2H, CH2-aliphatic), 3.18 (s, 3H, CH3-quinoline), 2.03 (p, 
3
J = 7.7 Hz, 2H, CH2-aliphatic), 1.60 - 1.34 (m, 4H, CH2-aliphatic), 0.94 (t, 
3
J = 7.0 Hz, 3H, 
CH3). 
13
C NMR (63 MHz, CDCl3) δ = 154.7 (CAr), 145.9 (CAr), 140.1 (CAr), 139.1 
(CAr), 129.6 (CHAr), 127.7 (CHAr), 125.1 (CHAr), 125.0 (CHAr), 122.2 (CHAr), 121.9 
(CAr), 121.5 (CHAr), 121.1 (CHAr), 116.9 (CAr), 114.1 (CAr), 109.4 (CHAr), 45.7 (CH2), 
29.4 (CH2), 29.1 (CH2), 24.8 (CH3-quinoline), 22.4 (CH2), 14.0 (CH3). IR (ATR, cm
-1
): 
ṽ =3054 (w), 2950 (m), 2923 (m), 2853 (w), 1560 (m), 1439 (m), 1364 (m), 1251 (m), 
1161 (m), 1111 (m), 1029 (w), 736 (s), 621 (m). MS (EI, 70 eV): m/z (%) = 303 (13), 
302 [M]
+
 (52), 246 (19), 245 (100), 204 (10). HRMS (EI): Calculated for C21H22N2 
[M]
+
 302.17775 found 302.17686. 
5.2.3.3.Indolo[2,3-b]quinolines 
6-(p-Tolyl)-6H-indolo[2,3-b]quinoline (12a): White solid, mp. 135 - 137 °C. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 8.79 (s, 1H, CHpyridine), 8.21 (dd, 
3
J = 7.7 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 8.09 (dd, 
3
J = 8.4 Hz, 
3
J = 1.2 Hz, 1H, CHAr), 8.02 (dd, 
3
J = 8.3 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.72 - 7.61 (m, 3H, CHAr), 7.53 - 7.42 (m, 5H, CHAr), 
7.38 - 7.34 (m, 1H, CHAr), 2.51 (s, 3H, CH3). 
13
C NMR (75 
MHz, CDCl3) δ = 152.9 (CAr), 147.0 (CAr), 142.9 (CAr), 137.5 (CAr), 133.8 (CAr), 130.4 
(2CHAr), 128.8 (CHAr), 128.4 (CHAr), 128.3 (CHAr), 128.2 (CHAr), 127.5 (CHAr), 127.4 
(2CHAr), 124.7 (CAr), 123.4 (CHAr), 121.5 (CHAr), 120.9 (CAr), 120.8 (CHAr), 118.5 
(CAr), 110.3 (CHAr), 21.5 (CH3). IR (ATR, cm
-1
): ṽ = 3064 (w), 3033 (w), 2958 (w), 
2918 (w), 2851 (w), 1602 (m), 1516 (m), 1460 (m), 1407 (m), 1226 (m), 897 (m), 740 
(s), 596 (m), 475 (m). MS (EI, 70 eV): m/z (%) = 309 (22), 308 [M]
+
 (100), 307 (86), 
292 (13). HRMS (ESI): Calculated for C22H16N2 [M+H]
+
 309.13862 found 309.13878. 
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6-(4-Methoxyphenyl)-6H-indolo[2,3-b]quinoline (12b): Pale yellow solid, 
mp. 182 - 184 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.80 
(s, 1H, CHpyridine), 8.21 (d, 
3
J = 7.3 Hz, 1H, CHAr), 8.10 (d, 
3
J = 8.5 Hz, 1H, CHAr), 8.03 (dd, 
3
J = 8.0 Hz, 
3
J = 1.6 Hz, 1H, 
CHAr), 7.73 - 7.60 (m, 3H, CHAr), 7.55 - 7.49 (m, 1H, CHAr), 
7.49 - 7.43 (m, 1H, CHAr), 7.40 (d, 
3
J = 8.2 Hz, 1H, CHAr), 
7.36 - 7.31 (m, 1H, CHAr), 7.16 (d, 
3
J = 8.9 Hz, 2H, CHAr), 3.94 
(s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.1 (CAr), 143.2 (CAr), 129.1 (CAr), 
129.0 (2CAr), 129.0 (2CHAr), 128.5 (CHAr), 128.3 (CHAr), 128.1 (CHAr), 127.8 (CHAr), 
124.7 (CAr), 124.7 (CAr), 123.5 (CHAr), 121.5 (CHAr), 120.9 (CHAr), 120.8 (CHAr), 118.6 
(CAr), 115.1 (2CHAr), 110.3 (CHAr), 55.7 (OCH3). IR (ATR, cm
-1
): ṽ =3050 (w), 3033 
(w), 3015 (w), 2955 (w), 2918 (w), 1602 (m), 1516 (m), 1461 (m), 1408 (m), 1227 (m), 
1176 (m), 1024 (m), 742 (s), 598 (m), 476 (m). MS (EI, 70 eV): m/z (%) = 325 (24), 
324 [M]
+
 (100), 323 (29), 309 (33), 281 (16), 280 (13), 279 (13), 218 (10), 140 (12). 
HRMS (ESI): Calculated for C22H16N2O [M+H]
+
 325.13354 found 325.13339. 
6-(4-Ethoxyphenyl)-6H-indolo[2,3-b]quinoline (12c): White solid, mp. 165 - 166 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.78 (s, 1H, CHpyridine), 
8.20 (dt, 
3
J = 7.6 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 8.10 (d, 
3
J = 8.6 Hz, 1H, CHAr), 8.02 (dd, 
3
J = 8.1 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.68 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.62 (d, 
3
J = 8.9 Hz, 2H, CHAr), 7.55 - 7.49 (m, 1H, 
CHAr), 7.49 - 7.44 (m, 1H, CHAr), 7.46 - 7.38 (m, 1H, CHAr), 7.34 (td, 
3
J = 7.5 Hz, 
4
J = 1.1 Hz, 1H, CHAr), 7.15 (d, 
3
J = 8.9 Hz, 2H, CHAr), 4.16 (q, 
3
J = 7.0 Hz, 2H, 
OCH2), 1.51 (t, 
3
J = 7.0 Hz, 3H, CH3). 
13
C NMR (63 MHz, CDCl3) δ = 158.4 (CAr), 
153.1 (CAr), 147.0 (CAr), 143.2 (CAr), 128.9 (CAr), 128.9 (2CHAr), 128.8 (CHAr), 128.8 
(CAr), 128.4 (CHAr), 128.3 (CHAr), 128.2 (CHAr), 127.5 (CHAr), 124.7 (CAr), 123.4 
(CHAr), 121.5 (CHAr), 120.8 (CHAr), 118.4 (CAr), 115.5 (2CHAr), 110.2 (CHAr), 63.9 
(OCH2), 15.0 (CH3). IR (ATR, cm
-1
): ṽ = 3044 (w), 2981 (w), 2934 (w), 2876 (w), 2738 
(w), 1603 (m), 1514 (m), 1473 (m), 1407 (m), 1224 (m), 1112 (m), 1041 (m), 742 (s), 
587 (m). MS (EI, 70 eV): m/z (%) = 339 (24), 338 [M]
+
 (100), 310 (29), 309 (94), 281 
(31), 280 (24), 279 (26), 218 (19), 29 (24). HRMS (ESI): Calculated for C23H18N2O 
[M+H]
+
 339.14919 found 339.14919. 
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6-(3,5-Dimethoxyphenyl)-6H-indolo[2,3-b]quinoline (12d): White solid, 
mp. 143 - 145 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.79 (s, 1H, CHAr), 8.20 (ddd, 
3
J = 7.7 Hz, 
4
J = 1.3 Hz, 
4
J = 0.8 Hz, 1H, CHAr), 8.12 (d, 
3
J = 8.5 Hz, 1H, CHAr), 
8.02 (ddd, 
3
J = 8.7 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 
7.69 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.57 (ddd, 
3
J = 8.2 Hz, 
4
J = 1.5 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.55 - 7.50 (m, 1H, CHAr), 
7.50 - 7.45 (m, 1H, CHAr), 7.35 (ddd, 
3
J = 7.6 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
6.95 (d, 
4
J = 2.3 Hz, 2H, CHAr), 6.61 (t, 
4
J = 2.3 Hz, 1H, CHAr), 3.88 (s, 6H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 161.5 (2CArOCH3), 152.7 (CAr), 147.0 (CAr), 142.6 
(CAr), 138.0 (CAr), 128.9 (CHAr), 128.4 (2CHAr), 128.3 (CHAr), 127.6 (CHAr), 124.8 
(CAr), 123.6 (CHAr), 121.5 (CHAr), 121.0 (CAr), 121.0 (CHAr), 118.5 (CAr), 110.6 (CHAr), 
105.8 (2CHAr), 100.2 (CHAr), 55.7 (2OCH3). IR (ATR, cm
-1
): ṽ = 3055 (w), 2998 (w), 
2931 (w), 2833 (w), 1593 (m), 1460 (m), 1405 (m), 1221 (m), 1193 (m), 1148 (m), 
1063 (m), 1016 (m), 782 (m), 731 (s), 685 (m), 574 (m), 473 (m). MS (EI, 70 eV): 
m/z (%) = 355 (24), 354 [M]
+
 (100), 353 (83), 325 (14), 324 (31), 281 (14), 280 (10), 
279 (12), 267 (22), 218 (23), 190 (10). HRMS (ESI): Calculated for C23H18N2O2 
[M+H]
+
 355.14410 found 355.14436. 
6-(Naphthalen-1-yl)-6H-indolo[2,3-b]quinoline (12e): Pale yellow solid, 
mp. 155 - 157 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.89 
(d, 
5
J = 0.8 Hz, 1H, CHAr), 8.28 (dd, 
3
J = 7.3 , 
5
J = 0.9 Hz, 1H, 
CHAr), 8.12 - 8.07 (m, 1H, CHAr), 8.07 - 8.01 (m, 2H, CHAr), 
7.99 (d, 
3
J = 8.7 Hz, 1H, CHAr), 7.79 - 7.69 (m, 2H, CHAr), 7.64 
(ddd, 
3
J = 8.5 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.57 - 7.49 (m, 1H, CHAr), 7.46 (dt, 
3
J = 6.8 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.46 - 7.25 (m, 
4H, CHAr), 6.96 (dt, 
3
J = 8.1 Hz, 
5
J = 0.8 Hz, 1H, CHAr). 
13
C NMR (63 MHz, CDCl3) 
δ = 153.8 (CAr), 146.9 (CAr), 144.0 (CAr), 135.1 (CAr), 133.0 (CAr), 131.1 (CAr), 129.5 
(CHAr), 129.0 (CHAr), 128.7 (CHAr), 128.5 (CHAr), 128.4 (CHAr), 128.2 (CHAr), 127.9 
(CHAr), 127.6 (CHAr), 127.0 (CHAr), 126.7 (CHAr), 126.2 (CHAr), 124.7 (CAr), 123.7 
(CHAr), 123.6 (CHAr), 122.2 (CAr), 121.5 (CHAr), 121.0, 120.8 (CHAr), 118.6 (CAr), 
110.8 (CHAr). IR (ATR, cm
-1
): ṽ = 3050 (w), 2957 (w), 2922 (m), 2851 (w), 1600 (m), 
1468 (m), 1409 (m), 1224 (m), 1015 (m), 741 (s), 587 (m), 478 (m). MS (EI, 70 eV): 
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m/z (%) = 345 (13), 344 [M]
+
 (61), 343 (100), 342 (31), 172 (11). HRMS (ESI): 
Calculated for C25H16N2 [M+H]
+
 345.13862 found 345.13882. 
6-(4-Fluorophenyl)-6H-indolo[2,3-b]quinoline (12f): Pale yellow solid, 
mp. 166 - 167 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.79 
(s, 1H, CHAr), 8.21 (dt, 
3
J = 7.6 Hz, 
4
J = 0.9 Hz, 1H, CHAr), 8.08 
(d, 
3
J = 8.5 Hz, 1H, CHAr), 8.03 (dd, 
3
J = 8.2 Hz, 
4
J = 1.5 Hz, 
1H, CHAr), 7.77 - 7.65 (m, 3H, CHAr), 7.51 (m, 2H, CHAr), 7.42 
(d, 
3
J = 8.1 Hz, 1H, CHAr), 7.40 - 7.30 (m, 3H, CHAr). 
13
C NMR 
(75 MHz, CDCl3) δ = 161.8 (d, 
1
JCF = 246.9 Hz, CFAr), 152.8 (CAr), 146.9 (CAr), 142.7 
(CAr), 132.4 (d, 
4
JCF = 3.1 Hz, CAr), 129.4 (CHAr), 129.3 (d, 
3
JCF = 8.5 Hz, 2CHAr), 
128.5 (CHAr), 128.3 (CHAr), 128.2 (CHAr), 127.7 (CHAr), 124.8 (CAr), 123.7 (CHAr), 
121.6 (CHAr), 121.1 (CHAr), 121.0 (CAr), 118.4 (CAr), 116.7 (d, 
2
JCF = 22.8 Hz, 2CHAr), 
110.1 (CHAr). IR (ATR, cm
-1
): ṽ = 3053 (w), 1604 (m), 1510 (m), 1461 (m), 1403 (m), 
1220 (m), 1159 (m), 839 (m), 783 (m), 732 (s), 595 (m), 509 (m), 446 (m). MS 
(EI, 70 eV): m/z (%) = 313 (21), 312 [M]
+
 (99), 311 (100), 310 (19; 156 (12), 75 (16). 
HRMS (ESI): Calculated for C21H13FN2 [M+H]
+
 313.11355 found 313.11384. 
6-(4-Chlorophenyl)-6H-indolo[2,3-b]quinoline (12g): Pale yellow solid, 
mp. 193 - 195 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.77 
(s, 1H, CHAr), 8.20 (dd, 
3
J = 7.7 Hz, 
4
J = 0.9 Hz, 1H, CHAr), 8.08 
(dd, 
3
J = 8.7 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 8.02 (dd, 
3
J = 8.2, 
4
J = 1.5 Hz, 1H, CHAr), 7.76 - 7.66 (m, 3H, CHAr), 7.65 - 7.57 
(m, 2H, CHAr), 7.59 - 7.48 (m, 1H, CHAr), 7.51 - 7.43 (m, 2H, 
CHAr), 7.43 - 7.31 (m, 1H, CHAr). 
13
C NMR (75 MHz, CDCl3) δ = 152.5 (CAr), 146.9 
(CAr), 142.3 (CAr), 135.0 (CAr), 133.1 (CAr), 129.9 (2CHAr), 129.1 (CHAr), 128.7 
(2CHAr), 128.5 (CHAr), 128.4 (CHAr), 128.2 (CHAr), 127.7 (CHAr), 124.9 (CAr), 123.7 
(CHAr), 121.7 (CHAr), 121.3 (CHAr), 121.1 (CAr), 118.5 (CAr), 110.1 (CHAr). 
IR (ATR, cm
-1
): ṽ = 3421 (w). 3044 (w), 2959 (w), 2923 (w), 2852 (w), 1601 (m), 1496 
(m), 1405 (m), 1223 (m), 1088 (m), 1014 (m), 740 (s), 586 (m). MS (EI, 70 eV): 
m/z (%) = 330 (33), 329 (45), 328 [M]
+
 (100), 327 (74), 293 (19), 292 (37), 291 (13), 
146 (30), 75 (16). HRMS (ESI): Calculated for C21H13ClN2 [M+H]
+
 329.0840 found 
329.08391, calculated for C21H13N2Cl [M]
+
 328.07618 found 328.07527, calculated for 
C21H13N2
37
Cl [M]
+
 330.07323 found 330.07376. 
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6-(4-Methoxybenzyl)-6H-indolo[2,3-b]quinoline (12h): Pale yellow solid, 
mp. 157 - 159 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.76 
(s, 1H), 8.17 (d, 
3
J = 8.4 Hz, 1H, CHAr), 8.16 (ddd, 
3
J = 7.7 Hz, 
4
J = 1.2 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 8.03 (dd, 
3
J = 8.2 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.73 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.53 - 7.48 (m, 1H, CHAr), 7.48 - 7.44 
(m, 1H, CHAr), 7.34 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.35 - 7.27 (m, 
2H, CHAr), 7.30 - 7.27 (m, 1H, CHAr), 6.80 (d, 
3
J = 8.6 Hz, 2H, CHAr), 5.72 (s, 2H, 
CH2-benzyl), 3.74 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.1 (CAr), 142.2 
(CAr), 129.5 (CAr), 129.0 (CHAr), 128.8 (2CHAr), 128.6 (CHAr), 128.2 (CHAr), 127.8 
(CAr), 127.7 (CHAr), 124.5 (CAr), 123.2 (CHAr), 121.6 (CHAr), 121.1 (CHAr), 120.8 (CAr), 
120.3 (CHAr), 120.2 (CAr), 118.4 (CAr), 114.2 (2CHAr), 109.9 (CHAr), 55.4 (OCH3), 44.7 
(CH2-aliphatic). IR (ATR, cm
-1
): ṽ = 3053 (w), 3033 (w), 3002 (w), 2957 (w), 2929 (w), 
2838 (w), 2552 (w), 1605 (m), 1514 (m), 1467 (m), 1403 (m), 1244 (m), 1203 (m), 
1116 (m), 1031 (m), 742 (s), 475 (m). MS (EI, 70 eV): m/z (%) = 339 (16), 338 [M]
+
 
(67), 337 (14), 323 (10), 190 (11), 121 (100), 78 (10). HRMS (ESI): Calculated for 
C23H18N2O [M+H]
+
 339.14919 found 339.14898. 
5.2.4. Synthesis of benzo[a]carbazoles by sequential regioselective Suzuki 
reaction/double C-N coupling 
5.2.4.1.Starting material for double C-N coupling 
1-Bromo-2-(2-bromophenyl)naphthalene (14): Colorless oil. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.29 (dd, 3J = 8.4 Hz, 4J = 0.7 Hz, 1H, CHAr), 
7.81 - 7.69 (m, 1H, CHAr), 7.60 (dd, 
3
J = 7.9 Hz, 
4
J = 0.9 Hz, 1H, 
CHAr), 7.52 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.45 (ddd, 
3
J = 8.1 Hz, 
3
J = 6.9 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.33 - 7.26 (m, 1H, CHAr), 
7.24 - 7.19 (m, 3H, CHAr), 7.19 - 7.10 (m, 1H, CHAr). 
13
C NMR (75 MHz, CDCl3) 
δ = 143.1 (CAr), 140.2 (CAr), 134.0 (CAr), 132.7 (CHAr), 132.4 (CAr), 131.2 (CHAr), 
129.5 (CHAr), 128.4 (CHAr), 128.0 (CHAr), 127.9 (CHAr), 127.8 (CHAr), 127.6 (CHAr), 
127.3 (CHAr), 127.0 (CHAr), 123.6 (CAr), 123.5 (CAr). IR (ATR, cm
-1
): ṽ = 3051 (w), 
2924 (w), 1425 (m), 1321 (m), 1021 (m), 954 (m), 817 (m), 750 (s), 654 (m), 527 (m), 
455 (m). MS (EI, 70 eV): m/z (%) = 364 (21), 362 (42), 360 (21), 293 (25), 281 (24), 
203 (16), 202 (100), 201 (25), 200 (36), 101 (22), 100 (13). HRMS (EI): Calculated for 
C16H10Br2 [M]
+
 359.91438 found 359.91420, calculated for C16H10Br
81
Br [M]
+
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361.91233 found 361.91190, calculated for C16H10
81
Br2 [M]
+
 363.91028 found 
363.91017. 
5.2.4.2.Benzo[a]carbazoles 
11-(4-Methoxyphenyl)-11H-benzo[a]carbazole (15a): Colorless solid, 
mp. 198 - 200 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.13 
(d, 
3
J = 8.5 Hz, 1H, CHAr), 8.11 - 8.07 (m, 1H, CHAr), 7.89 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.61 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.40 
(dd, 
3
J = 8.5 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 7.38 - 7.30 (m, 3H, 
CHAr), 7.30 - 7.21 (m, 2H, CHAr), 7.18 - 7.11 (m, 1H, CHAr), 
7.10 - 7.03 (m, 3H, CHAr), 3.87 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.9 
(CAr), 142.5 (CAr), 135.8 (CAr), 133.6 (CAr), 132.7 (CAr), 130.3 (2CHAr), 129.2 (CHAr), 
125.1 (CHAr), 125.0 (CHAr), 124.8 (CHAr), 123.3 (CAr), 122.3 (CHAr), 122.2 (CAr), 121.1 
(CHAr), 120.3 (CHAr), 119.6 (CHAr), 119.34 (CAr), 119.2 (CHAr), 115.4 (2CHAr), 110.5 
(CHAr), 55.8 (OCH3). IR (ATR, cm
-1
): ṽ = 3051 (w), 3008 (w), 2956 (w), 2928 (w), 
2834 (w), 1509 (m), 1439 (m), 1248 (m), 1224 (m), 1024 (m), 812 (m), 747 (s), 621 
(m), 553 (m). MS (EI, 70 eV): m/z (%) = 324 (24), 323 [M]
+
 (100), 308 (11), 279 (17), 
278 (23), 139 (10). HRMS (EI): Calculated for C23H17ON [M]
+
 323.13047 found 
323.13082. 
11-(2-Methoxyphenyl)-11H-benzo[a]carbazole (15b): Yellow oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.24 (d, 3J = 8.5 Hz, 1H, CHAr), 
8.22 - 8.17 (m, 1H, CHAr), 7.98 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.70 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.62 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.5 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 7.50 (dd, 
3
J = 7.9 Hz, 
4
J = 1.8 Hz, 1H, 
CHAr), 7.51 - 7.46 (m, 1H, CHAr), 7.45 - 7.40 (m, 1H, CHAr), 
7.39 - 7.32 (m, 2H, CHAr), 7.26 - 7.18 (m, 3H, CHAr), 7.13 - 7.07 (m, 1H, CHAr), 3.60 
(s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 157.0 (CAr), 141.7 (CAr), 135.7 (CAr), 
133.4 (CAr), 131.0 (CHAr), 130.6 (CHAr), 129.1 (CHAr), 128.6 (CAr), 125.1 (CHAr), 124.9 
(CHAr), 124.7 (CHAr), 123.5 (CAr), 122.6 (CAr), 121.68 (CHAr), 121.5 (CHAr), 120.9 
(CHAr), 120.2 (CHAr), 119.6 (CHAr), 119.4 (CAr), 119.3 (CHAr), 112.9 (CHAr), 110.4 
(CHAr), 56.0 (OCH3). IR (ATR, cm
-1
): ṽ = 3078 (w), 3016 (w), 2959 (w), 2930 (w), 
2836 (w), 1594 (w), 1503 (m), 1460 (m), 1404 (m), 1274 (m), 1224 (m), 1120 (m), 
1023 (m), 811 (m), 742 (s), 439 (m). MS (EI, 70 eV): m/z (%) = 324 (26), 323 [M]
+
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(100), 308 (20), 307 (20), 279 (12), 278 (25). HRMS (ESI): Calculated for C23H17ON 
[M+H]
+
 324.13829 found 324.13865. 
11-(2,4-Dimethoxyphenyl)-11H-benzo[a]carbazole (15c): White solid, 
mp. 156 - 158 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.23 
(d, 
3
J = 8.5 Hz, 1H, CHAr), 8.19 (ddd, 
3
J = 7.4 Hz, 
4
J = 1.6 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.98 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.69 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.58 (d, 
3
J = 8.6 Hz, 1H, CHAr), 
7.46 - 7.42 (m, 1H, CHAr), 7.40 (d, 
3
J = 8.5 Hz, 1H, CHAr), 
7.36 - 7.34 (m, 1H, CHAr), 7.33 - 7.27 (m, 1H, CHAr), 7.14 - 7.09 (m, 1H, CHAr), 3.98 
(s, 3H, OCH3), 3.57 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 161.4 (CAr), 157.9 
(CAr), 142.0 (CAr), 135.9 (CAr), 133.4 (CAr), 131.3 (CHAr), 129.1 (CHAr), 125.1 (CHAr), 
124.8 (CHAr), 124.7 (CHAr), 123.4 (CAr), 122.6 (CAr), 121.7 (CHAr), 121.5 (CAr), 120.7 
(CHAr), 120.1 (CHAr), 119.5 (CHAr), 119.3 (CHAr), 119.2 (CAr), 110.4 (CHAr), 105.1 
(CHAr), 100.3 (CHAr), 56.0 (OCH3), 55.8 (OCH3). IR (ATR, cm
-1
): ṽ = 3378 (w), 3026 
(w), 2858 (w), 2767 (w), 2664 (w), 1505 (w), 1119 (m), 1083 (m), 973 (m), 949 (m), 
901 (m), 800 (m), 719 (s), 639 (m), 547 (m), 438 (m). MS (EI, 70 eV): m/z (%) = 354 
(27), 353 [M]
+
 (100), 278 (12), 265 (10), 177 (10), 139 (14), 133 (15). HRMS (EI): 
Calculated for C24H19O2N [M]
+
 353.14103 found 353.14075.  
11-(3,4,5-Trimethoxyphenyl)-11H-benzo[a]carbazole (15d): White solid, 
mp. 157 - 159 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.23 
(d, 
3
J = 8.6 Hz, 1H), 8.22 - 8.18 (m, 1H), 8.00 (ddd, 
3
J = 8.7 Hz, 
4
J = 1.2 Hz, 
5
J = 0.6 Hz, 1H), 7.73 (d, 
3
J = 8.3 Hz, 
1H), 7.54 (d, 
3
J = 8.6 Hz, 1H), 7.49 - 7.45 (m, 1H), 7.44 - 7.40 
(m, 1H), 7.39 - 7.35 (m, 1H), 7.32 (dt, 
3
J = 8.6 Hz, 
4
J = 1.5 Hz, 
1H), 7.29 - 7.26 (m, 1H), 6.78 (s, 2H, CHAr), 4.05 (s, 3H, OCH3), 3.83 (s, 6H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 154.4 (2CArOCH3), 142.1 (CAr), 138.4 (CAr), 135.6 
(CAr), 135.5 (CAr), 133.6 (CAr), 129.2 (CHAr), 125.3 (CHAr), 125.1 (CHAr), 125.0 (CHAr), 
123.4 (CAr), 122.4 (CHAr), 122.0 (CAr), 121.3 (CHAr), 120.4 (CHAr), 119.7 (CHAr), 119.4 
(CAr), 119.2 (2CHAr), 110.5 (CHAr), 106.4 (CHAr), 61.4 (OCH3), 56.5 (2OCH3). 
IR (ATR, cm
-1
): ṽ = 3053 (w), 2998 (w), 2961 (w), 2936 (m), 2828 (w), 2592 (w), 1589 
(m), 1500 (m), 1460 (m), 1412 (m), 1361 (m), 1300 (m), 1223 (m), 1122 (s), 1004 (m), 
809 (m), 732 (s), 654 (m), 441 (m). MS (EI, 70 eV): m/z (%) = 384 (23), 383 [M]
+
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(100), 281 (12), 216 (11). HRMS (EI): Calculated for C25H21O3N [M]
+
 383.15160 found 
383.15163. 
11-(Naphthalen-1-yl)-11H-benzo[a]carbazole (15e): White solid, mp. 189 - 191 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.37 - 8.26 (m, 1H, CHAr), 
8.30 - 8.25 (m, 1H, CHAr), 8.17 (dd, 
3
J = 7.2 Hz, 
4
J = 2.3 Hz, 1H, 
CHAr), 8.06 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.97 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.76 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.73 (d, 
3
J = 5.7 Hz, 1H, 
CHAr), 7.71 (m, 1H, CHAr), 7.54 (ddd, 
3
J = 8.2 Hz, 
3
J = 6.4 Hz, 
4
J = 1.7 Hz, 1H, CHAr), 7.41 - 7.36 (m, 1H, CHAr), 7.36 - 7.33 (m, 1H, CHAr), 
7.32 - 7.29 (m, 1H, CHAr), 7.29 - 7.26 (m, 1H, CHAr), 7.25 - 7.18 (m, 1H, CHAr), 
7.15 - 7.04 (m, 1H, CHAr), 7.02 (dd, 
3
J = 6.8 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 6.96 - 6.91 (m, 
1H, CHAr). 
13
C NMR (63 MHz, CDCl3) δ = 142.44 (CAr), 136.67 (CAr), 136.32 (CAr), 
134.87 (CAr), 133.53 (CAr), 131.81 (CAr), 129.70 (CHAr), 129.12 (CHAr), 128.52 (CHAr), 
127.64 (CHAr), 127.46 (CHAr), 127.12 (CHAr), 126.17 (CHAr), 125.25 (CHAr), 125.15 
(CHAr), 124.82 (CHAr), 123.54 (CAr), 123.51 (CHAr), 122.11 (CAr), 121.98 (CHAr), 
121.32 (CHAr), 120.45 (CHAr), 119.65 (CHAr), 119.48 (CAr), 119.30 (CHAr), 110.75 
(CHAr). IR (ATR, cm
-1
): ṽ = 3054 (w), 1594 (w), 1460 (m), 1432 (m), 1409 (m), 1377 
(m), 1228 (m), 1112 (m), 781 (m), 748 (s), 682 (m), 544 (m), 418 (m). MS (EI, 70 eV): 
m/z (%) = 344 (28), 343 [M]
+
 (100), 342 (16), 341 (22), 170 (28), 158 (14). HRMS (EI): 
Calculated for C26H17N [M]
+
 343.13555 found 343.13524. 
11-(Anthracen-2-yl)-11H-benzo[a]carbazole (15f): Pale yellow solid, 
mp. 218 - 220 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.63 (d, 
4
J = 1.2 Hz, 1H, CHAr), 8.53 (d, 
4
J = 1.1 Hz, 1H, CHAr), 8.31 - 8.27 
(m, 2H, CHAr), 8.27 - 8.25 (m, 1H, CHAr), 8.25 - 8.22 (m, 1H, 
CHAr), 8.16 - 8.09 (m, 1H, CHAr), 8.09 - 8.03 (m, 1H, CHAr), 8.01 
(d, 
3
J = 8.2 Hz, 1H, CHAr), 7.77 (d, 
3
J = 8.3 Hz, 1H, CHAr), 
7.62 - 7.54 (m, 3H, CHAr), 7.51 (dd, 
3
J = 8.9 Hz, 
4
J = 2.1 Hz, 1H, 
CHAr), 7.45 - 7.35 (m, 3H, CHAr), 7.35 - 7.27 (m, 1H, CHAr), 7.12 
(ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.3 Hz, 1H, CHAr). 
13
C NMR (63 MHz, CDCl3) 
δ = 142.2 (CAr), 137.0 (CAr), 135.7 (CAr), 133.6 (CAr), 132.5 (CAr), 132.4 (CAr), 131.7 
(CAr), 131.1 (CAr), 130.8 (CHAr), 129.3 (CHAr), 128.4 (CHAr), 128.3 (CHAr), 127.6 
(CHAr), 127.0 (CHAr), 126.8 (CHAr), 126.6 (CHAr), 126.3 (CHAr), 126.2 (CHAr), 125.2 
(2CHAr), 124.9 (CHAr), 123.7 (CAr), 122.5 (CHAr), 122.3 (CAr), 121.5 (CHAr), 120.6 
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(CHAr), 119.9 (CAr), 119.7 (CHAr), 119.3 (CHAr), 110.6 (CHAr). IR (ATR, cm
-1
): 
ṽ = 3047 (w), 1616 (w), 1461 (m), 1433 (m), 1381 (m), 1324 (m), 1219 (m), 1155 (m), 
893 (m), 809 (m), 741 (s), 650 (m), 468 (m). MS (EI, 70 eV): m/z (%) = 394 (29), 393 
[M]
+
 (100), 392 (36), 391 (29), 390 (11), 197 (23), 196 (27), 195 (20), 189 (11), 176 
(11). HRMS (EI): Calculated for C30H19N [M]
+
 393.15120 found 393.15099. 
11-(4-(Methylthio)phenyl)-11H-benzo[a]carbazole (15g): Pale yellow solid, 
mp. 147 - 149 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.23 
(d, 
3
J = 8.5 Hz, 1H, CHAr), 8.21 - 8.16 (m, 1H, CHAr), 7.99 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.72 (d, 
3
J = 8.5 Hz, 1H, CHAr), 
7.55 - 7.52 (m, 1H, CHAr), 7.52 - 7.50 (m, 1H, CHAr), 
7.50 - 7.46 (m, 3H, CHAr), 7.44 (q, 
4
J = 1.6 Hz, 1H, CHAr), 
7.42 - 7.38 (m, 1H, CHAr), 7.38 - 7.33 (m, 1H, CHAr), 7.30 - 7.23 (m, 1H, CHAr), 
7.21 - 7.16 (m, 1H, CHAr), 2.64 (s, 3H, SCH3). 
13
C NMR (75 MHz, CDCl3) δ = 142.2 
(CAr), 139.8 (CAr), 136.9 (CAr), 135.6 (CAr), 133.6 (CAr), 129.6 (2CHAr), 129.3 (CHAr), 
127.5 (2CHAr), 125.2 (CHAr), 125.1 (CHAr), 124.9 (CHAr), 123.5 (CAr), 122.3 (CHAr), 
122.1 (CAr), 121.3 (CHAr), 120.5 (CHAr), 119.6 (CAr), 119.6 (CHAr), 119.2 (CHAr), 110.5 
(CHAr), 15.8 (SCH3). IR (ATR, cm
-1
): ṽ = 3076 (w), 3043 (w), 2982 (w), 2917 (w), 
2818 (w), 1495 (m), 1560 (m), 1403 (m), 1224 (m), 1094(m), 809 (m), 738 (s), 617 (m), 
552 (m). MS (EI, 70 eV): m/z (%) = 340 (26), 339 [M]
+
 (100), 325 (18), 291 (26), 146 
(32). HRMS (EI): Calculated for C23H17NS 339.10762 found 339.10776. 
11-(3,5-Dimethylphenyl)-11H-benzo[a]carbazole (15h): Yellow oil. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 8.23 (d, 3J = 8.5 Hz, 1H, CHAr), 
8.21 - 8.17 (m, 1H, CHAr), 7.99 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.72 
(d, 
3
J = 8.2 Hz, 1H, CHAr), 7.51 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.44 
(ddd, 
3
J = 8.1 Hz, 
3
J = 6.9 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 
7.40 - 7.36 (m, 1H, CHAr), 7.36 - 7.30 (m, 1H, CHAr), 
7.28 - 7.24 (m, 2H, CHAr), 7.23 - 7.18 (m, 1H, CHAr), 7.16 (s, 2H, CHAr), 2.44 (s, 6H, 
CH3). 
13
C NMR (75 MHz, CDCl3) δ = 142.2 (CAr), 140.0 (CAr), 139.9 (2CAr), 135.6 
(CAr), 133.6 (CAr), 130.6 (CHAr), 129.2 (CHAr), 126.7 (2CHAr), 125.0 (CHAr), 124.9 
(CHAr), 124.8 (CHAr), 123.4 (CAr), 122.6 (CHAr), 122.2 (CAr), 121.1 (CHAr), 120.2 
(CHAr), 119.6 (CHAr), 119.4 (CAr), 119.2 (CHAr), 110.6 (CHAr), 21.5 (2CH3). 
IR (ATR, cm
-1
): ṽ = 3006 (w), 2930 (w), 2837 (w), 2820 (w), 1591 (m), 1504 (m), 1460 
(m), 1204 (m), 1120 (m), 1026 (m), 809 (m), 740 (s), 702 (m), 437 (m). MS (EI, 70 eV): 
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m/z (%) = 322 (26), 321 [M]
+
 (100), 305 (12), 146 (19). HRMS (EI): Calculated for 
C24H19N [M]
+
 321.15120 found 321.15109. 
11-(4-(tert-Butyl)phenyl)-11H-benzo[a]carbazole (15i): Yellow solid, 
mp. 258 - 259 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.24 
(d, 
3
J = 8.5 Hz, 1H, CHAr), 8.22 - 8.17 (m, 1H, CHAr), 7.99 (dd, 
3
J = 8.2 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 7.72 (dd, 
3
J = 8.5 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 7.66 (d, 
3
J = 8.6 Hz, 2H, CHAr), 
7.49 - 7.41 (m, 4H, CHAr), 7.41 - 7.30 (m, 2H, CHAr), 7.26 - 7.18 
(m, 2H, CHAr), 1.49 (s, 9H, CH3-tBu). 
13
C NMR (75 MHz, CDCl3) δ = 152.1 (CAr), 142.3 
(CAr), 137.4 (CAr), 135.7 (CAr), 133.6 (CAr), 129.2 (CHAr), 128.7 (2CHAr), 127.1 
(2CHAr), 125.0 (CHAr), 125.0 (CHAr), 124.8 (CHAr), 123.4 (CAr), 122.4 (CHAr), 122.2 
(CAr), 121.1 (CHAr), 120.3 (CHAr), 119.6 (CHAr), 119.5 (CAr), 119.2 (CHAr), 110.6 
(CHAr), 35.1 (CtBu), 31.7 (3CH3). IR (ATR, cm
-1
): ṽ = 3051 (w), 2960 (w), 2902 (w), 
2866 (w), 1516 (m), 1462 (m), 1405 (m), 1306 (m), 1226 (s), 1190 (m), 1119 (m), 981 
(m), 810 (m), 741 (m), 625 (m), 557 (m). MS (EI, 70 eV): m/z (%) = 350 (29), 349 
(100), 334 (26), 319 (13), 291 (13), 216 (14), 153 (11), 146 (30). HRMS (EI): 
Calculated for C30H19N [M]
+
 393.15120 found 3903.15099. 
11-Phenyl-11H-benzo[a]carbazole (15j): Colorless oil. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.13 (d, 3J = 8.6 Hz, 1H, CHAr), 8.11 - 8.08 (m, 
1H, CHAr), 7.89 (dd, 
3
J = 8.5 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.62 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.58 - 7.50 (m, 3H, CHAr), 7.44 (dd, 
3
J = 7.7 Hz, 
4
J = 2.0 Hz, 2H, CHAr), 7.37 - 7.23 (m, 4H, CHAr), 
7.15 - 7.06 (m, 2H, CHAr). 
13
C NMR (63 MHz, CDCl3) δ = 142.2 
(CAr), 140.2 (CAr), 135.6 (CAr), 133.6 (CAr), 130.2 (2CHAr), 129.3 (3CHAr), 128.9 
(CHAr), 125.1 (CHAr), 125.0 (CHAr), 124.8 (CHAr), 123.5 (CAr), 122.4 (CHAr), 122.1 
(CAr), 121.3 (CHAr), 120.4 (CHAr), 119.6 (CHAr), 119.2 (CHAr), 118.4 (CAr), 110.5 
(CHAr). IR (ATR, cm
-1
): ṽ = 3397 (w), 3053 (m), 2957 (w), 2867 (w), 1594 (m), 1496 
(m), 1461 (m), 1401 (m), 1224 (m), 1157 (m), 1025 (m), 906 (m), 807 (m), 740 (s), 695 
(m), 622 (m), 554 (m). MS (EI, 70 eV): m/z (%) = 294 (23), 293 [M]
+
 (100), 292 (30), 
291 (36), 214 (12), 146 (14), 77 (15), 51 (13). HRMS (EI): Calculated for C22H15N [M]
+
 
293.11990 found 293.11970. 
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11-(4-Fluorophenyl)-11H-benzo[a]carbazole (15k): Colorless oil. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 8.11 (d, 3J = 8.6 Hz, 1H, CHAr), 
8.10 - 8.06 (m, 1H, CHAr), 7.89 (dd, 
3
J = 8.1 Hz, 
4
J = 0.9 Hz, 1H, 
CHAr), 7.65 - 7.59 (m, 1H, CHAr), 7.40 (dd, 
3
J = 8.9 Hz, 
3
J = 4.9 Hz, 2H, CHAr), 7.36 - 7.20 (m, 6H, CHAr), 7.16 (dd, 
3
J = 6.8 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.09 - 6.99 (m, 1H, CHAr).
 
19
F NMR (282 MHz, CDCl3) δ = -112.0 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 162. 7 
(d, 
1
JCF = 248.8 Hz, CFAr), 142.2 (CAr), 136.2 (d, 
4
JCF = 3.3 Hz, CAr), 135.6 (CAr), 133.6 
(CAr), 130.99 (d, 
3
JCF = 8.6 Hz, 2CHAr), 129.4 (CHAr), 125.2 (CHAr), 125.2 (CHAr), 
124.9 (CHAr), 123.5 (CAr), 122.1 (CHAr), 122.0 (CAr), 121.5 (CHAr), 120.6 (CHAr), 119.7 
(CHAr), 119.7 (CAr), 119.2 (CHAr), 117.25 (d, 
2
JCF = 22.7 Hz, 2CHAr), 110.3 (CHAr). 
IR (ATR, cm
-1
): ṽ = 3399 (w), 3052 (w), 2956 (w), 2925 (w), 2867 (w), 2688 (w), 2565 
(w), 2245 (w), 1891 (w), 1506 (s), 1462 (m), 1402 (m), 1219 (m), 1151 (m), 1089 (m), 
907 (m), 807 (m), 740 (s), 618 (m), 515 (m). MS (EI, 70 eV): m/z (%) = 312 (25), 311 
[M]
+
 (100), 310 (29), 309 (32), 214 (11), 75 (16). HRMS (EI): Calculated for C22H14NF 
[M]
+
 311.11048 found 311.11027. 
11-(4-Chlorophenyl)-11H-benzo[a]carbazole (15l): Colorless oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.23 (d, 3J = 8.5 Hz, 1H, CHAr), 
8.21 - 8.17 (m, 1H, CHAr), 8.01 (dd, 
3
J = 8.4 Hz, 
4
J = 1.4 Hz, 2H, 
CHAr), 7.74 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.64 (d, 
3
J = 8.7 Hz, 1H, 
CHAr), 7.49 (d, 
3
J = 8.7 Hz, 2H, CHAr), 7.46 - 7.34 (m, 4H, CHAr), 
7.32 - 7.27 (m, 1H, CHAr), 7.21 - 7.14 (m, 1H, CHAr). 
13
C NMR 
(126 MHz, CDCl3) δ = 142.1 (CAr), 138.9 (CAr), 135.4 (CAr), 134.8 (CAr), 133.6 (CHAr), 
130.6 (CHAr), 130.5 (2CHAr), 129.4 (CAr), 129.4 (CHAr), 125.3 (2CHAr), 125.0 (CHAr), 
123.7 (CAr), 122.2 (CAr), 122.0 (CHAr), 121.6 (CHAr), 120.7 (CHAr), 119.9 (CAr), 119.8 
(CHAr), 119.2 (CHAr), 110.3 (CHAr). IR (ATR, cm
-1
): ṽ = 3392 (w), 3054 (w), 2959 (w), 
2932 (w), 2867 (w), 1492 (m), 1461 (m), 1224 (m), 1086 (m), 807 (m), 741 (s), 501 
(m). MS (EI, 70 eV): m/z (%) = 329 (36), 328 (29), 327 [M]
+
 (100), 325 (10), 291 (27), 
146 (21). HRMS (EI): Calculated for C22H14NCl [M]
+
 327.08093.  
11-Benzyl-11H-benzo[a]carbazole (15m): White solid, mp. 146 - 148 °C. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 8.32 - 8.21 (m, 3H, CHAr), 8.04 (dd, 
3
J = 8.3 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.73 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.55 - 7.20 (m, 10H, CHAr), 
6.02 (d, 
4
J = 1.0 Hz, 2H, CH2-benzyl). 
13
C NMR (126 MHz, CDCl3) δ = 141.2 (CAr), 
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137.7 (CAr), 135.4 (CAr), 133.8 (CAr), 129.5 (CHAr), 129.2 (2CHAr), 
127.6 (CHAr), 126.1 (2CHAr), 125.6 (CHAr), 125.2 (CHAr), 124.8 
(CHAr), 123.5 (CAr), 122.2 (CAr), 122.1 (CHAr), 121.1 (CAr), 120.2 
(CHAr), 119.8 (CHAr), 119.5 (CHAr), 119.3 (CHAr), 109.4 (CHAr), 
49.9 (CH2-aliphatic). IR (ATR, cm
-1
): ṽ = 3052 (w), 3022 (w), 2935 
(w), 1467 (m), 1407 (m), 1326 (m), 1189 (m), 808 (m), 739 (s), 739 (s), 693 (m), 436 
(m). MS (EI, 70 eV): m/z (%) = 308 (25), 307 [M]
+
 (99), 217 (17), 216 (100), 215 (23), 
214 (20), 190 (11), 189 (13), 91 (66), 65 (12). HRMS (EI): Calculated for C23H17N [M]
+
 
307.13555 found 307.13537. 
11-(4-Methoxybenzyl)-11H-benzo[a]carbazole (15n): White solid, mp. 139 - 140 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.31 (d, 3J = 7.9 Hz, 1H, 
CHAr), 8.24 (d, 
3
J = 8.5 Hz, 2H, CHAr), 8.03 (dd, 
3
J = 8.0 , 
4
J = 1.5 Hz, 1H, CHAr), 7.71 (d, 
3
J = 8.5 Hz, 1H, CHAr), 7.52 - 7.41 
(m, 4H, CHAr), 7.40 - 7.32 (m, 1H, CHAr), 7.18 (d, 
3
J = 8.7 Hz, 2H, 
CHAr), 6.86 (d, 
3
J = 8.7 Hz, 2H, CHAr), 5.96 (t, 
5
J = 0.8 Hz, 2H, 
CH2-benzyl), 3.76 (s, 3H, OCH3). 
13
C NMR (126 MHz, CDCl3) 
δ = 159.1 (CAr), 141.2 (CAr), 135.4 (CAr), 133.8 (CAr), 129.6 (CAr), 129.5 (CHAr), 127.3 
(2CHAr), 125.6 (CHAr), 125.2 (CHAr), 124.8 (CHAr), 123.4 (CAr), 122.2 (CAr), 122.2 
(CHAr), 121.0 (CHAr), 120.1 (CHAr), 119.8 (CHAr), 119.5 (CAr), 119.3 (CHAr), 114.6 
(2CHAr), 109.5 (CHAr), 55.4 (OCH3), 49.3 (CH2-benzyl). IR (ATR, cm
-1
): ṽ = 3142 (w), 
3116 (w), 3074 (w), 3032 (w), 2989 (w), 2917 (w), 1612 (m), 1509 (m), 1472 (m), 1385 
(m), 1330 (m), 1289 (m), 1241 (s), 1171 (m), 1032 (m), 902 (m), 840 (m), 791 (m), 705 
(m), 626 (m), 536 (m). MS (EI, 70 eV): m/z (%) = 337 [M]
+
 (28), 216 (18), 121 (100). 
HRMS (EI): Calculated for C24H19NO [M]
+
 337.14612 found 337.14594. 
11-Hexyl-11H-benzo[a]carbazole (15o): Colorless oil. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.52 (dd, 3J = 8.5 Hz, 3J = 1.2 Hz, 1H), 8.21 (d, 
3
J = 8.4 Hz, 1H), 8.19 (d, 
3
J = 7.7 Hz, 1H), 8.07 (dd, 
3
J = 8.0 Hz, 
3
J = 1.5 Hz, 1H), 7.69 (d, 
3
J = 8.5 Hz, 1H), 7.64 (ddd, 
3
J = 8.5 Hz, 
3
J = 6.9 Hz, 
4
J = 1.6 Hz, 1H), 7.60 - 7.57 (m, 1H), 7.58 - 7.54 (m, 
1H), 7.54 - 7.49 (m, 1H), 7.34 (ddd, 
3
J = 7.9 Hz,
 3
J = 6.8 Hz, 
3
J = 1.2 Hz, 1H), 4.88 - 4.72 (m, 2H), 2.09 (p, 
3
J = 7.6 Hz, 2H), 
1.57 (p, 
3
J = 7.6 Hz, 
3
J = 7.1 Hz, 2H), 1.48 - 1.35 (m, 4H), 0.94 (t, 
3
J = 7.1 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ = 140.5 (CAr), 134.6 (CAr), 133.8 (CAr), 129.8 (CHAr), 
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125.5 (CHAr), 124.8 (CHAr), 124.6 (CHAr), 123.1 (CAr), 122.4 (CAr), 122.0 (CHAr), 120.6 
(CHAr), 119.7 (CAr), 119.6 (CHAr), 119.4 (CHAr), 119.3 (CHAr), 109.2 (CHAr), 46.1 
(CH2-aliphatic), 31.7 (CH2-aliphatic), 30.1 (CH2-aliphatic), 26.9 (CH2-aliphatic), 22.7 (CH2-aliphatic), 
14.2 (CH3-aliphatic). IR (ATR, cm
-1
): ṽ = 3051 (w), 2953 (m), 2925 (m), 2854 (m), 1466 
(m), 1407 (m), 1383 (m), 1333 (m), 1186 (m), 1125 (m), 804 (m), 737 (s), 553 (m), 438 
(m). MS (EI, 70 eV): m/z (%) = 302 (14), 301 [M]
+
 (57), 231 (19), 230 (100), 217 (11), 
216 (20), 202 (17). HRMS (EI): Calculated for C22H23N 301.18250 [M]
+ 
found 
301.18213. 
 
5.2.5. Synthesis of thienoindoles by sequential site-selective Suzuki 
reaction/double C-N coupling 
5.2.5.1.Starting materials for double C-N coupling 
3-Bromo-2-(2-bromophenyl)thiophene (17a): White solid, mp. 63 - 64 °C. 
1
H NMR 
(500 MHz, Chloroform-d) δ = 7.69 (d, 3J = 8.0 Hz, 1H, CHAr), 
7.42 - 7.34 (m, 3H, CHAr), 7.28 (ddd, 
3
J = 8.0 Hz, 
3
J = 6.7 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 7.07 (d, 
3
J = 5.3 Hz, 1H, CHthiophene). 
13
C NMR 
(126 MHz, CDCl3) δ = 137.3 (CAr), 134.0 (CAr), 133.1 (CHAr), 132.9 
(CHAr), 130.6 (CHAr), 130.3 (CHAr), 127.3 (CHAr), 126.2 (CHAr), 125.2 (CAr), 111.2 
(CAr). IR (ATR, cm
-1
): ṽ = 3110 (w), 3085 (w), 3059 (w), 1528 (w), 1463 (m), 1419 
(m), 1340 (m), 1148 (w), 1024 (m), 857 (m), 756 (s), 712 (s), 654 (m), 620 (m), 522 
(m), 446 (m). MS (EI, 70 eV): m/z (%) = 318 [M]
+
 (45), 239 (22), 158 (100), 114 (30), 
79 (21). HRMS (EI): Calculated for C10H6Br2S [M]
+
 315.85515 found 315.85464, 
calculated for C10H6Br
81
BrS [M]
+
 317.85310 found 317.85281, calculated for 
C10H6
81
Br2S [M]
+
 319.85105 found 319.85069. 
3-Bromo-4-(2-bromophenyl)thiophene (17b): Colorless oil. 
1
H NMR (500 MHz, 
Chloroform-d) δ = 7.67 (d, 3J = 8.1 Hz, 1HAr), 7.39 - 7.34 (m, 2H, 
CHAr), 7.31 - 7.24 (m, 3H, CHAr). 
13
C NMR (126 MHz, CDCl3) 
δ = 141.5 (CAr), 136.6 (CAr), 132.9 (CHAr), 132.0 (CHAr), 129.8 (CHAr), 
127.2 (CHAr), 124.9 (CHAr), 124.5 (CAr), 123.3 (CHAr), 112.4 (CAr). 
IR (ATR, cm
-1
): ṽ = 3107 (w), 3057 (w), 1560 (w), 1525 (w), 1464 (m), 1425 (m), 1339 
(m), 1257 (w), 1081 (w), 1026 (m), 921 (m), 852 (m), 792 (m), 751 (s), 710 (m), 653 
(m), 451 (m). MS (EI, 70 eV): m/z (%) = 320 (23), 318 [M]
+
 (43), 239 (31), 158 (100), 
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114 (26), 113 (20), 79 (24). HRMS (EI): Calculated for C10H6Br2S [M]
+
 315.85515 
found 315.85490, calculated for C10H6Br
81
BrS [M]
+
 317.85310 found 317.85301, 
calculated for C10H6
81
Br2S [M]
+
 319.85105 found 319.85073.  
 
5.2.5.2.Indolo[3,2-b]thiophene 
4-(p-Tolyl)-4H-thieno[3,2-b]indole (18a): Yellow solid, mp. 92 - 93 °C. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 7.82 - 7.77 (m, 1H, CHAr), 7.55 - 7.50 
(m, 1H, CHAr), 7.47 (d, 
3
J = 8.3 Hz, 2H, CHAr), 7.40 - 7.33 (m, 3H, 
CHAr), 7.30 - 7.19 (m, 2H, CHAr), 7.08 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
2.47 (s, 3H, CH3). 
13
C NMR (75 MHz, CDCl3) δ = 145.3 (CAr), 141.6 
(CAr), 136.8 (CAr), 136.4 (CAr), 130.5 (2CHAr), 126.9 (CHAr), 125.2 
(2CHAr), 123.0 (CHAr), 122.4 (CAr), 120.2 (CHAr), 119.1 (CHAr), 117.8 (CAr), 111.6 
(CHAr), 111.2 (CHAr), 21.3 (CH3). IR (ATR, cm
-1
): ṽ = 3393 (w), 3109 (w), 3080 (w), 
3056 (w), 3030 (w), 2917 (w), 2857 (w), 1600 (m), 1510 (s), 1450 (s), 1392 (m), 1337 
(m), 1200 (m), 1085 (m), 1044 (m), 847 (m), 812 (m), 709 (s), 663 (m), 650 (m), 568 
(m), 506 (m), 433 (m). MS (EI, 70 eV): m/z (%) = 264 (20), 263 [M]
+
 (100), 262 (15), 
248 (7), 247 (6), 128 (5). HRMS (EI): Calculated for C17H13NS [M]
+
 263.07632 found 
263.07598.  
4-(o-Tolyl)-4H-thieno[3,2-b]indole (18b): Yellow oil. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.74 - 7.68 (m, 1H, CHAr), 7.34 - 7.29 (m, 2H, 
CHAr), 7.28 - 7.24 (m, 2H, CHAr), 7.23 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
7.15 - 7.10 (m, 2H, CHAr), 7.01 - 6.95 (m, 1H, CHAr), 6.70 (d, 
3
J = 5.2 
Hz, 1H, CHthiophene), 1.94 (s, 3H, CH3). 
13
C NMR (63 MHz, CDCl3) 
δ = 145.8 (CAr), 142.3 (CAr), 137.2 (CAr), 136.5 (CAr), 131.6 (CHAr), 
128.6 (CHAr), 128.6 (CHAr), 127.2 (CHAr), 127.0 (CHAr), 122.9 (CHAr), 122.0 (CAr), 
119.9 (CHAr), 119.0 (CHAr), 117.1 (CAr), 111.3 (CHAr), 111.2 (CHAr), 17.9 (CH3). 
IR (ATR, cm
-1
): ṽ = 3048 (w), 2917 (w), 1601 (w), 1505 (m), 1486 (m), 1451 (m), 1486 
(m), 1450 (s), 1332 (m), 1082 (m), 820 (m), 734 (s), 649 (s), 431 (m). MS (EI, 70 eV): 
m/z (%) = 264 (21), 263 [M]
+
 (100), 262 (47), 230 (16), 218 (11), 217 (13), HRMS (EI): 
Calculated for C17H13NS [M]
+
 263.07632 found 263.07591.  
4-Phenyl-4H-thieno[3,2-b]indole (18c): Yellow oil. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 7.86 - 7.79 (m, 1H, CHAr), 7.66 - 7.54 (m, 5H, CHAr), 7.45 - 7.39 (m, 
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1H, CHAr), 7.38 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.34 - 7.21 (m, 2H, 
CHAr), 7.12 (d, 
3
J = 5.2 Hz, 1H, CHthiophene). 
13
C NMR (75 MHz, 
CDCl3) δ = 145.1 (CAr), 141.4 (CAr), 139.0 (CAr), 129.9 (2CHPh), 127.0 
(CHAr), 126.9 (CHAr), 125.2 (2CHPh), 123.2 (CHAr), 122.5 (CAr), 120.4 
(CHAr), 119.1 (CHAr), 118.1 (CAr), 111.6 (CHAr), 111.2 (CHAr). 
IR (ATR, cm
-1
): ṽ = 3083 (w), 3050 (w), 1594 (m), 1505 (s), 1449 (s), 1392 (m), 1337 
(m), 1201 (m), 1086 (m), 839 (m), 779 (m), 737 (s), 696 (s), 653 (s), 430 (m). 
MS (EI, 70 eV): m/z (%) = 249 [M]
+
 (100), 217 (6), 204 (9), 172 (5), 128 (8), 77 (9), 51 
(13). HRMS (EI): Calculated for C16H11NS [M]
+
 249.06067 found 249.06073.  
4-(3,5-Dimethylphenyl)-4H-thieno[3,2-b]indole (18d): Yellow solid, 
mp. 112 - 113 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.73 - 7.67 
(m, 1H, CHAr), 7.51 - 7.44 (m, 1H, CHAr), 7.27 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 7.22 - 7.09 (m, 4H, CHAr), 7.01 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 6.95 (s, 1H, CHAr), 2.33 (s, 6H, CH3). 
13
C NMR (63 MHz, 
CDCl3) δ = 145.2 (CAr), 141.4 (CAr), 139.7 (2CAr), 138.8 (CAr), 128.6 
(CHAr), 126.8 (CHAr), 123.0 (CHAr), 122.9 (2CHAr), 122.4 (CAr), 120.2 (CHAr), 119.1 
(CHAr), 117.8 (CAr), 111.8 (CHAr), 111.3 (CHAr), 21.5 (2CH3). IR (ATR, cm
-1
): 
ṽ = 3051 (w), 3006 (w), 2956 (m), 2915 (m), 2851 (w), 1731 (m), 1594 (m), 1504 (m), 
1449 (m), 1343 (m), 1173 (m), 1090 (m), 839 (m), 815 (m), 738 (s), 701 (m), 568 (s). 
MS (EI, 70 eV): m/z (%) = 278 (21), 277 [M]
+
 (100), 276 (7), 262 (8), 260 (7), 228 (5), 
77 (5). HRMS (EI): Calculated for C18H15NS [M]
+
 277.09197 found 277.09166.  
4-(2,3-Dihydro-1H-inden-5-yl)-4H-thieno[3,2-b]indole (18e): Yellow solid, 
mp. 81 - 82 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.74 - 7.68 (m, 
1H, CHAr), 7.49 - 7.42 (m, 1H, CHAr), 7.37 - 7.20 (m, 4H, CHAr), 7.15 
(m, 2H, CHAr), 7.00 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 2.92 (t, 
3
J = 7.4 Hz, 4H, CH2), 2.10 (p, 
3
J = 7.5 Hz, 2H, CH2). 
13
C NMR 
(63 MHz, CDCl3) δ = 146.2 (CAr), 145.4 (CAr), 143.1 (CAr), 141.7 
(CAr), 137.1 (CAr), 126.8 (CHAr), 125.4 (CHAr), 123.3 (CHAr), 123.0 (CHAr), 122.3 (CAr), 
121.4 (CHAr), 120.1 (CHAr), 119.0 (CHAr), 117.6 (CAr), 111.7 (CHAr), 111.3 (CHAr), 
33.2 (CH2), 32.7 (CH2), 25.8 (CH2). IR (ATR, cm
-1
): ṽ = 2933 (w), 2837 (w), 1606 (w), 
1505 (m), 1486 (m), 1451 (m), 1344 (m), 1099 (m), 820 (m), 736 (s), 648 (s), 426 (m). 
MS (EI, 70 eV): m/z (%) = 289 [M]
+
 (100), 255 (5), 172 (12), 115 (10). HRMS (EI): 
Calculated for C19H15NS [M]
+
 289.09197 found 289.09201. 
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4-(4-(Methylthio)phenyl)-4H-thieno[3,2-b]indole (18f): White solid, mp. 91 - 92 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.69 - 7.63 (m, 1H, CHAr), 
7.41 - 7.27 (m, 5H, CHAr), 7.21 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
7.15 - 7.08 (m, 2H, CHAr), 6.92 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 2.41 (s, 
3H, SCH3). 
13
C NMR (63 MHz, CDCl3) δ = 145.0 (CAr), 141.3 (CAr), 
137.1 (CAr), 136.1 (CAr), 127.9 (2CHAr), 127.1 (CHAr), 125.6 (2CHAr), 
123.1 (CHAr), 122.5 (CAr), 120.4 (CHAr), 119.1 (CHAr), 118.0 (CAr), 
111.4 (CHAr), 111.0 (CHAr), 16.2 (SCH3). IR (ATR, cm
-1
): ṽ = 3381 (w), 3095 (w), 
3082 (w), 3046 (w), 2917 (w), 1591 (w), 1505 (s), 1491 (s), 1450 (s), 1393 (m), 1339 
(m), 1294 (m), 1094 (m), 1044 (m), 1012 (m), 814 (s), 750 (s), 709 (m), 662 (s), 506 
(m). MS (EI, 70 eV): m/z (%) = 295 [M]
+
 (100), 280 (68), 247 (22), 148 (10). 
HRMS (EI): Calculated for C17H13NS2 295.04839 found 295.04844. 
4-(4-Methoxyphenyl)-4H-thieno[3,2-b]indole (18g): White solid, mp. 124 - 125 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.77 - 7.65 (m, 1H, CHAr), 
7.46 - 7.34 (m, 3H, CHAr), 7.27 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
7.22 - 7.08 (m, 2H, CHAr), 6.99 (m, 2H, CHAr), 6.95 (d, 
3
J = 5.2 Hz, 
1H, CHthiophene), 3.82 (s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) 
δ = 158.5 (CAr), 145.6 (CAr), 141.9 (CAr), 131.8 (CAr), 126.9 (CHAr), 
126.8 (2CHAr), 123.0 (CHAr), 122.2 (CAr), 120.1 (CHAr), 119.1 (CHAr), 
117.5 (CAr), 115.1 (2CHAr), 111.4 (CHAr), 111.0 (CHAr), 55.7 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3140 (w), 3097 (w), 3082 (w), 2838 (w), 1510 (m), 1243 (m), 1024 
(m), 824 (m), 754 (s), 713 (m). MS (EI, 70 eV): m/z (%) = 279 [M]
+
 (100), 264 (45), 
236 (15), 191 (9), 140 (8). HRMS (EI): Calculated for C17H13ONS [M]
+
 279.07124 
found 279.07129.  
4-(3-Methoxyphenyl)-4H-thieno[3,2-b]indole (18h): Yellow oil. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 7.73 - 7.67 (m, 1H, CHAr), 7.54 - 7.48 (m, 1H, 
CHAr), 7.36 (t, 
3
J = 8.1 Hz, 1H, CHAr), 7.26 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 7.22 - 7.12 (m, 2H, CHAr), 7.12 - 7.06 (m, 1H, CHAr), 
7.06 - 7.00 (m, 2H, CHAr), 6.84 (ddd, 
3
J = 8.4 Hz, 
4
J = 2.5 Hz, 
5
J = 0.9 Hz, 1H, CHAr), 3.76 (s, 3H, OCH3). 
13
C NMR (75 MHz, 
CDCl3) δ = 160.8 (CAr), 145.0 (CAr), 141.3 (CAr), 140.1 (CAr), 130.6 (CHAr), 127.0 
(CHAr), 123.2 (CHAr), 122.6 (CAr), 120.4 (CHAr), 119.1 (CHAr), 118.2 (CAr), 117.4 
(CHAr), 112.5 (CHAr), 111.7 (CHAr), 111.3 (CHAr), 111.0 (CHAr), 55.6 (OCH3). 
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IR (ATR, cm
-1
): ṽ = 3392 (w), 3084 (w), 3051 (w), 3000 (w), 2956 (w), 2833 (w), 1589 
(s), 1505 (s), 1489 (s), 1450 (s), 1391 (m), 1340 (m), 1313 (m), 1278 (m), 1252 (m), 
1233 (m), 1193 (m), 1160 (m), 1086 (m), 1036 (m), 821 (m), 777 (m), 738 (s), 695 (s), 
656 (s), 431 (m). MS (EI, 70 eV): m/z (%) = 279 [M]
+
 (100), 236 (23), 204 (5), 191 (8), 
139 (9). HRMS (EI): Calculated for C17H13ONS [M]
+
 279.07124 found 279.07131.  
4-(2-Methoxyphenyl)-4H-thieno[3,2-b]indole (18i): Yellow oil. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 7.81 - 7.76 (m, 1H, CHAr), 7.50 - 7.41 (m, 2H, 
CHAr), 7.32 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.25 - 7.18 (m, 3H, 
CHAr), 7.18 - 7.08 (m, 2H, CHAr), 6.88 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 3.77 (s, 3H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 155.1 
(CAr), 145.8 (CAr), 142.2 (CAr), 129.1 (CHAr), 128.7 (CHAr), 127.2 
(CAr), 126.5 (CHAr), 122.8 (CHAr), 122.3 (CAr), 121.2 (CHAr), 119.9 (CHAr), 118.9 
(CHAr), 117.4 (CAr), 112.8 (CHAr), 112.1 (CHAr), 111.7 (CHAr), 55.8 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3396 (w), 3048 (w), 3006 (w), 2958 (w), 2930 (w), 2835 (w), 1594 
(m), 1509 (s), 1449 (s), 1393 (m), 1337 (m), 1273 (m), 1243 (m), 1118 (m), 1083 (m), 
1021 (m), 702 (m), 654 (m), 430 (m). MS (EI, 70 eV): m/z (%) = 279 [M]
+
 (100), 263 
(20), 236 (11), 204 (5), 191 (7), 139 (8). HRMS (EI): Calculated for C17H13ONS [M]
+
 
279.07124 found 279.07092.  
4-(3,5-Dimethoxyphenyl)-4H-thieno[3,2-b]indole (18j): Yellow oil. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 7.74 - 7.66 (m, 1H, CHAr), 
7.59 - 7.52 (m, 1H, CHAr), 7.28 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
7.24 - 7.11 (m, 2H, CHAr), 7.07 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
6.67 (d, 
4
J = 2.3 Hz, 2H, CHAr), 6.42 (t, 
4
J = 2.3 Hz, 1H, CHAr), 
3.76 (s, 6H, OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 160.8 
(2CArOCH3), 143.9 (CAr), 140.3 (CAr), 139.6 (CAr), 126.0 (CHAr), 122.2 (CHAr), 121.6 
(CAr), 119.5 (CHAr), 118.1 (CHAr), 117.2 (CAr), 110.9 (CHAr), 110.5 (CHAr), 102.5 
(2CHAr), 98.0 (CHAr), 54.7 (2OCH3). IR (ATR, cm
-1
): ṽ = 3084 (w), 3050 (w), 2959 
(w), 2930 (w), 2837 (w), 1590 (s), 1505 (m), 1477 (m), 1449 (s), 1362 (m), 1285 (m), 
1267 (m), 1202 (m), 1150 (s), 1062 (m), 1037 (m), 813 (m), 737 (s). MS (EI, 70 eV): 
m/z (%) = 310 (20), 309 [M]
+
 (100), 266 (12), 251 (13), 234 (5). HRMS (EI): 
Calculated for C18H15O2NS [M]
+
 309.08180 found 309.08198.  
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4-(2,4-Dimethoxyphenyl)-4H-thieno[3,2-b]indole (18k): Colorless solid, 
mp. 165 - 166 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.83 - 7.76 
(m, 1H, CHAr), 7.36 (d, 
3
J = 8.6 Hz, 1H, CHAr), 7.32 (d, 
3
J = 5.2 Hz, 
1H, CHthiophene), 7.25 - 7.16 (m, 3H, CHAr), 6.87 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 6.71 (d, 
4
J = 2.6 Hz, 1H, CHAr), 6.63 (dd, 
3
J = 8.6 Hz, 
4
J = 2.6 Hz, 1H, CHAr), 3.91 (s, 3H, OCH3), 3.73 (s, 3H, OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 160.5 (CAr), 156.3 (CAr), 146.2 (CAr), 142.5 (CAr), 129.4 
(CHAr), 126.4 (CHAr), 122.7 (CHAr), 122.1 (CAr), 120.2 (CAr), 119.7 (CHAr), 118.9 
(CHAr), 116.9 (CAr), 111.9 (CHAr), 111.5 (CHAr), 104.8 (CHAr), 100.2 (CHAr), 55.8 
(OCH3), 55.8 (OCH3). IR (ATR, cm
-1
): ṽ = 3087 (w), 3045 (w), 3005 (w), 2965 (w), 
2931 (w), 2835 (w), 1611 (m), 1584 (m), 1518 (s), 1451 (s), 1305 (m), 1204 (s), 1158 
(s), 1050 (m), 1022 (m), 928 (w), 827 (m), 740 (s), 651 (m), 581 (m). MS (EI, 70 eV): 
m/z (%) = 309 [M]
+
 (100), 294 (19), 251 (12), 223 (8). HRMS (EI): Calculated for 
C18H15O2NS [M]
+
 309.08180 found 309.08151.  
4-(3,4,5-Trimethoxyphenyl)-4H-thieno[3,2-b]indole (18l): White solid, 
mp. 94 - 95 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.75 - 7.67 
(m, 1H, CHAr), 7.52 - 7.46 (m, 1H, CHAr), 7.30 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 7.26 - 7.10 (m, 2H, CHAr), 7.02 (d, 
3
J = 5.2 Hz, 1H, 
CHthiophene), 6.72 (s, 2H, CHAr), 3.87 (s, 3H, OCH3), 3.80 (s, 6H, 
OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 154.1 (2CArOCH3), 145.2 
(CAr), 141.6 (CAr), 137.0 (CAr), 134.7 (CAr), 127.1 (CHAr), 123.2 
(CHAr), 122.4 (CAr), 120.4 (CHAr), 119.2 (CHAr), 117.9 (CAr), 111.6 (CHAr), 111.2 
(CHAr), 103.0 (2CHAr), 61.2 (OCH3), 56.5 (2OCH3). IR (ATR, cm
-1
): ṽ = 3082 (w), 
3051 (w), 2926 (m), 2824 (w), 1593 (m), 1505 (m), 1450 (m), 1415 (m), 1289 (m), 
1226 (m), 1124 (s), 1007 (m), 818 (m), 740 (m), 655 (m). MS (EI, 70 eV): 
m/z (%) = 339 [M]
+
 (100), 324 (75), 296 (10), 266 (9), 210 (9), 172 (13), 154 (8). 
HRMS (EI): Calculated for C19H17O3NS [M]
+
 339.09237 found 339.09217.  
4-(4-(tert-Butyl)phenyl)-4H-thieno[3,2-b]indole (18m): Yellow oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 7.75 - 7.67 (m, 1H, CHAr), 7.52 - 7.39 (m, 5H, CHAr), 
7.26 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.20 - 7.12 (m, 2H, CHAr), 7.02 (d, 
3
J = 5.2 Hz, 
1H, CHthiophene), 1.32 (s, 9H, tBu). 
13
C NMR (63 MHz, CDCl3) δ = 149.9 (CAr), 145.2 
(CAr), 141.5 (CAr), 136.3 (CAr), 126.9 (CHAr), 126.7 (2CHAr), 124.7 (2CHAr), 123.0 
(CHAr), 122.4 (CAr), 120.2 (CHAr), 119.1 (CHAr), 117.8 (CAr), 111.7 (CHAr), 111.3 
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(CHAr), 34.9 (CtBu), 31.6 (3CH3). IR (ATR, cm
-1
): ṽ = 3049 (w), 2959 
(m), 2901 (w), 2865 (w), 1602 (w), 1519 (s), 1451 (s), 1394 (m), 1337 
(m), 1267 (m), 1205 (m), 1112 (m), 1086 (m), 1046 (m), 1016 (m), 922 
(w), 825 (m), 705 (m), 648 (m), 552 (m). MS (EI, 70 eV): 
m/z (%) = 305 [M]
+
 (100), 290 (95), 275 (16), 262 (11), 172 (17), 131 
(11). HRMS (EI): Calculated for C20H19NS [M]
+
 305.12327 found 305.12374.   
4-(Naphthalen-1-yl)-4H-thieno[3,2-b]indole (18n): Colorless solid, mp. 141 - 142 °C. 
1
H NMR (300 MHz, Acetone-d6) δ = 8.19 - 8.09 (m, 2H, CHAr), 
7.92 - 7.87 (m, 1H, CHAr), 7.79 - 7.70 (m, 2H, CHAr), 7.61 (ddd, 
3
J = 8.2 Hz, 
3
J = 6.8 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.54 (d, 
3
J = 5.2 Hz, 
1H, CHthiophene), 7.45 (ddd, 
3
J = 8.2 Hz, 
3
J = 6.8 Hz, 
4
J = 1.3 Hz, 1H, 
CHAr), 7.32 - 7.27 (m, 1H, CHAr), 7.27 - 7.16 (m, 2H, CHAr), 
7.06 - 6.99 (m, 1H, CHAr), 6.79 (d, 
3
J = 5.2 Hz, 1H, CHthiophene). 
13
C NMR (75 MHz, 
Acetone-d6) δ = 147.6 (CAr), 144.0 (CAr), 135.8 (CAr), 135.6 (CAr), 131.2 (CAr), 129.8 
(CHAr), 129.5 (CHAr), 128.4 (CHAr), 128.0 (CHAr), 127.7 (CHAr), 126.9 (CHAr), 126.7 
(CHAr), 123.9 (CHAr), 123.8 (CHAr), 123.0 (CAr), 121.1 (CHAr), 119.7 (CHAr), 117.9 
(CAr), 112.3 (CHAr), 112.1 (CHAr). IR (ATR, cm
-1
): ṽ = 3047 (m), 1592 (w), 1575 (w), 
1504 (m), 1448 (m), 1401 (m), 1327 (m), 1211 (m), 1110 (m), 1076 (m), 1914 (m), 800 
(m), 773 (m), 735 (s), 657 (m). MS (EI, 70 eV): m/z (%) = 299 [M]
+
 (100), 265 (18), 
149 (8), 127 (7). HRMS (EI): Calculated for C20H13NS [M]
+
 299.07632 found 
299.07610.   
4-(Anthracen-2-yl)-4H-thieno[3,2-b]indole (18o): Yellow solid, mp. 176 - 177 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.53 (s, 1H, CHAr), 8.47 (s, 
1H, CHAr), 8.25 - 8.14 (m, 2H, CHAr), 8.05 (m, 2H, CHAr), 7.90 - 7.78 
(m, 1H, CHAr), 7.78 - 7.65 (m, 2H, CHAr), 7.59 - 7.47 (m, 2H, CHAr), 
7.42 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.37 - 7.18 (m, 3H, CHAr). 
13
C NMR (63 MHz, CDCl3) δ = 145.2 (CAr), 141.5 (CAr), 135.7 (CAr), 
132.3 (CAr), 131.9 (CAr), 131.7 (CAr), 130.2 (CHAr), 130.1 (CAr), 128.3 
(CHAr), 128.0 (CHAr), 127.0 (CHAr), 126.5 (CHAr), 126.1 (CHAr), 126.0 
(CHAr), 125.7 (CHAr), 123.7 (CHAr), 123.1 (CHAr), 122.6 (CAr), 122.3 (CHAr), 120.5 
(CHAr), 119.1 (CHAr), 118.3 (CAr), 111.8 (CHAr), 111.4 (CHAr). IR (ATR, cm
-1
): 
ṽ = 3049 (w), 2954 (w), 1670 (w), 1592 (w), 1504 (m), 1450 (m), 1321 (m), 887 (m), 
738 (s), 652 (m), 603 (m), 469 (m), 429 (m). MS (EI, 70 eV): m/z (%) = 349 [M]
+
 (100), 
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315 (4), 176 (7). HRMS (EI): Calculated for C24H15NS [M]
+
 349.09197 found 
349.09165.  
4-(4-Fluorophenyl)-4H-thieno[3,2-b]indole (18p): White solid, mp. 117 - 118 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 7.75 - 7.68 (m, 1H, CHAr), 
7.50 - 7.41 (m, 2H, CHAr), 7.40 - 7.36 (m, 1H, CHAr), 7.28 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.23 - 7.11 (m, 4H, CHAr), 6.95 (d, 
3
J = 5.2 Hz, 1H, CHthiophene). 
19
F NMR (282 MHz, CDCl3) δ = -114.6 
(FCAr). 
13
C NMR (75 MHz, CDCl3) δ = 161.2 (d, 
1
JCF = 246.7 Hz, 
CFAr), 145.2 (CAr), 141.6 (CAr), 134.6 (d, 
4
JCF = 3.1 Hz, CAr), 127.1 (CHAr), 127.0 (d, 
3
JCF = 8.5 Hz, 2CHAr), 123.2 (CHAr), 122.3 (CAr), 120.4 (CHAr), 119.1 (CHAr), 118.0 
(CAr), 116.7 (d, 
2
JCF = 22.8 Hz, 2CHAr), 111.2 (CHAr), 110.9 (CHAr). IR (ATR, cm
-1
): 
ṽ = 3106 (w), 3093 (w), 3050 (w), 1600 (w), 1510 (s), 1451 (m), 1340 (m), 1218 (m), 
1090 (m), 826 (m), 740 (s), 708 (m), 571 (m), 515 (m). MS (EI, 70 eV): m/z (%) = 267 
[M]
+
 (100), 235 (9), 222 (9), 128 (5), 75 (10). HRMS (EI): Calculated for C16H10NFS 
[M]
+
 267.05125 found 267.05098.  
4-(4-Chlorophenyl)-4H-thieno[3,2-b]indole (18q): Colorless solid, mp. 114 - 115 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.76 - 7.69 (m, 1H, CHAr), 
7.46 (m, 5H, CHAr), 7.31 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.25 - 7.13 
(m, 2H, CHAr), 6.99 (d, 
3
J = 5.2 Hz, 1H, CHthiophene). 
13
C NMR 
(63 MHz, CDCl3) δ = 144.8 (CAr), 141.2 (CAr), 137.6 (CAr), 132.4 
(CAr), 130.1 (2CHAr), 127.3 (CHAr), 126.4 (2CHAr), 123.4 (CHAr), 
122.6 (CAr), 120.7 (CHAr), 119.3 (CHAr), 118.5 (CAr), 111.3 (CHAr), 110.9 (CHAr). 
IR (ATR, cm
-1
): ṽ = 3099 (w), 3084 (w), 3050 (w), 2959 (w), 2920 (w), 2848 (w), 1592 
(w), 1505 (s), 1488 (m), 1452 (m), 1390 (m), 1356 (w), 1338 (m), 1204 (m), 1088 (s), 
1012 (m), 823 (s), 748 (s), 708 (s), 661 (m), 646 (m), 509 (m), 479 (m), 431 (w). 
MS (EI, 70 eV): m/z (%) = 285 (32), 283 [M]
+
 (100), 247 (12), 128 (10), 75 (18). 
HRMS (EI): Calculated for C16H10NClS 283.02170 found 283.02225, calculated for 
C16H10N
37
ClS [M]
+
 285.01875 found 285.01936.  
4-Benzyl-4H-thieno[3,2-b]indole (18r): Yellow oil. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.69 (ddd, 3J = 7.6 Hz, 4J = 1.5 Hz, 5J = 0.7 Hz, 1H, CHAr), 7.25 (dd, 
4
J = 1.4 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.23 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 7.21 - 7.11 
(m, 5H, CHAr), 7.11 - 7.03 (m, 2H, CHAr), 6.84 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 5.36 (s, 
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2Haliphatic, CH2). 
13
C NMR (63 MHz, CDCl3) δ = 145.6 (CAr), 141.7 
(CAr), 137.3 (CAr), 128.9 (2CHAr), 127.7 (CHAr), 127.0 (CHAr), 126.8 
(2CHAr), 122.7 (CHAr), 122.1 (CAr), 119.5 (CHAr), 119.1 (CHAr), 116.7 
(CAr), 110.7 (CHAr), 110.3 (CHAr), 48.9 (CH2). IR (ATR, cm
-1
): 
ṽ = 3422 (w), 3081 (w), 3054 (w), 3025 (w), 2921 (w), 2852 (w), 1733 
(w), 1583 (w), 1507 (m), 1463 (m), 1349 (m), 1161 (m), 736 (s), 695 (m), 654 (s), 430 
(m). MS (EI, 70 eV): m/z (%) = 264 (15), 263 [M]
+
 (71), 172 (27), 128 (13), 91 (100), 
65 (17). HRMS (EI): Calculated for C17H13NS [M]
+
 263.07632 found 263.07642.  
4-(4-methoxybenzyl)-4H-thieno[3,2-b]indole (18s): Colorless oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 7.68 (m, 1H, CHAr), 7.28 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.22 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
7.20 - 7.12 (m, 1H, CHAr), 7.12 - 7.04 (m, 1H, CHAr), 7.00 (d, 
3
J = 8.6 Hz, 2H, CHAr), 6.82 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 
6.70 (d, 
3
J = 8.6 Hz, 2H, CHAr), 5.28 (s, 2Haliphatic, CH2), 3.65 (s, 
3H, OCH3). 
13
C NMR (63 MHz, CDCl3) δ = 159.2 (CAr), 145.5 (CAr), 141.7 (CAr), 129.4 
(CAr), 128.2 (2CHAr), 126.9 (CHAr), 122.7 (CHAr), 122.1 (CAr), 119.4 (CHAr), 119.1 
(CHAr), 116.6 (CAr), 114.3 (2CHAr), 110.7 (CHAr), 110.3 (CHAr), 55.4 (OCH3), 48.4 
(CH2). IR (ATR, cm
-1
): ṽ = 3105 (w), 3051 (w), 3024 (w), 2997 (m), 2955 (m), 2915 
(w), 2832 (m), 1613 (m), 1584 (m), 1508 (s), 1457 (s), 1439 (m), 1348 (m), 1245 (s), 
1161 (s), 1025 (m), 807 (s), 735 (s), 653 (s), 430 (m). MS (EI, 70 eV): m/z (%) = 294 
(6), 293 [M]
+
 (28), 121 (100), 78 (10). HRMS (EI): Calculated for C18H15ONS [M]
+
 
293.08689 found 293.08643.  
4-Pentyl-4H-thieno[3,2-b]indole (18t): Yellow oil. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.76 (ddd, 3J = 7.8 Hz, 4J = 1.3 Hz, 5J = 0.7 Hz, 
1H, CHAr), 7.43 - 7.35 (m, 2H, CHAr), 7.34 - 7.26 (m, 1H, CHAr), 
7.17 (ddd, 
3
J = 8.1 Hz, 
3
J = 7.0 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.08 (d, 
3
J = 5.2 Hz, 1H, CHthiophene), 4.27 (t, 
3
J = 7.1 Hz, 2Haliphatic, CH2), 
2.00 - 1.74 (m, 2Haliphatic, CH2), 1.34 (m, 4Haliphatic, 2CH2), 0.98 - 0.80 (m, 3Haliphatic, 
CH3). 
13
C NMR (63 MHz, CDCl3) δ = 145.5 (CAr), 141.4 (CAr), 126.8 (CHAr), 122.4 
(CHAr), 121.9 (CAr), 119.1 (CHAr), 119.0 (CHAr), 116.0 (CAr), 110.5 (CHAr), 110.0 
(CHAr), 45.4 (CH2, pentyl), 29.6 (CH2, pentyl), 29.4 (CH2, pentyl), 22.5 (CH2, pentyl), 
14.1 (CH3, pentyl). IR (ATR, cm
-1
): ṽ = 3081 (w), 3052 (w), 2954 (m), 2927 (m), 2856 
(m), 1610 (w), 1509 (m), 1123 (m), 1348 (m), 1317 (m), 1162 (m), 1079 (m), 1017 (w), 
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815 (w), 735 (s), 653 (m), 431 (m). MS (EI, 70 eV): m/z (%) = 243 [M]
+
 (30), 186 
(100), 115 (12). HRMS (EI): Calculated for C15H17NS [M]
+
 243.10762 found 
243.10811. 
5.2.5.3.Indolo[3,4-b]thiophene 
4-(p-Tolyl)-4H-thieno[3,4-b]indole (19a): Yellow oil. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.86 (dt, 3J = 7.6 Hz, 4J = 1.0 Hz, 1H, 
CHAr), 7.54 (m, 1H, CHAr), 7.50 (s, 1H, CHAr), 7.49 (s, 1H, 
CHAr), 7.31 - 7.21 (m, 4H, CHAr), 7.14 (ddd, 
3
J = 7.6 Hz, 
3
J = 6.6 Hz, 
4
J = 1.7 Hz, 1H, CHAr), 6.59 (m, 1H, CHAr), 2.36 
(s, 3H, CH3). 
13
C NMR (63 MHz, CDCl3) δ = 148.1 (CAr), 146.3 (CAr), 136.8 (CAr), 
136.1 (CAr), 133.5 (CAr), 130.5 (2CHAr), 126.5 (CHAr), 124.4 (2CHAr), 121.5 (CHAr), 
120.3 (CAr), 119.8 (CHAr), 110.6 (CHAr), 109.9 (CHAr), 92.6 (CHAr), 21.3 (CH3). 
IR (ATR, cm
-1
): ṽ = 3399 (w), 3101 (w), 3030 (w), 2917 (w), 2859 (w), 1608 (w), 1576 
(m), 1512 (s), 1449 (m), 1397 (m), 1321 (m), 1223 (m), 1152 (m), 1108 (w), 1020 (w), 
928 (w), 816 (m), 740 (s), 619 (m), 499 (m). MS (EI, 70 eV): m/z (%) = 263 [M]
+
 (100), 
247 (8), 218 (12), 128 (7). HRMS (EI): Calculated for C17H13NS [M]
+
 263.07632 found 
263.07634.  
4-(o-Tolyl)-4H-thieno[3,4-b]indole (19b): Yellow oil. 
1
H NMR (300 MHz, 
Acetone-d6) δ = 8.02 - 7.92 (m, 2H, CHAr), 7.89 - 7.79 (m, 1H, 
CHAr), 7.79 (d, 
4
J = 2.5 Hz, 1H, CHthiophene), 7.58 (d, 
3
J = 8.2 Hz, 
1H, CHAr), 7.48 - 7.32 (m, 2H, CHAr), 7.16 (m, 1H, CHAr), 6.93 (d, 
3
J = 8.2 Hz, 1H, CHAr), 6.51 (d, 
4
J = 2.5 Hz, 1H, CHthiophene), 2.22 (s, 
3H, CH3). 
13
C NMR (75 MHz, Acetone-d6) δ = 149.9 (CAr), 147.5 (CAr), 141.0 (CAr), 
137.8 (CAr), 134.1 (CAr), 131.2 (CHAr), 129.5 (CHAr), 127.5 (CHAr), 126.9 (CHAr), 122.3 
(CHAr), 121.3 (CHAr), 120.8 (CAr), 120.4 (CHAr), 112.0 (CHAr), 110.5 (CHAr), 93.2 
(CHAr), 18.2 (CH3). IR (ATR, cm
-1
): ṽ = 3412 (w), 3103 (w), 3052 (w), 2919 (w), 2853 
(w), 1577 (m), 1499 (m), 1450 (m), 1395 (m), 1316 (m), 1227 (m), 1151 (m), 824 (m), 
741 (s), 622 (m), 445 (m). MS (EI, 70 eV): m/z (%) = 264 (21), 263 [M]
+
 (100), 262 
(41), 260 (11), 231 (16), 228 (11), 218 (20), 217 (32), 216 (11), 204 (15), 128 (17). 
HRMS (EI): Calculated for C17H13NS [M]
+
 263.07632 found 263.07567.  
4-(4-(tert-Butyl)phenyl)-4H-thieno[3,4-b]indole (19c): Yellow oil. 
1
H NMR 
(250 MHz, Chloroform-d) δ = 7.78 (m, 1H, CHAr), 7.48 (m, 4H, CHAr), 7.41 (s, 1HAr), 
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7.33 (ddd, 
3
J = 8.3 Hz, 
4
J = 1.2 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 
7.25 (dd, 
3
J = 7.1 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.18 (s, 1H, 
CHAr), 7.09 - 7.02 (m, 1H, CHAr), 1.33 (s, 9H, tBu). 
13
C NMR 
(63 MHz, CDCl3) δ = 149.2 (CAr), 148.1 (CAr), 146.2 (CAr), 
136.8 (CAr), 133.5 (CAr), 126.8 (2CHAr), 126.5 (CHAr), 123.9 (2CHAr), 121.5 (CHAr), 
120.4 (CAr), 119.8 (CHAr), 110.5 (CHAr), 110.0 (CHAr), 92.7 (CHAr), 34.8 (CtBu), 31.6 
(3CH3). IR (ATR, cm
-1
): ṽ = 3401 (w), 3053 (w), 2958 (m), 2865 (w), 1605 (w), 1578 
(m), 1517 (s), 1451 (m), 1399 (m), 1323 (m), 1224 (m), 1190 (m), 1152 (m), 1017 (w), 
827 (m), 742 (s), 622 (m), 552 (m). MS (EI, 70 eV): m/z (%) = 305 [M]
+
 (97), 290 
(100), 275 (18), 262 (8), 172 (20), 131 (40), 109 (9). HRMS (EI): Calculated for 
C20H19NS [M]
+
 305.12327 found 305.12400.   
4-(3,5-Dimethoxyphenyl)-4H-thieno[3,4-b]indole (19d): Yellow oil. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 7.85 (m, 1H, CHAr), 7.52 - 7.45 
(m, 2H, CHAr), 7.33 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.3 Hz, 
4
J = 1.3 Hz, 
1H, CHAr), 7.15 (td, 
3
J = 7.3 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 6.81 
(d, 
4
J = 2.3 Hz, 2H, CHAr), 6.68 (d, 
4
J = 2.5 Hz, 1H, 
CHthiophene), 6.45 (t, 
4
J = 2.3 Hz, 1H, CHAr), 3.85 (s, 6H, 
OCH3). 
13
C NMR (75 MHz, CDCl3) δ = 161.9 (2CAr), 147.7 (CAr), 145.8 (CAr), 141.2 
(CAr), 133.5 (CAr), 126.6 (CHAr), 121.5 (CHAr), 120.6 (CAr), 120.1 (CHAr), 110.8 (CHAr), 
110.4 (CHAr), 102.6 (2CHAr), 98.4 (CHAr), 93.3 (CHAr), 55.7 (2OCH3). IR (ATR, cm
-1
): 
ṽ = 3388 (w), 3102 (w), 3056 (w), 2998 (w), 2929 (w), 2837 (w), 1591 (s), 1498 (m), 
1451 (s), 1293 (m), 1258 (s), 1202 (s), 1149 (s), 1056 (m), 929 (m), 823 (m), 742 (s), 
689 (m), 627 (m). MS (EI, 70 eV): m/z (%) = 310 (21), 309 [M]
+
 (100), 294 (22), 264 
(8), 251 (19), 250 (18), 234 (10), 191 (6), 178 (11), 128 (9). HRMS (EI): Calculated for 
C18H15O2NS [M]
+
 309.08180 found 309.08182.  
4-(3,4,5-Trimethoxyphenyl)-4H-thieno[3,4-b]indole (19e): Colorless solid, 
mp. 96 - 97 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 7.87 
(ddd, 
3
J = 7.7 Hz, 
4
J = 1.3 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.50 
(d, 
4
J = 1.8 Hz, 1H, CHthiophene), 7.40 (ddd, 
3
J = 8.2 Hz, 
4
J = 1.3 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.33 (ddd, 
3
J = 8.2 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.16 (ddd, 
3
J = 7.7 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 6.85 (s, 2H, CHAr), 6.61 (d, 
4
J = 2.5 Hz, 1H, 
CHthiophene), 3.94 (s, 3H, CH3), 3.89 (s, 6H, CH3). 
13
C NMR (75 MHz, CDCl3) δ = 154.2 
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(2CArOCH3), 148.1 (CAr), 146.3 (CAr), 136.5 (CAr), 135.1 (CAr), 133.4 (CAr), 126.6 
(CHAr), 121.6 (CHAr), 120.4 (CAr), 120.0 (CHAr), 110.9 (CHAr), 110.0 (CHAr), 102.2 
(2CHAr), 92.7 (CHAr), 61.2 (OCH3), 56.5 (2OCH3). IR (ATR, cm
-1
): ṽ = 3101 (m), 3056 
(w), 2999 (m), 2929 (m), 2829 (w), 1592 (m), 1502 (m), 1450 (m), 1416 (m), 1354 (m), 
1262 (m), 1226 (m), 1123 (s), 998 (m), 823 (m), 736 (s). MS (EI, 70 eV): m/z (%) = 339 
[M]
+
 (100), 324 (78), 296 (6), 280 (8), 238 (10), 210 (8), 172 (14). HRMS (EI): 
Calculated for C19H17O3NS [M]
+
 339.09237 found 339.09241.  
4-(Anthracen-2-yl)-4H-thieno[3,4-b]indole (19f): Light yellow solid, 
mp. 171 - 172 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.50 (s, 1H, CHAr), 8.44 (s, 1H, CHAr), 8.24 - 8.13 (m, 
2H, CHAr), 8.11 - 7.96 (m, 2H, CHAr), 7.91 (ddd, 
3
J = 7.5 Hz, 
4
J = 1.3 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 7.79 (dd, 
3
J = 9.0 Hz, 
4
J = 2.1 Hz, 1H, CHAr), 7.59 - 7.44 (m, 4H, CHAr), 7.36 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.3 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.20 (td, 
3
J = 7.5 Hz, 
4
J = 1.0 Hz, 1H, CHAr), 6.76 (d, 
4
J = 2.5 Hz, 1H, CHthiophene). 
13
C NMR 
(63 MHz, CDCl3) δ = 147.9 (CAr), 146.0 (CAr), 136.4 (CAr), 133.5 (CAr), 132.4 (CAr), 
132.0 (CAr), 131.9 (CAr), 130.4 (CHAr), 130.1 (CAr), 128.4 (CHAr), 128.1 (CHAr), 126.7 
(CHAr), 126.6 (CHAr), 126.1 (CHAr), 125.9 (CHAr), 125.7 (CHAr), 123.2 (CHAr), 121.6 
(CHAr), 121.3 (CHAr), 120.7 (CAr), 120.3 (CHAr), 110.9 (CHAr), 110.2 (CHAr), 93.2 
(CHAr). IR (ATR, cm
-1
): ṽ = 3093 (w), 3050 (w), 2956 (w), 1628 (w), 1573 (m), 1451 
(m), 1389 (w), 1216 (w), 891 (m), 742 (s), 472 (m). MS (EI, 70 eV): m/z (%) = 349 
[M]
+
 (100), 304 (48), 174 (24), 152 (20), 128 (6). HRMS (EI): Calculated for C24H15NS 
[M]
+
 349.09197 found 349.09161.   
 
5.2.6. Synthesis of benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridines by 
site-selective Sonogashira reaction followed by domino C-N 
coupling/hydroamination/C-H arylation. 
5.2.6.1.Starting materials 
3-Bromo-2-((2-bromophenyl)ethynyl)benzo[b]thiophene (25): White solid, 
mp. 190 - 191 °C. 
1
H NMR (300 MHz, Chloroform-d): δ = 7.70 - 7.62 (m, 2H, CHAr), 
7.53 - 7.49 (m, 2H, CHAr), 7.37 - 7.29 (m, 2H, CHAr), 7.22 - 7.17 (m, 1H, CHAr), 
7.13 - 7.07 (m, 1H, CHAr). 
13
C NMR (75.5 MHz, CDCl3): δ = 138.5 (CAr), 137.5 (CAr), 
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133.5 (CHAr), 132.6 (CHAr), 130.2 (CHAr), 127.1 (CHAr), 
126.7 (CHAr), 125.6 (CHAr), 125.5 (CAr), 124.6 (CAr), 123.8 
(CHAr), 122.3 (CHAr), 120.0 (CAr), 114.5 (CAr), 97.4 (Csp), 
86.1 (Csp).IR (ATR, cm
-1
): ṽ = 3111, 3056, 3026, 2747, 2324, 2286, 2211 (w), 1942, 
1907, 1879, 1820, 1782, 1688 (m), 1659, 1603 (w), 1587, 1555, 1522 (m), 1504, 1480 
(w), 1463, 1451, 1432 (s), 1320, 1311, 1287 (m), 1271 (w), 1240 (s), 1210, 1201 (w), 
1160, 1124 (m), 1105, 1079 (w), 1063 (m), 1038, 1025, 1017 (s), 974, 939 (w), 924 (s), 
855 (m), 820 (s), 762 (m), 740, 717, 662 (s), 634, 599, 546 (m). MS (EI, 70 eV): 
m/z (%) = 394 (54) 392 [M]
+
 (100), 390 (50), 232 (84), 196 (15), 187 (62), 161 (10), 
116 (42). HRMS (EI): Calculated for C16H8Br
81
BrS [M]
+
 391.86875 found: 391.8684; 
calculated for C16H8
81
Br2S1 [M]
+
 393.86670 found 393.86649. 
5.2.6.2.Benzothieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridines 
Benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24a/26a): Pale yellow 
solid, mp. 188 - 189 °C. 
1
H NMR (250 MHz, DMSO): δ = 8.51 
(d, 1H, 
3
J = 8.1 Hz, CHAr), 8.46 - 8.41 (m, 2H, CHAr), 8.33 (d, 
1H, 
3
J = 8.2 Hz, CHAr), 8.21 - 8.17 (m, 1H, CHAr), 7.98 (d, 1H, 
3
J = 7.9 Hz, CHAr), 7.75 - 7.69 (m, 1H, CHAr), 7.60 - 7.46 (m, 
5H, CHAr), 7.36 - 7.30 (m, 1H, CHAr). 
13
C NMR (62.9 MHz, 
CDCl3): δ = 141.4 (CAr), 135.9 (CAr), 133.2 (CAr), 129.6 (CAr), 129.2 (CAr), 128.5 
(CHAr), 128.0 (CHAr), 127.7 (CAr), 127.2 (CHAr), 125.7 (CAr), 125.6 (CAr), 124.6 (CHAr), 
124.5 (CHAr), 124.4 (CHAr), 124.2 (CHAr), 123.2 (CHAr), 123.0 (CHAr), 122.8 (CHAr), 
121.8 (CAr), 120.6 (CHAr), 117.7 (CHAr), 96.4 (CHAr). IR (ATR, cm
-1
): ṽ = 3116 (w), 
3052 (w), 3029 (w), 2918 (m), 2849 (m), 1892 (w), 1807 (w), 1682 (w), 1605 (m), 1585 
(m), 1532 (m), 1471 (m), 1455, 1436 (s), 1376 (m), 1354 (s), 1293 (w), 1233 (w), 1160 
(m), 1010 (w), 975 (w), 962 (w), 948, 922 (m), 863 (w), 847 (w), 796 (w), 750, 735, 
710, 694 (s), 666 (m), 652 (m), 614 (m), 563, 532 (m). MS (EI, 70 eV): m/z (%) = 324 
(26), 323 [M]
+
 (100), 322 (22), 321 (07), 221 (07), 162 (06), 146 (06). HRMS (EI): 
Calculated for C22H13NS [M]
+
 323.07632 found 323.07692. 
6-Methylbenzo[4’,5’]thieno[2’,3’:4,5]pyrrolo[1,2-f]phenanthridine (24b/26b): Pale 
yellow solid, mp. 159 - 160 °C. 
1
H NMR (250 MHz, Chloroform-d): δ = 8.31 (d, 1H, 
3
J = 8.4 Hz, CHAr), 8.27 (d, 1H, 
3
J = 8.4 Hz, CHAr), 8.24 - 8.21 (m, 1H, CHAr), 8.09 (s, 
1H, CHAr), 7.96 - 8.01 (m, 1H, CHAr), 7.80 (dd, 1H, 
3
J = 7.9 Hz, 
5
J = 0.6 Hz, CHAr), 
7.47 - 7.32 (m, 4H, CHAr), 7.25 - 7.20 (m, 1H, CHAr), 7.19 (s, 1H, CHAr), 2.50 (s, 3H, 
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CH3). 
13
C NMR (62.9 MHz, CDCl3): δ = 142.0 (CAr), 136.2 
(CAr), 133.6 (CAr), 131.9 (CAr), 130.1 (CAr), 129.2 (CAr), 128.5 
(CHAr), 128.4 (CAr), 128.2 (CHAr), 126.7 (CHAr), 126.4 (CAr), 
126.2 (CAr), 124.4 (CHAr), 124.3 (CHAr), 123.8 (CHAr), 123.2 
(CHAr), 122.7 (CHAr), 122.5 (CHAr), 122.2 (CAr), 120.8 (CHAr), 
118.2 (CHAr), 95.4 (CHAr), 21.3 (CH3). IR (ATR, cm
-1
): 
ṽ = 3037 (w), 2913 (w), 2851 (w), 1606 (w), 1532 (m), 1498 (m), 1482 (m), 1447 (s), 
1409, 1372 (m), 1352 (s), 1292 (w), 1196 (w), 1181 (w), 1117 (w), 874, 843 (w), 817 
(s), 811 (s), 767 (s), 750 (s), 738 (s), 721 (s), 681 (w), 665 (m), 578 (s). MS (EI, 70 eV): 
m/z (%) = 338 (27), 337 [M]
+
 (100), 336 (18), 322 (08), 161 (16). HRMS (EI): 
Calculated for C23H15NS [M]
+
 337.09199 found 337.09137. 
6-Chlorobenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24c/26c): Pale 
yellow solid, mp. 227 - 228 °C. 
1
H NMR (250 MHz, DMSO): 
δ = 8.53 (d, 4J = 2.4 Hz, 1H, CHAr), 8.47 - 8.43 (m, 2H, CHAr), 
8.31 (d, 
3
J = 8.2 Hz, 1H, CHAr), 8.22 - 8.19 (m, 1H, CHAr), 
8.01 - 7.97 (m, 1H, CHAr), 7.75 (d, 
3
J = 8.8 Hz, 1H, CHAr), 
7.62 - 7.58 (m, 1H, CHAr), 7.58 - 7.46 (m, 3H, CHAr), 7.36 (ddd, 
3
J = 8.2 Hz, 
3
J = 7.2 Hz, 
4
J = 1.2 Hz, 1H, CHAr). 
13
C NMR 
(62.9 MHz, CDCl3): δ = 141.6 (CAr), 135.8 (CAr), 132.0 (CAr), 129.7 (CAr), 129.6 (CAr), 
129.2 (CHAr), 129.1 (CAr), 127.8 (CHAr), 127.6 (CAr), 127.3 (CHAr), 126.0 (CAr), 124.7 
(CAr), 124.5 (CHAr), 124.3 (CHAr), 124.0 (CHAr), 123.7 (CAr), 123.3 (CHAr), 123.2 
(CHAr), 123.1 (CHAr), 120.5 (CHAr), 119.4 (CHAr), 96.8 (CHAr). IR (ATR, cm
-1
): 
ṽ = 3119 (w), 3056 (w), 2925 (w), 2850 (w), 1942 (w), 1897 (w), 1606 (m), 1585 (m), 
1557 (m), 1529 (s), 1491 (w), 1605, 1476 (m), 1444, 1408 (s), 1371 (w), 1352 (m), 
1293 (m), 1253 (m), 1188 (m), 1158 (m), 1102 (s), 950 (m), 923 (m), 861 (m), 835 (m), 
811 (s), 767 (m), 758 (m), 739 (s), 722 (s), 710 (s), 652 (m), 578 (s), 529 (s). 
MS (EI, 70 eV): m/z (%) = 359 (40), 357 [M]
+
 (100), 322 (21), 321 (10), 255 (08), 178 
(08), 161 (33). HRMS (EI): Calculated for C22H12N
35
ClS [M]
+
 357.03735 found 
357.03685, calculated for C22H12N
37
ClS  [M]
+
 359.03440 found 359.03457. 
6-Isopropylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24d): Pale 
yellow solid, mp. 111 - 112 °C. 
1
H NMR (300 MHz, Chloroform-d): δ = 8.31 (d, 
3
J = 8.5 Hz, 1H, CHAr), 8.26 (d, 
3
J = 8.3 Hz, 1H, CHAr), 8.21 (dd, 
3
J = 6.8 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 8.01 (d, 
4
J = 1.8 Hz, 1H, CHAr), 7.92 - 7.96 (m, 1H, CHAr), 7.78 
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(d, 
3
J = 8.1 Hz, 1H, CHAr), 7.30 - 7.42 (m, 4H, CHAr), 
2.17 - 7.22 (m, 1H, CHAr), 7.13 (s, 1H, CHAr), 2.97 - 3.09 (m, 
1H, CHiPr), 1.32 (d, 
3
J = 6.9 Hz, 6H, CH3-iPr). 
13
C NMR 
(75.5 MHz, CDCl3): δ = 144.6 (CAr), 142.0 (CAr), 136.2 (CAr), 
132.2 (CAr), 130.1 (CAr), 129.2 (CAr), 128.4 (CAr), 128.1 (CHAr), 
126.7 (CHAr), 126.4 (CAr), 126.3 (CAr), 125.9 (CHAr), 124.4 
(CHAr), 123.8 (CHAr), 123.2 (CHAr), 122.7 (CHAr), 122.4 (CHAr), 122.1 (CAr), 121.8 
(CHAr), 120.9 (CHAr), 118.3 (CHAr), 95.4 (CHAr), 34.1 (CHiPr), 24.2 (CH3). 
IR (ATR, cm
-1
): ṽ = 3125 (w), 3065 (w), 2949, 2920 (m), 2863 (m), 1608 (m), 1584 (s), 
1562 (w), 1532 (s), 1497, 1483, 1471 (w), 1446 (s), 1410 (m), 1374 (m), 1353 (m), 
1291 (m), 949 (m), 873 (m), 858 (m), 822 (s), 787 (m), 772 (m), 761 (m), 559 (m) cm
-1
. 
MS (EI, 70 eV): m/z (%) = 366 (27), 365 [M]
+
 (100), 350 (29), 349 (14), 348 (10), 323 
(7), 322 (8), 175 (5). HRMS (EI): Calculated for C25H19NS [M]
+
 365.12327 found 
365.12286. 
6-Fluorobenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24e): Pale 
yellow solid, mp. 184 - 185 °C. 
1
H NMR (500 MHz, DMSO): 
δ = 8.49 - 8.44 (m, 2H, CHAr), 8.38 (dd, 
3
J = 10.4 Hz, 
4
J = 2.9 Hz, 1H, CHAr), 8.31 (d, 
3
J = 8.3 Hz, 1H, CHAr), 8.23 (d, 
3
J = 8.0 Hz, 1H, CHAr), 8.02 (d, 
3
J = 8.1 Hz, 1H, CHAr), 
7.65 - 7.62 (m, 1H, CHAr), 7.61 (s, 1H, CHAr), 7.60 - 7.57 (m, 
1H, CHAr), 7.55 - 7.49 (m, 2H, CHAr), 7.40 - 7.36 (m, 1H, CHAr). 
19
F NMR (235.4 MHz, CDCl3): δ = -118.5 (FCAr).
 13
C NMR (125.8 MHz, DMSO): 
δ = 159.5 (d, 1JCF = 242.8 Hz, CFAr), 141.4 (CAr), 135.5 (CAr), 131.9 (CAr), 129.8 (d, 
4
JCF = 3.3 Hz, CAr), 129.5 (CAr), 129.3 (CHAr), 129.0 (d,
 3
JCF = 8.7 Hz, CAr), 127.4 (CAr), 
127.3 (CHAr), 125.8 (CAr), 125.0 (d, 
4
JCF = 3.3 Hz, CAr), 124.6 (CHAr), 124.3 (CHAr), 
123.5 (CHAr), 123.3 (CHAr), 123.2 (CHAr), 120.4 (CHAr), 119.5 (d, 
3
JCF = 8.5 Hz, CHAr), 
115.3 (d, 
2
JCF = 23.7 Hz, CHAr), 110.6 (d, 
2
JCF = 23.4 Hz, CHAr), 95.6 (CHAr). 
IR (ATR, cm
-1
): ṽ = 3119 (w), 3062 (w), 2920 (w), 2850 (w), 1621 (m), 1591 (m), 1563 
(m), 1535 (m), 1496 (m), 1484 (m), 1446 (m), 1425 (s), 1375, 1354 (m), 1269 (m), 1252 
(s), 1175 (s), 950 (m), 922 (m), 896 (s), 852 (s), 810 (s), 617 (m), 595 (m), 554 (s). 
MS (EI, 70 eV): m/z (%) = 342 (25), 341 [M]
+
 (100), 239 (08), 169 (05), 154 (06). 
HRMS (EI): Calculated for C22H12NFS [M]
+
 341.06690 found 341.06633. 
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3-Methylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24f): Pale 
yellow solid, mp. 152 - 153 °C. 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.38 (d, 3J = 8.3 Hz, 1H, CHAr), 
8.28 - 8.23 (m, 2H, CHAr), 7.99 (s, 1H, CHAr), 7.85 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.79 (dd, 
3
J = 7.9 Hz, 
5
J = 0.7 Hz, 
1H, CHAr), 7.52 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.3 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.38 - 7.26 (m, 3H, CHAr), 7.24 - 7.20 (m, 1H, CHAr), 7.11 (s, 
1H, CHAr), 2.44 (s, 3H, CH3). 
13
C NMR (62.9 MHz, CDCl3): δ = 140.9 (CAr), 135.6 
(CAr), 135.5 (CAr), 133.0 (CAr), 128.8 (CAr), 128.6 (CHAr), 128.5 (CAr), 127.4 (CAr), 
126.4 (CHAr), 125.1 (CAr), 123.3 (CHAr), 123.1 (CHAr), 123.0 (CHAr), 122.9 (CAr), 122.8 
(CHAr), 122.1 (CHAr), 121.6 (CHAr), 121.5 (CHAr), 121.2 (CAr), 119.7 (CHAr), 117.3 
(CHAr), 94.0 (CHAr), 20.8 (CH3). IR (ATR, cm
-1
): ṽ = 1606 (w), 1584 (w), 1563 (w), 
1532 (m), 1498 (m), 1482 (m), 1447 (s), 1411 (m), 1362 (m), 1353 (s), 815 (m), 813 
(m), 766 (m), 751 (m), 739 (m), 722 (s), 665 (m), 578 (s). MS (EI, 70 eV): 
m/z (%) = 338 (26), 337 [M]
+
 (100), 336 (19), 322 (07), 169 (06), 161 (06). HRMS (EI): 
Calculated for C23H15NS [M]
+
 337.09197 found 337.09137. 
3,6-Dimethylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24g): Pale 
yellow solid, mp. 154 - 155 °C. 
1
H NMR (300 MHz, 
Chloroform-d): δ = 8.25 (d, 3J = 8.7 Hz, 1H, CHAr), 8.20 
(d, 
3
J = 8.4 Hz, 1H, CHAr), 8.00 (s, 1H, CHAr), 7.94 (s, 
1H, CHAr), 7.81 - 7.76 (m, 2H, CHAr), 7.34 - 7.27 (m, 2H, 
CHAr), 7.22 - 7.17 (m, 2H, CHAr), 7.06 (s, 1H, CHAr), 2.44 
(s, 3H, CH3), 2.42 (s, 3H, CH3). 
13
C NMR (75.5 MHz, 
CDCl3): δ = 141.9 (CAr), 136.5 (CAr), 136.4 (CAr), 133.4 (CAr), 132.0 (CAr), 129.7 (CAr), 
129.4 (CHAr), 129.2 (CAr), 128.4 (CAr), 128.3 (CHAr), 126.1 (CAr), 124.3 (CHAr), 124.2 
(CHAr), 123.9 (CAr), 123.7 (CHAr), 123.1 (CHAr), 122.5 (CHAr), 122.4 (CHAr), 122.0 
(CAr), 120.7 (CHAr), 118.1 (CHAr), 94.7 (CHAr), 21.8 (CH3), 21.3 (CH3). 
IR (ATR, cm
-1
): ṽ = 3049 (w), 2914 (w), 2851 (w), 2729 (w), 1896 (w), 1810 (w), 1765 
(w), 1585 (m), 1563 (m), 1537 (m), 1453 (s), 1374 (m), 1351 (s), 1153 (m), 1030 (m), 
877 (m), 870 (m), 845 (m), 814 (m), 767 (m), 736 (m), 720 (s), 667 (m), 646 (m), 538 
(s). MS (EI, 70 eV): m/z (%) = 352 (27), 351 [M]
+
 (100), 350 (14), 334 (06), 176 (11), 
168 (10), 167 (11), 161 (12), 145 (06). HRMS (EI): Calculated for C24H17NS [M]
+
  
351.10762 found 351.10722. 
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6-Fluoro-3-methylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24h): 
Pale yellow solid, mp. 142 - 143 °C. 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.20 (dd, 3J = 9.0 Hz, 3J = 5.0 Hz, 1H, 
CHAr), 8.08 (d, 
3
J = 8.2 Hz, 1H, CHAr), 7.78 (d, 
4
J = 2.8 Hz, 1H, CHAr), 7.74 - 7.69 (m, 3H, CHAr), 7.30 
(ddd, 
3
J = 8.3 Hz, 
3
J = 7.5 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 
7.22 - 7.09 (m, 3H, CHAr), 6.96 (s, 1H, CHAr), 2.37 (s, 3H, 
CH3). 
19
F NMR (235.4 MHz, CDCl3): δ = -118.3 (FCAr).
 13
C NMR (62.9 MHz, CDCl3): 
δ = 159.3 (d, 1JCF = 242.6 Hz, CFAr), 141.9 (CAr), 136.6 (CAr), 136.0 (CAr), 130.3 (d, 
4
JCF = 3.5 Hz, CAr), 130.1 (CHAr), 129.6 (CAr), 129.4 (CAr), 128.1 (CAr), 125.2 (d, 
4
JCF = 3.3 Hz, CAr), 124.4 (CHAr), 124.0 (CAr), 123.9 (CAr), 123.8 (CHAr), 123.1 (CHAr), 
122.7 (CHAr), 122.6 (CHAr), 120.3 (CHAr), 119.3 (d, 
3
JCF = 8.3 Hz, CHAr), 114.4 (d, 
2
JCF = 23.9 Hz, CHAr), 109.8 (d, 
2
JCF = 23.6 Hz, CHAr), 95.1 (CHAr), 21.7 (CH3). 
IR (ATR, cm
-1
): ṽ = 3117 (w), 3056 (w), 2919 (w), 2852 (w), 1898 (w), 1689 (w), 1620 
(m), 1587 (m), 1562 (m), 1537 (m), 1494 (m), 1432 (s), 1374 (m), 1353 (m), 1293 (m), 
1256 (m), 1196 (m), 1170 (s), 939 (m), 871 (m), 857 (m), 809 (s), 734 (m), 718 (m), 
709 (s), 668 (m), 651 (m), 620 (m), 607 (m), 541 (s) cm
-1
. MS (EI, 70 eV): 
m/z (%) = 356 (25), 355 [M]
+
 (100), 340 (07), 253 (05), 177 (14), 170 (07). HRMS (EI): 
Calculated for C23H14NFS [M]
+
 355.08255 found 355.08186. 
6-Chloro-3-methylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24i): 
Pale yellow solid, mp. 182 - 183 °C. 
1
H NMR (300 MHz, 
Chloroform-d): δ = 8.19 (d, 3J = 8.9 Hz, 1H, CHAr), 
8.12 - 7.09 (m, 2H, CHAr), 7.81 (s, 1H, CHAr), 7.77 (dd, 
3
J = 8.7 Hz, 2H, 
3
J = 8.0 Hz, CHAr), 7.40 (dd, 
3
J = 8.8 Hz, 
4
J = 2.3 Hz, 1H, CHAr), 7.29 - 7.34 (m, 1H, CHAr), 7.22 (d, 
3
J = 7.4 Hz, 2H,CHAr), 7.02 (s, 1H, CHAr), 2.41 (s, 3H, 
CH3). 
13
C NMR (75.5 MHz, CDCl3): δ = 142.0 (CAr), 136.8 (CAr), 136.2 (CAr), 132.4 
(CAr), 130.2 (CHAr), 129.6 (CAr), 129.3 (CAr), 128.5 (CAr), 128.1 (CAr), 127.2 (CHAr), 
125.0 (CAr), 124.4 (CHAr), 124.0 (CAr), 123.9 (CHAr), 123.8 (CHAr), 123.7 (CAr), 123.1 
(CHAr), 122.8 (CHAr), 122.6 (CHAr), 120.4 (CHAr), 119.3 (CHAr), 95.4 (CHAr), 21.8 
(CH3). IR (ATR, cm
-1
): ṽ = 3110 (w), 3045 (w), 2917 (w), 2849 (w), 1905 (w), 1673 
(w), 1603 (w), 1586 (m), 1554 (m), 1529 (m), 1487 (m), 1453 (m), 1416 (s), 1350 (m), 
1294 (m), 1254 (m), 1102 (m), 900 (m), 859 (m), 845 (m), 812 (m), 762 (m), 738 (m), 
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721 (s), 666 (m), 649 (m), 537 (m). MS (EI, 70 eV): m/z (%) = 373 (40), 371 [M]
+
 
(100), 336 (09), 334 (10), 186 (13), 167 (14), 161 (14), 151 (08). HRMS (EI): 
Calculated for C23H14N
35
ClS [M]
+
 371.05300 found 371.05213, calculated for 
C23H14N
37
ClS [M]
+
 373.05005 found 373.05078. 
6-Isopropyl-3-methylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine 
(24j): Pale yellow solid, mp. 94 - 95 °C. 
1
H NMR 
(250 MHz, Chloroform-d): δ = 8.28 (d, 3J = 8.6 Hz, 1H, 
CHAr), 8.24 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.07 (d, 
4
J = 1.9 Hz, 1H, CHAr), 7.98 (s, 1H, CHAr), 7.82 - 7.74 (m, 
2H, CHAr), 7.40 - 7.28 (m, 2H, CHAr), 7.21 - 7.15 (m, 2H, 
CHAr), 7.05 (s, 1H, CHAr), 3.09 - 2.88 (m, 1H, CHiPr), 2.43 
(s, 3H, CH3), 1.33 (d, 6H, 
3
J = 6.9 Hz, CH3-iPr). 
13
C NMR (62.9 MHz, CDCl3): δ = 144.5 
(CAr), 141.9 (CAr), 136.5 (CAr), 136.4 (CAr), 132.3 (CAr), 129.7 (CAr), 129.4 (CHAr), 
129.2 (CAr), 128.4 (CAr), 126.3 (CAr), 125.7 (CHAr), 124.3 (CHAr), 123.9 (CAr), 123.7 
(CHAr), 123.2 (CHAr), 122.5 (CHAr), 122.4 (CHAr), 122.0 (CAr), 121.7 (CHAr), 120.7 
(CHAr), 118.3 (CHAr), 94.8 (CHAr), 34.1 (CHiPr), 24.3 (2CH3-iPr), 21.8 (CH3). 
IR (ATR, cm
-1
): ṽ = 3043 (w), 3010 (w), 2952 (m), 2926 (m), 1617 (m), 1583 (m), 1563 
(m), 1540 (m), 1488 (m), 1444 (m), 1427 (s), 1353 (m), 1309 (m), 1287 (m), 1220 (s), 
1173 (m), 1093 (m), 1066 (m), 1049 (m), 1038 (s), 873 (m), 854 (m), 810 (m), 772 (m), 
739 (m), 720 (s), 578 (m), 568 (s). MS (EI, 70 eV): m/z (%) = 380 (29), 379 [M]
+
 (100), 
364 (18), 349 (10), 348 (06), 182 (05). HRMS (EI): Calculated for C26H21NS [M]
+
 
379.13384 found 379.13367. 
3-Methoxybenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24k): Pale 
yellow solid, mp. 133 - 134 °C. 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.30 (d, 3J = 8.3 Hz, 1H, CHAr), 8.17 
(d, 
3
J = 8.2 Hz, 1H, CHAr), 8.10 (dd, 
3
J = 8.1 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.78 - 7.74 (m, 2H, CHAr), 7.52 (d, 
4
J = 2.5 Hz, 1H, CHAr), 7.47 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.3 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.33 - 7.27 (m, 2H, CHAr), 7.20 - 7.14 (m, 1H, 
CHAr), 6.95 (dd, 
3
J = 8.8 Hz, 
4
J = 2.5 Hz, 2H, CHAr), 3.82 (s, 3H, OCH3). 
13
C NMR 
(62.9 MHz, CDCl3): δ = 158.7 (CAr), 141.7 (CAr), 136.5 (CAr), 134.1 (CAr), 129.7 (CAr), 
129.3 (CAr), 128.4 (CAr), 127.6 (CHAr), 127.5 (CAr), 124.7 (CHAr), 124.3 (CHAr), 124.1 
(CHAr), 123.8 (CHAr), 123.7 (CHAr), 122.4 (CHAr), 121.9 (CAr), 120.5 (CHAr), 120.0 
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(CAr), 118.3 (CHAr), 116.4 (CHAr), 105.6 (CHAr), 94.2 (CHAr), 55.4 (OCH3). 
IR (ATR, cm
-1
): ṽ = 3120 (w), 3050 (w), 3006 (w), 2955 (w), 2918 (w), 2849 (w), 2830 
(w), 1616 (m), 1584 (m), 1560 (m), 1540 (m), 1487 (m), 1467 (m), 1446 (m), 1428 (s), 
1354 (s), 1214 (s), 1071 (m), 1034 (m), 1017 (m), 860 (m), 812 (m), 752 (m), 735 (m), 
713 (s), 695 (m), 662 (m), 610 (m), 573 (m), 542 (m) cm
-1
. MS (EI, 70 eV): 
m/z (%) = 354 (26), 353 [M]
+
 (100), 339 (11), 338 (45), 310 (31), 309 (22), 177 (21), 
155 (16), 154 (19), 133 (09). HRMS (EI): Calculated for C23H15ONS [M]
+
 353.08689 
found 353.08653. 
3-Methoxy-6-methylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24l): 
Pale yellow solid, mp. 129 - 130 °C. 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.27 - 8.19 (m, 2H, CHAr), 7.95 (s, 1H, 
CHAr), 7.85 (d, 
3
J = 8.8 Hz, 1H, CHAr), 7.77 (dd, 
4
J = 0.7 Hz, 
3
J = 8.0 Hz, 1H, CHAr), 7.59 (d, 
4
J = 2.5 Hz, 
1H, CHAr), 7.36 - 7.29 (m, 2H, CHAr), 7.22 - 7.15 (m, 1H, 
CHAr), 7.01 (dd, 
3
J = 8.8 Hz, 
4
J = 2.5 Hz, 2H, CHAr), 3.89 
(s, 3H, OCH3), 2.46 (s, 3H, CH3). 
13
C NMR (75.5 MHz, CDCl3): δ = 158.7 (CAr), 141.7 
(CAr), 136.4 (CAr), 133.3 (CAr), 132.2 (CAr), 129.4 (CAr), 129.3 (CAr), 128.6 (CHAr), 
128.4 (CAr), 127.6 (CAr), 124.8 (CHAr), 124.3 (CHAr), 124.2 (CHAr), 123.7 (CHAr), 122.3 
(CHAr), 121.8 (CAr), 120.4 (CHAr), 120.2 (CAr), 118.2 (CHAr), 116.3 (CHAr), 105.4 
(CHAr), 94.0 (CHAr), 55.5 (OCH3), 21.3 (CH3). IR (ATR, cm
-1
): ṽ = 3055 (w), 2917 (m), 
2848 (m), 1614 (m), 1586 (m), 1564 (m), 1541 (m), 1488 (m), 1448 (m), 1431 (m), 
1417 (s), 1374 (w), 1355 (m), 1308, 1300 (w), 1283 (m), 1221 (s), 1066 (m), 1053 (m), 
1032 (s), 859 (m), 851 (m), 842 (m), 805 (m), 759 (m), 732 (m), 717 (m), 710 (s), 567 
(m), 549 (s). MS (EI, 70 eV): m/z (%) = 368 (27), 367 [M]
+
 (100), 352 (42), 324 (19), 
309 (06), 183 (08), 160 (06). HRMS (EI): Calculated for C24H17ONS [M]
+
 367.10254 
found 367.10298. 
6-Isopropyl-3-methoxybenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine 
(24m): Pale yellow solid, mp. 136 - 137 °C. 
1
H NMR 
(300 MHz, Chloroform-d): δ = 8.34 (d, 3J = 8.5 Hz, 1H, 
CHAr), 8.26 (d, 
3
J = 8.2 Hz, 1H, CHAr), 8.04 (d, 
4
J = 1.9 Hz, 1H, CHAr), 7.91 (d, 
3
J = 7.9 Hz, 1H, CHAr), 
7.79 (dd, 
4
J = 0.6 Hz, 
3
J = 8.0 Hz, 1H, CHAr), 7.67 (d, 
3
J = 2.5 Hz, 1H, CHAr), 7.43 (dd, 
4
J = 1.9 Hz, 
3
J = 8.5 Hz, 1H, CHAr), 7.34 (ddd, 
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4
J = 1.2 Hz, 
3
J = 7.2 Hz, 
3
J = 8.3 Hz, 1H, CHAr), 7.22 - 7.17 (m, 1H, CHAr), 7.05 (dd, 
4
J = 2.5 Hz, 
3
J = 8.8 Hz, 2H, CHAr), 3.92 (s, 3H, OCH3), 3.04 - 3.09 (m, 1H, CHiPr), 
1.34 (d, 
3
J = 6.9 Hz, 6H, CH3-iPr). 
13
C NMR (75.5 MHz, CDCl3): δ = 157.7 (CAr), 144.3 
(CAr), 143.5 (CAr), 142.4 (CAr), 140.7 (CAr), 135.4 (CAr), 131.5 (CAr), 128.4 (CAr), 127.5 
(CAr), 126.8 (CAr), 125.0 (CHAr), 123.8 (CHAr), 123.3 (CHAr), 122.7 (CHAr), 121.3 
(CHAr), 120.8 (CAr), 119.5 (CHAr), 119.2 (CHAr), 117.4 (CHAr), 114.9 (CHAr), 104.9 
(CHAr), 93.0 (CHAr), 55.6 (OCH3), 33.1 (CHiPr), 23.2 (2CH3). IR (ATR, cm
-1
): ṽ = 3119 
(w), 3046 (w), 3008 (w), 2957 (m), 2922 (m), 1614 (m), 1585 (m), 1561 (m), 1539 (m), 
1484 (m), 1446, 1423 (s), 1351 (m), 1307 (m), 1282 (m), 1218 (s), 1170 (m), 1093 (m), 
1065 (m), 1049 (m), 1036 (s), 873 (m), 854 (m), 810 (m), 772 (m), 739 (m), 720 (s), 
578 (m), 568 (s) cm
-1
. MS (EI, 70 eV): m/z (%) = 396 (30), 395 [M]
+
 (100), 380 (30), 
364 (06), 336 (15), 308 (06), 190 (10), 173 (08). HRMS (EI): Calculated for 
C26H21ONS [M]
+
 395.13384 found 395.13367.  
6-Chloro-3-methoxybenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine 
(24n): Pale yellow solid, mp. 202 - 203 °C. 
1
H NMR 
(250 MHz, Chloroform-d): δ = 8.27 (d, 3J = 8.6 Hz, 1H, 
CHAr), 8.14 - 8.08 (m, 2H, CHAr), 7.81 (dd, 
3
J = 10.7 Hz, 
3
J = 8.4 Hz, 2H, CHAr), 7.48 - 7.43 (m, 2H, CHAr), 
7.36 - 7.29 (m, 1H, CHAr), 7.24 - 7.21 (m, 1H, CHAr), 7.04 
(dd, 
3
J = 8.8 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 6.99 (s, 1H, 
CHAr), 3.87 (s, 3H, OCH3). 
13
C NMR (62.9 MHz, CDCl3): δ = 158.8 (CAr), 141.8 (CAr), 
136.2 (CAr), 132.6 (CAr), 129.9 (CAr), 129.3 (CAr), 129.2 (CAr), 128.1 (CAr), 127.5 
(CHAr), 126.4 (CAr), 124.9 (CHAr), 124.4 (CHAr), 123.9 (CHAr), 123.8 (CHAr), 123.5 
(CAr), 122.6 (CHAr), 120.3 (CAr), 120.2 (CHAr), 119.4 (CHAr), 117.3 (CHAr), 105.4 
(CHAr), 94.6 (CHAr), 55.7 (OCH3). IR (ATR, cm
-1
): ṽ = 3131 (w), 3047 (w), 2924 (w), 
2835 (w), 1614 (m), 1586 (m), 1557 (m), 1537 (m), 1485 (m), 1466 (m), 1453 (m), 
1441 (m), 1431 (m), 1416 (s), 1291 (m), 1284 (m), 1228 (m), 1216 (s), 1107 (m), 1097 
(m), 1065 (m), 1053 (m), 1029 (s), 909 (m), 868 (m), 837 (m), 761 (m), 719 (s), 548 (s). 
MS (EI, 70 eV): m/z (%) = 389 (39), 387 [M]
+
 (100), 374 (15), 372 (46), 344 (20), 309 
(14), 194 (09), 154 (10). HRMS (EI): Calculated for C23H14NClS [M]
+
 387.04791 found 
387.04692, calculated for C23H14N
37
ClS [M]
+
 389.04496 found 389.04425. 
6-Fluoro-3-methoxybenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (24o): 
Pale yellow solid, mp. 172 - 173 °C. 
1
H NMR (250 MHz, Chloroform-d): δ = 8.29 (dd, 
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3
J = 9.0 Hz, 
3
J = 5.0 Hz, 1H, CHAr), 8.12 (d, 
3
J = 8.2 Hz, 
1H, CHAr), 7.84 - 7.76 (m, 3H, CHAr), 7.43 (d, 
4
J = 2.8 Hz, 1H, CHAr), 7.36 - 7.29 (m, 1H, CHAr), 
7.25 - 7.18 (m, 2H, CHAr), 7.03 (dd, 
3
J = 8.8 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 6.96 (s, 1H, CHAr), 3.86 (s, 3H, 
OCH3). 
19
F NMR (235.4 MHz, CDCl3): δ = -118.2 (FCAr).
 
13
C NMR (62.9 MHz, CDCl3): δ = 159.0 (d, 
1
JCF = 242.8 Hz, CFAr), 158.7 (CAr), 141.8 
(CAr), 136.1 (CAr), 130.6 (d, 
4
JCF = 3.3 Hz, CAr), 129.6 (CAr), 129.3 (CAr), 128.1 (CAr), 
126.8 (d, 
4
JCF = 3.2 Hz, CAr), 124.8 (CHAr), 124.4 (CHAr), 123.8 (CHAr), 123.8 (d, 
3
JCF = 8.5 Hz, CAr), 122.6 (CHAr), 120.3 (CAr), 120.1 (CHAr), 119.6 (d, 
3
JCF = 8.3 Hz, 
CHAr), 117.2 (CHAr), 114.8 (d, 
2
JCF = 23.4 Hz, CHAr), 110.1 (d, 
2
JCF = 23.9 Hz, CHAr), 
105.6 (CHAr), 94.4 (CHAr), 55.5 (OCH3). IR (ATR, cm
-1
): ṽ = 3116 (w), 3045 (w), 3001 
(w), 2922 (w), 2846 (w), 2254 (w), 2054 (w), 1903 (w), 1731 (w), 1614 (m), 1564 (m), 
1538 (m), 1490 (m), 1464 (m), 1446 (m), 1426 (s), 1336 (m), 1282 (m), 1259 (m), 1228 
(m), 1191 (m), 1171 (s), 1065 (m), 1031 (s), 964 (m), 916 (m), 834 (m), 758 (m), 732, 
715 (s). MS (EI, 70 eV): m/z (%) = 372 (25), 371 [M]
+
 (100), 356 (40), 328 (27), 281 
(08), 253 (06), 207 (06), 185 (26), 163 (20), 141 (15). HRMS (EI): Calculated for 
C23H14O1NFS [M]
+
 371.07746 found 371.07755. 
6-(tert-Butyl)benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (26d): Pale 
yellow solid,  mp. 75 - 76 °C. 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.35 (d, 3J = 8.3 Hz, 1H, CHAr), 8.28 (dd, 
3
J = 8.1 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 8.24 - 8.19 (m, 2H, CHAr), 
7.86 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.76 (d, 
3
J = 8.1 Hz, 1H, CHAr), 
7.52 - 7.46 (m, 2H, CHAr), 7.34 - 7.29 (m, 2H, CHAr), 2.18 - 7.14 
(m, 1H, CHAr), 7.08 (s, 1H, CHAr), 1.37 (s, 9H, CH3). 
13
C NMR 
(62.9 MHz, CDCl3): δ = 149.8 (CAr), 141.9 (CAr), 136.4 (CAr), 134.0 (CAr), 129.9 (CAr), 
129.6 (CAr), 128.4 (CAr), 127.3 (CHAr), 126.2 (CHAr), 125.7 (CAr), 124.4 (CHAr), 124.0 
(CHAr), 123.9 (CHAr), 123.8 (CHAr), 123.0 (CHAr), 122.6 (CHAr), 120.7 (CHAr), 120.6 
(CAr), 118.6 (CHAr), 118.5 (CAr), 118.3 (CHAr), 95.1 (CHAr), 35.1 (CtBu), 31.4 (CH3). 
IR (ATR, cm
-1
): ṽ = 3119 (w), 3055 (w), 2951, 2862 (m), 1607 (w), 1585 (m), 1554 
(m), 1538 (m), 1474 (m), 1441 (m), 1427 (s), 1347 (s), 1191 (m), 1121 (m), 1054 (m), 
1026 (m), 877 (m), 821 (m), 736 (m), 623 (m), 542 (s). MS (EI, 70 eV): m/z (%) = 380 
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(29), 379 [M]
+
 (100), 365 (17), 364 (60), 350 (08), 349 (31), 348 (09), 323 (09), 168 
(15). HRMS (EI): Calculated for C26H21NS [M]
+
 379.13892 found 379.13866. 
6-Methoxybenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (26e): Pale 
yellow solid, mp. 152 - 153 °C.
 1
H NMR (250 MHz, DMSO): 
δ = 8.60 (d, 3J = 7.2 Hz, 1H, CHAr), 8.38 (d, 
3
J = 8.3 Hz, 1H, 
CHAr), 8.27 (d, 
3
J = 8.2 Hz, 1H, CHAr), 8.11 (d, 
3
J = 8.8 Hz, 1H, 
CHAr), 7.99 (d, 
3
J = 7.3 Hz, 1H, CHAr), 7.92 (d, 
4
J = 2.4 Hz, 1H, 
CHAr), 7.75 - 7.63 (m, 1H, CHAr), 7.50 (d, 
3
J = 7.9 Hz, 1H, 
CHAr), 7.45 - 7.42 (m, 2H, CHAr), 7.30 (t, 
3
J = 7.2 Hz, 1H, 
CHAr), 7.18 (dd, 
3
J = 8.8 Hz, 
4
J = 2.4 Hz, 1H, CHAr), 3.94 (s, 3H, OCH3). 
13
C NMR 
(62.9 MHz, CDCl3): δ = 158.7 (CAr), 140.7 (CAr), 136.0 (CAr), 133.1 (CAr), 129.2 (CAr), 
128.4 (CAr), 128.3 (CHAr), 127.7 (CAr), 127.1 (CAr), 125.0 (2CHAr), 124.6 (CHAr), 124.3 
(2CHAr), 122.7 (CHAr), 121.4 (CAr), 120.3 (CHAr), 119.1 (CAr), 117.7 (CHAr), 117.2 
(CHAr), 105.8 (CHAr), 94.9 (CHAr), 55.5 (OCH3). IR (ATR, cm
-1
): ṽ = 3119 (w), 3005 
(w), 2955 (w), 2830 (w), 1681 (m), 1615 (m), 1590 (m), 1560 (m), 1487 (m), 1467 (w), 
1446 (m), 1428 (s), 1376 (w), 1353 (m), 1285 (m), 1214 (s), 1019 (m), 994 (s), 860 (m), 
812 (m), 752 (m), 712 (s). MS (EI, 70 eV): m/z (%) = 354 (26), 353 [M]
+
 (100), 339 
(11), 338 (45), 311 (08), 310 (32), 309 (22), 308 (14), 177 (22), 155 (22), 154 (20), 133 
(10). HRMS (EI): Calculated for C23H15ONS [M]
+
 353.08685 found 353.08676. 
7-Methoxybenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (26f): Pale 
yellow solid, mp. 108 - 109 °C. 
1
H NMR (250 MHz, 
Chloroform-d): δ = 8.59 (d, 3J = 8.6 Hz, 1H, CHAr), 8.37 (d, 
3
J = 8.3 Hz, 1H, CHAr), 8.26 (d, 
3
J = 8.2 Hz, 1H, CHAr), 8.11 (d, 
3
J = 8.8 Hz, 1H, CHAr), 7.99 (d, 
3
J = 8.0 Hz, 1H, CHAr), 7.92 (d, 
4
J = 2.4 Hz, 1H, CHAr), 7.73 - 7.68 (m, 1H, CHAr), 7.42 - 7.52 
(m, 3H, CHAr), 7.29 (m, 1H, CHAr), 7.17 (dd, 1H, 
3
J = 8.8 Hz, 
4
J = 2.4 Hz, CHAr), 3.93 
(s, 3H, OCH3). 
13
C NMR (62.9 MHz, CDCl3): δ = 158.7 (CAr), 141.8 (CAr), 136.5 (CAr), 
134.2 (CAr), 129.7 (CAr), 129.5 (CAr), 128.5 (CAr), 127.7 (CHAr), 127.6 (CAr), 124.8 
(CHAr), 124.4 (CHAr), 124.2 (CHAr), 123.9 (CHAr), 123.8 (CHAr), 122.4 (CHAr), 122.0 
(CAr), 120.5 (CHAr), 120.1 (CAr), 118.4 (CHAr), 116.5 (CHAr), 105.7 (CHAr), 94.3 
(CHAr), 55.5 (OCH3). IR (ATR, cm
-1
): ṽ = 3119 (w), 3005 (w), 2955 (w), 2830 (w), 
1681 (m), 1615 (m), 1590 (m), 1560 (m), 1487 (m), 1467 (w), 1446 (m), 1428 (s), 1376 
(w), 1353 (m), 1285 (m), 1214 (s), 1019 (m), 994 (s), 860 (m), 812 (m), 752 (m), 735 
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(m), 712 (s). MS (EI, 70 eV): m/z (%) = 354 (26), 353 [M]
+
 (100), 339 (12), 338 (47), 
310 (34), 309 (23), 308 (15), 177 (18), 155 (14), 154 (19). HRMS (EI): Calculated for 
C23H15ONS [M]
+
 353.08689 found 353.08628. 
8-Fluorobenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (26g): Pale 
yellow solid, mp. 194 - 195 °C.
 1
H NMR (300 MHz, DMSO): 
δ = 8.49 (d, J = 8.5 Hz, 1H, CHAr), 8.44 - 8.38 (m, 2H, CHAr), 
8.27 (d, 
3
J = 8.2 Hz, 1H, CHAr), 8.22 (d, 
3
J = 8.0 Hz, 1H, CHAr), 
8.04 (d, 
3
J = 7.8 Hz, 1H, CHAr), 7.62 - 7.56 (m, 3H, CHAr), 
7.53 - 7.46 (m, 2H, CHAr), 7.38 - 7.34 (m, 1H, CHAr). 
19
F NMR 
(282.4 MHz, CDCl3): δ = -117.3.
 13
C NMR (75.5 MHz, DMSO): δ = 159.2 (d, 
1
JCF = 242.8 Hz, CFAr), 141.2 (CAr), 135.5 (CAr), 129.6 (d, 
4
JCF = 3.3 Hz, CAr), 129.3 
(CHAr), 129.2 (CAr), 128.9 (CAr), 128.1 (CAr), 127.2 (CHAr), 125.6 (CAr), 124.8 (d, 
4
JCF = 3.3 Hz, CAr), 124.6 (CHAr), 124.3 (CHAr), 123.7 (CAr), 123.5 (CHAr), 123.3 
(CHAr), 123.2 (CHAr), 120.4 (CHAr), 119.5 (d, 
3
JCF = 8.7 Hz, CHAr), 115.4 (d, 
2
JCF = 23.5 Hz, CHAr), 110.7 (d, 
2
JCF = 23.6 Hz, CHAr), 96.6 (CHAr). IR (ATR, cm
-1
): 
ṽ = 3062 (w), 2920 (w), 2850 (w), 1623 (m), 1589 (m), 1559 (m), 1537 (m), 1497 (m), 
1479 (m), 1443 (m), 1421 (s), 1374 (m), 1351 (m), 1309 (w), 1295 (m), 1270 (m), 953 
(m), 926 (m), 893 (m), 849 (m), 811 (s), 786 (m), 767 (m), 755 (m), 617 (m), 595 (m), 
560 (s) cm
-1
. MS (EI, 70 eV): m/z (%) = 342 (30), 341 [M]
+
 (100), 239 (16), 239 (18), 
171 (16), 155 (15). HRMS (EI): Calculated for C22H12NFS [M]
+
 341.06690 found 
341.06653.  
6-(Methylthio)benzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine (26h): Dark 
brown solid, mp. 182 - 183 °C.
 1
H NMR (500 MHz, 
Chloroform-d): δ = 8.54 (d, 4J = 2.1 Hz, 1H, CHAr), 8.52 (d, 
3
J = 8.5 Hz, 1H, CHAr), 8.46 (d, 
3
J = 8.5 Hz, 1H, CHAr), 8.32 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.87 (d, 
3
J = 7.9 Hz, 1H, CHAr), 7.78 (d, 
3
J = 7.5 Hz, 1H, CHAr), 7.49 - 7.46 (m, 2H, CHAr), 7.39 - 7.30 
(m, 3H, CHAr), 6.93 (s, 1H, CHAr), 2.59 (s, 3H, SCH3). 
13
C NMR (125.7 MHz, CDCl3): δ = 139.8 (CAr), 136.3 (CAr), 133.5 (CAr), 132.6 (CAr), 
132.1 (CAr), 131.8 (CAr), 130.6 (CAr), 126.7 (CHAr), 125.5 (CHAr), 125.3 (CHAr), 125.2 
(CAr), 124.1 (CAr), 123.8 (CHAr), 123.4 (CHAr), 123.3 (CHAr), 122.7 (CAr), 122.5 (CHAr), 
122.3 (CHAr), 121.4 (CHAr), 116.9 (CHAr), 114.3 (CHAr), 96.4 (CHAr), 17.3 (SCH3). 
IR (ATR, cm
-1
): ṽ = 3119 (w), 3005 (w), 2955 (w), 2830 (w), 1681 (m), 1615 (m), 1590 
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(m), 1560 (m), 1540 (m), 1487 (m), 1467 (w), 1446 (m), 1428 (s), 1376 (w), 1353 (m), 
1285 (m), 1214 (s), 1019 (m), 994 (s), 860 (m), 812 (m), 752 (m), 735 (m), 712 (s). 
MS (EI, 70 eV): m/z (%) = 370 (26), 369 [M]
+
 (100), 354 (25), 321 (13), 310 (38), 184 
(19), 160 (26), 155 (16). HRMS (EI): Calculated for C23H15N1S2  [M]
+
 369.06404 found 
369.06379. 
5.2.7. Synthesis of quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines by 
regioselective Sonogashira reaction followed by domino C-N 
coupling/hydroamination/C-H arylation 
5.2.7.1.Starting materials 
4-Chloro-2-methyl-3-(phenylethynyl)quinoline (27a): Yellow solid, mp. 95 - 96 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.14 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 7.99 (ddd, 
3
J = 8.4 Hz, 
4
J = 1.3 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 7.68 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.64 - 7.59 
(m, 2H, CHAr), 7.54 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.9 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.41 - 7.35 
(m, 3H, CHAr), 2.92 (s, 3H, CH3-quinoline). 
13
C NMR (75 MHz, CDCl3) δ = 159.7 (CAr), 
146.6 (CAr), 143.9 (CAr), 131.8 (2CHAr), 130.6 (CHAr), 129.1 (CHAr), 129.0 (CHAr), 
128.6 (2CHAr), 127.2 (CHAr), 124.6 (CAr), 124.3 (CHAr), 122.7 (CAr), 117.5 (CAr), 100.8 
(Csp), 84.5 (Csp), 25.2 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3058 (w), 3030 (w), 2997 (w), 
2913 (w), 2207 (w), 1553 (w), 1477 (m), 1442 (m), 1405 (m), 1354 (m), 941 (m), 833 
(m), 752 (s), 683 (m), 638 (m), 599 (m), 524 (m), 468 (m). MS (EI, 70 eV): 
m/z (%) = 279 (37), 278 (23), 277 (100), 276 (12), 243 (11), 242 (66), 241 (55), 240 
(18), 201 (11), 200 (25), 174 (12), 150 (12), 121 (16), 100 (13), 51 (12). HRMS (ESI): 
Calculated for C18H12ClN [M+H]
+
 278.07310 found 278.07296, calculated for 
C18H12
37
ClN [M+H]
+
 280.07068 found 280.07087. 
4-Chloro-2-methyl-3-(p-tolylethynyl)quinoline (27b): Yellow solid, mp. 94 - 95 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.18 (ddd, 
3
J = 8.3 Hz, 
4
J = 1.4 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 8.02 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.71 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.58 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.52 (d, 
3
J = 8.1 Hz, 2H, CHAr), 7.20 
(d, 
3
J = 7.8 Hz, 2H, CHAr), 2.93 (s, 3H, CH3-quinoline), 2.40 (s, 3H, CH3). 
13
C NMR 
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(75 MHz, CDCl3) δ = 159.9 (CAr), 146.5 (CAr), 143.8 (CAr), 139.6 (CAr), 131.8 (2CHAr), 
130.6 (CHAr), 129.4 (2CHAr), 129.0 (CHAr), 127.3 (CHAr), 124.7 (CAr), 124.4 (CHAr), 
119.7 (CAr), 117.8 (CAr), 101.2 (Csp), 83.9 (Csp), 25.3 (CH3), 21.8 (CH3). 
IR (ATR, cm
-1
): ṽ = 3079 (w), 3059 (m), 2983 (m), 2945 (w), 2912 (m), 2847 (w), 2728 
(w), 2206 (m), 1960 (w), 1933 (w), 1880 (w), 1819 (w), 1584 (m), 1510 (m), 1478 (m), 
1406 (m), 1372 (m), 1354 (m), 1342 (m), 1267 (m), 1088 (m), 941 (m), 834 (m), 811 
(s), 753 (s), 639 (m), 598 (m). MS (EI, 70 eV): m/z (%) = 293 (34), 292 (26), 291 [M]
+
 
(100), 290 (20), 256 (35), 255 (14), 254 (16), 241 (26), 240 (11), 213 (19), 128 (11). 
HRMS (EI): Calculated for C19H14NCl [M]
+
 291.08093 found 291.09085.  
4-Chloro-2-methyl-3-((4-propylphenyl)ethynyl)quinoline (27c): Yellow solid, 
mp. 95 - 96 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 8.21 (dd, 3J = 8.3 Hz, 4J = 1.3 Hz, 1H, CHAr), 8.12 
(d, 
3
J = 8.1 Hz, 1H, CHAr), 7.75 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.63 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.55 (d, 
3
J = 8.1 Hz, 2H, CHAr), 7.22 (d, 
3
J = 8.5 Hz, 2H, CHAr), 
2.98 (s, 3H, CH3-quinoline), 2.76 - 2.50 (m, 2H, CH2-aliphatic), 1.67 (m, 2H, CH2-aliphatic), 0.96 
(t, 
3
J = 7.3 Hz, 3H, CH3). 
13
C NMR (63 MHz, CDCl3) δ = 159.8 (CAr), 146.3 (CAr), 
144.4 (CAr), 144.0 (CAr), 131.8 (2CHAr), 130.7 (CHAr), 128.9 (CHAr), 128.8 (2CHAr), 
127.4 (CHAr), 124.8 (CAr), 124.4 (CHAr), 119.9 (CAr), 117.9 (CAr), 101.4 (Csp), 83.8 
(Csp), 38.2 (CH2), 25.2 (CH3), 24.5 (CH2), 13.9 (CH3). IR (ATR, cm
-1
): ṽ = 3065 (w), 
3048 (w), 3030 (w), 2957 (m), 2918 (w), 2859 (w), 2208 (w), 1898 (w), 1552 (w), 1510 
(m), 1479 (m), 1406 (m), 1355 (m), 1089 (w), 942 (w), 831 (m), 810 (m), 758 (s), 640 
(m), 540 (m). MS (EI, 70 eV): m/z (%) = 321 (23), 320 (17), 319 [M]
+
 (68), 292 (35), 
291 (21), 290 (100), 255 (10), 254 (33), 253 (11), 213 (15), 127 (12). HRMS (EI): 
Calculated for C21H18NCl [M]
+
 319.11223 found 319.11219, calculated for C21H18N
37
Cl 
[M]
+
 321.10928 found 321.10997. 
3-((4-(tert-Butyl)phenyl)ethynyl)-4-chloro-2-methylquinoline (27d): Yellow oil. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.19 (ddd, 
3
J = 8.3 Hz, 
4
J = 1.5 Hz, 
5
J = 0.6 Hz, 1H, CHAr), 8.04 
(d, 
3
J = 8.4 Hz, 1H, CHAr), 7.72 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.63 - 7.53 (m, 3H, 
CHAr), 7.47 - 7.39 (m, 2H, CHAr), 2.94 (s, 3H, CH3-quinoline), 1.35 (s, 9H, CH3-tBu). 
13
C NMR (63 MHz, CDCl3) δ = 159.9 (CAr), 152.7 (CAr), 146.4 (CAr), 144.0 (CAr), 131.6 
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(2CHAr), 130.7 (CHAr), 128.9 (CHAr), 127.4 (CHAr), 125.7 (2CHAr), 124.8 (CAr), 124.4 
(CHAr), 119.7 (CAr), 117.9 (CAr), 101.3 (Csp), 83.8 (Csp), 35.1 (CtBu), 31.3 (3CH3), 25.2 
(CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3063 (w), 2958 (m), 2904 (w), 2867 (w), 2208 (w), 
1554 (m), 1504 (m), 1477 (m), 1403 (m), 1353 (m), 1267 (m), 1087 (m), 1015 (m), 942 
(m), 831 (s), 755 (s), 638 (m), 560 (m). MS (EI, 70 eV): m/z (%) = 335 (18), 334 (13), 
333 [M]
+
 (52), 320 (34), 319 (23), 318 (100), 128 (12). HRMS (EI): Calculated for 
C22H20N
35
Cl [M]
+
 333.12788 found 333.12789, calculated for C22H20N
37
Cl [M]
+
 
335.12493 found 335.12556.  
4-Chloro-3-((4-methoxyphenyl)ethynyl)-2-methylquinoline (27e): Yellow solid, 
mp. 111 - 113 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.15 (ddd, 3J = 8.3 Hz, 4J = 1.5 Hz, 5J = 0.6 Hz, 1H, 
CHAr), 8.00 (dd, 
3
J = 8.4 Hz, 
4
J = 1.3 Hz, 
5
J = 0.6 Hz, 
1H, CHAr), 7.68 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.60 - 7.50 (m, 3H, CHAr), 6.90 (d, 
3
J = 8.8 Hz, 2H, CHAr), 3.83 
(s, 3H, OCH3), 2.92 (s, 3H, CH3-quinoline). 
13
C NMR (75 MHz, CDCl3) δ = 160.4 (CAr), 
159.7 (CAr), 146.4 (CAr), 143.5 (CAr), 133.4 (2CHAr), 130.5 (CHAr), 129.0 (CHAr), 127.2 
(CHAr), 124.7 (CAr), 124.3 (CHAr), 117.9 (CAr), 114.8 (CAr), 114.3 (2CHAr), 101.2 (Csp), 
83.4 (Csp), 55.5 (OCH3), 25.2 (CH3-quinoline). IR (ATR, cm
-1
): ṽ = 3362 (w), 3228 (w), 
3100 (w), 3033 (w), 2964 (w), 2930 (w), 2913 (w), 2835 (w), 2539 (w), 2205 (w), 2164 
(w), 2050 (w), 1602 (w), 1509 (w), 1480 (w), 1291 (w), 1247 (s), 1170 (m), 1104 (m), 
1024 (m), 942 (m), 827 (s), 753 (s), 640 (m), 531 (m). MS (EI, 70 eV): m/z (%) = 309 
(34), 308 (21), 307 [M]
+
 (100), 294 (14), 293 (10), 292 (43), 272 (14), 264 (16), 229 
(23), 228 (23), 227 (11), 187 (19), 136 (11). HRMS (ESI): Calculated for C19H14
35
ClNO 
[M+H]
+
 308.08367 found 308.08381, calculated for C19H14
37
ClNO [M+H]
+
 310.08135 
found 310.08124. 
4-chloro-3-((4-fluorophenyl)ethynyl)-2-methylquinoline (27f): Yellow solid, 
mp. 147 - 148 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.10 (ddd, 3J = 8.4 Hz, 4J = 1.5 Hz, 5J = 0.6 Hz, 1H, 
CHAr), 7.96 (ddd, 
3
J = 8.4 Hz, 
3
J = 1.2 Hz, 
5
J = 0.6 Hz, 
1H, CHAr), 7.66 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.59 - 7.46 (m, 3H, CHAr), 7.05 (pt, 
3
J = 8.7 Hz, 2H, CHAr), 
2.88 (s, 3H, CH3-quinoline). 
19
F NMR (282 MHz, CDCl3) δ = -109.3 (FCAr). 
13
C NMR 
(75 MHz, CDCl3) δ = 163.0 (d, 
1
JCF = 251.0 Hz, CFAr), 159.5 (CAr), 146.5 (CAr), 143.9 
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(CAr), 133.63 (d, 
3
JCF = 8.5 Hz, 2CHAr), 130.7 (CHAr), 129.0 (CHAr), 127.2 (CHAr), 
124.5 (CAr), 124.3 (CHAr), 118.8 (d, 
4
JCF = 3.5 Hz, CAr), 117.3 (CAr), 115.8 (d, 
2
JCF = 22.2 Hz, 2CHAr), 99.6 (Csp), 84.2 (Csp), 25.2 (CH3-quinoline). 
IR (ATR, cm
-1
): ṽ = 3060 (w), 3000 (w), 2958 (w), 2922 (w), 2845 (w), 2208 (w), 2165 
(w), 1931 (w), 1889 (w), 1599 (m), 1506 (m), 1478 (m), 1406 (m), 1355 (m); 1215 (m), 
1159 (m), 1091 (m), 940 (m), 828 (s), 749 (s), 639 (m), 524 (m). MS (EI, 70 eV): 
m/z (%) = 297 (34), 296 (24), 295 (100), 261 (13), 260 (69), 259 (45), 258 (13), 218 
(29), 130 (11). HRMS (ESI): Calculated for C18H11
35
ClFN [M+H]
+
 296.06368 found 
296.06375, calculated for C18H11
37
ClFN [M+H]
+
 298.06126 found 298.06147. 
4-Chloro-2-methyl-3-((4-(trifluoromethyl)phenyl)ethynyl)quinoline (27g): White 
solid, mp. 138 – 139 °C.1H NMR (250 MHz, 
Chloroform-d) δ = 8.22 (dd, 3J = 8.5 Hz, 4J = 1.2 Hz, 
1H, CHAr), 8.07 (d, 
3
J = 7.9 Hz, 1H, CHAr), 7.81 - 7.58 
(m, 6H, CHAr), 2.96 (s, 3H, CH3-quinoline).
 19F NMR 
(235 MHz, CDCl3) δ = -62.9 (F3C).
 13
C NMR (63 MHz, CDCl3) δ = 159.6 (CAr), 146.8 
(CAr), 144.7 (CAr), 132.0 (2CHAr), 132.0 (CHAr), 130.8 (d, 
2
JCF = 32.8 Hz, CAr), 129.1 
(CAr), 128.9 (CHAr), 127.5 (CHAr), 125.6 (q, 
3
JCF = 3.8 Hz, 2CHAr), 125.2 (q, 
1
JCF = 262.3 Hz, CF3), 124.6 (CAr), 124.5 (CHAr), 116.9 (CAr), 99.0 (Csp), 86.6 (Csp), 
25.2 (CH3). IR (ATR, cm
-1
): ṽ = 3062 (w), 3052 (w), 2921 (w), 1614 (m), 1581 (m), 
1555 (m), 1478 (m), 1403 (m), 1356 (m), 1315 (s), 1167 (m), 1114 (m). 
MS (EI, 70 eV): m/z (%) = 347 (34), 346 (22), 345 (100), 310 (47), 241 (16). 
HRMS (ESI): Calculated for C19H11
35
ClF3N [M+H]
+
 346.06049 found 346.06062, 
calculated for C19H11
37
ClF3N [M+H]
+
 348.05812 found 348.05842.   
5.2.7.2.Quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridines 
6,13-Dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28a): Pale yellow 
solid, m.p. 177 - 178 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.36 (dd, 3J = 8.4 Hz, 4J = 1.0 Hz, 1H, CHAr), 8.22 (m, 2H, 
CHAr), 8.09 (d, 
3
J = 8.5 Hz, 1H, CHAr), 8.10 - 8.02 (m, 1H, 
CHAr), 8.04 - 8.02 (m, 1H, CHAr), 7.59 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.52 - 7.47 (m, 2H, CHAr), 
7.41 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.30 (s, 1H, CHAr), 7.21 
(dd, 
3
J = 8.5 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 3.00 (s, 3H, CH3-quinoline), 2.51 (s, 3H, CH3). 
13
C NMR (75 MHz, CDCl3) δ = 154.5 (CAr), 144.5 (CAr), 136.3 (CAr), 134.7 (CAr), 132.3 
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(CAr), 132.0 (CAr), 129.7 (CHAr), 128.4 (CHAr), 128.1 (CHAr), 127.9 (CHAr), 127.6 (CAr), 
126.6 (CAr), 126.4 (CHAr), 124.8 (CHAr), 124.1 (CHAr), 124.0 (CAr), 123.8 (CHAr), 123.6 
(CAr), 122.7 (CHAr), 122.4 (CHAr), 119.5 (CHAr), 118.5 (CAr), 96.5 (CHAr), 22.8 (CH3), 
21.4 (CH3). IR (ATR, cm
-1
): ṽ = 3042 (m), 2987 (m), 2915 (m), 2850 (m), 1567 (m), 
1511 (m), 1496 (m), 1453 (m), 1371 (m), 1294 (m), 827 (m), 758 (s), 744 (s), 713 (m), 
585 (m). MS (EI, 70 eV): m/z (%) = 347 (26), 346 [M]
+
 (100), 345 (28), 330 (12), 165 
(11). HRMS (EI): Calculated for C25H18N2 [M]
+
 346.14645 found 346.14601.  
13-Isopropyl-6-methylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28b): Pale 
yellow solid, m.p. 118 - 120 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.43 (dd, 3J = 8.6 Hz, 4J = 1.3 Hz, 1H, CHAr), 
8.36 - 8.27 (m, 1H, CHAr), 8.25 - 8.20 (m, 1H, CHAr), 8.19 (d, 
3
J = 8.7 Hz, 1H, CHAr), 8.15 - 8.10 (m, 2H, CHAr), 7.61 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.56 - 7.51 (m, 
2H, CHAr), 7.45 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.36 (s, 1H, 
CHAr), 7.33 (dd, 
3
J = 8.7 Hz, 
4
J = 2.0 Hz, 1H, CHAr), 3.11 (sept, 
3
J = 6.9 Hz, 1H, CHiPr), 
3.02 (s, 3H, CH3-quinoline), 1.40 (d, 
3
J = 6.9 Hz, 6H, CH3-iPr). 
13
C NMR (75 MHz, CDCl3) 
δ = 154.5 (CAr), 145.8 (CAr), 144.5 (CAr), 136.5 (CAr), 132.7 (CAr), 132.2 (CAr), 129.7 
(CHAr), 128.5 (CHAr), 128.0 (CHAr), 127.8 (CAr), 126.6 (CAr), 126.5 (CHAr), 125.6 
(CHAr), 124.2 (CHAr), 124.1 (CAr), 123.9 (CHAr), 123.62(CAr), 122.7 (CHAr), 122.5 
(CHAr), 122.3 (CHAr), 119.7 (CHAr), 118.5 (CAr), 96.6 (CHAr), 34.2 (CH3), 24.3 (2CH3), 
22.8 (CHiPr). IR (ATR, cm
-1
): ṽ = 3058 (m), 2956 (m), 2921 (m), 2866 (m), 1567 (m), 
1512 (m), 1453 (m), 1416 (m), 1370 (m), 1256 (m), 866 (m), 758 (s), 744 (s), 705 (m), 
629 (m). MS (EI, 70 eV): m/z (%) = 375 (30), 374 [M]
+
 (100), 360 (10), 359 (36), 331 
(13). HRMS (EI): Calculated for C27H22N2 [M]
+
 374.17775 found 374.17728.  
13-Fluoro-6-methylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28c): Pale 
yellow solid, m.p. 168 - 169 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.25 (d, 3J = 8.4 Hz, 1H, CHAr), 8.20 (d, 
3
J = 8.4 Hz, 1H, CHAr), 8.14 (dd, 
3
J = 9.1 Hz, 
3
J = 5.0 Hz, 1H, 
CHAr), 8.10 - 8.02 (m, 2H, CHAr), 7.84 (dd, 
3
J = 9.8 Hz, 
4
J = 2.8 Hz, 1H, CHAr), 7.59 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.54 - 7.47 (m, 2H, CHAr), 7.39 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 7.27 (s, 1H, CHAr), 7.10 (ddd, 
3
J = 9.2 Hz, 
3
J = 7.5 Hz, 
4
J = 2.8 Hz, 1H, CHAr), 2.97 (s, 3H, CH3-quinoline). 
13
C NMR (75 MHz, CDCl3) δ = 159.9 
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(d, 
1
JCF = 244.6 Hz, CFAr), 154.5 (CAr), 144.5 (CAr), 136.0 (CAr), 132.1 (CAr), 130.8 (d, 
4
JCF = 2.4 Hz, CAr), 129.8 (CHAr), 129.2 (CHAr), 128.1 (CHAr), 126.8 (CAr), 126.7 (CAr), 
126.7 (CHAr), 125.6 (d, 
3
JCF = 7.9 Hz, CAr), 124.1 (CHAr), 124.0 (CHAr), 122.9 (CHAr), 
121.9 (CHAr), 121.0 (d, 
3
JCF = 8.3 Hz, CHAr), 118.1 (CAr), 116.8 (CAr), 114.4 (d, 
2
JCF = 23.4 Hz, CHAr), 110.7 (d, 
2
JCF = 24.0 Hz, CHAr), 96.9 (CHAr), 22.8 (CH3). 
IR (ATR, cm
-1
): ṽ = 3059 (w), 2954 (w), 2918 (m), 2849 (m), 1616 (m), 1576 (m), 1511 
(m), 1494 (m), 1451 (m), 1416 (m), 1372 (m), 1278 (m), 1177 (m), 863 (m), 820 (m), 
758 (s), 744 (s), 708 (m), 626 (m). MS (EI, 70 eV): m/z (%) = 351 (25), 350 [M]
+
 (100). 
349 (42), 348 (20), 347 (10), 175 (9). HRMS (EI): Calculated for C24H15N2F [M]
+
 
350.12138 found 350.12067. 
6,10-Dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28d): Pale yellow 
solid, m.p. 221 - 222 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 8.39 (dd, 3J = 8.4 Hz, 4J = 1.4 Hz, 1H, CHAr), 8.31 - 8.21 (m, 
3H, CHAr), 8.07 (s, 1H, CHPyrrole), 8.01 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.47 - 7.40 (m, 3H, CHAr), 7.36 (ddd, 
3
J = 8.2 Hz, 
4
J = 1.7 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.32 (s, 1H, CHAr), 3.02 (s, 
3H, CH3-quinoline), 2.55 (s, 3H, CH3). 
13
C NMR (75 MHz, CDCl3) δ = 154.4 (CAr), 138.1 
(CAr), 136.9 (CAr), 134.6 (CAr), 132.1 (CAr), 130.0 (CHAr), 129.6 (CHAr), 129.6 (CAr), 
127.6 (CAr), 127.2 (CHAr), 126.5 (CHAr), 125.1 (CHAr), 126.0 (CAr), 124.7 (CHAr), 124.3 
(CAr), 124.2 (CHAr), 123.9 (CHAr), 123.8 (CAr), 122.9 (CHAr), 122.4 (CHAr), 119.8 
(CHAr), 118.5 (CAr), 96.1 (CHAr), 22.7 (CH3), 22.0 (CH3). IR (ATR, cm
-1
): ṽ = 3058 
(m), 2919 (m), 2851 (w), 1567 (w), 1512 (m), 1489 (m), 1446 (m), 1435 (m), 1370 (m), 
1297 (w), 1175 (w), 1032 (w), 814 (m), 756 (s), 747 (s), 695 (m). MS (EI, 70 eV): 
m/z (%) = 347 (26), 346 [M]
+
 (100), 345 (31), 330 (10), 165 (10). HRMS (EI): 
Calculated for C25H18N2 [M]
+
 346.14645 found 346.14570.  
6,10,13-Trimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28e): Pale 
yellow solid, m.p. 217 - 218 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.37 (dd, 3J = 8.4 Hz, 4J = 1.4 Hz, 1H, 
CHAr), 8.20 (d, 
3
J = 8.0 Hz, 1H, CHAr), 8.11 (d, 
3
J = 8.4 Hz, 
1H, CHAr), 8.06 - 8.01 (m, 2H, CHAr), 7.97 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.57 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, 
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CHAr), 7.40 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.31 (ddd, 
3
J = 8.2 Hz, 
4
J = 1.6 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.24 (s, 1H, CHAr), 7.26 - 7.17 (m, 1H, 
CHAr), 2.98 (s, 3H, CH3-quinoline), 2.52 (s, 3H, CH3), 2.51 (s, 3H, CH3). 
13
C NMR 
(75 MHz, CDCl3) δ = 154.4 (CAr), 138.0 (CAr), 136.7 (CAr), 134.7 (CAr), 132.5 (CAr), 
131.9 (CAr), 129.8 (CHAr), 129.6 (CHAr), 129.5 (CAr), 128.0 (CHAr), 127.6 (CAr), 126.4 
(CHAr), 124.7 (CHAr), 124.2 (CAr), 124.1 (CAr), 124.1 (CHAr), 123.8 (CHAr), 123.6 (CAr), 
122.9 (CHAr), 122.4 (CHAr), 119.6 (CHAr), 118.5 (CAr), 95.8 (CHAr), 22.7 (CH3), 22.0 
(CH3), 21.4 (CH3). IR (ATR, cm
-1
): ṽ = 3026 (w), 2914 (m), 2855 (m), 1566 (w), 1512 
(m), 1454 (m), 1369 (m), 1274 (m), 1254 (m), 1032 (m), 949 (m), 863 (m), 811 (m), 
760 (s), 694 (m), 538 (m). MS (EI, 70 eV): m/z (%) = 361 (27), 360 [M]
+
 (100), 359 
(21), 344 (11), 172 (9). HRMS (EI): Calculated for C26H20N2 [M]
+
 360.16210 found 
360.16150. 
13-Isopropyl-6,10-dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28f): 
Yellow solid, m.p. 126 – 127 °C. 1H NMR (250 MHz, 
Chloroform-d) δ = 8.44 (dd, 3J = 8.5 Hz, 4J = 1.4 Hz, 1H, 
CHAr), 8.22 (d, 
3
J = 7.9 Hz, 1H, CHAr), 8.21 (d, 
3
J = 8.5 Hz, 
1H, CHAr), 8.13 (d, 
4
J = 2.0 Hz, 1H, CHAr), 8.11 (s, 1H, CHAr), 
8.03 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.45 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.39 - 7.30 (m, 3H, CHAr), 3.12 (sept, 
3
J = 6.9 Hz, 
1H, CHiPr), 3.02 (s, 3H, CH3-quinoline), 2.57 (s, 3H, CH3), 1.41 (d, 
3
J = 6.9 Hz, 6H, 
CH3-iPr). 
13
C NMR (63 MHz, CDCl3) δ = 154.4 (CAr), 145.8 (CAr), 138.0 (CAr), 136.8 
(CAr), 132.8 (CAr), 132.0 (CAr), 129.8 (CHAr), 129.6 (CHAr), 127.8 (CAr), 126.4 (CHAr), 
125.5 (CHAr), 124.2 (CAr), 124.2 (CAr), 124.2 (CHAr), 123.8 (CHAr), 123.6 (CAr), 122.9 
(CHAr), 122.5 (CHAr), 122.3 (CHAr), 120.7 (CAr), 119.8 (CHAr), 118.5 (CAr), 95.9 
(CHAr), 34.2 (CH3), 24.3 (2CH3), 22.6 (CHaliphatic), 22.1 (CH3). 
IR (ATR, cm
-1
): ṽ = 3053 (w), 2956 (m), 2920 (m), 2865 (m), 1615 (w), 1566 (m), 1513 
(m), 1482 (w), 1456 (m), 1424 (m), 1370 (m), 1304 (m), 1256 (m), 814 (m), 777 (m), 
757 (s), 700 (m), 554 (m). MS (EI, 70 eV): m/z (%) = 389 (30), 388 [M]
+
 (100), 373 
(26), 345 (9). HRMS (EI): Calculated for C28H24N2 [M]
+
 388.19340 found 388.19309. 
13-Fluoro-6,10-dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28g): 
Yellow solid, m.p. 185 - 186 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 8.25 (d, 
3
J = 8.4 Hz, 1H, CHAr), 8.19 (d, 
3
J = 8.3 Hz, 1H, CHAr), 8.14 (dd, 
3
J = 9.1 Hz, 
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4
J = 5.0 Hz, 1H, CHAr), 7.91 (d, 
3
J = 8.1 Hz, 1H, CHAr), 
7.88 - 7.79 (m, 2H, CHAr), 7.58 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.39 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.33 (d, 
3
J = 7.6 Hz, 1H, CHAr), 7.20 (s, 
1H, CHAr), 7.09 (ddd, 
3
J = 9.0 Hz, 
3
J = 7.4 Hz, 
4
J = 2.7 Hz, 1H, 
CHAr), 2.96 (s, 3H, CH3-quinoline), 2.51 (s, 3H, CH3). 
19
F NMR 
(235 MHz, CDCl3) δ = -116.8 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 159.9 (d, 
1
JCF = 244.5 Hz, CFAr), 154.4 (CAr), 144.4 (CAr), 138.2 (CAr), 136.3 (CAr), 131.9 (CAr), 
130.8 (d, 
4
JCF = 2.5 Hz, CAr), 130.5 (CHAr), 129.8 (CHAr), 129.5 (CAr), 129.1 (CAr), 
126.5 (CHAr), 125.6 (d, 
3
JCF = 7.9 Hz, CAr), 124.3 (CAr), 124.1 (CHAr), 123.9 (CHAr), 
123.0 (CHAr), 121.9 (CHAr), 121.0 (d, 
3
JCF = 8.3 Hz, CHAr), 118.2 (CAr), 114.2 (d, 
2
JCF = 23.5 Hz, CHAr), 110.6 (d, 
2
JCF = 23.9 Hz, CHAr), 96.1 (CHAr), 22.7 (CH3), 21.9 
(CH3). IR (ATR, cm
-1
): ṽ = 3050 (w), 2918 (w), 2851 (w), 1567 (w), 1549 (w), 1512 
(w), 1494 (m), 1484 (m), 1429 (m), 1371 (m), 1282 (m), 1259 (m), 1201 (m), 1173 (m), 
871 (m), 864 (m), 812 (m), 774 (m), 759 (s), 695 (m). MS (EI, 70 eV): m/z (%) = 355 
(27), 364 [M]
+
 (100), 363 (29), 348 (9), 174 (9). HRMS (EI): Calculated for C25H17N2F 
[M]
+
 364.13703 found 364.13645. 
6,13-Dimethyl-10-propylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28h): 
Brown solid, mp. 153 - 154 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 8.37 (dd, 3J = 8.4 Hz, 4J = 1.4 Hz, 1H, 
CHAr), 8.29 - 8.20 (m, 1H, CHAr), 8.09 (d, 
3
J = 8.5 Hz, 1H, 
CHAr), 8.06 - 8.03 (m, 2H, CHAr), 7.98 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.58 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, 
CHAr), 7.41 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, 
CHAr), 7.34 (dd, 
3
J = 8.1 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 7.26 (s, 1H, CHAr), 7.21 (ddd, 
3
J = 8.5 Hz, 
4
J = 2.1 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 3.00 (s, 3H, CH3), 2.81 - 2.73 (m, 2H, 
CH2-nPr), 2.52 (s, 3H, CH3), 1.77 (m, 2H, CH2-nPr), 1.03 (t, 
3
J = 7.3 Hz, 3H, CH3-nPr). 
13
C NMR (63 MHz, CDCl3) δ = 154.3 (CAr), 144.0 (CAr), 142.9 (CAr), 136.7 (CAr), 134.7 
(CAr), 132.4 (CAr), 131.9 (CAr), 129.4 (CHAr), 129.2 (CHAr), 128.0 (CHAr), 127.5 (CAr), 
126.4 (CHAr), 124.7 (CHAr), 124.3 (CAr), 124.1 (CAr), 124.0 (CHAr), 123.8 (CHAr), 123.7 
(CHAr), 123.7 (CAr), 122.3 (CHAr), 119.6 (CHAr), 118.4 (CAr), 95.9 (CHAr), 38.5 
(CH2-nPr), 24.8 (CH2-nPr), 22.6 (CH3), 21.4 (CH3), 14.0 (CH3). IR (ATR, cm
-1
): ṽ = 3366 
(w), 3053 (w), 2955 (m), 2921 (m), 2867 (m), 2184 (w), 1916 (w), 1565 (m), 1511 (m), 
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1434 (m), 1369 (m), 1925 (m), 1254 (m), 1157 (m), 1033 (m), 906 (m), 863 (m), 820 
(m), 777 (m), 758 (s), 726 (s), 642 (m), 550 (m), 439 (m). MS (EI, 70 eV): 
m/z (%) = 389 (30), 388 [M]
+
 (100), 360 (17), 359 (58), 343 (11), 171 (12). HRMS (EI): 
Calculated for C28H24N2 [M]
+
 388.19340 found 388.19296. 
10-(tert-Butyl)-6-methylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28i): Pale 
yellow solid, mp. 180 - 181 °C. 
1
H NMR (300 MHz, DMSO-d6) 
δ = 8.66 - 8.56 (m, 1H, CHAr), 8.43 (s, 1H, CHAr), 8.31 (d, 
3
J = 8.0 Hz, 1H, CHAr), 8.27 (dd, 
3
J = 8.4 Hz, 
4
J = 1.4 Hz, 1H, 
CHAr), 8.18 (d, 
3
J = 8.2 Hz, 1H, CHAr), 8.09 (dd, 
3
J = 8.3 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.76 (d, 
4
J = 1.7 Hz, 1H, CHAr), 
7.72 - 7.66 (m, 1H, CHAr), 7.62 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.59 - 7.47 (m, 3H, CHAr), 2.93 (s, 3H, CH3-quinoline), 1.44 (s, 9H, 
CH3-tBu). 
13
C NMR (75 MHz, DMSO) δ = 154.0 (CAr), 151.2 (CAr), 144.0 (CAr), 135.9 
(CAr), 133.6 (CAr), 129.4 (CHAr), 128.1 (CAr), 127.5 (CHAr), 126.6 (CHAr), 126.5 (CHAr), 
125.9 (CAr), 125.4 (CHAr), 124.2 (CHAr), 124.0 (CHAr), 123.9 (CAr), 123.5 (CAr), 123.3 
(CAr), 121.8 (CHAr), 119.2 (CHAr), 119.0 (CHAr), 117.8 (CAr), 97.0 (CHAr), 35.0 (CH3), 
31.1 (3CH3), 22.4 (CtBu). IR (ATR, cm
-1
): ṽ = 3061 (w), 2954 (m), 2922 (m), 2866 (w), 
1563 (w), 1491 (m), 1435 (m), 1368 (m), 1297 (m), 1255 (m), 824 (m), 756 (s), 703 
(m), 638 (m). MS (EI, 70 eV): m/z (%) = 389 (33), 388 [M]
+
 (100), 374 (19), 373 (60), 
358 (21), 357 (14), 172 (16). HRMS (EI): Calculated for C28H24N2 [M]
+
 388.19340 
found 388.19318. 
10-(tert-Butyl)-6,13-dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28j): 
Pale yellow solid, mp. 198 - 200 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.40 (dd, 3J = 8.4 Hz, 4J = 1.0 Hz, 1H, 
CHAr), 8.29 (d, 
4
J = 1.9 Hz, 1H, CHAr), 8.25 (d, 
3
J = 7.8 Hz, 
1H, CHAr), 8.13 (d, 
3
J = 8.4 Hz, 1H, CHAr), 8.10 (s, 1H, CHAr), 
8.05 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.59 (ddd, 
3
J = 8.2 Hz, 
3
J = 6.4 Hz, 
4
J = 1.7 Hz, 2H, CHAr), 7.43 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.31 (s, 1H, CHAr), 7.29 - 7.19 (m, 1H, CHAr), 3.03 
(s, 3H, CH3-quinoline), 2.56 (s, 3H, CH3), 1.49 (s, 9H, CH3-tBu). 
13
C NMR (75 MHz, 
CDCl3) δ = 154.3 (CAr), 151.3 (CAr), 144.0 (CAr), 136.7 (CAr), 134.8 (CAr), 132.4 (CAr), 
132.0 (CAr), 129.4 (CHAr), 128.0 (CHAr), 127.2 (CAr), 126.5 (CHAr), 126.4 (CHAr), 124.7 
(CHAr), 124.2 (CAr), 124.1 (CAr), 124.0 (CAr), 124.0 (CHAr), 123.9 (CHAr), 122.3 (CHAr), 
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119.7 (CHAr), 118.9 (CHAr), 118.4 (CAr), 96.0 (CHAr), 35.3 (CH3), 31.5 (3CH3), 22.6 
(CH3), 21.5 (CtBu). IR (ATR, cm
-1
): ṽ = 3398 (w), 3055 (w), 2953 (m), 2921 (m), 2861 
(w), 1562 (m), 1509 (m), 1479 (m), 1422 (m), 1373 (m), 1295 (m); 1254 (m), 1032 (m), 
820 (m), 788 (m), 758 (s), 711 (m), 555 (m). MS (EI, 70 eV): m/z (%) = 403 (34), 402 
[M]
+
 (100), 388 (16), 387 (50), 382 (19), 371 (11), 172 (11). HRMS (EI): Calculated for 
C29H26N2 [M]
+
 402.20905 found 402.20888. 
10-(tert-Butyl)-13-fluoro-6-methylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine 
(28k): Pale yellow solid, mp. 242 - 244 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.32 - 8.25 (m, 2H, CHAr), 8.15 (d, 
3
J = 8.3 Hz, 1H, CHAr), 8.09 (d, 
3
J = 8.4 Hz, 1H, CHAr), 8.02 (t, 
3
J = 9.2 Hz, 1H, CHAr), 7.69 - 7.57 (m, 2H, CHAr), 7.50 (dd, 
3
J = 8.1 Hz, 
3
J = 5.0 Hz, 1H, CHAr), 7.49 - 7.37 (m, 2H, CHAr), 
7.28 (ddd, 
3
J = 11.2 Hz, 
3
J = 8.1 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 3.09 
(s, 3H, CH3-quinoline), 1.47 (s, 9H, CH3-tBu). 
19
F NMR (282 MHz, CDCl3) δ = -108.2 
(FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 153.8 (d, 
1
JCF = 254.2 Hz, CFAr), 153.8 (CHAr), 
151.8 (CAr), 136.0 (CAr), 135.3 (CAr), 135.3 (CAr), 128.0 (CHAr), 127.2 (d, 
2
JCF = 25.1 Hz, CHAr), 126.1 (d, 
4
JCF = 2.5 Hz, CAr), 125.7 (d, 
3
JCF = 8.2 Hz, CAr), 125.8 
(CAr), 125.67 (CHAr), 124.3 (CAr), 124.2 (CHAr), 123.8 (CHAr), 123.1 (CAr), 121.5 (d, 
3
JCF = 10.3 Hz, CHAr), 120.0 (CHAr), 119.7 (CAr), 119.6 (CAr), 119.5 (CHAr), 115.2 (d, 
2
JCF = 20.3 Hz, CHAr), 97.0 (CHAr), 35.4 (CH3), 31.5 (3CH3), 22.2 (CtBu). IR (ATR, cm
-
1
): ṽ = 3361 (w), 3055 (w), 2954 (m), 2865 (w), 2212 (w), 1911 (w), 1563 (m), 1511 
(m), 1456 (m), 1365 (m), 1247 (m), 1187 (m), 1077 (m), 826 (m), 760 (s), 712 (s), 642 
(m), 557 (m). MS (EI, 70 eV): m/z (%) = 407 (30), 406 [M]
+
 (100), 392 (18), 391 (61), 
376 (18), 356 (10), 196 (10), 181 (24), 172 (16), 171 (12). HRMS (EI): Calculated for 
C28H23N2F [M]
+
 406.18398 found 406.18345.
 
10-Methoxy-6,13-dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28l): 
Pale yellow solid, mp. 197 – 199 °C. 1H NMR (300 MHz, Chloroform-d) δ = 8.35 (dd, 
3
J = 8.7 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 8.31 (d, 
3
J = 8.1 Hz, 1H, CHAr), 8.07 (d, 
3
J = 8.4 Hz, 1H, CHAr), 7.98 (d, 
3
J = 8.6 Hz, 1H, CHAr), 7.97 (s, 1H, CHAr), 7.65 (d, 
4
J = 2.5 Hz, 1H, CHAr), 7.59 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.42 
(ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
3
J = 1.4 Hz, 1H, CHAr), 7.22 (ddd, 
3
J = 8.5 Hz, 
4
J = 2.0 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.17 (s, 1H, CHAr), 7.10 (dd, 
3
J = 8.8 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 3.99 (s, 3H, OCH3), 3.03 (s, 3H, CH3-quinoline), 2.52 (s, 3H, CH3). 
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13
C NMR (63 MHz, CDCl3) δ = 159.8 (CAr), 154.0 (CAr), 
137.0 (CAr), 134.9 (CAr), 132.4 (CAr), 131.8 (CAr), 129.1 
(CAr), 128.9 (CHAr), 128.3 (CHAr), 126.6 (CHAr), 126.2 (CAr), 
125.8 (CHAr), 124.8 (CHAr), 124.1 (CAr), 124.0 (CHAr), 123.5 
(CAr), 122.2 (CHAr), 120.0 (CAr), 119.6 (CHAr), 118.3 (CAr), 
116.4 (CHAr), 106.2 (CHAr), 95.1 (CHAr), 55.7 (OCH3), 22.2 
(CH3), 21.4 (CH3). IR (ATR, cm
-1
): ṽ = 2920 (w), 2831 (w), 1611 (m), 1558 (m), 1482 
(m), 1408 (m), 1368 (m), 1282 (m), 1222 (m), 1170 (m), 1030 (m), 862 (m), 817 (m), 
759 (m), 729 (m), 697 (m), 583 (m). MS (EI, 70 eV): m/z (%) = 377 (25), 376 [M]
+
 
(100), 361 (25), 333 (11), 332 (16), 331 (13), 317 (13), 359 (11). HRMS (EI): 
Calculated for C26H20ON2 [M]
+
 376.15071 found 376.15721. 
13-Isopropyl-10-methoxy-6-methylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine 
(28m): White solid, mp. 178 – 180 °C. 1H NMR (250 MHz, 
Chloroform-d) δ = 8.35 (dd, 3J = 8.4 Hz, 4J = 1.4 Hz, 1H, 
CHAr), 8.21 (dd, 
3
J = 8.3 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 8.10 (d, 
3
J = 8.6 Hz, 1H, CHAr), 8.00 (d, 
4
J = 2.0 Hz, 1H, CHAr), 7.92 
(d, 
3
J = 8.7 Hz, 1H, CHAr), 7.27 (dd, 
3
J = 8.7 Hz, 
4
J = 2.4 Hz, 
1H, CHAr), 7.57 (ddd, 
3
J = 8.3 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 
1H, CHAr), 7.41 (ddd, 
3
J = 8.4 Hz, 
3
J = 6.9 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.29 (d, 
4
J = 1.9 Hz, 1H, CHAr), 7.11 (s, 1H, CHAr), 7.05 (dd, 
3
J = 8.8 Hz, 
4
J = 2.4 Hz, 1H, 
CHAr), 3.96 (s, 3H, OCH3), 3.08 (p, 
3
J = 6.9 Hz, 1H, CHiPr), 2.97 (s, 3H, CH3-quinoline), 
1.38 (d, 
3
J = 6.9 Hz, 6H, CH3-iPr). 
13
C NMR (63 MHz, CDCl3) δ = 159.6 (CAr), 154.1 
(CAr), 145.6 (CAr), 144.0 (CAr), 136.6 (CAr), 132.8 (CAr), 131.6 (CAr), 129.5 (CHAr), 
129.3 (CAr), 126.2 (CHAr), 125.7 (CHAr), 125.6 (CHAr), 124.1 (CAr), 123.7 (CHAr), 123.3 
(CAr), 122.3 (CHAr), 122.2 (CHAr), 120.1 (CAr), 119.7 (CHAr), 118.4 (CAr), 115.8 (CHAr), 
106.5 (CHAr), 94.9 (CHAr), 55.7 (OCH3), 34.1 (CHiPr), 24.2 (2CH3), 22.7 (CH3). 
IR (ATR, cm
-1
): ṽ = 3528 (w). 3160 (w), 3077 (w), 2958 (m), 2868 (w), 2838 (w), 2398 
(w), 2084 (w), 2008 (w), 1613 (m), 1568 (m), 1485 (m), 1417 (m), 1369 (m), 1278 (m), 
1225 (s), 1030 (m), 864 (m), 814 (m), 760 (s), 699 (m). MS (EI, 70 eV): m/z (%) = 405 
(30), 404 [M]
+
 (100), 389 (24), 345 (11). HRMS (EI): Calculated for C28H24ON2 [M]
+
 
404.18831 found 404.18819. 
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10-Fluoro-6,13-dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine (28n): 
Brown solid, mp. 198 - 200 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 8.30 (dd, 3J = 8.4 Hz, 4J = 1.5 Hz, 2H, CHAr), 
8.04 (d, 
3
J = 8.5 Hz, 2H, CHAr), 8.02 - 7.98 (m, 1H, CHAr), 7.89 
(s, 1H, CHAr), 7.84 (dd, 
3
J = 10.3 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 
7.60 (ddd, 
3
J = 8.4 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, CHAr), 7.41 
(ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.28 - 7.15 
(m, 2H, CHAr), 3.01 (s, 3H, CH3-quinoline), 2.50 (s, 3H, CH3). 
19
F NMR (282 MHz, 
CDCl3) δ = -111.7 (FCAr). 
13
C NMR (75 MHz, CDCl3) δ = 162.6 (d, 
1
JCF = 247.6 Hz, 
CFAr), 154.1 (CAr), 150.5 (CAr), 143.3 (CAr), 136.0 (CAr), 135.2 (CHAr), 132.4 (CAr), 
132.0 (CAr), 129.6 (d, 
3
JCF = 8.2 Hz, CAr), 129.0 (CAr), 128.9 (CHAr), 126.9 (CHAr), 
126.3 (d, 
3
JCF = 8.8 Hz, CHAr), 124.9 (CHAr), 124.2 (CHAr), 123.8 (CAr), 122.8 (d, 
4
JCF = 2.8 Hz, CAr), 122.2 (CHAr), 119.6 (CHAr), 118.1 (CAr), 116.5 (d, 
2
JCF = 23.2 Hz, 
CHAr), 108.9 (d, 
2
JCF = 23.2 Hz, CHAr), 96.2 (CHAr), 22.2 (CH3), 21.4 (CH3). 
IR (ATR, cm
-1
): ṽ = 3063 (w), 3034 (w), 2983 (w), 2904 (w), 1614 (w), 1568 (m), 1481 
(m), 1440 (m), 1371 (m), 1273 (m), 1180 (m), 941 (m), 856 (m), 809 (m), 764 (m), 748 
(s), 735 (m), 541 (m). MS (EI, 70 eV): m/z (%) = 365 (27), 364 (100), 363 (29), 348 
(12), 174 (14). HRMS (EI): Calculated for C25H17N2F [M]
+
 364.13703 found 
364.13640. 
6-Methyl-10-(trifluoromethyl)quinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine 
(28o): White solid, mp. 169 - 171 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 8.44 (s, 1H, CHAr), 8.27 (d, 
3
J = 8.6 Hz, 2H, 
CHAr), 8.21 (d, 
3
J = 9.5 Hz, 1H, CHAr), 8.15 (d, 
3
J = 9.5 Hz, 1H, 
CHAr), 8.08 (d, 
3
J = 8.3 Hz, 1H, CHAr), 7.70 (d, 
3
J = 8.3 Hz, 1H, 
CHAr), 7.63 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.4 Hz, 1H, 
CHAr), 7.48 - 7.39 (m, 3H, CHAr), 7.34 (s, 1H, CHAr), 3.00 (s, 3H, 
CH3-quinoline).
 19
F NMR (235 MHz, CDCl3) δ = -62.4 (FCaliphatic). 
13
C NMR (63 MHz, 
CDCl3) δ = 154.4 (CAr), 144.0 (CAr), 135.2 (CAr), 134.4 (CAr), 132.7 (CAr), 130.0 (CAr), 
129.8 (q, 
2
JCF = 32.7 Hz, CAr), 129.3 (CHAr), 129.0 (CAr), 128.2 (CHAr), 127.6 (CAr), 
127.3 (CHAr), 125.6 (CHAr), 124.9 (q, 
3
JCF = 3.6 Hz, CHAr), 124.8 (CHAr), 124.6 (CHAr), 
124.3 (CHAr), 124.2 (q, 
1
JCF = 272 Hz, CF3), 123.8 (CAr), 122.7 (CAr), 122.4 (CHAr), 
120.0 (q, 
3
JCF = 4.0 Hz, CHAr), 119.7 (CHAr), 118.0 (CAr), 98.5 (CHAr), 22.2 (CH3). 
IR (ATR, cm
-1
): ṽ = 3362 (w), 3062 (w), 2917 (w), 1621 (m), 1514 (m),k 1441 (m), 
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1370 (m), 1341 (m), 1315 (m), 1264 (m), 1169 (m), 1113 (s), 1080 (m); 1022 (m), 827 
(m), 758 (s), 644 (m). MS (EI, 70 eV): m/z (%) = 401 (25), 400 (100), 399 (47), 398 
(13), 166 (9). HRMS (EI): Calculated for C25H15N2F3 [M]
+
 400.11818 found 400.11760. 
6,13-Dimethyl-10-(trifluoromethyl)quinolino[3',4':4,5]pyrrolo[1,2-f]-
phenanthridine (28p): White solid, mp. 190 - 192 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 8.34 (s, 1H, CHAr), 
8.26 - 8.18 (m, 2H, CHAr), 7.93 (t, 
3
J = 8.8 Hz, 2H, CHAr), 7.88 
(s, 1H, CHAr), 7.60 (ddd, 
3
J = 7.6 Hz, 
3
J = 7.0 Hz, 
4
J = 1.3 Hz, 
2H, CHAr), 7.37 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.0 Hz, 
4
J = 1.2 Hz, 1H, 
CHAr), 7.18 - 7.11 (m, 2H, CHAr), 2.92 (s, 3H, CH3-quinoline), 
2.45 (s, 3H). 
19
F NMR (282 MHz, CDCl3) δ = -62.3 (FCaliphatic).
 13
C NMR (75 MHz, 
CDCl3) δ = 154.4 (CAr), 144.2 (CAr), 135.2 (CAr), 134.7 (CAr), 132.3 (CAr), 132.2 (CAr), 
129.5 (CHAr), 129.4 (d, 
2
JCF = 32.6 Hz, CAr), 128.9 (q, 
4
JCF = 1.1 Hz, CHAr), 127.4 
(CAr), 127.0 (CHAr), 126.1 (CAr), 124.8 (CAr), 124.6 (CHAr), 124.5 (q, 
3
JCF = 4.0 Hz, 
CHAr), 124.5 (CHAr), 124.2 (q, 
1
JCF = 274 Hz, CF3), 124.0 (CHAr), 123.6 (CAr), 122.3 
(CHAr), 119.7 (q, 
3
JCF = 4.4 Hz, CHAr), 119.4 (CHAr), 118.0 (CAr), 98.1 (CHAr), 22.4 
(CH3), 21.3 (CH3). IR (ATR, cm
-1
): ṽ = 3376 (w), 3067 (w), 2919 (w), 2856 (w), 2641 
(w), 1618 (w), 1515 (w), 1501 (w), 1435 (m), 1372 (m), 1339 (m), 1316 (s), 1262 (m), 
1168 (m), 1106 (s), 1079 (m), 824 (m), 758 (s), 566 (m). MS (EI, 70 eV): m/z (%) = 415 
(28), 414 (100), 413 (30), 398 (10), 199 (8). HRMS (EI): Calculated for C26H17F3N2 
[M]
+
 415.14166 found 415.14181.  
5.2.8. Synthesis of pyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines by 
regioselective Sonogashira reaction followed by one-pot C-N 
coupling/hydroamination/C-H arylation 
5.2.8.1.Starting materials 
4-Chloro-2,6-dimethyl-5-(phenylethynyl)pyrimidine (30a): Yellow solid, 
mp. 125 - 126 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 7.59 - 7.53 (m, 2H, CHPh), 7.40 - 7.36 (m, 3H, CHPh), 
2.70 (s, 3H, CH3), 2.68 (s, 3H, CH3). 
13
C NMR (63 MHz, 
CDCl3) δ = 170.1 (CAr), 165.7 (CAr), 161.2 (CAr), 131.7 
(2CHPh), 129.4 (CHAr), 128.6 (2CHPh), 122.3 (CAr), 115.3 (CAr), 102.0 (Csp), 81.5 (Csp), 
25.9 (CH3-pyrimidine), 23.8 (CH3-pyrimidine). IR (ATR, cm
-1
): ṽ = 3048 (w), 2993 (w), 2960 
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(w), 2923 (w), 2852 (w), 1560 (m), 1503 (m), 1488 (m), 1418 (s), 1351 (m), 1308 (m), 
1245 (m), 1073 (m), 863 (m), 766 (s), 695 (m), 565 (m). MS (EI, 70 eV): m/z (%) = 244 
(33), 243 (17), 242 [M]
+
 (100), 207 (10), 167 (11), 166 (85), 160 (26), 140 (18), 139 
(26), 125 (11). HRMS (EI): Calculated for C14H11N2Cl [M]
+
 242.06053 found 
242.06022, calculated for C14H11N2
37
Cl [M]
+
 244.05758 found 244.05770. 
4-Chloro-2,6-dimethyl-5-(p-tolylethynyl)pyrimidine (30b): Yellow solid, 
mp. 67 - 68 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 7.45 (d, 3J = 8.1 Hz, 2H), 7.18 (d, 3J = 8.1 Hz, 2H), 
2.69 (s, 3H, CH3), 2.68 (s, 3H, CH3), 2.38 (s, 3H, CH3). 
13
C NMR (63 MHz, CDCl3) δ = 170.0 (CAr), 165.5 (CAr), 
161.1 (CAr), 139.8 (CAr), 131.6 (2CHAr), 129.4 (2CHAr), 119.2 (CAr), 115.5 (CAr), 102.4 
(Csp), 80.9 (Csp), 25.9 (CH3-pyrimidine), 23.8 (CH3-pyrimidine), 21.7 (CH3). IR (ATR, cm
-1
): 
ṽ = 2957 (w), 2919 (w), 2859 (w), 2214 (w), 1897 (w), 1506 (m), 1419 (m), 1249 (m), 
1031 (m), 812 (s), 526 (m). MS (EI, 70 eV): m/z (%) = 258 (40), 257 (23), 256 (100), 
255 (12), 200 (16), 181 (12), 180 (80), 178 (12), 175 (10), 174 (13), 173 (25), 164 (18), 
153 (19), 152 (24), 151 (13), 139 (31), 138 (16), 127 (10), 42 (37). HRMS (EI): 
Calculated for C15H13N2Cl 256.07618 [M]
+
 found 256.07597, calculated for 
C15H13N2
37
Cl 258.07323 [M]
+
 found 258.07349. 
4-Chloro-2,6-dimethyl-5-((4-propylphenyl)ethynyl)pyrimidine (30c): Yellow solid, 
mp. 51 - 52 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 7.44 (d, 3J = 8.1 Hz, 2H, CHAr), 7.21 - 7.12 (m, 2H, 
CHAr), 2.66 (s, 3H, CH3-pyrimidine), 2.65 (s, 3H, 
CH3-pyrimidine), 2.65 - 2.51 (m, 2H, CH2-aliphatic), 1.62 (h, 
3
J = 7.3 Hz, 2H, CH2-aliphatic), 0.91 (t, 
3
J = 7.3 Hz, 3H, CH3-nPr). 
13
C NMR (63 MHz, 
CDCl3) δ = 169.9 (CAr), 165.4 (CAr), 161.0 (CAr), 144.4 (CAr), 131.6 (2CHAr), 128.7 
(2CHAr), 119.4 (CAr), 115.4 (CAr), 102.4 (Calkynyl), 80.9 (Calkynyl), 38.1 (CH2), 25.8 
(CH3), 24.4 (CH2), 23.8 (CH3), 13.8 (CH3). IR (ATR, cm
-1
): ṽ = 3032 (w), 2961 (m), 
2932 (m), 2868 (w), 2216 (w), 1903 (w), 1503 (m), 1418 (s), 1366 (m), 1309 (m), 1245 
(m), 1112 (m), 842 (m), 824 (s), 740 (m), 563 (m), 544 (m). MS (EI, 70 eV): 
m/z (%) = 286 (16), 285 (11), 284 [M]
+
 (49), 257 (32), 256 (17), 255 (100), 179 (11), 
173 (16), 164 (14), 152 (10), 151 (11), 138 (14), 42 (11), 29 (12). HRMS (EI): 
Calculated for C17H17N2Cl [M]
+
 284.10748 found 284.10761, calculated for 
C17H17N2
37
Cl [M]
+
 286.10453 found 286.10539.  
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4-Chloro-5-((4-methoxyphenyl)ethynyl)-2,6-dimethylpyrimidine (30d): Yellow 
solid, mp.  104 - 105 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 7.42 (d, 3J = 8.9 Hz, 2H, CHAr), 6.83 
(d, 
3
J = 8.9 Hz, 2H, CHAr), 3.76 (s, 3H, OCH3), 2.62 (s, 
3H, CH3-pyrimidine), 2.61 (s, 3H, CH3-pyrimidine). 
13
C NMR 
(63 MHz, CDCl3) δ = 169.8 (CAr), 165.3 (CAr), 161.0 (CAr), 160.6 (CAr), 133.3 (2CHAr), 
115.7 (CAr), 114.3 (2CHAr), 102.4 (Csp), 80.4 (Csp), 55.5 (OCH3), 25.8 (CH3-pyrimidine), 
23.8 (CH3-pyrimidine). (One CAr is overlapped by other peaks). IR (ATR, cm
-1
): ṽ = 3003 
(w), 2914 (w), 2838 (w), 2535 (w), 2215 (w), 1904 (w), 1604 (m), 1504 (s), 1443 (m), 
1287 (m), 1248 (s), 1172 (m), 1107 (m), 1024 (m), 866 (m), 836 (s), 635 (m), 592 (m), 
537 (m). MS (EI, 70 eV): m/z (%) = 274 (38), 273 [M]
+
 (20), 272 (100), 259 (14), 257 
(39), 196 (26), 175 (10), 153 (19), 149 (19). HRMS (EI): Calculated for C15H13ClN2O 
[M]
+
 273.07892 found 273.07924, calculated for C15H13
37
ClN2O [M]
+
 275.07639 found 
275.07620. 
4-Chloro-5-((4-fluorophenyl)ethynyl)-2,6-dimethylpyrimidine (30e): Yellow soild, 
mp. 90 - 91 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 7.53 (dd, 3J = 8.9 Hz, 3J = 5.4 Hz, 2H, CHAr), 7.07 (dd, 
3
J = 8.9 Hz, 
3
J = 8.5 Hz, 2H, CHAr), 2.68 (s, 3H, 
CH3-pyrimidine), 2.68 (s, 3H, CH3-pyrimidine). 
19
F NMR 
(282 MHz, CDCl3) δ = -109.0 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 170.1 (CAr), 
165.8 (CAr), 165.2 (CAr), 163.22 (d, 
1
JCF = 251.4 Hz, CFAr), 161.2 (CAr), 133.7 (d, 
3
JCF = 8.6 Hz, 2CHAr), 118.4 (d, 
4
JCF = 3.6 Hz, CAr), 116.1 (d, 
2
JCF = 22.2 Hz, 2CHAr), 
115.2 (CAr), 100.9 (Csp), 81.2 (d, 
5
JCF = 1.5 Hz, Csp), 25.9 (CH3-pyridine), 23.8 
(CH3-pyridine). IR (ATR, cm
-1
): ṽ = 3106 (w), 3080 (w), 3055 (w), 2919 (w), 2220 (w), 
1888 (w), 1602 (m), 1505 (m), 1419 (m), 1227 (m), 1155 (m), 861 (m), 833 (s), 759 
(m), 639 (m), 557 (m), 528 (m). MS (EI, 70 eV): m/z (%) = 262 (28), [M]
+
 261 (12), 
260 (78), 225 (12), 184 (100), 180 (11), 178 (27), 169 (13), 158 (11), 157 (29), 143 
(14), 133 (17), 89 (17), 42 (16). HRMS (EI): Calculated for C14H10ClFN2 261.05893 
found 261.05941, calculated for C14H10
37
ClFN2 263.05631 found 263.05655. 
5-((4-(tert-Butyl)phenyl)ethynyl)-4-chloro-2,6-dimethylpyrimidine (30f): Brown 
solid, mp. 67 - 68 °C. 
1
H NMR (250 MHz, Chloroform-d) δ = 7.42 (d, 3J = 8.4 Hz, 2H, 
CHAr), 7.31 (d, 
3
J = 8.4 Hz, 2H, CHAr), 2.61 (s, 3H, CH3-pyrimidine), 2.60 (s, 3H, 
CH3-pyrimidine), 1.24 (s, 9H, CH3-tBu). 
13
C NMR (63 MHz, CDCl3) δ = 170.0 (CAr), 165.5 
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(CAr), 161.0 (CAr), 152.9 (CAr), 131.5 (2CH), 125.6 
(2CH), 119.2 (CAr), 115.5 (CAr), 102.3 (Csp), 80.9 (Csp), 
35.0 (CtBu), 31.2 (3CH3-tBu), 25.9 (CH3-pyrimidine), 23.8 
(CH3-pyrimidine). IR (ATR, cm
-1
): ṽ = 3040 (w), 2959 (m), 
2907 (w), 2869 (w), 2832 (w), 2214 (m), 1556 (m), 1502 (m), 1418 (m), 1364 (m), 1251 
(m), 1101 (m), 1022 (m), 864 (m), 837 (s), 761 (m), 714 (m), 562 (m). MS (EI, 70 eV): 
m/z (%) = 300 (12). 298 (36), 285 (30), 284 (19), 283 (100), 255 (13), 165 (12), 42 (15), 
31 (15). HRMS (EI): Calculated for C18H19ClN2 299.13095 found 299.13092, 
calculated for C18H19
37
ClN2 301.12854 found 301.12879.  
5.2.8.2.Pyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridines 
11,13-Dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32a): Pale yellow 
solid, mp. 210 - 211 °C. 
1
H NMR (300 MHz, Chloroform-d) 
δ = 10.03 (dd, 3J = 8.5 Hz, 4J = 1.2 Hz, 1H, CHAr), 8.22 (dd, 
3
J = 8.1 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 8.18 (dd, 
3
J = 8.0 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 8.05 - 7.99 (m, 1H, CHAr), 7.60 
(ddd, 
3
J = 8.6 Hz, 
3
J = 7.2 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.52 - 7.45 (m, 2H, CHAr), 7.38 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.2 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 
7.00 (s, 1H, CHpyrrole), 2.90 (s, 3H, CH3), 2.79 (s, 3H, CH3). 
13
C NMR (75 MHz, CDCl3) 
δ = 159.4 (CAr), 159.0 (CAr), 150.3 (CAr), 135.0 (CAr), 134.1 (CAr), 129.3 (CHAr), 128.8 
(CHAr), 128.4 (CHAr), 127.5 (CAr), 125.2 (CAr), 124.5 (CHAr), 124.1 (CHAr), 123.2 
(CHAr), 122.8 (CHAr), 121.7 (CAr), 119.7 (CHAr), 116.5 (CAr), 91.4 (CHAr), 26.4 (CH3), 
21.8 (CH3). IR (ATR, cm
-1
): ṽ = 3033 (w), 2959 (w), 2917 (m), 2850 (m), 1955 (w), 
1927 (w), 1895 (w), 1722 (w), 1586 (m), 1550 (m), 1465 (m), 1440 (m), 1360 (m), 1290 
(m), 1257 (m), 1021 (m), 743 (s), 715 (m). MS (EI, 70 eV): m/z (%) = 298 (22), 297 
[M]
+
 (100), 255 (26), 253 (11). HRMS (EI): Calculated for C20H15N3 [M]
+
 297.12605 
found 297.12588. 
6,11,13-Trimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32b): Pale 
yellow solid, mp. 226 - 227 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 9.79 (d, 3J = 8.5 
Hz, 1H, CHAr-22), 8.10 (dd, 
3
J = 7.5 Hz, 
4
J = 1.9 Hz, 1H), 7.99 - 7.86 (m, 2H), 7.42 (pd, 
3
J = 7.1 Hz, 
4
J = 1.5 Hz, 2H), 7.32 (dd, 
3
J = 8.6 Hz, 
4
J = 1.4 Hz, 1H), 6.88 (s, 1H, 
CHpyrrole), 2.86 (s, 3H, CH3), 2.74 (s, 3H, CH3), 2.47 (s, 3H, CH3). 
13
C NMR (63 MHz, 
CDCl3) δ = 158.0 (CAr), 157.6 (CAr), 148.7 (CAr), 132.6 (CAr), 132.5 (CAr), 131.5 (CAr), 
128.8 (CHAr), 127.3 (CHAr), 126.9 (CHAr), 126.2 (CAr), 124.0 (CAr), 122.8 (CHAr), 122.1 
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(CHAr), 121.4 (CHAr), 120.2 (CAr), 118.2 (CHAr), 115.1 
(CAr), 89.8 (CHAr), 25.2 (CH3), 20.6 (CH3), 20.3 (CH3). 
IR (ATR, cm
-1
): ṽ = 3090 (w), 2958 (m), 2917 (m), 2851 
(m), 1923 (w), 1721 (m), 1659 (m), 1583 (m), 1546 (m), 
1499 (m), 1460 (m), 1414 (m), 1387 (m), 1358 (m), 1286 
(m), 1252 (m), 1178 (m), 1155 (m), 1024 (m), 944 (m), 819 
(m), 773 (m), 761 (m), 725 (s), 577 (m). MS (EI, 70 eV): m/z (%) = 312 (24), 311 [M]
+
 
(100), 269 (18), 253 (10), 156 (4). HRMS (EI): Calculated for C21H17N3 [M]
+
 
311.14170 found 311.14147. 
6-Isopropyl-11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32c): 
Pale yellow solid, mp. 180 - 181 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 9.93 (d, 3J = 8.7 Hz, 1H, CHAr), 8.20 (dd, 
3
J = 7.9 Hz, 
4
J = 1.7 Hz, 1H, CHAr), 8.06 (d, 
4
J = 2.0 Hz, 1H, 
CHAr), 7.99 (dd, 
3
J = 7.7 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 
7.54 - 7.40 (m, 3H, CHAr), 6.95 (s, 1H), 3.09 (sept, 
3
J = 6.9 Hz, 1H, CHiPr), 2.88 (s, 3H, CH3), 2.77 (s, 3H, CH3), 
1.39 (d, 
3
J = 6.9 Hz, 6H, CH3-iPr). 
13
C NMR (75 MHz, CDCl3) δ = 159.33 (CAr), 158.91 
(CAr), 149.97 (CAr), 144.72 (CAr), 133.86 (CAr), 133.02 (CAr), 128.56 (CHAr), 128.12 
(CHAr), 127.60 (CAr), 127.52 (CHAr), 125.23 (CAr), 124.09 (CHAr), 122.66 (CHAr), 
121.47 (CAr), 120.82 (CHAr), 119.58 (CHAr), 116.31 (CAr), 91.01 (CHAr), 34.2 (CHiPr), 
26.4 (CH3), 24.3 (2CH3-iPr), 21.8 (CH3). IR (ATR, cm
-1
): ṽ = 3090 (w), 2957 (s), 2923 
(m), 2865 (m), 1725 (w), 1661 (w), 1583 (m), 1548 (m), 1461 (m), 1419 (m), 1388 (m), 
1360 (m), 1259 (m), 1080 (m), 1016 (m), 944 (m), 824 (m), 797 (m), 755 (s), 726 (s), 
719 (m), 621 (m). MS (EI, 70 eV): m/z (%) = 340 (17), 339 [M]
+
 (100), 337 (12), 325 
(19), 324 (50), 281 (13), 268 (14), 267 (11). HRMS (EI): Calculated for C21H21N3 [M]
+
 
339.17300 found 339.17298.  
6-Chloro-11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32d): 
Pale yellow solid, mp. 284 - 285 °C. 
1
H NMR (500 MHz, DMSO-d6) δ = 9.95 (d, 
3
J = 9.0 Hz, 1H, CHAr), 8.42 (d, 
4
J = 2.4 Hz, 1H, CHAr), 8.40 - 8.37 (m, 1H, CHAr), 8.28 
(dd, 
3
J = 7.5 Hz, 
4
J = 1.9 Hz, 1H, CHAr), 7.65 (dd, 
3
J = 9.0 Hz, 
4
J = 2.4 Hz, 1H, CHAr), 
7.63 - 7.59 (m, 2H, CHAr), 7.46 (s, 1H, CHpyrrole), 2.79 (s, 3H, CH3-pyrimidine), 2.78 (s, 3H, 
CH3-pyrimidine). 
13
C NMR (126 MHz, DMSO) δ = 158.9 (CAr), 158.7 (CAr), 149.2 (CAr), 
132.4 (CAr), 128.7 (CHAr), 128.7 (CHAr), 128.3 (CHAr), 128.0 (CAr), 125.1 (CAr), 124.5 
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(CHAr), 123.6 (CAr), 122.9 (CAr), 122.7 (CHAr), 122.6 (CHAr), 
119.8 (CHAr), 115.6 (CAr), 98.8 (CAr), 91.9 (CHAr), 25.1 
(CH3), 20.6 (CH3). IR (ATR, cm
-1
): ṽ = 3379 (m), 3288 (m), 
3111 (m), 2962 (w), 2922 (m), 2851 (w), 1651 (m), 1585 
(m), 1548 (m), 1462 (m), 1414 (m), 1387 (m), 1279 (m), 
1022 (m), 993 (m), 822 (m), 761 (s), 732 (s), 579 (s), 540 (s). 
MS (EI, 70 eV): m/z (%) = 333 (34), 332 (23), 331 [M]
+
 (100), 289 (22), 254 (11), 253 
(24), 166 (14). HRMS (EI): Calculated for C20H14N3Cl [M]
+
 331.08708 found 
331.08702, calculated for C20H14N3
37
Cl [M]
+
 333.08413 found 333.08511. 
3,11,13-Trimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32e): Pale 
yellow solid, mp. 190 - 191 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 9.95 (dd, 3J = 8.5 Hz, 4J = 1.2 Hz, 
1H, CHAr), 8.14 (dd, 
3
J = 8.1 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.87 (s, 1H, CHAr), 7.78 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.54 (ddd, 
3
J = 8.6 Hz, 
3
J = 7.2 Hz, 
4
J = 1.5 Hz, 
1H, CHAr), 7.32 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.2 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.19 (d, 
3
J = 8.1 Hz, 1H, CHAr), 6.80 (s, 1H, CHpyrrole), 2.87 (s, 3H CH3-pyrimidine), 2.73 (s, 3H, 
CH3-pyrimidine), 2.47 (s, 3H, CH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.1 (CAr), 158.6 
(CAr), 150.1 (CAr), 138.6 (CAr), 135.0 (CAr), 134.1 (CAr), 129.5 (CHAr), 129.0 (CHAr), 
127.2 (CAr), 124.2 (CHAr), 124.0 (CHAr), 123.0 (CHAr), 122.8 (CHAr), 122.6 (CAr), 121.6 
(CAr), 119.6 (CHAr), 116.5 (CAr), 90.5 (CHAr), 26.4 (CH3), 22.0 (CH3), 21.8 (CH3). 
IR (ATR, cm
-1
): ṽ = 3116 (w), 3087 (w), 2919 (m), 2851 (m), 1715 (w), 1699 (w), 1661 
(w), 1583 (m), 1563 (m), 1549 (m), 1496 (m), 1445 (s), 1416 (m), 1386 (m), 1359 (m), 
1292 (m), 1023 (m), 943 (m), 813 (m), 749 (s), 633 (m). MS (EI, 70 eV): m/z (%) = 312 
(25), 311 [M]
+
 (100), 269 (22), 253 (11), 155 (12). HRMS (EI): Calculated for 
C21H17N3 [M]
+
 311.14170 found 311.14129. 
3,6,11,13-Tetramethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32f): 
Yellow solid, mp. 203 - 204 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 9.76 (d, 
3
J = 8.6 Hz, 1H, CHAr), 7.88 (s, 1H, CHAr), 7.84 (s, 1H, CHAr), 7.76 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.30 (ddd, 
3
J = 8.5 Hz, 
4
J = 1.9 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.17 (dd, 
3
J = 8.2 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 6.78 (s, 1H, CHAr), 2.86 (s, 3H, CH3-pyrimidine), 2.73 
(s, 3H, CH3-pyrimidine), 2.49 - 2.42 (m, 6H, 2CH3).
 13C NMR (63 MHz, CDCl3) δ = 158.9 
(CAr), 158.4 (CAr), 149.8 (CAr), 138.4 (CAr), 134.0 (CAr), 133.5 (CAr), 132.7 (CAr), 129.8 
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(CHAr), 129.3 (CHAr), 127.2 (CAr), 123.9 (CHAr), 123.1 
(CHAr), 122.7 (CHAr), 122.6 (CAr), 121.4 (CAr), 119.3 
(CHAr), 116.3 (CAr), 90.1 (CHAr), 26.4 (CH3), 22.0 
(CH3), 21.7 (CH3), 21.5 (CH3). IR (ATR, cm
-1
): 
ṽ = 3090 (w), 2918 (m), 2853 (m), 2166 (m), 1723 (w), 
1616 (w), 1583 (m), 1552 (m), 1501 (m), 1423 (m), 
1388 (m), 1359 (m), 1306 (m), 1289 (m), 1249 (m), 1190 (m), 944 (m), 816 (m), 768 
(m), 732 (s), 724 (s), 714 (m), 641 (m), 536 (m). MS (EI, 70 eV): m/z (%) = 326 (24), 
325 [M]
+
 (100); 283 (15), 163 (12), 141 (5), 121 (5). HRMS (EI): Calculated for 
C22H19N3 [M]
+
 325.15735 found 325.15688. 
6-Isopropyl-3,11,13-trimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine 
(32g): Yellow solid, mp. 191 - 192 °C. 
1
H NMR 
(300 MHz, Chloroform-d) δ = 9.90 (d, 3J = 8.7 Hz, 1H, 
CHAr), 8.02 (d, 
4
J = 2.0 Hz, 1H, CHAr), 7.93 (d, 
4
J = 1.7 Hz, 1H, CHAr), 7.82 (d, 
3
J = 8.1 Hz, 1H, CHAr), 
7.47 (dd, 
3
J = 8.7 Hz, 
4
J = 2.0 Hz, 1H, CHAr), 7.21 (d, 
3
J = 8.4 Hz, 1H, CHAr), 6.84 (s, 1H, CHpyrrole), 3.09 
(sept, 
3
J = 6.9 Hz, 1H, CHiPr), 2.87 (s, 3H, CH3), 2.74 (s, 3H, CH3), 2.50 (s, 3H, CH3), 
1.40 (d, 
3
J = 6.9 Hz, 6H, 3CH3-iPr). 
13
C NMR (75 MHz, CDCl3) δ = 159.0 (CAr), 158.5 
(CAr), 149.9 (CAr), 144.6 (CAr), 138.5 (CAr), 134.1 (CAr), 133.1 (CAr), 129.5 (CHAr), 
127.5 (CAr), 127.3 (CHAr), 124.0 (CHAr), 122.7 (CAr), 122.7 (CHAr), 121.5 (CAr), 120.7 
(CHAr), 119.6 (CHAr), 116.4 (CAr), 90.2 (CHAr), 34.2 (CHiPr), 26.4 (CH3), 24.3 
(2CH3-iPr), 22.1 (CH3), 21.8 (CH3). IR (ATR, cm
-1
): ṽ = 3087 (w), 3062 (w), 3021 (w), 
2958 (m), 2920 (m), 2870 (m), 1699 (w), 1584 (m), 1551 (m), 1496 (m), 1432 (m), 
1388 (m), 1359 (m), 1193 (m), 1177 (m), 1045 (m), 944 (m), 830 (m), 808 (m), 768 
(m), 737 (m), 720 (s), 551 (m). MS (EI, 70 eV): m/z (%) = 354 (28). 353 [M]
+
 (100), 
339 (16), 338 (58), 282 (13), 169 (12). HRMS (EI): Calculated for C24H23N3 [M]
+
 
353.18865 found 353.18798.  
6-Fluoro-3,11,13-trimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32h): 
Yellow solid, mp. 235 - 236 °C. 
1
H NMR (500 MHz, Chloroform-d) δ 9.83 (dd, 
3
J = 9.2 Hz, 
3
J = 5.4 Hz, 1HAr), 7.69 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.67 - 7.59 (m, 2H, 
CHAr), 7.19 - 7.15 (m, 1H, CHAr), 7.13 (ddd, 
3
J = 9.2 Hz, 
3
J = 7.5 Hz, 
4
J = 2.8 Hz, 1H, 
CHAr), 6.70 (s, 1H, CHpyrrole), 2.83 (s, 3H, CH3-pyrimidine), 2.71 (s, 3H, CH3-pyrimidine), 2.44 
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(s, 3H, CH3). 
19
F NMR (282 MHz, CDCl3) δ = -117.7 
(FCAr).
 13
C NMR (126 MHz, CDCl3) δ = 159.5 (d, 
1
JCF = 243.2 Hz, CFAr), 159.4 (CAr), 158.8 (CAr), 149.8 
(CAr), 138.7 (CAr), 133.6 (CAr), 131.3 (d, 
4
JCF = 2.3 Hz, 
CAr), 130.1 (CHAr), 126.4 (d, 
4
JCF = 2.5 Hz, CAr), 123.9 
(CHAr), 123.64 (d, 
3
JCF = 7.6 Hz, CAr), 122.9 (CAr), 
122.9 (CHAr), 121.4 (d, 
3
JCF = 7.8 Hz, CHAr), 116.3 (CAr), 115.7 (d, 
2
JCF = 22.5 Hz, 
CHAr), 109.0 (d, 
2
JCF = 24.1 Hz, CHAr), 90.5 (CHAr), 26.3 (CH3), 21.9 (CH3), 21.7 
(CH3). IR (ATR, cm
-1
): ṽ = 3089 (w), 3039 (w), 2961 (m), 2919 (m), 2851 (m), 1582 
(m), 1566 (m), 1551 (m), 1497 (m), 1438 (m), 1258 (m), 1201 (m), 1191 (m), 1169 (m), 
1156 (m), 1014 (m), 937 (m), 795 (s), 766 (m), 726 (m), 584 (m). MS (EI, 70 eV): 
m/z (%) = 330 (24), 329 [M]
+
 (100), 287 (25), 165 (10), 143 (5), 130 (4). HRMS (EI): 
Calculated for C21H16N3F [M]
+
 329.13228 found 329.13204. 
6-Chloro-3,11,13-trimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32i): 
Yellow solid, mp. 265 - 266 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 9.87 (d, 3J = 9.0 Hz, 1H, CHAr), 8.03 
(d, 
4
J = 2.4 Hz, 1H, CHAr), 7.81 (d, 
3
J = 8.1 Hz, 1H, 
CHAr), 7.77 (s, 1H, CHAr), 7.43 (dd, 
3
J = 9.0 Hz, 
4
J = 2.4 Hz, 1H, CHAr), 7.29 - 7.22 (m, 1H, CHAr), 6.85 
(s, 1H, CHAr), 2.87 (s, 3H, CH3), 2.77 (s, 3H, CH3), 2.49 
(s, 3H, CH3). 
13
C NMR (75 MHz, CDCl3) δ = 159.3 (CAr), 158.9 (CAr), 150.0 (CAr), 
138.9 (CAr), 133.8 (CAr), 133.3 (CAr), 130.2 (CHAr), 129.9 (CAr), 128.7 (CHAr), 128.1 
(CAr), 126.1 (CAr), 124.0 (CHAr), 123.3 (CAr), 122.9 (CHAr), 122.8 (CHAr), 121.0 (CHAr), 
116.5 (CAr), 90.9 (CHAr), 26.3 (CH3), 22.0 (CH3), 21.8 (CH3). IR (ATR, cm
-1
): ṽ = 3375 
(m), 3112 (m), 3046 (m), 3030 (m), 2917 (m), 2850 (m), 1584 (m), 1549 (m), 1488 (m), 
1419 (m), 1384 (m), 1305 (m), 1279 (m), 1176 (m), 1161 (m), 1108 (m), 1023 (m), 994 
(m), 943 (m), 827 (m), 810 (m), 766 (s), 728 (s), 534 (m). MS (EI, 70 eV): 
m/z (%) = 347 (35), 346 (26), 345 [M]
+
 (100), 303 (18), 267 (13), 172 (12), 120 (10). 
HRMS (EI): Calculated for C21H16N3Cl [M]
+
 345.10273 found 345.10249. 
11,13-Dimethyl-3-propylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32j): 
Yellow solid, mp. 106 - 108 °C. 
1
H NMR (300 MHz, Chloroform-d) δ = 9.89 (dd, 
3
J = 8.5 Hz, 
4
J = 1.2 Hz, 1H, CHAr), 8.12 (dd, 
3
J = 8.2 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.86 
(s, 1H, CHAr), 7.76 (d, 
3
J = 8.1 Hz, 1H, CHAr), 7.50 (ddd, 
3
J = 8.6 Hz, 
3
J = 7.2 Hz, 
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4
J = 1.5 Hz, 1H, CHAr), 7.30 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.2 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 7.20 (dd, 
3
J = 8.2 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 6.75 (s, 1H, CHAr), 
2.84 (s, 3H, CH3-pyrimidine), 2.76 - 2.64 (m, 5H, 
CH2-aliphatic and CH3-pyrimidine), 1.74 (h, 
3
J = 7.3 Hz, 2H, 
CH2-aliphatic), 1.02 (t, 
3
J = 7.3 Hz, 3H, CH3-nPr). 
13
C NMR (75 MHz, CDCl3) δ = 159.0 
(CAr), 158.5 (CAr), 150.0 (CAr), 143.3 (CAr), 134.8 (CAr), 134.1 (CAr), 128.9 (CHAr), 
128.8 (CHAr), 127.2 (CAr), 124.2 (CHAr), 123.9 (CHAr), 122.9 (CHAr), 122.8 (CAr), 122.2 
(CHAr), 121.6 (CAr), 119.5 (CHAr), 116.4 (CAr), 90.4 (CHAr), 38.5 (CH2-aliphatic), 26.3 
(CH3), 24.6 (CH2-aliphatic), 21.7 (CH3), 14.0 (CH3). IR (ATR, cm
-1
): ṽ = 2956 (w), 2926 
(m), 2869 (w), 1586 (m), 1444 (m), 1385 (m), 1289 (m), 944 (m), 816 (m), 752 (s), 504 
(m). MS (EI, 70 eV): m/z (%) = 340 (25), 339 [M]
+
 (100), 311 (16), 310 (69), 267 (10), 
253 (6). HRMS (ESI): Calculated for C23H21N3 [M+H]
+
 340.18082 found 34018071. 
6,11,13-Trimethyl-3-propylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32k): 
White solid, mp. 163 - 164 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 9.70 (d, 3J = 8.6 Hz, 1H, CHAr), 7.87 
(s, 1H, CHAr), 7.83 (s, 1H, CHAr), 7.75 (d, 
3
J = 8.1 Hz, 
1H, CHAr), 7.26 (ddd, 
3
J = 8.6 Hz, 
4
J = 2.0 Hz, 
5
J = 0.8 Hz, 1H, CHAr), 7.18 (dd, 
3
J = 8.1 Hz, 
4
J = 1.6 Hz, 1H, CHAr), 6.73 (s, 1H, CHpyrrole), 2.84 (s, 
3H, CH3-pyrimidine), 2.72 - 2.67 (m, 5H, CH2-aliphatic and CH3-pyrimidine), 2.45 (s, 3H, CH3), 
1.74 (h, 
3
J = 7.3 Hz, 2H, CH2-aliphatic), 1.03 (t, 
3
J = 7.3 Hz, 3H, CH3). 
13
C NMR 
(75 MHz, CDCl3) δ = 158.7 (CAr), 158.4 (CAr), 149.7 (CAr), 143.2 (CAr), 134.0 (CAr), 
133.5 (CAr), 132.6 (CAr), 129.7 (CHAr), 128.6 (CHAr), 127.2 (CAr), 123.9 (CHAr), 123.1 
(CHAr), 122.9 (CAr), 122.1 (CHAr), 121.4 (CAr), 119.3 (CHAr), 116.3 (CAr), 90.1 (CHAr), 
38.5 (CH2-aliphatic), 26.3 (CH3), 24.7 (CH2-aliphatic), 21.6 (CH3), 21.5 (CH3), 14.0 (CH3). 
IR (ATR, cm
-1
): ṽ = 3086 (w), 3028 (w), 2954 (m), 2920 (m), 2864 (m), 1582 (m), 1552 
(m), 1440 (m), 1360 (m), 1287 (m), 1251 (m), 943 (m), 818 (s), 770 (m), 734 (s), 722 
(m), 548 (m). MS (EI, 70 eV): m/z (%) = 354 (26), 353 [M]
+ 
(100), 325 (14), 324 (56), 
267 (8), 133 (5). HRMS (EI): Calculated for C24H23N3 [M+H]
+
 354.19647 found 
354.19654. 
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3-Methoxy-11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32l): 
Yellow solid, mp. 192 - 193 °C. 
1
H NMR (250 MHz, 
Chloroform-d) δ = 9.80 (dd, 3J = 8.5 Hz, 4J = 1.2 Hz, 
1H, CHAr), 7.93 (dd, 
3
J = 8.2 Hz, 
4
J = 1.5 Hz, 1H, 
CHAr), 7.60 (d, 
3
J = 8.8 Hz, 1H, CHAr), 7.46 (ddd, 
3
J = 8.6 Hz, 
3
J = 7.2 Hz, 
4
J = 1.5 Hz, 1H, CHAr), 7.33 
(d, 
4
J = 2.4 Hz, 1H, CHAr), 7.24 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.2 Hz, 
4
J = 1.3 Hz, 1H, CHAr), 
6.85 (dd, 
3
J = 8.8 Hz, 
4
J = 2.4 Hz, 1H, CHAr), 6.49 (s, 1H, CHpyrrole), 3.88 (s, 3H, 
OCH3), 2.82 (s, 3H, CH3-pyrimidine), 2.65 (s, 3H, CH3-pyrimidine). 
13
C NMR (63 MHz, 
CDCl3) δ = 159.9 (CAr), 158.5 (CAr), 157.9 (CAr), 149.8 (CAr), 134.9 (CAr), 133.9 (CAr), 
129.1 (CHAr), 128.6 (CAr), 125.5 (CHAr), 124.0 (CHAr), 122.9 (CHAr), 121.2 (CAr), 119.5 
(CHAr), 118.3 (CAr), 116.4 (CAr), 115.9 (CHAr), 105.7 (CHAr), 89.3 (CHAr), 55.4 
(OCH3), 26.2 (CH3-pyrimidine), 21.6 (CH3-pyrimidine). IR (ATR, cm
-1
): ṽ = 3398 (w), 3121 
(w), 3073 (w), 3031 (w), 3005 (w), 2917 (w), 2837 (w), 2173 (w), 1614 (m), 1489 (m), 
1451 (m), 1386 (m), 1280 (m), 1219 (m), 1148 (m), 1033 (m), 940 (m), 837 (m), 749 
(m), 719 (s), 637 (m), 501 (m). MS (EI, 70 eV): m/z (%) = 328 (24), 327 [M]
+
 (100), 
312 (14), 284 (22), 242 (10). HRMS (ESI): Calculated for C21H17N3O 328.14444 found 
328.14425. 
 6-Isopropyl-3-methoxy-11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]-
phenanthridine (32m): Pale yellow solid, 
mp. 207 - 208 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 9.69 (d, 3J = 8.8 Hz, 1H, CHAr), 7.75 (s, 1H, 
CHAr), 7.57 (dd, 
3
J = 9.5 Hz, 
3
J = 3.9 Hz, 1H, CHAr), 
7.33 (dd, 
3
J = 7.0 Hz, 
4
J = 2.0 Hz, 2H, CHAr), 
6.86 - 6.73 (m, 1H, CHAr), 6.45 (d, 
4
J = 2.0 Hz, 1H, 
CHAr), 3.82 (s, 3H, OCH3), 2.96 (p, 
3
J = 6.9 Hz, 1H, CHiPr), 2.75 (s, 3H, CH3-pyrimidine), 
2.57 (s, 3H, CH3-pyrimidine), 1.29 (d, 
3
J = 6.9 Hz, 6H, CH3-iPr). 
13
C NMR (63 MHz, 
CDCl3) δ = 159.8 (CAr), 158.5 (CAr), 157.9 (CAr), 149.7 (CAr), 144.3 (CAr), 133.9 (CAr), 
133.1 (CAr), 128.9 (CAr), 127.4 (CHAr), 125.5 (CHAr), 121.1 (CAr), 120.6 (CHAr), 119.5 
(CHAr), 118.5 (CAr), 116.3 (CAr), 115.4 (CHAr), 105.9 (CHAr), 89.1 (CHAr), 55.5 
(OCH3), 34.1 (CHi-Pr), 26.3(CH3-pyrimidine), 24.2 (2CH3-iPr), 21.6 (CH3-pyrimidine). 
IR (ATR, cm
-1
): ṽ =  3084 (w), 3004 (w), 2960 (m), 2924 (w), 2834 (w), 2182 (w), 1614 
(m), 1586 (m), 1556 (m), 1492 (m), 1429 (m), 1390 (m), 1278 (m), 1224 (s), 1035 (m), 
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936 (m), 835 (m), 736 (m), 718 (s), 638 (m), 578 (m). MS (EI, 70 eV): m/z (%) = 370 
(27), 369 [M]
+
 (100), 354 (37), 311 (11), 177 (7). HRMS (ESI): Calculated for 
C24H23N3O [M+H]
+
 370.19139 found 370.19112. 
3-Fluoro-11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine (32n): 
Yellow solid, mp. 233 - 234 °C. 
1
H NMR (300 MHz, 
Chloroform-d) δ = 9.90 (dd, 3J = 8.6 Hz, 4J = 1.2 Hz, 1H, 
CHAr), 7.97 (dd, 
3
J = 8.1 Hz, 
3
J = 1.5 Hz, 1H, CHAr), 7.83 
(dd, 
3
J = 8.8 Hz, 
3
J = 5.6 Hz, 1H, CHAr), 7.68 (dd, 
3
J = 10.6 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 7.55 (ddd, 
3
J = 8.6 Hz, 
3
J = 7.2 Hz, 
3
J = 1.5 Hz, 1H, CHAr), 7.32 (ddd, 
3
J = 8.3 Hz, 
3
J = 7.2 Hz, 
3
J = 1.2 Hz, 1H, CHAr), 7.10 (ddd, 
3
J = 8.8 Hz, 
3
J = 7.9 Hz, 
4
J = 2.5 Hz, 1H, CHAr), 6.75 
(s, 1H, CHpyrrole), 2.88 (s, 3H, CH3-pyrimidine), 2.75 (s, 3H, CH3-pyrimidine). 
19
F NMR 
(282 MHz, CDCl3) δ = -111.0. 
13
C NMR (75 MHz, CDCl3) δ = 163.1 (d, 
1
JCF = 248.1 Hz, CFAr), 159.2 (CAr), 158.7 (CAr), 150.0 (CAr), 134.9 (CAr), 133.3 (CAr), 
129.9 (CHAr), 129.6 (d, 
3
JCF = 8.3 Hz, CAr), 126.2 (d, 
3
JCF = 8.8 Hz, CHAr), 124.5 
(CHAr), 123.3 (CHAr), 121.4 (d, 
4
JCF = 2.5 Hz, CAr), 120.7 (d, 
4
JCF = 3.0 Hz, CAr), 119.6 
(CHAr), 116.3 (CAr), 116.3 (d, 
2
JCF = 23.3 Hz, CHAr), 108.82 (d, 
2
JCF = 23.4 Hz, CHAr), 
90.9 (d, 
5
JCF = 1.8 Hz, CHAr), 26.2 (CH3-pyrimidine), 21.6 (CH3-pyrimidine). IR (ATR, cm
-1
): 
ṽ = 3063 (w), 2992 (w), 2918 (w), 1555 (m), 1452 (m), 1276 (m), 1197 (m), 898 (m), 
822 (m), 751 (s), 603 (m), 507 (m). MS (EI, 70 eV): m/z (%) = 316 (23), 315 (100), 274 
(14), 273 (37), 271 (11), 42 (15). HRMS (ESI): Calculated for C20H14FN3 [M+H]
+
 
316.12445 found 316.12459. 
3-(tert-Butyl)-6,11,13-trimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]phenanthridine 
(32o): Pale yellow solid, mp. 255 – 256 °C. 1H NMR 
(250 MHz, Chloroform-d) δ = 9.87 (d, 3J = 8.6 Hz, 1H, 
CHAr), 8.21 (d, 
4
J = 1.8 Hz, 1H, CHAr), 8.03 (d, 
4
J = 1.4 Hz, 1H, CHAr), 7.97 (d, 
3
J = 8.4 Hz, 1H, CHAr), 
7.55 (dd, 
3
J = 8.4 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 7.37 
(ddd, 
3
J = 8.6 Hz, 
4
J = 2.0 Hz, 
5
J = 0.7 Hz, 1H, CHAr), 
6.96 (s, 1H, CHpyrrole), 2.89 (s, 3H, CH3-aliphatic), 2.80 (s, 3H, CH3-aliphatic), 2.53 (s, 3H, 
CH3-aliphatic), 1.48 (s, 9H, CH3-tBu). 
13
C NMR (63 MHz, CDCl3) δ = 158.8 (CAr), 158.5 
(CAr), 151.9 (CAr), 149.9 (CAr), 134.3 (CAr), 133.8 (CAr), 132.8 (CAr), 130.0 (CHAr), 
127.1 (CAr), 126.1 (CHAr), 124.1 (CHAr), 123.2 (CHAr), 122.8 (CAr), 121.9 (CAr), 119.5 
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(CHAr), 119.0 (CHAr), 116.5 (CAr), 90.5 (CHAr), 35.4 (CtBu), 31.5 (3CH3-tBu), 26.3 
(CH3-aliphatic), 21.7 (CH3-aliphatic), 21.6 (CH3-aliphatic). IR (ATR, cm
-1
): ṽ = 2951 (m), 2915 
(m), 2862 (m), 2166 (m), 1583 (m), 1489 (m), 1429 (m), 1357 (m), 1182 (m), 945 (m), 
820 (m), 722 (s), 638 (m), 551 (m). MS (EI, 70 eV): m/z (%) = 368 (27), 367 (100), 353 
(16), 352 (59), 337 (18), 162 (11). HRMS (ESI): Calculated for C25H25N3 [M+H]
+
 
368.21212 found 368.21201. 
3-(tert-Butyl)-6-fluoro-11,13-dimethylpyrimido[5',4':4,5]pyrrolo[1,2-f]-
phenanthridine (32p): Pale yellow solid, 
mp. 226 - 228 °C. 
1
H NMR (250 MHz, Chloroform-d) 
δ = 9.92 (dd, 3J = 9.3 Hz, 3J = 5.5 Hz, 1H, CHAr), 8.03 
(d, 
4
J = 1.8 Hz, 1H, CHAr), 7.91 (d, 
3
J = 8.4 Hz, 1H, 
CHAr), 7.82 (dd, 
3
J = 10.4 Hz, 
4
J = 2.9 Hz, 1H, CHAr), 
7.57 (dd, 
3
J = 8.4 Hz, 
4
J = 1.8 Hz, 1H, CHAr), 7.20 
(ddd, 
3
J = 9.3 Hz, 
3
J = 7.5 Hz, 
4
J = 2.8 Hz, 1H, CHAr), 6.88 (s, 1H, CHpyrrole), 2.86 (s, 
3H, CH3-pyrimidine), 2.78 (s, 3H, CH3-pyrimidine), 1.47 (s, 9H, 3CH3-tBu). 
19
F NMR 
(235 MHz, CDCl3) δ = -117.3 (FCAr). 
13
C NMR (63 MHz, CDCl3) δ = 159.5 (d, 
1
JCF = 243.0 Hz, CFAr), 159.1 (CAr), 158.7 (CAr), 152.1 (CAr), 149.7 (CAr), 133.9 (CAr), 
131.20 (d, 
4
JCF = 2.2 Hz, CAr), 126.9 (CHAr), 126.14 (d, 
4
JCF = 2.4 Hz, CAr), 124.1 (d, 
3
JCF = 7.6 Hz, CAr), 124.0 (CHAr), 122.9 (CAr), 121.4 (d, 
3
JCF = 7.8 Hz, CAr), 119.2 
(CHAr), 116.3 (CAr), 115.9 (d, 
2
JCF = 22.7 Hz, CHAr), 109.1 (d, 
2
JCF = 24.0 Hz, CHAr), 
90.7 (CHAr), 35.4 (CtBu), 31.4 (3CH3-tBu), 26.2 (CH3-pyrimidine), 21.7 (CH3-pyrimidine). 
IR (ATR, cm
-1
): ṽ = 3096 (w), 2965 (m), 2868 (m), 2184 (m), 1582 (m), 1562 (m), 1496 
(m), 1437 (m), 1389 (m), 1278 (m), 1177 (m), 931 (m), 850 (m), 871 (s), 772 (m), 733 
(m), 574 (m). MS (EI, 70 eV): m/z (%) = 372 (30), 371 (100), 357 (21), 356 (72), 341 
(21), 328 (10), 164 (16). HRMS (ESI): Calculated for C24H22FN3 [M+H]
+
 372.18705 
found 372.18693. 
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5.3. Crystallographic data 
5.3.1. 2-(4-Methoxyphenyl)-1-phenyl-1H-pyrrolo[3,2-b]pyridine (3c) 
 
Chemical formular C20H16N2O 
Mr 320.35 
Crystal system, space group Triclinic, P
1
 
Temperature (K) 173 
a, b, c (Å) 8.5374 (2), 10.3276 (2), 18.5918 (3) 
α, β, γ (°) 74.951 (1), 77.508 (1), 84.490 (1) 
V (Å
3
) 1544.18 (5) 
Z 4 
Radiation type Mo Kα 
µ (mm
−1
) 0.08 
Crystal size (mm) 0.29 × 0.28 × 0.25 
  
Data collection  
Diffractometer Bruker-Nonius Apex X8-CCD-diffractometer 
Absorption correction Multi-scan (SADABS; Sheldrick, 2004) 
Tmin, Tmax 0.718, 0.746 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
53379, 11167, 8411 
Rint 0.031 
(sin θ/λ)max (Å
−1
) 0.756 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.053, 0.128, 1.05 
No. of reflections 11167 
No. of parameters 417 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.30, -0.25 
* Computer programs: Bruker Apex V7.51A, Bruker SAINT, SHELXS2013 (Sheldrick, 2013), SHELXL2013 (Sheldrick, 2013), 
ORTEP-3.2.01 (Farrugia, 1997), SHELXL2013. 
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5.3.2. 1-(4-Methoxyphenyl)-2-phenyl-1H-pyrrolo[2,3-b]pyridine (4g) 
 
Chemical formular C20H16N2O 
Mr 300.35 
Crystal system, space group Monoclinic, P21  
Temperature (K) 173 
a, b, c (Å) 5.9896 (1), 11.3423 (2), 11.1347 (2) 
α, β, γ (°) 96.311 (1) 
V (Å
3
) 751.86 (2) 
Z 2 
Radiation type Mo Kα 
µ (mm
−1
) 0.08 
Crystal size (mm) 0.43 × 0.29 × 0.07 
  
Data collection  
Diffractometer Bruker-Nonius Apex X8-CCD-diffractometer 
Absorption correction Multi-scan (SADABS; Sheldrick, 2004) 
Tmin, Tmax 0.723, 0.746 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
14227, 5379, 4806 
Rint 0.023 
(sin θ/λ)max (Å
−1
) 0.756 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.046, 0.110, 1.06 
No. of reflections 5379 
No. of parameters 209 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.30, -0.28 
* Computer programs: Bruker Apex V7.51A, Bruker SAINT, SHELXS2013 (Sheldrick, 2013), SHELXL2013 (Sheldrick, 2013), 
ORTEP-3.2.01 (Farrugia, 1997), SHELXL2013. 
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5.3.3. 2-(Naphthalen-2-yl)-1-phenyl-1H-pyrrolo[2,3-b]pyridine (4n) 
 
Chemical formular C23H16N2 
Mr 320.38 
Crystal system, space group Monoclinic, P21/c 
Temperature (K) 173 
a, b, c (Å) 8.9404 (3), 19.2009 (5), 9.6620 (3) 
α, β, γ (°) 92.373 (1) 
V (Å
3
) 1657.19 (9) 
Z 4 
Radiation type Mo Kα 
µ (mm
−1
) 0.08 
Crystal size (mm) 0.53 × 0.22 × 0.11 
  
Data collection  
Diffractometer Bruker-Nonius Apex X8-CCD-diffractometer 
Absorption correction Multi-scan (SADABS; Sheldrick, 2004) 
Tmin, Tmax 0.713, 0.746 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
26989, 4828, 3789 
Rint 0.031 
(sin θ/λ)max (Å
−1
) 0.703 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.051, 0.133, 1.07 
No. of reflections 4828 
No. of parameters 226 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.29, -0.24 
* Computer programs: Bruker Apex V7.51A, Bruker SAINT, SHELXS2013 (Sheldrick, 2013), SHELXL2013 (Sheldrick, 2013), 
ORTEP-3.2.01 (Farrugia, 1997), SHELXL2013. 
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5.3.4. 1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrolo[3,2-
c]quinoline (7f) 
 
Chemical formular C25H17F3N2O 
Mr 418.13 
Crystal system, space group Triclinic, P  
Temperature (K) 150 
a, b, c (Å) 10.5714 (2), 11.3891 (2), 12.0542 (2) 
α, β, γ (°) 62.4386 (5), 82.6061 (6), 68.6034 (5) 
V (Å
3
) 1196.52 (4) 
Z 2 
Radiation type Mo Kα 
µ (mm
−1
) 0.43 
Crystal size (mm) 0.43 × 0.30 × 0.26 
  
Data collection  
Diffractometer Bruker APEX-II CCD diffractometer 
Absorption correction Multi-scan SADABS (Bruker, 2014) 
Tmin, Tmax 0.85, 0.90 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
35088, 6370, 5619 
Rint 0.018 
(sin θ/λ)max (Å
−1
) 0.682 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.035, 0.096, 1.06 
No. of reflections 6370 
No. of parameters 317 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.49, -0.34 
* Computer programs: APEX2 (Bruker, 2014), SAINT (Bruker, 2013), SAINT, SHELXS97 (Sheldrick, 2008), SHELXL2014/7 
(Sheldrick, 2015). 
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5.3.5. 11-(4-Methoxyphenyl)-6-methyl-11H-indolo[3,2-c]quinoline (11g) 
 
Chemical formular C23H18N2O 
Mr 338.39 
Crystal system, space group Triclinic, P  
Temperature (K) 150 
a, b, c (Å) 11.9183 (2), 14.2302 (3), 16.0093 (3) 
α, β, γ (°) 99.1242 (8), 93.7878 (8), 101.7422 (8) 
V (Å
3
) 2611.10 (9) 
Z 6 
Radiation type Mo Kα 
µ (mm
−1
) 0.08 
Crystal size (mm) 0.42 × 0.37 × 0.30 
  
Data collection  
Diffractometer Bruker APEX-II CCD diffractometer 
Absorption correction Multi-scan SADABS (Bruker, 2014) 
Tmin, Tmax 0.93, 0.98 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
70195, 10264, 8228 
Rint 0.027 
(sin θ/λ)max (Å
−1
) 0.617 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.047, 0.133, 1.02 
No. of reflections 10264 
No. of parameters 709 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.74, -0.29 
* Computer programs: APEX2 (Bruker, 2014), SAINT (Bruker, 2013), SAINT, SHELXS97 (Sheldrick, 2008), SHELXL2014/7 
(Sheldrick, 2015).. 
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5.3.6. 6-Fluoro-3-methylbenzo[4',5']thieno[2',3':4,5]pyrrolo[1,2-f]phenanthridine 
(24h) 
 
Chemical formular C23H14FNS 
Mr 355.41 
Crystal system, space group Orthorhombic, P212121  
Temperature (K) 123 
a, b, c (Å) 3.8697 (3), 13.8753 (13), 29.542 (3) 
V (Å
3
) 1586.2 (2) 
Z 4 
Radiation type Mo Kα 
µ (mm
−1
) 0.22 
Crystal size (mm) 0.49 × 0.03 × 0.02 
  
Data collection  
Diffractometer Bruker-Nonius Apex X8-CCD-diffractometer 
Absorption correction Multi-scan (SADABS; Sheldrick, 2004) 
Tmin, Tmax 0.625, 0.745 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
8022, 2778, 2160 
Rint 0.086 
(sin θ/λ)max (Å
−1
) 0.594 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.048, 0.098, 1.03 
No. of reflections 2278 
No. of parameters 237 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.25, -0.28 
* Computer programs: Bruker Apex V7.51A, Bruker SAINT, SHELXS2013 (Sheldrick, 2013), SHELXL2013 (Sheldrick, 2013), 
ORTEP-3.2.01 (Farrugia, 1997), SHELXL2013. 
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5.3.7. 10-Methoxy-6,13-dimethylquinolino[3',4':4,5]pyrrolo[1,2-f]phenanthridine 
(28l) 
 
Chemical formular C26H20N2O 
Mr 376.15 
Crystal system, space group Triclinic, P
1
 
Temperature (K) 150 
a, b, c (Å) 7.2427 (2), 10.3539 (2), 15.8131 (3) 
α, β, γ (°) 90.3390 (7), 102.6184 (7), 96.4918 (7) 
V (Å
3
) 1149.19 (4) 
Z 2 
Radiation type Mo Kα 
µ (mm
−1
) 0.42 
Crystal size (mm) 0.43 × 0.17 × 0.16 
  
Data collection  
Diffractometer Bruker APEX-II CCD diffractometer 
Absorption correction Multi-scan SADABS (Bruker, 2014) 
Tmin, Tmax 0.94, 0.99 
No. of measured, independent  
and observed [I > 2σ(I)] 
reflections 
24568, 5298, 4567 
Rint 0.018 
(sin θ/λ)max (Å
−1
) 0.650 
  
Refinement  
R[F
2
 > 2σ(F2)], wR(F2), S 0.044, 0.123, 1.05 
No. of reflections 5298 
No. of parameters 301 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.87, -0.53 
* Computer programs: APEX2 (Bruker, 2014), SAINT (Bruker, 2013), SAINT, SHELXS97 (Sheldrick, 2008), SHELXL2014/7 
(Sheldrick, 2015).. 
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